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Abstract 
 
In Spain, two smoke-free laws have been passed after the approval of the FCTC. In 2005, it 
came into effect a smoke-free legislation (Law 28/2005). This law was a great advance for 
public health in Spain; however, it was not complete in terms of health protection to 
secondhand smoke (SHS) exposure because it allowed smoking in hospitality sectors according 
to size of venues. The scientific evaluation of this law showed the need to promote a total ban 
and motivate the modification of the law in 2010 (Law 42/2010), extending the smoke-free 
regulation to all hospitality venues without exception and to some outdoors areas, including 
hospital premises, educational campuses, and playgrounds.  
 
The objectives of this doctoral thesis were: To assess the impact of the Spanish smoking 
legislations (Law 28/2005 and Law 42/2010) on tobacco epidemic (changes in consumption, 
dependence, motivation to quit and smoking cessation) among smokers of a general 
population cohort through self-reported information and biomarkers. To evaluate the impact 
of the Spanish tobacco control legislation on exposure to environmental tobacco smoke (self-
reported and according to levels of cotinine in saliva) on non-smokers in a cohort population. 
To analyze the changes in the pattern of passive smoking of the non-smokers (displacement of 
exposure at workplace and leisure time to home) according to age, sex, and socioeconomic 
level. To analyze the correlation between the implementation of tobacco control policies and 
tobacco consumption, particularly rolling tobacco, electronic cigarettes (e-cigarettes) users 
and the intent to quit smoking in 27 countries of the European Union. To describe the 
acceptability of the recently implemented tobacco products regulations and to explore their 
relation with tobacco control legislation levels in Europe. 
 XII 
 
The results of this doctoral thesis has been conducted through seven scientific articles, four of 
them published in journals indexed in Web of Science and three of them in peer review in 
journals indexed in Web of Science (please see the Section Scientific Articles of this thesis). 
Moreover, during my training in this doctoral thesis I got involved in other two articles one 
published and the other in peer review, both in journals indexed in Web of Science.  
 
In conclusion, the implementation of the two smoke-free legislations in Spain is related to a 
reduction in smoking prevalence and SHS exposure (either using salivary cotinine 
concentrations or information on self-reported exposure). However, the consumption of other 
tobacco products, particularly hand-rolled tobacco, has increased specially among young 
population. A significant increase was found in the salivary cotinine concentration among adult 
continuing smokers after both Spanish legislations. After the implementation of the two 
Spanish smoke-free bans, the main setting of SHS is in the leisure time and in work, where 
most of the exposed ones declared expending most of the time outdoor and not having 
specific areas for smokers. However, cotinine concentrations in non-smokers were significantly 
higher only among those declaring exposure to SHS at home after both legislations. The 
implementation of the two smoke-free legislations in Spain is related to an increasing of 
voluntary adoption of smoke-free homes (SFH) rules, in particular with an increase in complete 
SFH rules. In addition, we observed an association between complete indoor SFH adoption and 
the perceived risk of SHS exposure. In addition, great support for the studied tobacco products 
regulations was found which were positively related with European tobacco control levels of 
implementation at both ecological and individual levels.  
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1.1 Active and passive smoking: a known 
health risk 
 
Tobacco is one of the biggest threats to the public health the world has ever faced, yet it 
continues to be the single leading cause of preventable death in the world and the second risk 
factor of death globally (1). In this sense, the Institute for Health Metrics estimated that about 
18% of worldwide population smoked in 2012 causing 11.5% of the global deaths in 2015 
attributable to active smoking and 1.6% to passive smoking (1). In Spain, the latest data 
reported showed that 23.6% of Spanish population were tobacco users (2012) (2), causing 
60,456 deaths attributable to active smoking (2). 
 
Moreover, active smoking has been causally linked to diseases of nearly all organs of the body, 
being related to more than 25 diseases and being responsible for 30% of all cancers, 
respiratory diseases and cardiovascular diseases (3). Cancers that are considered by the 
International Agency for Research on Cancer (IARC) to be causally related to active smoking 
are lung, oral cavity, nasal cavity and paranasal sinuses, nasopharynx, oropharynx, 
hypopharynx, larynx, oesophagus (adenocarcinoma and squamous cell carcinoma), upper 
aerodigestive tract combined, stomach, pancreas, liver, kidney (body and pelvis), ureter, 
urinary bladder, cervix and myeloid leukaemia (4). A recent meta-analysis shows that smoking 
is also associated with head, neck, higher colorectal gastric and breast cancer (5). Furthermore, 
smoking during pregnancy is associated with placental abruption, placenta previa, premature 
rupture of membranes, premature birth, spontaneous miscarriage, ectopic pregnancy and 
harmful effects on fetuses, infants and children such as stunted gestational development, 
stillbirth, sudden infant death syndrome, reduced lung function and impaired lung 
development, asthma and bronchitis exacerbation, acute lower respiratory infection, 
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respiratory irritation, childhood cancers, orofacial cleft, possible increased risk of allergic 
diseases and possible increased risk of learning disability and attention deficit (6).  
 
Taking into account the harmful effects associated with active smoking, it is important to try to 
define the tobacco epidemic in order to be able to control it. For this, a four stage descriptive 
model (7) is commonly used allowing us to categorize a given country into a specific stage of a 
defined process. According to this model, the beginning of the epidemic in a given population 
would be defined as the first stage in which the prevalence of smoking in men is relatively low 
(<15%), whereas in women it will rarely exceed 10% and may be less than 5% in many cases. 
Death and illnesses caused by tobacco use are not yet evident. This first stage may be 
relatively rapid, in one or two decades. During the second stage, which can last between two 
to three decades, the prevalence of tobacco use in men continues to increase rapidly, reaching 
a maximum of 50-80%. This prevalence in women, which normally follows the pattern of that 
of men with a time span of one to two decades, also increases rapidly. At this stage the 
proportion of former smokers is still relatively low. At the end of this stage tobacco 
consumption causes about 10% of deaths in men but relatively few in women. The third stage 
is characterized by a decrease in the prevalence of consumption in men, quite possibly after 
exceeding 60% for an extended period, to about 40% at the end of this stage, which can last 
for three decades or more. The prevalence of tobacco use tends to be lower in middle or 
advanced age men, many of whom have become former smokers. The end of this stage is 
characterized by the beginning of the decrease in women prevalence, in whom the maximum 
reached generally is considered inferior to the one of the men. But the main characteristic of 
this stage is the rapid increase in mortality attributable to tobacco, which in the case of men 
reaches 25-30%, but in the case of women still does not exceed 5%. Finally, in the fourth stage, 
prevalence in both sexes continues to decrease, reaching in women around 30% and 33-35% in 
men. The increase in mortality reaches its maximum in men, possibly between 30-35%, while 
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in women it continues to rise to reach its maximum of 20-25%. Finally, the mortality 
attributable to tobacco in both sexes will decrease progressively. 
 
Data of 2009 about tobacco epidemic worldwide stages (8) suggested that, among men, trends 
in smoking prevalence and in the proportion of all smoking attributed deaths at ages 35-69 had 
generally been stable or decreasing in developed countries. This smoking-attributed 
proportion is not yet decreasing much in Spain, Portugal, Greece, Bulgaria, Romania, Hungary, 
Norway and Japan; and the most extreme decreases are in Finland (from 38% in 1970 to 15% 
in 2009) and United Kingdom (UK) (from 47% in 1970 to 22% in 2009). Among women, in many 
developed countries smoking prevalence also decreased, although more slowly than in men. 
Nonetheless, the female proportion of all smoking attributed deaths at ages 35-69 had not yet 
decreased much in any developed country, and in some it continues to increase rapidly. This 
smoking-attributed proportion is currently higher (26% to 30%) in The Netherlands, Denmark, 
Hungary and Canada; and is also high (18% to 20%) in the United States of America (USA), UK, 
Norway, Sweden, Poland and New Zealand. Regarding Spain, the Institute for Health Metrics 
(1) estimated the age-standardizes smoking prevalence between 1980 and 2012 and the 
smoking attributed deaths prevalence between 1990 and 2016 (1). According to these trends, 
smoking prevalence has clearly decreased among men, in which smoking attributed deaths 
prevalence begins to decrease in the last decades. However, smoking prevalence among 
women reminds more stable, showing a slightly increase in smoking attributed deaths 
prevalence. 
 
Moreover, tobacco smoke is also known to be harmful for non-smokers. During the 1970s, a 
growing body of evidence about the dangers of environmental tobacco smoke (ETS), or 
secondhand smoke (SHS), made evident that tobacco smoke can harm non-smokers who 
inhale it passively (9). The smoke that cigarette smokers draw into their lungs is "mainstream" 
1. INTRODUCTION 
6 
 
smoke, while the smoke that comes off the burning tip of a cigarette is "sidestream" smoke 
which actually contains higher concentrations of many toxic chemicals than mainstream smoke 
(10), because sidestream smoke is not filtered and because cigarettes burn at a lower 
temperature when they are smoldering, leading to a less complete, dirtier combustion. The air 
pollution resulting from sidestream and extracted mainstream smoke is called SHS or ETS, and 
people who breathe this smoke are known as passive smokers or involuntary smokers. 
 
Furthermore, SHS exposure has been classified as a type I carcinogen by the International 
Agency for Research on Cancer (11) and has been associated with larynx, pharynx (4) and lung 
cancer, coronary artery disease, stroke, reproductive effects in women, nasal irritation and 
harmful effects on children such as sudden infant death syndrome, low birth weight, impaired 
lung function, lower respiratory illness, respiratory symptoms and middle ear disease (6).  
According to the Tobacco Atlas, globally, about 40% of children and a third of non-smoking 
adults were exposed to SHS in 2004 (12). What is more, SHS exposure is responsible of 1% of 
the global mortality (more than 600.000 deaths) (13) and 1,028 to passive smoking at home 
and work (2011) (14). 
 
 
1.2 Monitoring the tobacco epidemic 
 
High-quality representative data are needed in order to regularly have available updated 
information about the extent of the epidemic in a country. In this sense, the monitoring of the 
tobacco epidemic informs the leaders of governments and civil society about the tobacco 
epidemic damages on their countries, and helps them allocate tobacco control resources 
where they are most needed and will be most effective (15). At present, more than a quarter 
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of countries, with 40% of the world’s population, regularly monitor tobacco use among adults 
and youth using nationally representative surveys (16). This highlights the need to urge other 
countries to implement regular monitoring programs of tobacco epidemic and SHS exposure as 
WHO recommend (17).  
 
In general, monitoring and measurement of tobacco epidemic and SHS exposure can be 
performed by direct and indirect methods. Among the direct methods, environmental markers 
(e.g. airborne nicotine and benzene) (18,19) and/or human biomarkers such as cotinine in 
biological samples (the main ones being saliva, urine, plasma, and hair) (20,21) can be 
measured. Although direct methods are the most reliable to measure SHS exposure, indirect 
methods –such as questionnaires- are the most commonly used in the scientific literature 
(4,22) because they are low cost and simple to implement. 
 
Cotinine, the major proximate metabolite of nicotine, has been widely used as a biomarker of 
tobacco smoke absorption as a direct method (23). Cotinine concentration in biological fluids 
(blood, urine or oral fluid, widely referred to as saliva) (24) indicate tobacco exposure over the 
previous 1-2 days (25) and are strongly correlated with the number of cigarettes smoked daily 
(26). Furthermore, biomarkers allow to objectively ascertaining smoking status by consistent 
salivary concentration. For instance, when using salivary cotinine, a concentration inferior to 
10 ng/ml (27) would define a non-smoker and otherwise a smoker would be defined. By doing 
this, self-reported data can be validated potentially minimizing limitations related to survey 
based studies. 
 
Among indirect methods, questionnaires are the most commonly used method to measure the 
tobacco epidemic. According with WHO suggestions, such surveys should gather information 
on tobacco use prevalence and consumption levels by age group, sex, income and other 
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demographic subdivisions, carried out both nationally and by province or region (15). These 
surveys should also be repeated at regular intervals using the same questions, sampling, data 
analysis and reporting techniques. Only taking these requirements into account can 
comparable data across different survey periods be obtained to accurately monitor tobacco 
epidemic and additionally evaluate the impact of tobacco control interventions over time. 
Moreover, standardized questions about tobacco use can be embedded in existing population-
based surveys or censuses (28). 
 
 
1.3 Framework Convention on tobacco 
Control  
 
Whit the aim to protect present and future generations from the devastating health, social, 
environmental and economic consequences of tobacco consumption and exposure to tobacco 
smoke, the WHO Framework Convention on Tobacco Control (WHO FCTC) emerged (29). This 
international treaty was adopted by WHO member countries in 2003 and entered into force in 
2005, after it had been ratified, accepted, or approved by 40 States. International efforts led by 
WHO resulted in rapid entry into force of the WHO FTCT which in 2015 already covered about 
90% of the world’s population (6).  
 
The core suggestions of demand reduction in the WHO FCTC include price and tax measures to 
reduce the tobacco consumption, and non-price measures to reduce the demand for tobacco. 
Article 8 of the treaty also addresses SHS exposure as a health risk and identifies interventions, 
such as smoke-free bans, to protect citizens from its hazardous exposure. Fundamentally, the 
treaty requires parties to implement clear indoor air laws. Smoke-free legislations can be 
implemented in a variety of sectors and facilities to protect the population from the harmful 
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effects of SHS. Other measures included in the WHO FCTC are regulation of tobacco product 
disclosures; packaging and labelling of tobacco products; education, communication, training 
and public awareness; tobacco advertising, promotion and sponsorship; and demand 
reduction measures concerning tobacco dependence and cessation (30). Further suggestions 
refer to illicit trade in tobacco products sales to and by minors; and provision of support for 
economically viable alternative activities (30).  
 
With these suggestions, WHO FTCT provides the basis for countries to implement and manage 
tobacco control interventions. To help make this a reality, in 2008 WHO introduced the 
MPOWER measures which correspond to one or more articles of the Framework Convention 
that have been proven to reduce smoking prevalence, in order to assist in reducing the 
demand for tobacco products at country-level (17). MPOWER policy package requires 
implementation of proven tobacco policies and interventions, with a high level of coverage, 
gather information to target and refine their implementation, and rigorous monitoring to 
evaluate their impact (17).  
 
To implement MPOWER policy package, countries need to (17): Monitor tobacco use, in order 
to obtain nationally representative and population based periodic data on key indicators of 
tobacco use and tobacco policies and interventions impacts. Protect people from tobacco 
smoke by enacting and enforcing completely smoke-free environments in health-care and 
educational facilities and in all indoor public places including workplaces, bars and restaurants. 
Offer help to quit tobacco use, strengthening health systems so they can make tobacco 
cessation advice available as part of primary health care and supporting quit lines and other 
community initiatives in conjunction with easily accessible, low cost pharmacological 
treatment where appropriate. Warn about the dangers of tobacco through effective packaging 
warning labels Intervention, application of counter-tobacco advertising interventions and free 
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media coverage of anti-tobacco activities. Enforce bans on tobacco advertising and promotion 
by enacting and enforcing effective legislations that comprehensively ban any form of direct 
tobacco advertising, promotion and sponsorship Intervention and legislations that ban indirect 
tobacco advertising, promotion and sponsorship. Raise taxes on tobacco products and ensure 
that they are adjusted periodically to keep pace with inflation and rise faster than consumer 
purchasing power in addition to strengthen tax administration to reduce the illicit trade in 
tobacco products.  
 
 
1.4 Tobacco control measures  
 
In 2003, the World Bank proposed in the fact sheet tobacco control at a glance (31) the six 
most cost effective tobacco control interventions based in the evidenced. These measures are 
higher taxes on cigarettes and other tobacco products; bans/restrictions on smoking in public 
and workplaces (schools, health facilities, public transport, restaurants, cinemas, etc.); 
comprehensive bans on advertising and promotion of all tobacco products, logos and brand 
names; better consumer information (counter-advertising, media coverage, research findings, 
etc.); large, direct warning labels on cigarette boxes and other tobacco products; help for 
smokers who wish to quit, including increased access to nicotine replacement and other 
cessation therapies. Price increase has been proven to be the most effective and cost-effective 
intervention in reducing smoking consumption, however, the best results are achieved when a 
comprehensive set of measures are implemented (31). 
 
A few years later, in 2005, Joosseens and Raw proposed a scale to quantify the 
implementation of tobacco control policies nationwide in European countries, namely the 
Tobacco Control Scale 'TCS' (32) that takes values from 0 to 100. The TCS is based on the six 
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policies described by 'The World Bank'. These policies are punctuated in the TCS with the 
following values: increase in prices by raising taxes in cigarettes and other tobacco products, 
which takes values from 0 to 30; prohibitions and restrictions on smoking in public places and 
work environments, which takes values from 0 to 22; better consumer information through 
public information campaigns, media and publication of research findings, which takes values 
from 0 to 15; prohibitions on advertising and promotion of all tobacco products, which takes 
values from 0 to 13; large and direct health warning labels on tobacco packets and on all 
tobacco products, which takes values from 0 to 10, and finally, treatments to help dependent 
smokers quit smoking, including increased smoking access to medicines, which takes values 
from 0 to 10. Through the sum of the measurement of these policies the TCS is obtained. This 
scale makes it possible to quantify tobacco control policies in the different countries of the 
European Union and thus to be able to assess the impact of these policies (i.e. on tobacco 
consumption or exposure to SHS). 
 
 
1.5 Tobacco control measures in Spain 
 
Although in Spain the smoking consumption in public places was regulated since the end of the 
1980s through law 192/1988 (33), more than half of the places breached this law (34). It 
wasn’t until 2005 when it came into effect a more comprehensive legislation (Law 28/2005 
(35)). This law was a great advance for public health in Spain being a compendium of public 
health measures against smoking and including regulations on publicity, sale, supply, and 
consumption of tobacco products (35). The law provided that retail sales and supply of tobacco 
products may solely be made through tobacco and stamps outlet networks, or through 
vending machines that had received the relevant administrative authorizations. All other 
places or means were expressly banned. It were further prohibited to sell or deliver tobacco 
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products to minors, same as any other product simulating them and leading them smoke. The 
law also regulated the prohibition of free or promotional distribution of products, goods or 
services, or any other action which has the direct or indirect purpose or effect of promoting a 
tobacco product, same as any form of advertising, promotion and sponsorship of tobacco 
products in all media. Measures for the prevention of tobacco use were also incorporated in 
the law, fostering actions for health education and information and addressing the promotion 
of programs for overcoming tobacco addiction in the assistance network of the National 
Health System.  
 
Moreover, smoking was banned in all indoor workplaces, public places, public transport 
facilities including enclosed stations, hospitals and other health care facilities, schools and 
universities as well as in retail stores and shopping centres. However, hospitality venues were 
subject to only a partial ban. In bars and restaurants of less than 100 m2, the proprietor could 
choose between permitting or prohibiting smoking. Bars and restaurants larger than 100 m2 
were defined as smoke-free, but the law allowed the proprietor to provide a physically 
separated and independently ventilated smoking area comprising less than 30% of the total 
floor area. For this exception the Spanish smoking law was known as the “Spanish model” (36).  
 
The scientific evaluation of this law showed the need to promote a total ban (37-39) and 
motivate the modification of the law in 2010 (Law 42/2010 (40)), that extended the smoke-
free regulation to all hospitality venues (41) without exception and extended the ban to some 
outdoors areas, including hospital premises, educational campuses, and outdoor children’s 
playgrounds. However, designated smoking rooms were permitted in psychiatric services, 
nursing homes, prisons and up to 30% of hotel rooms. Smoking is also allowed in outdoors 
areas in universities and adult educational centers. However, this new regulation made the 
Spanish legislation as one of the most stringent smoke-free National laws in Europe (42). 
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The introduction of both tobacco control laws was a great advance indeed, however, there are 
still points to improve (43). 
  
Regarding help smokers to quit, although Law 28/2005 encouraged the development of 
various initiatives to quit smoking, the assistance intervention in smoking, especially in primary 
care, has been also included in various strategies, both state and by regions. However, its 
application continues to be deficient. Pharmacological treatment for cessation, despite having 
proved its efficacy, is not financed by the National Health System on a global basis, although 
there are experiences in some Spanish regions that have offered it in specific population 
groups or periods. 
 
Moreover, in Spain, two prevention campaigns have been coordinated, one in July 2006 with 
the motto "Thank you for not smoking" and another in April 2007 with the motto "This girl 
smokes a daily package", aimed at raising awareness among adults on the harmful effects of 
ETS on children's health. In addition, some Spanish regions developed their own campaigns. In 
the year 2009, Catalonia launched a media campaign with the slogan "Smoke is fatal" which 
has also widely disseminated a telephone service to help quit smoking (061). However, it is 
evident that the number of media actions has been much lower than the Law 28/2005 itself 
established.  
 
However, in the period from 2004 to 2013 have notably improved measures regulating the 
sale, supply and consumption of products, and their advertising, promotion and sponsorship. 
The direct and indirect advertising is limited, but tobacco industry dodges the restriction 
through covert advertising on television and the media writing. In relation to labeling, new 
actions have been proposed in the recent years, such as increasing the percentage of warnings 
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or implementing generic or neutral packaging. However, such proposals are still pending 
development.  
 
Finally, fiscal policies are among the most cost-effective smoking control interventions. 
However, only 10% of the world's population lives in countries with sufficiently high taxes, 
making it the least applied measure. In Spain, the government has strengthened regulations on 
tobacco taxes since 2005. The implementation of Law 28/2005 was followed by several tax 
reforms. However, it should be noted that these changes have mainly affected to 
manufactured cigarettes, while other types of tobacco products have been less affected by tax 
increases and becoming cheaper and more affordable alternatives for smokers.  
 
 
1.6 New challenges in tobacco control 
 
Tobacco control policies in Spain have made a great advance in the last 10 years. However, 
there are still some points to improve in order to end the tobacco epidemic and taking into 
account that policymakers must use existing strategies that have been proven effective in 
reducing tobacco prevalence, and must explore innovative tactics to achieve the endgame for 
tobacco use. As follows, some important challenges that future Spanish tobacco control 
legislations need to introduce are going to be detailed. 
 
Tobacco control policies, particularly increasing of prices, are generally focused on 
conventional cigarettes, whereas other tobacco products receive relatively little attention, 
increasing the gap between their prices. In Spain, several tax reforms have accompanied the 
implementation of more restrictive tobacco regulations, but they have been mainly applied to 
manufactured cigarettes not including other tobacco products as hand-rolled cigarette (also 
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known as roll your own cigarette or RYO). In recent years, the prices of these products have 
been remarkably different in Spain, with RYO costing about 50% less than manufactured 
cigarettes until 2009, when a small tax was introduced. In addition, there is a widespread 
belief of minimal hazardous RYO health effects even though it has been proven that it is not so 
(44). All this has led in Spain, as well as in other countries, to a shift in smoking pattern of 
consumption from manufactured to RYO cigarettes, especially among younger smokers (45). In 
fact, one study showed that daily consumption per capita of RYO cigarettes increased on 
average by 14.1% per year between 1991 and 2012 in Spain while the consumption of 
manufactured cigarettes decreased by 3% on average (45).  
 
Other form of tobacco use to take into account is electronic cigarettes (e-cigarettes). The 
potential risks and benefits of e-cigarette in the medium and long term are still unknown, 
which has generated intense debate in scientific journals and in the media. Some researchers 
(46) and citizens, in particular e-cigarette users and the tobacco industry which have economic 
interests in e-cigarettes, defend these devices as a useful tool to quit smoking or reduce 
consumption and as a harm reduction strategy for smokers. A recent meta-analysis (47) based 
on 13 studies (two randomized controlled trials and 11 controlled cohort studies) has shown 
that e-cigarettes could help prevent relapse among former smokers or that could promote 
smoking cessation among smokers but has failed to demonstrate that e-cigarettes help smoker 
quit in the long term compared to placebo e-cigarettes. However, a later longitudinal study 
(48) showed that dropout depends on the type of e-cigarettes used and their frequency of use. 
On the other hand, other researchers and tobacco control activists show e-cigarettes as a 
threat to smoking-free legislation, normalizing again smoking in public, as well as favoring new 
nicotine addicts (and potential tobacco smokers), especially among the younger population 
(49-51), and promoting their dual use with other tobacco products, as shown by some studies 
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(51-53). In a previous study carried out in Barcelona (Spain) it was observed a prevalence of e-
cigarette use of 6,5% in 2013-2014 (51).  
  
However, e-cigarettes are regulated in Spain as a whole since 2014 by Law 3/2014 (54). This 
regulation prohibits the sale of e-cigarettes to minors and their use in certain public spaces, 
including hospitals, educational centers and buildings of the Administration, public transport 
and children's playgrounds, and limits their advertising in the media according to their 
broadcasting schedules with the goal of protecting minors. Moreover, some Spanish 
autonomous communities, such as Andalusia, Aragon, Catalonia and the Canary Islands, went 
ahead of the ban on e-cigarettes in playgrounds, Public Administration units as well as health 
and education centers. 
Other important challenge for the future of tobacco control regards to plain packaging, which 
involves the removal of all branding and advertising from packs, such that packs are relatively 
indistinguishable from one another, other than the brand name in mandated text, size and 
style (55). Moreover, available evidence suggests that plain packaging may reduce smoking 
prevalence (56). In 2012, Australia implemented laws requiring plain (standardized) packaging 
of tobacco products. Scientific evaluation shows support for plain packaging increased 
significantly among Australian smokers after implementation of the law (being 28.2% after the 
implementation and 49% before) (57). Moreover, support for plain packaging is associated 
with higher levels of quitting activity while opposition mainly comes from those who smoke 
heavily and those who underestimate the risk of future smoking related harms (57). In 
addition, a recent systematic review shows plain packaging is associated with a reduction in 
package attractiveness and smoking appeal, and that it will make the legally required health 
warnings to be more salient (58). Since then, France, Ireland and UK have passed laws to 
implement plain packaging and several other countries have initiated legislative processes with 
the same goal (55). Furthermore, evidence to support the implementation of plain packaging 
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was obtained in Australia, New Zealand, Canada, UK, Norway, Belgium, France, Italy, Brazil and 
India (59).  
 
Other action to consider would be implement further smoke-free policies as nowadays they 
are mainly focused on closed public spaces. As commented before, Spanish tobacco control 
legislation includes ban on smoking in specific outdoor spaces such as playground enclosures, 
school enclosures and hospital enclosures. However, in some cases as schools, hospitals and 
terraces of bars and restaurants some clarifications need to be done as some controversy can 
be found (43).  
 
Moreover, the Spanish smoke-free legislation should consider to include some restrictions in 
specific private areas, such as private transport, as it has been already done in other countries 
(42). In this regard, there is at present an open debate on whether smoke-free legislation 
should be extended to private settings, with some suggesting that this could further reduce 
the social acceptability of public tobacco use, thereby promoting smoking cessation efforts and 
positively benefitting the health of the entire population (60). 
 
Other area to consider in future smoke-free legislations may be households, as they are usually 
the main source of exposure to SHS in children (61). A study carried out in 21 countries 
showed that almost 50% of children had been exposed to SHS in their home between 2009 
and 2013 (62). In addition, children are especially vulnerable to SHS exposure due to they 
breathe more rapidly, inhaling more pollutants per pound of body weight than adults (63). 
What is more, passive smoking includes exposure to smoking behavioral models which implies 
that living with smokers doubles the risk that children become regular smokers (64). However, 
currently smoke-free multiunit housing are still uncommon in Europe although are gaining 
popularity in the USA where multiunit housing operators reported having complete or partial 
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smoke-free building policies for at least some of their properties (65). On the other hand, 
voluntary adoption of smoke-free homes (SFH) rules is growing. In Europe (66), 61% of 
households had some kind of SFH rules in 2009. The highest prevalence of SFH was observed in 
Finland (95%) and the lowest in Macedonia (30%), whereas 44% of the Spanish households had 
SFH rules. Nonetheless, SHS in private venues remains a challenge and further research on the 
topic is needed. 
 
Finally, some municipal jurisdictions, both in our country and in others, have approved 
smoking restrictions on beaches, sports venues, campuses, municipal swimming pools and, in 
general, places where there are minors (67). This type of normative not only protects from 
SHS, but also favors denormalisation of tobacco and reduces or delays the initialization of 
consumption among young people. In addition, some Spanish regions have made progress in 
developing their own regulatory framework, such as Basque Country, which in April 2016 
reformed its drug addiction law to prevent tobacco use in some open and semi-open places, as 
sports fields, and which regulates the use of the electronic cigarette equating it with tobacco.  
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Hypothesis  
 
 
 The Spanish comprehensive smoke-free legislations (Law 28/2005 and Law 42/2010) have 
led to a decrease in tobacco consumption and nicotine dependence among smokers, along 
with an increase in motivation to quit smoking. 
 
 The Spanish comprehensive smoke-free legislations (Law 28/2005 and Law 42/2010) have 
also led to a reduction in the exposure to environmental tobacco smoke among non-
smoking adult population.  
 
 The expected decrease in SHS exposure will mainly be due to a reduction in exposure in 
workplaces and leisure places, essentially in the hospitality sector. 
 
 Exposure to SHS in households has not increased by displacement of exposure in 
workplaces and recreational settings to private environments. 
 
 There exists an inverse correlation between the levels of tobacco control policies 
implemented across European countries and the consumption of conventional cigarettes 
and SHS exposure at the ecological level. 
 
 Support for tobacco products regulations is positively related with European tobacco 
control levels of implementation. 
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Objectives  
 
 
 To assess the impact of the Spanish smoking legislations (Law 28/2005 and Law 42/2010)  
on tobacco epidemic (changes in consumption, dependence, motivation to quit and 
smoking cessation) among smokers of a general population cohort through self-reported 
information and biomarkers. 
 
 To evaluate the impact of the Spanish tobacco control legislations on SHS exposure (self-
reported and according to levels of cotinine in saliva) in non-smokers in a cohort 
population. 
 
  To analyze the changes in the pattern of passive smoking of the non-smokers 
(displacement of exposure at workplace and leisure time to home) according to age, sex, 
and socioeconomic level. 
 
 To analyze the correlation between the implementation of tobacco control policies and 
tobacco consumption, particularly rolling tobacco, electronic cigarettes users and the 
intent to quit smoking in 27 countries of the European Union.  
 
 To describe the acceptability of the recently implemented tobacco products regulations 
and to explore their relation with tobacco control legislation levels in Europe. 
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In order to achieve the objectives of this doctoral thesis, different sources of information were 
used regarding tobacco consumption, passive exposure, and attitudes towards tobacco 
policies. Moreover, diverse epidemiological studies were used including cross-sectional, 
cohort, multilevel and ecological study; please see the methodology of the papers of the 
doctoral thesis. A brief description on the sources used in this doctoral thesis can be found as 
follows. 
 
 
3.1 Questionnaire information 
 
Self-reported information was obtained through a longitudinal study of a representative 
sample of the adult (≥ 16 years old) non-institutionalized population of Barcelona (Spain; 
n=1245, 694 women and 551 men) called ‘Determinants of Cotinine phase 3’ project (dCOT3, 
website: http://bioinfo.iconcologia.net/es/content/estudio-dcot3). The baseline survey was 
conducted between 2004 and 2005, before both Spanish smoking legislations, and it is detailed 
elsewhere (68,69). We followed up adult participants who responded to a face-to-face 
questionnaire in 2004-2005 and agreed to take part in future studies. At the beginning of 2013, 
we updated the vital status and contact information (addresses and telephone numbers) of all 
participants teaming with Insured Central Registry of Catalonia. We restricted the follow-up to 
the participants who were alive in 2013 and still lived in the province of Barcelona.  
 
We traced 1010 participants out of the 1245 from the baseline study (101 died, 49 migrated 
out of the province of Barcelona, and 85 did not give consent to be followed or were <18 years 
old in 2004-2005). The follow-up survey was conducted between May 2013 and February 
2014, after both Spanish smoking legislations. In total, 72.9% of the eligible sample agreed to 
3. METHODS  
26 
 
participate and answered the questionnaire, 18.5% refused to participate, 7.2% moved 
elsewhere and 1.3% died. The final sample analyzed was 736 individuals (400 women and 336 
men). We administered the same questionnaire that gathered information on the smoking 
status, tobacco consumption and exposure to SHS before and after Spanish smoking 
legislations. In addition, although there were no statistically significant differences between 
the followed-up sample and the participants lost according to age, sex, level of education and 
smoking status, the final sample was skewed as slightly older in comparison with the 
population of Barcelona. Therefore, we weighted our data according to age distribution of the 
city of Barcelona to maintain its representativeness of the sample.  
 
 
3.2 Biomarker information (cotinine) 
 
Biomarker information about tobacco exposure and consumption was obtained through 
salivary cotinine. We collected 9 ml of saliva sample (i.e. oral fluid) for cotinine analysis, 
following the same protocol, before and after the Spanish smoking legislations. Participants 
were asked to rinse their mouths and then suck a lemon candy (Smint) to stimulate saliva 
production. Saliva samples were frozen and sent to the ‘Hospital del Mar’ Medical Research 
Institute (IMIM) in Barcelona. Salivary samples from baseline survey (2004-2005) were 
analyzed with gas chromatography followed by mass spectrometry detection (GC/MS). The 
limit of quantification was 1 ng/mL and the limit of detection was 0.3 ng/mL. Salivary samples 
from the follow-up survey (2013-14) were analyzed with liquid chromatography coupled with 
tandem mass spectrometry (LC/MS/MS) (70) with multiple reaction monitoring. The limit of 
quantification was 0.1 ng/mL and the limit of detection was 0.03 ng/mL (quantification error 
<15%). Because the latter method was more sensitive and had a lower limit of quantification 
than the former method, all available saliva samples from the baseline survey (2004-2005) 
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were reanalyzed with the LC/MS/MS method. For cotinine concentrations below the limit of 
quantification a value of half the level of quantification (0.05 ng/mL) was assigned.  
 
 
3.3 Eurobarometer and tobacco control 
information 
 
The Eurobarometer is a series of multi-topic, pan-European surveys undertaken for 
the European Commission since 1970 on attitudes towards European integration, 
institutions, policies, social conditions, health, culture, the economy, citizenship, security, 
information technology, the environment and other topics. The European Commission 
maintains the Eurobarometer overview page were all available data obtained though the 
series of surveys can be found. Standard and Special Eurobarometer surveys consist of 
regular face-to-face interviews at the participants’ homes in their native languages with 
approximately 1,000 subjects in each EU member state.  
 
In some of the articles of this doctoral thesis, we used information obtained through different 
Eurobarometer. We used data on tobacco, SHS and attitudes towards tobacco control 
activities in 2009 (71), 2012 (72) and 2014 (73). The Eurobarometers used were the Special 
Eurobarometers conducted by ‘TNS Opinion & Social’. The fieldwork of each Eurobarometer 
was performed in October 2009, between February and March of 2012, and between 
November and December of 2014, respectively. The final sample was 80,831 ( Eurobarometer’ 
sample of 2009: 27,288; Eurobarometer’ sample of 2012: 26,751; and Eurobarometer’ sample 
of 2014: 26,792). The surveys were only conducted on adult (older than 15 years old) 
population. 
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In addition, we used data on tobacco control activities in 27 European countries in 2005 (74), 
2007 (74), 2010 (75) and 2013 (76) measured by TCS.  
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The present doctoral thesis is composed of seven scientific articles four of them published in 
journals indexed in Web of Science and three of them in peer review in journals indexed in 
Web of Science. The correspondence with the journal of the accepted paper of the present 
thesis can be found from the Annex III to the Annex VI. Moreover, during my training in this 
doctoral thesis I got involved in other two articles, one of them published in a journal indexed 
in Web of Science (see Annex I and Annex II). The articles included in this thesis are the 
following ones.  
 
1. Cristina Lidón-Moyano, Marcela Fu, Montse Ballbè, Juan Carlos Martín-Sánchez, Nuria 
Matilla-Santander, Cristina Martínez, Esteve Fernández, and José M. Martínez-Sánchez. Impact 
of the Spanish smoking laws on tobacco consumption and secondhand smoke exposure: a 
longitudinal population study. Addictive Behaviors 2017; 75:30-35. Addictive Behaviors is 
included in the Journal Citation Report of ISI-Web of Science with and impact factor in 2016 of 
2.944 (position 5/18 in the category Substance abuse). 
 
2. Cristina Lidón-Moyano, Marcela Fu, Raúl Perez-Ortuño, Montse Ballbè, Juan Carlos Martín-
Sánchez, Nuria Matilla-Santander, José A. Pascual, Esteve Fernández, and Jose M. Martínez-
Sánchez. Assessment of the Spanish smoking legislations among smokers: A longitudinal study 
with biomarkers in Barcelona (Spain). This manuscript is in peer review in a journal index in 
Web of Science. 
 
3. Cristina Lidón-Moyano, Marcela Fu, Raúl Pérez-Ortuño, Montse Ballbè, Marc Sampedro-
Vida, Juan Carlos Martín-Sánchez, José A. Pascual, Esteve Fernández, and José M. Martínez-
Sánchez. Assessment of salivary cotinine concentration among general non-smokers 
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population:  before and after Spanish smoking legislations. This manuscript is in peer review in 
a journal index in Web of Science. 
 
4. Cristina Lidón-Moyano, Marcela Fu, Montse Ballbè, Juan Carlos Martín-Sánchez, Cristina 
Martínez, Esteve Saltó, Esteve Fernández, and José M. Martínez-Sánchez. Impact of the 
Spanish smoking legislations in the adoption of smoke-free rules at home: a longitudinal study 
in Barcelona (Spain). Tobacco Control 2016 (in press). Doi:10.1136/tobaccocontrol-2016-
053114. Tobacco Control is included in the Journal Citation Report of ISI-Web of Science with 
and impact factor in 2016 of 5.469 (position 11/172 in the category Public, Environmental and 
Public Health). 
 
5. Cristina Lidón-Moyano, José M. Martínez-Sánchez, Marcela Fu, Montse Ballbè, Juan Carlos 
Martín-Sánchez, Cristina Martínez, Esteve Saltó, and Esteve Fernández. Secondhand smoke risk 
perception and smoke-free rules in homes: a cross-sectional study in Barcelona (Spain). BMJ 
Open 2017; 7: e014207. BMJ Open is included in the Journal Citation Report of ISI-Web of 
Science with and impact factor in 2016 of 2.369 (position 38/154 in the category Medicine 
General and International). 
 
6. Cristina Lidón-Moyano, Juan Carlos Martín-Sánchez, Patrick Saliba, Jan Graffelman, José M. 
Martínez-Sánchez. Correlation between tobacco control policies and consumption of rolled 
tobacco and e-cigarettes, and intention to quit conventional tobacco, in Europe. Tobacco 
Control 2016 (in press). Doi: 10.1136/tobaccocontrol-2015-052482. Tobacco Control is 
included in the Journal Citation Report of ISI-Web of Science with and impact factor in 2016 of 
5.469 (position 11/172 in the category Public, Environmental and Public Health). 
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7. Cristina Lidón-Moyano, Marc Sampedro-Vida, Nuria Matilla-Santander, Juan Carlos Martín-
Sánchez, Adrián González-Marrón, Kailey Bunch, and Jose M. Martínez-Sánchez. Attitudes 
towards policies of the tobacco product directive implemented in Europe in 2016 and the 
relationship with the tobacco control policies. This manuscript is in peer review in a journal 
index in Web of Science. 
 
 
The main objective and results of the articles of the thesis are: 
 
1. Cristina Lidón-Moyano, Marcela Fu, Montse Ballbè, Juan Carlos Martín-Sánchez, Nuria 
Matilla-Santander, Cristina Martínez, Esteve Fernández, and José M. Martínez-Sánchez. Impact 
of the Spanish smoking laws on tobacco consumption and secondhand smoke exposure: a 
longitudinal population study. Addictive Behaviors 2017; 75:30-35. 
 
Objective: To assess the impact of the Spanish smoking legislations on the active and passive 
smoking through a population cohort in Barcelona (Spain). 
 
Results: After the implementation of the two Spanish smoke-free bans, it was observed a 
significantly decrease in the smoking prevalence (from 34.5% to 26.1%, PR=0.76,p<0.001), in 
the average of conventional cigarette daily consumption (median from 15.2 cigarettes per day 
to 10.0,p<0.001), in the percentage of conventional tobacco consumption (from 92.6% to 
74.4%, PR=0.80,p<0.001) and in the self-reported SHS exposure in all the assessed settings 
(home, work, transport, and leisure time); as well as a significant increase in the percentage of 
hand-rolled tobacco (from 6.1% to 30.9%, PR=5.07,p<0.001) and other tobacco products (from 
17.1% to 32.8%, PR=1.92,p<0.001). 
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2. Cristina Lidón-Moyano, Marcela Fu, Raúl Perez-Ortuño, Montse Ballbè, Ariadna Feliu, Juan 
Carlos Martín-Sánchez, Nuria Matilla-Santander, José A. Pascual, Esteve Fernández, and Jose 
M. Martínez-Sánchez. Assessment of the Spanish smoking legislations among smokers: A 
longitudinal study with biomarkers in Barcelona (Spain) (in revision). 
 
Objective: To evaluate the impact of both Spanish smoking legislations in the tobacco 
consumption and the displacement to other tobacco products by using a cohort study of adult 
smokers in Barcelona (Spain) along with biomarker information (salivary cotinine 
concentration). 
 
Results: The salivary cotinine concentration significantly increase 28.7% (GM from 91.7 ng/ml 
to 117.3 ng/ml, p=0.015) after the implementation of the two Spanish smoke-free bans. 
Statistical significant decrease was found in the proportion of individuals classified as medium 
FTCD (from 23.3% to 9.1%, p=0.017) when comparing pre and post legislation. Nonetheless, 
there was no pattern of change observed in the number of cigarettes smoked daily. Even 
though, an increase in the number of cigarettes smoked daily can be observed in those who 
switch from conventional to dual use consumption (conventional and hand-rolling cigarettes, 
RYO) when differentiating between kinds of tobacco smoked. 
 
 
3. Cristina Lidón-Moyano, Marcela Fu, Raúl Pérez-Ortuño, Montse Ballbè, Marc Sampedro-
Vida, Juan Carlos Martín-Sánchez, José A. Pascual, Esteve Fernández, and José M. Martínez-
Sánchez. Assessment of salivary cotinine concentration among general non-smokers 
population:  before and after Spanish smoking legislations (in revision). 
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Objective: To assess the impact of the impact of the Spanish smoking legislations on the SHS 
exposure in an adult non-smoking population cohort in Barcelona (Spain) using salivary 
cotinine concentrations and information on self-reported exposure. 
 
Results: The geometric mean of salivary cotinine concentration significantly decreased 88% 
(from 0.98 ng/mL to 0.12 ng/mL, p<0.001) and salivary cotinine concentration was significantly 
higher only among those declaring exposure to second-hand smoke at home (exposed=0.33 
ng/mL vs non-exposed=0.11 ng/mL, p<0.001); after the implementation of the two Spanish 
smoke-free legislations. 
 
 
4. Cristina Lidón-Moyano, Marcela Fu, Montse Ballbè, Juan Carlos Martín-Sánchez, Cristina 
Martínez, Esteve Saltó, Esteve Fernández, and José M. Martínez-Sánchez. Impact of the 
Spanish smoking legislations in the adoption of smoke-free rules at home: a longitudinal study 
in Barcelona (Spain). Tobacco Control 2016 (in press). Doi:10.1136/tobaccocontrol-2016-
053114. 
 
Objective: To assess the impact of two Spanish smoking legislations in the adoption of 
voluntary smoke-free homes rules in Spain. 
 
Results: The households with voluntary smoke-free rules (complete or partial) relatively 
increased 31% after Spanish smoking bans (from 55.6% to 72.6%, p<0.001). The houses with 
complete rules relatively increased 57% (from 23.9% to 37.6%, p<0.001) whereas the houses 
with partial rules increased 11% (from 31.7% to 35.0%, p=0.148). The increase of any type of 
rules (complete and partial) was statistically significantly independent of sex (PR between 1.29 
and 1.33), age (PR between 1.24 and 1.33), educational level (PR between 1.19 and 1.47), and 
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minimum age in house (PR between 1.12 and 1.40). However, the increasing was statistically 
and significantly higher only among never smokers (PR=1.46) at baseline. 
 
 
5. Cristina Lidón-Moyano, José M. Martínez-Sánchez, Marcela Fu, Montse Ballbè, Juan Carlos 
Martín-Sánchez, Cristina Martínez, Esteve Saltó, and Esteve Fernández. Secondhand smoke risk 
perception and smoke-free rules in homes: a cross-sectional study in Barcelona. BMJ Open 
2017; 7: e014207.  
 
Objective: To describe the voluntary adoption of smoke-free homes in Spain among general 
population and to identify variables associated with its voluntary adoption. 
 
Results: 57.4% of households had complete indoor smoke-free rules. The prevalence of 
households with complete indoor rules was higher among women (PRa: 1.15; 95% CI: 1.00 - 
1.33), married (PRa: 1.18; 95% CI: 1.01 - 1.38), never-smokers (PRa: 2.68; 95% CI: 2.06 – 3.50), 
and in households where a minor lived (PRa: 1.40; 95% CI: 1.20 - 1.65) (table 1). Believe that 
breathing tobacco smoke from smokers is dangerous for non-smokers (PRa: 1.77; 95% CI: 1.06-
2.97) is associated with the voluntary adoption of complete indoor smoke-free home. 
 
 
6. Cristina Lidón-Moyano, Juan Carlos Martín-Sánchez, Patrick Saliba, Jan Graffelman, José M. 
Martínez-Sánchez. Correlation between tobacco control policies and consumption of rolled 
tobacco and e-cigarettes, and intention to quit conventional tobacco, in Europe. Tobacco 
Control 2016 (in press). Doi: 10.1136/tobaccocontrol-2015-052482. 
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Objective: To analyze the correlation between the implementation of tobacco control policies 
and tobacco consumption, particularly rolling tobacco, electronic cigarettes (e-cigarettes) 
users, and the intent to quit smoking in 27 countries of the European Union. 
 
Results: There was a negative correlation between TCS and prevalence of smoking (rsp=-0.41; 
95%CI: -0.67 - 0.07). We also found a negative correlation (rsp=-0.31) between TCS and the 
prevalence of ever e-cigarette users, but not statistically significant. Among former smokers, 
there was a positive and statistically significant correlation between TCS and the consumption 
of hand-rolled tobacco (rsp=0.46; 95%CI: 0.06 - 0.70). A similar correlation was observed 
between TCS and other tobacco products (cigars and pipe) among former smokers. There was 
a significant positive correlation between TCS and intent to quit smoking in the last 12 months 
(rsp=0.66; 95%CI: 0.36 - 0.87). 
 
 
7. Cristina Lidón-Moyano, Marc Sampedro-Vida, Nuria Matilla-Santander, Juan Carlos Martín-
Sánchez, Adrián González-Marrón, Kailey Bunch, and Jose M. Martínez-Sánchez. Attitudes 
towards policies of the tobacco product directive implemented in Europe in 2016 and the 
relationship with the tobacco control policies (in revision).  
 
Objective: To describe the acceptability of the recently implemented tobacco products 
regulations and to explore their relation with tobacco control legislation levels in Europe. 
 
Results: Great support for the studied tobacco products regulations, which modestly increased 
over time, was observed. The highest support was seen for health warnings (80.8% in 2012) 
while the lowest was found in increasing taxes (58.6% in 2012). Moreover, a positive relation 
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was generally observed between TCS and support for the studied tobacco products regulations 
at both ecological and individual level.  
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H I G H L I G H T S
• Smoke-free regulations in Spain were associated with a reduction in smoking prevalence and SHS exposure.
• There was a change on the smoking pattern in consuming cheaper tobacco products, such as hand rolled cigarettes.
• The main settings of SHS exposure after Spanish bans were leisure time and in work.
A R T I C L E I N F O
Keywords:
Smoke-free legislation
Smoking
Secondhand smoke
A B S T R A C T
Background: In Spain, two smoke-free laws have been passed after the approval of the WHO-FCTC. This study
assesses the impact of these Spanish smoking legislations on the active and passive smoking through a popu-
lation cohort in Barcelona (Spain).
Methods: This is a longitudinal study before and after the implementation of two national smoking bans in Spain
in a representative sample (n= 1245) of adults (≥16 years old) from Barcelona (Spain) surveyed in 2004–2005
and followed-up in 2013–2014. The ﬁnal sample analyzed was 736 individuals. Both questionnaires (before and
after the two laws) included the same variables about active and passive smoking. We calculated the prevalence
and the prevalence ratio (PR, with their 95% conﬁdence intervals, 95% CI) of smoking cigarettes and hand-
rolled tobacco and also the prevalence of exposure to secondhand smoke (SHS) at home, work, public transport,
leisure time and at any setting after vs. before Spanish legislations.
Results: After the implementation of the two Spanish smoke-free bans, a signiﬁcant decrease was observed in the
smoking prevalence (from 34.5% to 26.1%, PR = 0.76, p < 0.001), in the average cigarettes per day (median
from 15.2 to 10.0, p < 0.001), and in the percentage of conventional tobacco consumption (from 92.6% to
74.4%, PR = 0.80, p < 0.001). Furthermore, a signiﬁcant increase in the use of hand-rolled tobacco (from 6.1%
to 30.9%, PR = 5.07, p < 0.001) and other tobacco products (from 17.1% to 32.8%, PR = 1.92, p < 0.001)
was observed. In addition, a signiﬁcant decrease in the self-reported SHS exposure was observed in all the
assessed settings (home, work, transport, and leisure time).
Conclusions: The implementation of the two smoke-free legislations in Spain is related to a reduction in smoking
prevalence and SHS exposure. However, the smoking of other tobacco products, particularly hand-rolled to-
bacco, has increased among young population.
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1. Introduction
Tobacco smoking has been causally linked to diseases of nearly all
organs of the body and to diminish health status, including such
common diseases as diabetes mellitus, rheumatoid arthritis, and col-
orectal cancer (U.S. Department of Health and Human Services, 2014).
Similarly, exposure to secondhand tobacco smoke (SHS) has been as-
sociated with cancer, respiratory and cardiovascular diseases among
adults, and with adverse eﬀects on the health of infants and children
(U.S. Department of Health and Human Services, 2014).
The World Health Organization (WHO) estimated that about 22.1%
of worldwide population smoked in 2010 (World Health Organization,
n.d.) and that tobacco use is responsible for about six million deaths
across the world each year, which includes about 600,000 deaths from
the eﬀects of exposure to SHS (World Health Organization, n.d.). In
Spain, the latest data available shows that 23.6% of Spanish population
are tobacco users in 2012 (Gutiérrez-Abejón, Rejas-Gutiérrez, Criado-
Espegel, et al., 2015), and 60,456 deaths are annually attributable to
active smoking (Gutiérrez-Abejón et al., 2015) and 1,028 to passive
smoking at home and work (López, Pérez-Ríos, Schiaﬃno, et al., 2016).
To take action against this tobacco epidemic, several countries have
implemented smoke-free legislations, as suggested by the WHO
Framework Convention on Tobacco Control (FCTC) (World Health
Organization, 2015). Smoke-free legislations has already been asso-
ciated with a reduction in the SHS exposure, a decrease in the incidence
of acute coronary events, a reduction of respiratory symptoms, and an
improvement of perinatal and child health, along with a moderate de-
crease in tobacco use (Gupta, Ray, & Singh, n.d.; International Agency
for Research on Cancer World Health Organization, 2009).
In Spain, two smoke-free laws have been passed after the approval
of the WHO-FCTC. In 2006, a smoke-free legislation came into eﬀect
banning smoking in public and workplaces (Law 28/2005). This law
was not complete in terms of full health protection from SHS exposure,
because it included some exceptions, as allowing smoking in the hos-
pitality sector under some conditions (Fernández, 2006), leading to
identiﬁcation of the Spanish smoking law as the “Spanish model”
(Schneider, Sebrie, & Fernandez, 2011). The scientiﬁc evaluation of this
law evidenced the need to promote a total ban (Fernández, Fu, Pascual,
et al., 2009; Grupo de Trabajo sobre Tabaquismo de la Sociedad
Española de Epidemiología, 2009; Grupo de Trabajo sobre Tabaquismo
de la Sociedad Española de Epidemiología, 2017; Nebot, López, Ariza,
et al., 2009), which came into force in 2011 (Law 42/2010). That law
extended smoke-free regulation to all hospitality venues without ex-
ception and to some outdoor areas, including hospital premises, edu-
cational campuses, and playgrounds (Fernández &Nebot, 2011).
Currently, there are scarce studies that have evaluated the impact of
smoking legislation using a general population cohort, which increases
the internal validity of the results (International Agency for Research on
Cancer World Health Organization, 2009). in Spain, there are few
studies that have assessed the impact of both Spanish legislations (Law
28/2005 and Law 42/2010) on smoking and SHS exposure (Jiménez-
Ruiz, Riesco-Miranda, Altet-Gómez, et al., 2014; Lidón-Moyano,
Martínez-Sánchez, Fu, et al., 2016; López, Fernández, Pérez-Ríos, et al.,
2013; Sureda, Ballbè, Martínez, et al., 2014; Sureda, Martínez-Sánchez,
Fu, et al., 2014; Tarrazo, Pérez-Ríos, Santiago-Perez, et al., 2016).
Therefore, the objective of this study is to carry out a comprehensive
assessment of the impact of these two smoke-free laws in active and
passive smoking among a population-based cohort sample in Barcelona
(Spain).
2. Methods
This is a longitudinal study of a representative sample of non-in-
stitutionalized population (≥16 years old) of Barcelona (Spain;
n= 1245, 694 women and 551 men) (“Determinants of Cotinine phase
3” project, dCOT3; website: http://bioinfo.iconcologia.net/es/content/
estudio-dcot3). The baseline characteristics are detailed elsewhere (Fu,
Fernández, Martínez-Sánchez, et al., 2009; Martínez-Sánchez,
Fernández, Fu, et al., 2009). In brief, we followed-up participants who
responded to a face-to-face questionnaire in 2004–2005 and agreed to
take part in future studies. At the beginning of 2013, we updated the
vital status and contact information (addresses and telephone numbers)
of all participants using the Insured Central Registry of Catalonia. We
restricted the follow-up to the participants who were alive in 2013 and
still lived in the province of Barcelona.
We traced 1,010 participants out of the 1,245 from the baseline
study (101 died, 49 migrated out of the province of Barcelona, and 85
did not give consent to be followed or were minors (< 18 years old) in
2004–2005 as their parents were not asked to provide informed consent
to re-contact). The percentage of follow-up in this ﬁrst stage was 81.1%.
The follow-up survey was conducted between May 2013 and February
2014. In total, 72.9% of the eligible sample agreed to participate and
answered the questionnaire (736 out of 1,010 traced, second stage of
follow-up), and 18.5% refused to participate, 7.2% moved elsewhere
and 1.3% had died. The ﬁnal sample analyzed were 736 individuals
(400 women and 336 men). 51.9% (736 out of 1,245) of the cohort
subjects participated in both surveys. There were no statistically sig-
niﬁcant diﬀerences between the participants followed-up (n= 736)
and those lost in the second stage (n= 274) according to age, sex, level
of education, district, and smoking status. However, there were statis-
tically signiﬁcant diﬀerences according to age, level of education, and
smoking status between the follow-up sample (n= 736) and the par-
ticipants lost in both stages of the follow-up (n= 509) (data not
shown). For this reason, the ﬁnal sample was skewed as older in com-
parison with the population of Barcelona. Therefore, we used inverse
probability weights to balance our data according to age distribution of
the city of Barcelona to maintain the representativeness of the sample.
The research and Ethics Committee of the Bellvitge University Hospital
provided ethical approval for the study. This study meets the code of
the Declaration of Helsinki.
2.1. Variables
Both questionnaires (baseline and follow-up, before and after the
two laws) included the same following variables:
Smoking status, was obtained from the question: “Which of the
following statements better describes your smoking status?” with the
possible answers: “Nowadays I smoke everyday (at least one cigarette
per day)”, these are current daily smokers; “Nowadays I smoke occa-
sionally (less than one cigarette per day)”, these are current occasion-
ally smokers; “I don't smoke now, but I smoked before every day”, these
are former daily smokers; “I don't smoke now, but I smoked before
occasionally”, these are former occasionally smokers; and “I have never
smoked”, these are never smokers. We also aggregate these categories
when appropriate as “smokers” (current daily and occasionally smo-
kers) and “non-smokers” (former daily and occasionally smokers plus
never-smokers).
Number of cigarettes smoked per day, obtained from the question:
“On average, how many cigarettes per day do you usually smoke?”.
This question was only available for daily smokers.
Fagerström Test for Cigarette Dependence (FTCD) is a standard in-
strument for assessing the intensity of physical addiction to nicotine, it
includes 6 items/questions and the score ranges from 0 to 10. The six
items are: time to ﬁrst cigarette (0–3 points), diﬃculty to refrain (0–1
points), hardest cigarette to give up (0–1 points), cigarettes smoked per
day (0–3 points), smoking more in the morning than during the rest of
the day (0–1 points), and smoking when ill (0–1 points). The FTCD was
developed to decide whether or not nicotine replacement therapy is
needed to treat withdrawal syndrome. A previous study has demon-
strated the reliability of the test (0.66) (Becona & Vazquez, 1998). In
our study, these questions were only addressed to daily smokers as
recommended by guidelines (Guideline Update Panel, 2008).
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Type of tobacco product used, obtained through the question:
“What type of tobacco product do you usually smoke?” with the pos-
sible answers: “cigarettes”, “hand-rolled tobacco”, “cigars”, “little ci-
gars”, “pipes”, “hookah” and “e-cigarettes”. The answers to this ques-
tion were aggregated as ‘cigarettes’, ‘hand-rolled tobacco’ and ‘other
products’ including cigars and little cigars. This question was gathered
from daily and occasional smokers.
Exposure to SHS at home was determined through two questions:
“Currently, how many individuals usually smoke inside your home per
day?” and “During the last week, how many cigarettes per day have
been smoked in your presence inside your home?” Answers were
gathered for typical working and non-working days. These questions
were only provided for non-smokers (former and never smokers). Based
on these two questions, we derived a dichotomous variable: non-ex-
posed at all (responses = 0 to both questions) and exposed (re-
sponses≥ 1 to any of the questions).
Exposure to SHS at work, only provided for non-smokers, was de-
termined through two questions: “Does anybody smoke in close
proximity to you at work?” and “How many hours per day do you think
you are exposed to tobacco smoke at work?”. We also derived a di-
chotomous variable of exposure to SHS at the workplace: non-exposed
at all (responses = 0 to both questions) and exposed (responses≥ 1 to
any of the questions).
Exposure to SHS at public transport, only provided for non-smokers,
was obtained through the questions: “During the last week, were you in
a public transport vehicle while someone was smoking?” We deﬁned a
dichotomous variable of exposure to SHS in public transport: non-ex-
posed at all (responses = 0 to both questions) and exposed (re-
sponses≥ 1 to any of the questions).
Exposure to SHS at leisure time, only provided for non-smokers, was
determined through the question “How much time have you spent in
any place with tobacco smoke that was not at home or at work?”. The
answers were gathered for typical working and non-working days. We
derived a dichotomous variable of exposure to SHS during leisure time:
non-exposed at all (responses = 0 to both questions) and exposed (re-
sponses≥ 1 to any of the questions). Exposure to SHS in any setting
was deﬁned as exposure in at least one of the above mentioned settings.
2.2. Statistical analysis
We calculated the prevalence and the prevalence ratio (PR) after vs.
before both smoke-free legislations with their 95% conﬁdence intervals
(95% CIs) of smoking status, type of tobacco product smoked, and ex-
posure to SHS in the diﬀerent settings. We used Generalized Estimating
Equation (GEE) models with individuals as random eﬀects and using
Poisson family with log link to calculate the prevalence ratio adjusted
for sex, age and educational level (aPR). We also calculated the median
number of cigarettes smoked daily and the FTCD score. We assessed
median diﬀerences through Wilcoxon test for paired samples. The re-
sults were stratiﬁed by sex, age and educational level, categorized as
low (unschooled, elementary school completed or uncompleted and
special education); intermediate (high school and training cycles) and
high (university education). The statistical programs used were R-3.0.2
and STATA v.14.
3. Results
3.1. Tobacco consumption
Overall, it was observed a signiﬁcant decrease in smoker's pre-
valence from 34.5% to 26.1% (PR = 0.76, p-value = 0.006) along with
a signiﬁcant increase in former smoker's prevalence from 25.6% to
34.1% (PR = 1.33, p-value = 0.004) (Fig. 1).
Moreover, 22.6% (95% CI: 19.7–25.8) are smokers and 62.0% (95%
CI: 58.4–65.5) are non-smokers (never and former smokers) at baseline
and at follow-up. 11.9% (95% CI: 9.7–14.5) of smokers in the baseline
quit smoking at the follow-up and 3.5% (95% CI: 2.3–5.2) of non-
smokers in the baseline initiated or relapsed tobacco use at the follow-
up (0.2% were never smokers at baseline and 3.3% were former smo-
kers).
The smoking prevalence signiﬁcantly decreased, from 34.5% to
26.1%, after the implementation of the two Spanish smoke-free bans
(Table 1). In particular, a higher decrease was observed in women (aPR
in men = 0.77 vs. aPR in women = 0.74), as well as among older
people (> 65 years old) (aPR = 0.63), and in those with intermediate
(aPR = 0.70) or high education (aPR = 0.71). We obtained similar
unadjusted PRs.
A signiﬁcant decrease in the average cigarettes smoked per day was
observed (median from 15.2 to 10.0 cigarettes per day, p-value <
0.001; Table 1). A higher decrease was observed among men (median
diﬀerences between both surveys were 8.6 and 2.9 cigarettes per day
among men and women respectively; both p-values < 0.05), as well as
among people aged 45–64 years old (median diﬀerence = 6.6 cigar-
ettes per day, p-value < 0.001), and in those with high education
(median diﬀerence = 6.6, p-value = 0.003). Moreover, there was not
any signiﬁcant change in the cigarette dependence (Table 1).
Regarding type of tobacco used, a signiﬁcant decrease in the pre-
valence of conventional cigarettes was observed (from 92.6% to 74.4%,
PR = 0.80, p-value = 0.001), as well as in the prevalence of hand-
rolled tobacco (from 6.1% to 30.9%, PR = 5.07, p-value < 0.001) and
other tobacco products (from 17.1% to 32.8%, PR = 1.92, p-value <
0.001; Table 2). These changes were higher among young population
(< 44 years), men and intermediate or high educational level.
3.2. Exposure to secondhand smoke
We observed a statistically signiﬁcant decrease in the self-reported
SHS exposure in all the assessed settings (Table 3). The highest pre-
valence of self-reported exposure to SHS, before and after the two
Spanish smoke-free laws, as well as the lower reduction, was obtained
during the leisure time, from 71.7% to 52.2% (aPR = 0.75, p-
value < 0.001) and at work, from 36.1% to 29.8% (aPR = 0.82, p-
value = 0.045; Table 3).
4. Discussion
Our results show a reduction in smoking prevalence after both
smoke-free bans legislations: however, the use of other tobacco pro-
ducts, particularly hand-rolled tobacco, has increased among young
population (< 44 years). Moreover, we also observed an important
reduction in the self-reported exposure to SHS in all settings.
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Fig. 1. Prevalence and prevalence ratio (PR) of smoking status before and after the im-
plementation of both Spanish smoke-free bans.
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Our results on smoking consumption trends are consistent with a
recent evidence report published which shows a decline of prevalence
before the Spanish smoke-free laws, that became more striking after
their implementation mainly among women but not among men (Grupo
de Trabajo sobre Tabaquismo de la Sociedad Española de
Epidemiología, 2017). In regards to the increase of hand-rolled cigar-
ettes the economic crisis that took place in Spain in 2008 could have
aﬀected the shift on tobacco products as also reported (Grupo de
Trabajo sobre Tabaquismo de la Sociedad Española de Epidemiología,
2017; Sureda et al., 2017).
In addition, smoking prevalence observed in our follow-up survey
was higher than that observed in another studies (23.6% (Gutiérrez-
Abejón, Rejas-Gutiérrez, Criado-Espegel, et al., 2015) and 20.7%
(Pérez-Ríos, Fernández, Schiaﬃno, et al., 2015)), with information
gathered at national level in 2011–2012. This could be because our
study was carried out in the city of Barcelona while the other study
includes information about all the regions in Spain, and historically it
has been reported slight diﬀerences in smoking prevalence among re-
gions in Spain (Observatorio Español de las drogas y las toxicomanías,
2015). Another possible explanation is that young and smoker partici-
pants in our sample could have been overestimated because of the loss
of older and no-smoker participants.
Nevertheless, the impact of the two National smoke-free legislations
is in line with previous studies conducted in Spain (Jiménez-Ruiz et al.,
2014; Tarrazo et al., 2016). Speciﬁcally, with a national Spanish study
based on a representative sample, in which it has been seen a drop in
prevalence of smoking between 2005 and 2011 (from 21.2% to 18.7%)
as well as in exposure to SHS in all the analyzed settings (Jiménez-Ruiz
et al., 2014). Another Spanish work also showed a decrease in pre-
valence of smoking between 2006 and 2011 (from 23.4 to 20.7%)
(Pérez-Ríos et al., 2015). Moreover, a study carried out in Galicia
(Spain) showed a decrease in the prevalence of smoking between 2007
and 2015 (from 25.4% to 21.8%) (Tarrazo et al., 2016). As well, a study
carried out in Barcelona (Spain) reported a decline in the overall self-
reported exposure from 75.7% in 2004–05 to 56.7% in 2011–12
(Sureda, Martínez-Sánchez, Fu, et al., 2014). Similarly, a previous study
carried out in three Spanish regions showed that secondhand smoke
exposure, assessed with nicotine and PM2.5 concentrations, decreased
by> 90% in hospitality venues after the Law 42/2010 came into force
(López et al., 2013). Our results then give more evidence on the con-
clusions of a systematic review (Hoﬀman& Tan, 2015) that highlights
that smoke-free policies and smoking restrictions in public spaces,
workplaces or residences lead to a decrease in smoking prevalence and
cigarette consumption.
However, in our study we didn't observe any signiﬁcant change in
the cigarette dependence after the enactment of the two Spanish
smoking legislations (Law 28/2005 and Law 42/2010), counteracting
the hardening hypothesis, which suggests that when smoking
Table 1
Changes in the smoking status, number of cigarettes smoked per day and FTCD before and after both Spanish smoke-free laws.
n Current Smokers Cigarettes per daya Cigarette dependenceb
PRE % POST % PR aPR p-valuec PRE median POST median p-valued PRE median POST median p-valued
Overall 736 34.5 26.1 0.76 (0.68–0.84) 0.75 (0.68–0.84) < 0.001 15.2 10.0 < 0.001 3.0 3.3 0.462
Sex
Men 341 39.9 30.9 0.77 (0.68–0.88) 0.77 (0.68–0.88) < 0.001 18.6 10.0 < 0.001 4.0 4.0 0.801
Women 395 29.8 22.1 0.74 (0.62–0.88) 0.74 (0.62–0.88) < 0.001 12.9 10.0 0.028 2.7 3.0 0.441
Age
26–44 420 42.9 34.0 0.79 (0.69–0.91) 0.79 (0.69–0.91) < 0.001 15.0 10.0 0.010 3.0 3.5 0.074
45–64 203 31.0 20.9 0.67 (0.57–0.80) 0.67 (0.57–0.80) < 0.001 16.6 10.0 < 0.001 4.0 3.0 0.245
≥65 113 9.6 6.1 0.63 (0.39–1.03) 0.63 (0.39–1.03) 0.210 6.1 5.0 0.727 0.5 0.0 0.699
Educational level
Low 241 27.1 24.5 0.90 (0.77–1.07) 0.91 (0.77–1.07) 0.306 16.0 10.0 0.048 3.0 4.0 0.975
Intermediate 206 45.8 32.2 0.70 (0.58–0.86) 0.70 (0.58–0.86) < 0.001 15.4 10.5 0.016 4.0 4.0 0.178
High 289 32.6 23.1 0.71 (0.59, 0.85) 0.71 (0.59–0.85) < 0.001 14.3 7.7 0.003 2.7 3.0 0.802
PR: Prevalence Ratio, PRa: Prevalence Ratio adjusted for sex, age and educational level.
a Daily smokers PRE: (n= 199); Daily smokers POST: (n= 160).
b As measured with the Fagerström Test for Cigarette Dependence.
c p-value: Adjusted Generalized Estimating Equation (GEE) model.
d p-value: Paired samples Wilcoxon test.
Table 2
Changes in the type of tobacco product smoked among participants who were current smokers before and after both Spanish smoke-free laws.
Conventional cigarettes Hand-rolled tobacco Other tobacco products
PRE % POST % PR p-value PRE % POST % PR p-value PRE % POST % PR p-value
Overall 166 92.6 74.4 0.80 (0.73–0.88) 0.001 6.1 30.9 5.07 (2.67–9.33) < 0.001 17.1 32.8 1.92 (1.34–2.59) < 0.001
Sex
Men 94 87.4 68.2 0.78 (0.67–0.91) 0.001 7.4 33.6 4.54 (2.09–9.42) < 0.001 26.1 39.6 1.52 (1.12–2.22) 0.009
Women 72 98.7 81.8 0.83 (0.74–0.93) 0.001 4.6 27.7 6.02 (1.99–18.24) < 0.001 6.7 24.5 3.66 (1.55–9.14) 0.003
Age
26–44 121 94.4 71.7 0.76 (0.67–0.86) < 0.001 7.0 37.8 5.40 (2.60–11.13) < 0.001 15.5 32.7 2.11 (1.30–3.14) 0.002
45–64 39 90.1 82.6 0.92 (0.80–1.03) 0.133 4.6 12.7 2.76 (1.17–7.77) 0.022 17.2 30.9 1.80 (1.02–3.08) 0.043
≥65 6 78.9 78.8 1.00 (−) – 0.0 0.0 – – 42.3 45.5 1.08 (0.80–2.10) 0.296
Educational level
Low 50 93.6 80.0 0.85 (0.74–0.99) 0.033 4.4 26.1 5.93 (1.77–12.39) 0.002 16.8 22.8 1.36 (0.74–2.38) 0.339
Intermediate 57 94.2 68.8 0.73 (0.60–0.88) 0.001 7.8 37.4 4.79 (1.87–12.36) 0.001 14.5 32.9 2.27 (1.26–3.78) 0.005
High 59 90.4 74.9 0.83 (0.71–0.97) 0.018 5.5 28.7 5.22 (1.70–16.12) 0.004 19.9 41.4 2.08 (1.18–3.53) 0.010
PR: Prevalence Ratio.
Other tobacco products: cigars, little cigars, pipes, hookah and e-cigarettes.
p-value: Generalized Estimating Equation (GEE) model.
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prevalence decreases in the population, the smokers who quit are less
dependent, and the remaining smokers are those with hard smoking
dependence (Hughes, 2011). Similar results can be found in Italy
(Gallus, Paciﬁci, Colombo, et al., 2005) and Norway (Lund,
Lund, & Kvaavik, 2011). Moreover, a European study with data from 18
countries suggests that the lower the country-speciﬁc smoking pre-
valence, the lower the dependence (Fernández, Lugo, Clancy, et al.,
2015), giving more evidence to reject the hardening hypothesis.
Nevertheless, we observed a statistically signiﬁcant decrease in the
prevalence of consumption of conventional cigarettes, we also observed
a signiﬁcant increase in the consumption of hand-rolled tobacco and
other tobacco products, especially among young people; in fact, ac-
cording to our results, older people were not smoking hand-rolled to-
bacco neither before nor after the implementation of the Spanish
smoke-free legislations. In this sense, a previous study carried out in
Galicia (North West in Spain), showed an increase in consumption of
hand-rolled tobacco between 2007 and 2015, from 1.8% to 18.6%
(Tarrazo et al., 2016). Moreover, another work showed the prevalence
of use of hand-rolled tobacco rose between 2006 and 2011, from 1.5%
to 15.6% (Pérez-Ríos et al., 2015). In Europe, a similar pattern can be
found at ecological level, obtaining a negative correlation between the
level of implementation of smoke-free legislation and smoking pre-
valence of conventional cigarettes but a positive correlation with the
usage of other tobacco products, particularly hand-rolled tobacco
(Lidón-Moyano, Martin-Sánchez, Saliba, et al., 2016). A similar pattern
has been found in other countries like Canada, USA, UK, Australia
(Young, Yong, Borland, et al., 2012) and New Zealand (Young, Wilson,
Borland, et al., 2010). Thereby, our results provide more support to the
hypothesis of a change in the smoking pattern in using cheaper tobacco
products, such as hand-rolled tobacco, especially among young people.
In Spain, the sale to the public of hand-rolled tobacco increased by 60%
between 2010 and 2011 (200% between 2007 and 2011) (Granda-
Orive & Jiménez-Ruis, 2011). Taking this into account, there is a need
to equalize the prices of all tobacco products by applying the same
taxing level as, indeed, is recommended by the article 6 of the FCTC
(Tarrazo et al., 2016; World Health Organization, 2003).
Regarding self-exposure to SHS exposure, our results show a sig-
niﬁcant decrease in the exposure at workplaces, during leisure time, at
home, and public transport after the application of the two Spanish
smoking legislations (Law 28/2005 and Law 42/2010), In line with
some previous cross-sectional surveys at local and national level
(Jiménez-Ruiz et al., 2014; Sureda, Martínez-Sánchez, Fu, et al., 2014;
Villaverde-Royo, Marin-Izaguerri, Requeno-Jarabo, et al., 2012).
Moreover, previous results from our research group showed a sig-
niﬁcant increase in the prevalence of voluntary adoption of smoke-free
rules in homes between 2004 and 05 (55.6%) and 2013–14 (72.6%)
(Lidón-Moyano, Martínez-Sánchez, Fu, et al., 2016). A previous study
also found a signiﬁcant decrease in the mean of SHS exposure hours, as
a consequence of the Spanish legislation implementation (Villaverde-
Royo et al., 2012). Similarly, a systematic review (Hoﬀman & Tan,
2015) reported reductions in SHS exposure after the implementation of
smoke-free policies, in both adults and children, and across various
settings including workplaces, public spaces and hospitality establish-
ments. None of the above results support a displacement of tobacco
consumption to private venues, like home, counteracting the displace-
ment hypothesis. Nonetheless, the highest prevalence of self-exposure
to SHS, before and after the implementation of the two Spanish smoke-
free bans, as well as the lower reduction, was obtained in the leisure
time and in work. These results are consistent with another Spanish
study, which showed that more than one-third of the population were
passively exposed at work and at leisure time two years after the
Spanish smoking legislations (Sureda, Martínez-Sánchez, Fu, et al.,
2014). In this regard, previous studies have shown that both con-
sumption and self-reported SHS exposure were very low in indoor set-
tings regulated by the Spanish legislation, therefore, the exposure of
non-smokers to SHS mostly occurs in outdoor areas where smoking is
allowed (Sureda, Fernández, Martínez-Sánchez, et al., 2015). Taking
this into account, future smoking control legislations should consider
including some outdoor public and workplaces to ensure higher pro-
tection against SHS exposure.
4.1. Limitations to our study
The main limitation of our study is the potential participation bias
due to the attrition of the cohort of participants. In this sense, there
were statistically signiﬁcant diﬀerences between the participants who
were followed-up and those participants lost according to age, level of
education, and smoking status. Participants who were followed-up
overestimate young people and smokers in comparison with lost par-
ticipants; for this reason, the reduction of conventional cigarettes con-
sumption and the increase of hand-rolled tobacco consumption could be
higher among lost participants. In addition, regardless its longitudinal
nature, the study does not allow establishing strong causal inferences
regarding the eﬀectiveness of the smoke free legislation. On the other
hand, our ﬁnal sample overestimated the older people compared with
the distribution of population in Barcelona. However, we weighted the
sample to minimize these limitations and to generate estimations re-
presentative of the general population. Moreover, the baseline sample
size was representative of the city of Barcelona (Fu et al., 2009;
Martínez-Sánchez et al., 2009) and the longitudinal design of our work
maximizes the internal validity of the study. Other potential limitations
are those related to survey-based studies, as the use of a questionnaire
to collect self-reported information, and bias due to non-response.
Nevertheless, by using a face-to-face questionnaire with trained inter-
viewers we potentially increase the internal validity of our results as
compared with internet and self-administered surveys.
4.2. Conclusion
The implementation of the two smoke-free legislations in Spain is
related to a reduction in smoking prevalence and SHS exposure.
However, the use of other tobacco products, particularly hand-rolled
tobacco, has increased among young population. In addition, the main
setting of SHS exposure occurs during the leisure time and at work,
where most of the exposed ones declared expending most of the time.
Table 3
Changes in self-reported exposure to secondhand smoke in non-smokersa before and after
the implementation of both Spanish smoke-free bans.
% self-reported
exposure
PR aPR p-value
Any setting
PRE 74.2 (70.0–78.0) Ref. Ref.
POST 58.4 (54.1–62.5) 0.74
(0.68–0.81)
0.77
(0.73–0.82)
< 0.001
Home
PRE 17.1 (13.9–20.9) Ref. Ref.
POST 10.2 (7.9–13.1) 0.59
(0.45–0.79)
0.90
(0.78–1.05)
< 0.001
Work
PRE 36.1 (30.6–42.0) Ref. Ref.
POST 29.8 (24.8–35.4) 0.83
(0.64–1.07)
0.82
(0.63–1.07)
0.045
Public transport
PRE 14.2 (11.1–18.0) Ref. Ref.
POST 4.4 (2.7–7.0) 0.31
(0.17–0.54)
0.23
(0.14–0.38)
< 0.001
Leisure time
PRE 71.7 (67.4–75.6) Ref. Ref.
POST 52.2 (47.9–56.5) 0.73
(0.66–0.80)
0.75
(0.70–0.81)
< 0.001
PR: Prevalence Ratio, aPR: Prevalence Ratio adjusted for sex, age and educational level.
p-value: Adjusted Generalized Estimating Equation (GEE) model.
a Non-smokers PRE: (n= 482); Non-smokers POST: (n= 544).
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Therefore, future tobacco control measurements should consider ap-
plying the same taxing level to all tobacco products in order to equalize
their prices, as well as including some outdoor restrictions to ensure
higher protection against SHS exposure.
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ABSTRACT 
Objective: To evaluate the impact of both Spanish smoking legislations in the tobacco 
consumption and the displacement to other tobacco products by using a cohort study of adult 
smokers in Barcelona (Spain) along with biomarker information (salivary cotinine 
concentration).  
Methods: This is a longitudinal study, before and after the implementation of the two national 
smoking bans (in 2006 and 2011), in a representative sample of adults (≥ 16 years old) from 
Barcelona (Spain) surveyed in 2004-2005 and followed-up in 2013-2014 (n=736). For the 
purposes of this study we only analyzed continuing smokers; hence, the final sample analyzed 
was 116 individuals. We conducted a survey and obtained 9 ml sample of saliva for cotinine 
analysis following the same protocol. We also obtained information about the self-reported 
cigarette number smoked daily, kind of tobacco smoked, stage of change, and Fagerström Test 
for Cigarette Dependence (FTCD) score. We calculated geometric means of salivary cotinine 
concentration and their geometric standard deviation. We used linear mixed effect models 
with individuals as random effects to model the percentage change in salivary cotinine 
concentrations and their 95% confidence intervals.   
Results: The salivary cotinine concentration significantly increased 28.7% (GM from 91.7 ng/ml 
to 117.3 ng/ml, p=0.015) after the implementation of the two Spanish smoke-free bans. 
Statistical significant decrease was found in the proportion of individuals classified as medium 
FTCD (from 23.3% to 9.1%, p=0.017) when comparing pre and post legislation. Nonetheless, 
there was no pattern of change observed in the number of cigarettes smoked daily. Even 
though, an increase in the number of cigarettes smoked daily could be observed in those who 
switch from conventional to dual use consumption (conventional and hand-rolling cigarettes, 
RYO) when differentiating between kinds of tobacco smoked. 
Conclusions: Our study shows a significant increase in the salivary cotinine concentration 
among adult continuing smokers after both Spanish legislations. Moreover, we observed a 
shift to other tobacco products, particularly RYO cigarettes.  
Keywords: Smoke-free legislation; Smoking; Cotinine; Biomarker 
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INTRODUCTION 
Tobacco is the first single leading cause of preventable death in the world (1), being related to 
more than 25 diseases and being responsible for 30% of all cancers, respiratory diseases and 
cardiovascular diseases (2). In 2015, WHO estimated that about 15% (1.1 billion people) of 
worldwide population smoked (3) and that tobacco use is responsible for about six million 
deaths across the world each year, which includes about 600,000 deaths from the effects of 
second-hand smoke (SHS) (4). In Spain, the latest data reported showed that 23.6% of Spanish 
population were tobacco users in 2012 (5) and that more than 60,000 deaths per year were 
attributable to active smoking (5).   
Consequently, two smoke-free laws have been passed in Spain after the approval of the World 
Health Organization Framework Convention on Tobacco Control (WHO FCTC) (6). On the 1st of 
January, 2006, a smoke-free legislation came into effect (Law 28/2005). This law was a great 
advance for public health in Spain; however, it was not complete in terms of health protection 
from SHS exposure, because it allowed smoking in hospitality sectors according to the size of 
venues (7),  for this exception the Spanish smoking law was known as the “Spanish model” (8). 
The scientific evaluation of this law showed the need to promote a total ban (9-11). On the 2nd 
of January, 2011, a new law came into effect (Law 42/2010), extending the smoke-free 
regulation to all hospitality venues without exception (12) and to some outdoor areas, 
including hospital premises, educational campuses, and playgrounds. 
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The principal aim of both Spanish tobacco control legislations was to protect non-smoking 
population from tobacco smoke exposure. Therefore, their scientific evaluation focused on 
their effect on SHS reduction, often neglecting research about the effect on active smokers. In 
this sense, previous studies (13,14) suggest that active smokers could be changing their 
smoking pattern in consuming cheaper tobacco products, such as hand rolled tobacco, which is 
subject of little taxation in Spain. To our knowledge, there are scarce studies that assess the 
impact of smoking legislation among the general smoking population using a specific 
biomarker such as cotinine concentration.  
Therefore, the objective of this study is to evaluate changes on tobacco consumption and 
displacement to other tobacco products among smokers before and after both Spanish 
smoking legislations by using a cohort study of adult smokers in Barcelona (Spain) along with 
biomarker information (salivary cotinine concentration).  
METHODS 
We used the follow-up data of a cohort from a representative sample of the adult population 
(≥16 years) of the city of Barcelona (Catalonia, Spain). The baseline study was carried out 
during the years 2004-2005 (15,16) (n = 1,245) and the follow-up took place in 2013-2014, 
after both Spanish smoking legislations. 
From the baseline sample, we excluded 235 subjects: 150 after checking their data in the 
Insured Central Registry of Catalonia (101 died and 49 migrated out of the province of 
Barcelona) and 85 who did not give consent to be followed up or were minors (<18 years old) 
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in 2004-2005 to whom no consent to re-contact was asked. The follow-up was conducted in 
2013-2014. In total, 72.9% of the eligible sample (n=1010) agreed to participate, 18.5% refused 
to participate, 7.2% had moved elsewhere and 1.4% had died. The final sample included 736 
individuals (Figure 1) and was skewed as slightly older in comparison with the general 
population of Barcelona. For this reason, we weighted our data according to age distribution of 
the city of Barcelona to maintain its representativeness.  
We asked the participants to provide a 9 ml sample of saliva for cotinine analysis, using the 
same protocol before and after the Spanish smoking legislations. Participants were asked to 
rinse their mouths and then suck a lemon candy (Smint) to stimulate saliva production. Saliva 
samples were frozen and sent to the IMIM-Hospital del Mar Medical Research Institute in 
Barcelona. Saliva samples were analyzed using liquid chromatography-tandem mass 
spectrometry (LC/MS/MS) with multiple reaction monitoring. The limit of quantification was 
0.4 ng/ml (quantification error was <15%) (17).  
We used the same core questionnaire in both surveys to gather relevant information on 
smoking characteristics. For this analysis, we used self-reported smoking status for the 
identification of current smokers, along with the information on their cotinine concentration. 
Thus, we considered smokers those participants who identified themselves as current smokers 
and had salivary cotinine concentration consistent with active smoking (≥ 35 ng/ml per 
cigarette smoked (18)). The percentage of smokers with salivary cotinine higher than 35 ng/ml 
per cigarette smoked daily was 3.4% before the legislations and 12.1% after the legislations. 
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The final sample for this analysis consists of 116 individuals, who were smokers before and 
after the legislations (Figure 1).  
From the same questionnaire before and after the two laws, we also obtained information 
about the kind of tobacco smoked), obtained through the question: “What kind of tobacco 
product do you habitually consume?” with the possible answers: “cigarettes”, “hand-rolling 
tobacco”, “cigars”, “little cigars”, “pipes”, “hookah” and “e-cigarettes”. The answers to this 
question were dichotomized as ‘Always conv.’, indicating those who only smoked conventional 
cigarettes before and after the two laws, ‘Conv. - RYO’, indicating those who switched from 
conventional to hand-rolling tobacco or Roll Your Own (RYO) cigarettes, ‘Conv. – dual use’, 
indicating those who switched from conventional to dual use (conventional and RYO 
cigarettes) and ‘Other’, indicating other possible options. Moreover, we collected information 
about the smokers’ stage of change (19): precontemplation, when smokers were not seriously 
considering quitting within the next 6 months; contemplation, when smokers were seriously 
considering quitting within the next 6 months but not within the next 30 days; and 
preparation, when smokers were planning to quit within the next 30 days and had attempted 
to quit for at least 24 hours in the past year.  We also gathered information about the number 
of cigarettes smoked daily (either conventional or RYO cigarettes) and the Fagerström Test for 
Cigarette Dependence (FTCD) score (20), categorized as ‘low’ (≤4), ‘medium’ (5) and ‘high’ (≥6). 
Finally, we gathered information about several smoking characteristics, such as use of regular 
or non-regular cigarettes (light, ultralight, etc.), type of tobacco smoked (blond or black), use 
of cigarettes with or without filter, length of cigarettes left after smoking (in centimeters), and 
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depth (superficial, intermediate, deep) and frequency of inhalation (continuous, regular, 
scarce).  
For statistical analysis we calculated geometric means (GM) and their geometric standard 
deviation (GSD), given the skewed distribution of cotinine concentration. We used linear mixed 
effect models with individuals as random effects to model the change in cotinine 
concentration (after log10 transformation), their 95% confidence intervals and the p-value, 
adjusted for sex, age, and educational level. The results were stratified by sex, age, educational 
level, kind of tobacco smoked, FTCD score and stages of change. We also used generalized 
lineal mixed models with individuals as random effects to calculate the prevalence ratio of the 
change in smoking characteristics. The statistical programs used were R-3.0.2 and Stata v14. 
RESULTS 
We observed a general increase in salivary cotinine concentration after the implementation of 
the two Spanish smoke-free bans (figure 2). Salivary cotinine concentration significantly 
increased by 28.7% (GM from 91.1 ng/ml to 117.3 ng/ml, p=0.015) after the implementation of 
the two Spanish smoke-free bans (Table 1). The increase in the salivary concentration was 
statistically significant among young people, high educated and in those who switched from 
conventional to RYO (Table 1). In addition, statistical significant decrease was found in the 
proportion of individuals classified in the medium category of FTCD score (from 23.3% to 9.1%, 
p=0.017) when comparing pre and post legislation. Nonetheless, no clear pattern of change 
was observed in the number of cigarettes smoked daily (figure 2). Even though, a non-
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significant increase in the number of cigarettes smoked daily can be observed in those who 
switched from conventional cigarettes only to dual use (from 16.6 cigarettes/day to 24.3 
cigarettes/day, p=0.270) when differentiating between kinds of tobacco smoked (figure 2). In 
this regard, 8.3% of smokers switched from conventional to dual use, 13.0% switched from 
conventional to RYO, and 59.1% smoked only conventional cigarettes before and after the two 
laws and.  
Regarding other smoking characteristics (Table 2), we observed an increase in the use of 
regular  cigarettes (from 66.6% to 76.3%, p=0.019), in the length of cigarettes left after 
smoking (from 1.13 cm to 2.26 cm, p=0.023) and in deep inhalations when smoking at the 
expense of the reduction of intermediate depth of inhalation (deep inhalation from 42.4% to 
57.5%, p=0.001) along with a reduction in low frequency of inhalation (from 28.2% to 10.1%, 
p=0.036) (Table 2). 
DISCUSSION  
Our study shows an increase in salivary cotinine concentration of around 29% among 
continuing smokers after both Spanish smoking legislations, particularly among younger and 
high educated smokers. We also observed a switch in the type of tobacco used, from 
conventional to RYO cigarettes or to dual use in 21.3% of smokers. In addition, statistical 
significant decrease was found in the proportion of individuals classified as medium in the 
FTCD score.  
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The hardening hypothesis (21) suggests that smokers in the populations who quit over the 
time are those who are less dependent, and the remaining smokers are more dependent. 
However, previous studies have counteracted this hypothesis (22-24) using questionnaires to 
measure the tobacco or nicotine dependence. In this sense, we did not find differences in 
salivary cotinine concentration nor in FTCD scores among smokers before Spanish smoking 
legislations who quit smoking and continue smoking (data not shown). On the other hand, we 
found that continuing smokers had higher salivary cotinine. In this sense, using biomarkers as a 
proxy of tobacco dependence (25), our results could indicate that continuing smokers became 
more dependent after Spanish smoking legislations. However, our study did not show any 
significant increase in the FTCD score among smokers who continue smoking, this could be due 
to FTCD only measures the dependence of conventional manufactured cigarettes (20). A 
previous study showed that the FTCD has some limitations, such as low internal consistency, 
floor effects, and that it does not address important aspects of addiction to cigarettes (26). 
Although there is a positive relation between the FTCD score, tobacco consumption and 
salivary cotinine (25,26), other factors might also have an effect on cotinine concentration, 
such as smoking topography (27). According to our results, an increase in smoking regular 
cigarettes, in the centimeters left without smoking and in the depth of inhalation when 
smoking along with a reduction in low frequency of inhalation can be observed after the 
application of the Spanish tobacco laws. This could be explained because, under these smoking 
restriction policies, smokers have fewer opportunities to smoke in public places and lesser 
time to do it, thus changes in the smoking topography may be evident. In addition, the low 
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increase in salivary cotinine found in our study in high dependent smokers in baseline could be 
due to a ceiling effect, since the highest value of salivary cotinine before bans was observed in 
this group. Furthermore, it is important to bear in mind that the information about FTCD score 
and the number of cigarettes smoked daily was self-reported, therefore it can be subject to 
potential limitations related to survey based studies. Further research is needed to analyze 
possible factors related to cotinine concentration, as well as to ensure cotinine concentration 
properly measures nicotine dependence.  
According to the Tobacco Control Scale report of 2013 (28), the Spanish score for its policies 
related to treatment to help smokers quit was low (6 out of 10 points) in comparison with its 
other policies score. This could mean that smokers may not receive the help needed to 
succeed when trying to stop smoking or that they are not properly identified. Therefore, there 
is a need to implement better treatments policies to help smokers stop smoking.  
Additionally, our study showed a switch from conventional to RYO cigarettes or to dual use in 
21.3% of continuing smokers, after both Spanish smoking legislations. Thereby, our results 
could be backing the hypothesis of a switch of smokers to cheaper tobacco products, such as 
RYO cigarettes, because the tobacco control policies, particularly increasing of prices, are 
traditionally focused on conventional cigarettes. Bearing this in mind, there is a need to 
equalize the prices of all tobacco products by applying the same taxing level as, indeed, is 
recommended by the article 6 of the FCTC (30). Furthermore, the highest value of salivary 
cotinine after Spanish smoking bans, according to the kind of tobacco smoked, was observed in 
11 
 
smokers who switched from conventional to RYO cigarettes or to dual use, may counteract the 
popular belief that RYO cigarettes are less harmful than conventional cigarettes. This aspect 
may also be involved in the observed increase in salivary cotinine after the implementation of 
Spanish smoking bans. Given the switch of smokers to other tobacco products, the FTCD score 
should be redefined and validated to measure cigarette dependence.  
The main limitation of our study is the potential participation bias due to the attrition of the 
cohort of participants. In this sense, there were statistically significant differences according to 
age, level of education, and smoking status between the follow-up sample and the participants 
lost in the follow-up (31). The followed up sample overestimated young people and smokers in 
comparison with lost participants, for this reason the increase in salivary cotinine could be 
smaller among lost participants. On the other hand, our sample, being a cohort, overestimated 
the older people compared with the distribution of population in Barcelona. However, we 
weighted the sample to minimize these limitations and to generate estimations representative 
of the general population. Moreover, the baseline sample size was representative of the city of 
Barcelona (15,16) and the longitudinal design maximizes the internal validity of the study. 
Other potential limitations are those related to potential information biases derived from the 
use of a self-reported questionnaire to collect information, and non-response. However, 
trained interviewers administered a face-to-face questionnaire and used the same definition of 
smoking status in both studies, potentially increasing the internal validity of our results.  In 
addition, we used salivary cotinine, a specific biomarker of nicotine.  
12 
 
In conclusion, this study shows a significant increase in salivary cotinine concentration among 
adult continuing smokers after both Spanish legislations. Moreover, we observed a shift in the 
type of tobacco product used, particularly from conventional cigarettes to RYO. Our results, 
therefore, suggest the need to extend tobacco control policies, focusing on reduction of use of 
any kind of tobacco product (i.e. equalizing the prices of all tobacco products) and 
implementing better treatment policies to help smokers stop smoking.  
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Figure1. Flow chart of sample followed-up from Barcelona, Spain, in 2013-2014.   
 
 
 
                                                                                                                       85 did not give consent in 2004-05 to be followed               
 
Information obtained from the Insured Central         
Registry of Catalonia at the beginning of 2013: 
  101 died  
                                                                                   49 migrated out of the province of Barcelona  
                                                                                      
 
 
                                                
     
                                                                                                                       187 refused to participate 
                                                       73 moved away 
                                         14 died  
 
 
 
                                                                                                                          30 without saliva sample 
590 self-declared being non-smokers or former 
smokers (pre or post) 
                                                                                                                           
 
 
 
 
 
 
Pre: before Spanish smoke-free bans (2004-2005). 
Post: after Spanish smoke-free bans (2013-2014). 
 
 
 
 
 
  
Sample in 2004-2005 
(n=1,245)  
Target subjects to be 
followed up 
(n=1,010) 
Subjects followed up 
(n=736) 
Smokers 
 (n=116) 
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Figure 2. Changes in salivary cotinine concentration (log scale), in the number of cigarettes 
smoked daily (log scale), and in the Fagerström Test for Cigarette Dependence (FTCD, 
categorized as ‘low’ (≤4), ‘medium’ (5) and ‘high’ (≥6)) before and after the implementation of 
both Spanish smoking bans.  
 
 
 
 
 
 
 
*Daily smokers 
Statistical significant differences were only found in the ‘medium’ group when comparing FTCD categories pre and 
post legislation (proportion test).   
Pre: before Spanish smoke-free bans (2004-2005). 
Post: after Spanish smoke-free bans (2013-2014). 
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Table 1. Geometric mean (GM) and geometric standard deviation (GSD), adjusted linear mixed 
effect coefficient (% change*) and their 95% confidence interval (95%CIs) of salivary cotinine 
concentration (ng/mL) according to sociodemographic variables, kind of tobacco smoked, 
Fagerström Test for Cigarette Dependence score (FTCD) and stages of change before (2004-
2005) and after (2013-2014) the implementation of both Spanish smoking legislations. 
 
 
na 
GM (GSD)  
ng/mL (PRE) 
GM (GSD)  
ng/mL (POST) 
% change* (95% CI) p-value 
Overall 116 91.1 (0.16) 117.3 (0.18) 28.7 (4.9; 58.0) 0.015 
Sex 
   
  
               Men 62 103.9 (0.26) 135.2 (0.28) 30.1 (-0.1; 69.4) 0.051 
               Women 54 78.3 (0.19) 99.6 (0.22) 27.2 (-7.8; 75.6) 0.143 
Age 
   
  
               26-44 62 104.3 (0.15) 174.3 (0.09) 67.2 (30.7; 113.8) <0.001 
               45-64 34 132.7 (0.18) 112.9 (0.28) -14.9 (-46.5; 35.2) 0.494 
               65-98 20 30.7 (0.22) 35.3 (0.34) 15.0 (-13.5; 52.9) 0.336 
Educational level 
   
  
               Low 46 102.1 (0.32) 112.5 (0.35) 10.2 (-11.8; 37.7) 0.392 
               Intermediate 33 100.9 (0.22) 142.2 (0.27) 40.9 (-21.1; 151.6) 0.246 
               High 37 72.4 (0.16) 104.0 (0.24) 43.8 (13.9; 81.4) 0.002 
Kind of tobacco smoked      
               Always conv.  64 106.6 (0.18) 114.9 (0.20) 7.8 (-18.0; 41.9) 0.590 
               Conv. – RYO 14 145.6 (0.16) 243.2 (0.12) 70.0 (16.7; 138.8) 0.005 
               Conv. – dual use 9 205.2 (0.16) 236.9 (0.14) 15.5 (-12.1; 51.6) 0.301 
               Other 21 74.3 (0.55) 80.8 (0.63) 8.8 (-15.2; 39.5) 0.509 
FTCDd score (PRE)    
  
               Low 53 115.7 (0.12) 137.4 (0.18) 18.7 (-15.3; 66.3) 0.319 
               Medium 20 86.6 (0.43) 103.3 (0.39) 19.3 (-0.9; 43.5) 0.062 
               High 14 237.6 (0.15) 272.3 (0.12) 14.6 (-12.8; 50.7) 0.329 
Stages of Change (PRE) 
   
  
               Precontemplation 6 186.7 (0.36) 257.1 (0.20) 37.7 (-26.0; 156.3) 0.313 
               Contemplation 9 136.8 (0.30) 172.5 (0.25) 26.1 (-11.5; 79.8) 0.200 
               Preparation 79 93.5 (0.21) 115.1 (0.23) 23.1 (-7.3; 63.6) 0.151 
FTCDd: FTCD daily smokers. 
n
a
: The sum does not up the total for some variables because of some missing values. 
Pre: Before Spanish smoke-free bans (2004-2005). 
Post: After Spanish smoke-free bans (2013-2014). 
% change*: Adjusted by sex, age, educational level. 
P-value: Obtained through adjusted linear mixed effect coefficient. 
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Table 2. Prevalence and generalized linear mixed effect coefficient (Prevalence Ratio PR), or 
mean (standard deviation) and mean difference, about tobacco topography before (2004-
2005) and after (2013-2014) the implementation of both Spanish smoking legislations. 
 
 na  PRE POST PR  (95% CI) p-value 
Type of cigarettes (%) 
     
               Regular 66 66.6 76.3 1.15 (1.02, 1.28) 0.0191 
               Other 33 33.4 23.7 0.71 (0.50, 0.99) 0.0491 
Type of tobacco (%) 
     
               Blond 82 82.2 88.1 1.07 (0.99, 1.16) 0.0971 
               Black 18 17.8 11.9 0.67 (0.42, 1.06) 0.0861 
Filter (%) 
     
               Yes 97 98 98 1.00 (0.98, 1.02) 0.961 
               No 2 2 2 1.04 (0.35, 3.07) 0.941 
Length of cigarettes left 
after smoking in cm 
(mean, SD) 
107 1.13 (0.12) 2.26 (0.39) -  0.0232 
Frequency of inhalation 
(%)      
               Continuous 13 11.7 16.9 1.44 (0.83, 2.52) 0.1981 
               Regular 65 60.1 73 1.21 (0.86, 1.71) 0.2641 
               Scarce 30 28.2 10.1 0.36 (0.14, 0.93) 0.0361 
Depth of inhalation (%) 
     
               Superficial 17 16.2 24.7 1.56 (0.73, 3.32) 0.2461 
               Intermediate 45 41.4 17.8 0.43 (0.26, 0.72) 0.0011 
               Deep 46 42.4 57.5 1.35 (1.13, 1.61) 0.0011 
n
a
: The sum does not up the total for some variables because of some missing values. 
Pre: Before Spanish smoke-free ban of 2004-2005. 
Post: After Spanish smoke-free ban of 2013-2014. 
PR: Prevalence ratio 
1
Generalized linear mixed effect coefficient p-value.  
2
T-test for paired samples.  
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ABSTRACT 
Backgound: This study assesses the impact of Spanish smoking legislations on the second-hand 
smoke (SHS) exposure in an adult non-smoking population cohort in Barcelona (Spain). 
Methods This is a longitudinal study, before and after the implementation of two national 
smoking bans, in a representative sample of adults (≥ 16 years old) from Barcelona (Spain) 
surveyed in 2004-2005 and followed-up in 2013-2014 (n=736). We only analyzed non-smokers 
(n=397). We conducted a survey about the self-reported exposure to SHS and obtained 9 ml of 
saliva sample for cotinine analysis following the same protocol. We calculate geometric means 
of salivary cotinine concentration and their geometric standard deviation. We use linear mixed 
effect models with individuals as random effects to model the percentage change in salivary 
cotinine concentrations and their 95% confidence intervals.  
Results: The geometric mean of salivary cotinine concentration significantly decreased 88% 
(from 0.98 ng/mL to 0.12 ng/mL, p<0.001) and salivary cotinine concentration was significantly 
higher only among those declaring exposure to second-hand smoke at home (exposed=0.33 
ng/mL vs non-exposed=0.11 ng/mL, p<0.001); after the implementation of the two Spanish 
smoke-free legislations.  
Conclusion: There was a large reduction in the salivary cotinine concentration among adult 
non-smokers and higher cotinine concentrations among those declaring exposure to SHS at 
home after both legislations. 
  
Keywords: Smoke-free legislation; Secondhand smoke; Cotinine; Biomarker  
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1. INTRODUCTION 
The effects of secondhand tobacco smoke (SHS) on the health of non-smokers are well-known. 
SHS exposure has been associated with many adverse health effects 1 and it is classified as a 
Group I carcinogen in humans 2 by the International Agency for Research on Cancer (IARC). In 
2010, WHO estimates that SHS exposure is responsible of about 600,000 deaths across the 
world each year 3. In Spain, passive smoking at home and work caused 1,028 deaths in 2011 4.  
Consequently, several countries have implemented tobacco control legislations, as suggested 
by the World Health Organization Framework Convention on Tobacco Control (WHO FCTC) 5. 
Regarding Spain, two smoke-free laws have been passed after the approval of the WHO FCTC. 
On the 1st of January 2006, it came into effect a smoke-free legislation (Law 28/2005). This law 
was a great step forward for public health in Spain, but it was incomplete in terms of 
protection to SHS exposure because it allowed smoking in hospitality sectors depending on the 
size of venues 6. Because of this exception this Spanish smoking law was known as the “Spanish 
model” 7. The scientific evaluation of this law showed the need to promote a total ban 8-10 and 
motivated the modification of the law accordingly. Hence, a new law (Law 42/2010) came into 
effect on the 2nd of January 2011, applying the smoke-free regulation to all hospitality venues 
11 without exception, and extending the prohibition to some outdoor areas, including hospital 
premises, educational campuses, and playgrounds. 
In order to asses SHS exposure, self-reported data are likely to be imprecise. Thus, it is 
desirable to use biomarkers as they allow to objectively quantifying SHS exposure. In this 
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regard, cotinine, the main nicotine metabolite, has been widely used as a biomarker of 
tobacco exposure 12. Cotinine concentration in biological fluids (blood, urine or oral fluid, 
widely referred to as saliva) 13 indicate tobacco exposure over the previous 1-2 days 14.  
Currently, there are scarce studies that evaluate the impact of both Spanish smoking 
legislations using a general population cohort which increases the internal validity of the 
results 15. Moreover, few studies assessed the legislations impact among general population 
using a specific biomarker of SHS exposure such as cotinine concentration, and only one in 
Spain using a repeated cross-sectional study 16. In a previous Spanish cohort of hospitality 
workers, salivary cotinine concentration decreased significantly (by 56.6%) among hospitality 
workers at venues where smoking was totally banned after the Spanish partial ban (law 
28/2005) took effect 17. Therefore, the objective of this study is to evaluate the impact of both 
Spanish smoking legislations on the SHS exposure in an adult non-smoking population cohort 
in Barcelona (Spain) using salivary cotinine concentrations and information on self-reported 
exposure.  
2. METHODS 
This is a longitudinal study from a representative sample of the adult population (≥16 years) of 
the city of Barcelona (Catalonia, Spain). The baseline study was carried out during the years 
2004-2005 18,19 (n = 1,245) and follow-up took place in 2013-1014, after both Spanish smoking 
legislations (n=736). 
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From the baseline sample, we excluded 235 subjects, 150 after checking their data in the 
Insured Central Registry of Catalonia (101 died and 49 migrated out of the province of 
Barcelona) and another 85 without consent to be followed up or being minor (<18 years old) in 
2004-2005 whose parents did not provide informed consent to be re-contacted. Follow-up was 
conducted between May 2013 and February 2014. In total, 72.9% of the eligible sample agreed 
to participate, 18.5% refused to participate, 7.2% had moved elsewhere and 1.3% had died. 
The final sample included 736 individuals (Figure 1).  
Figure1. Flow chart of sample followed-up from Barcelona, Spain, in 2013-2014.   
 
 
 
                                                                                                                       85 did not give consent in 2004-05 to be followed               
 
Information obtained from the Insured Central         
Registry of Catalonia at the beginning of 2013: 
  101 died  
                                                                                   49 migrated out of the province of Barcelona  
                                                                                      
 
 
                                                
     
                                                                                                                       187 refused to participate 
                                                   73 moved away 
                                       14 died  
 
 
 
                                                                                                                      60 without available saliva sample 
                                                                                                                      237 self-declared being smokers (pre or post) 
                                                                                                                      42 with cotinine levels > 10 mg/ml (pre or post) 
 
 
 
 
 
 
Non-smokers 
(n=397) 
Sample in 2004-2005 
(n=1,245)  
Target subjects to be 
followed up 
(n=1,010) 
Subjects followed up 
(n=736) 
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The final sample was skewed as slightly older in comparison with the general population of 
Barcelona. For this reason, we weight our data according to age distribution of the city of 
Barcelona to maintain its representativeness.  
We administered the same questionnaire that gathered information on the smoking status, 
tobacco consumption and exposure to second-hand smoke before and after Spanish smoking 
legislations. Specifically, we obtained information about the self-reported exposure to SHS at 
home, work, public transport and leisure time (dichotomous variable of exposure to SHS in 
each setting). Exposure to SHS in any setting was defined as exposure in at least one of the 
above mentioned settings. We also obtained 9 ml of saliva sample (i.e. oral fluid) for cotinine 
analysis before and after the Spanish smoking legislations, following the same protocol before 
and after smoking legislations. Participants were asked to rinse their mouths and then suck a 
lemon candy (Smint) to stimulate saliva production. Saliva samples were frozen and sent to the 
‘Hospital del Mar’ Medical Research Institute (IMIM) in Barcelona. Salivary samples from 
baseline survey (2004-2005) were analyzed with gas chromatography followed by mass 
spectrometry detection (GC/MS). The limit of quantification was 1 ng/mL and the limit of 
detection was 0.3 ng/mL. Salivary samples from the follow-up survey (2013-14) were analyzed 
with liquid chromatography coupled with tandem mass spectrometry (LC/MS/MS) 20 with 
multiple reaction monitoring. The limit of quantification was 0.1 ng/mL and the limit of 
detection was 0.03 ng/mL (quantification error <15%). Because the latter method was more 
sensitive and had a lower limit of quantification than the former method, all available saliva 
samples from the baseline survey (2004-2005) with cotinine concentrations below 1 ng/mL (n= 
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245) were reanalyzed with the LC/MS/MS method. For cotinine concentrations below the limit 
of quantification a value of half the level of quantification (0.05 ng/mL) was assigned.  
The same definition of smoking status was used in both studies. We considered as non-smoker 
the person who declares to have never smoked or to have formerly smoked, and has a salivary 
cotinine concentration compatible with non-smoking (≤10 ng/ml) 21. The final sample for this 
study consists of 397 non-smokers before and after the Spanish smoking legislations (Figure 1).  
Given the skewed distribution of cotinine concentration, we calculated geometric means (GM) 
and their geometric standard deviation (GSD). We used linear mixed effect models with 
individuals as random effects adjusted for sex, age and educational level to model the change 
percentage in salivary cotinine concentrations (after log 10 transformation) and their 95% 
confidence intervals. We obtained the p-value for the median difference through Wilcoxon 
test for paired samples and Mann Whitney test for independent samples. Moreover, the 
results were stratified by sex, age and educational level. The statistical program used was R-
3.0.2 and Stata v14. 
3. RESULTS 
The percentage of participants with saliva samples with measurable concentrations of cotinine 
fell from 92.4% to 64.2% after both Spanish smoking legislations. We also found a leftward 
shift in the salivary cotinine distribution after both Spanish smoking legislations (Figure 2), i.e. 
it is more frequent to obtain lower values in the salivary cotinine concentration after the 
legislations.  
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Figure 2. Distribution (histogram) of cotinine in saliva (ng/mL) before and after the implementation of both Spanish 
smoking bans.  
 
 
Pre: before Spanish smoke-free bans (2004-2005). 
Post: after Spanish smoke-free bans (2013-2014). 
The darker color in the histogram indicates the overlap of the two distributions.  
 
 
The overall GM of salivary cotinine concentration significantly decreased 87.9% (from 0.98 
ng/mL to 0.12 ng/mL, p<0.001) after the implementation of the two Spanish smoke-free bans 
(Table 1). We found a statistically significant decrease in the GM of salivary cotinine 
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concentration independently of the sociodemographic variables (sex, age, and level of 
education) (Table 1). Before both legislations, there was higher salivary cotinine 
concentrations among young (GM 26-44 years=1.12 ng/mL, GM 45-64 years=0.80 ng/mL, GM 
65-98 years=0.87 ng/mL), men (GM men=1.22 ng/mL vs GM women=0.84 ng/mL), and with 
intermediate educational level (GM low level=0.78 ng/mL, GM intermediate level=1.11 ng/mL, 
GM high level=1.07 ng/mL). Nevertheless, after both legislations, the salivary cotinine 
concentration was similar according to sociodemographic variables (Table 1).   
Table 1. Geometric mean (GM) and geometric standard deviation (GSD), adjusted linear mixed effect coefficient (% 
change*) and their 95% confidence interval (95%CIs) of salivary cotinine concentration (ng/mL) according to 
sociodemographic variables. Before (2004-2005) and after (2013-2014) the implementation of both Spanish smoking 
legislations. 
 
n 
GM (GSD) 
ng/mL (PRE) 
GM (GSD) 
ng/mL (POST) 
% change * p-value 
Overall 397 0.98 (0.08) 0.12 (0.05) -87.9 (-89.8; -85.6) <0.001 
Sex  
    
Men 170 1.22 (0.11) 0.12 (0.08) -89.9 (-92.3; -86.7) <0.001 
    Women 227 0.84 (0.10) 0.12 (0.06) -86.2 (-88.9; -82.8) <0.001 
Age  
    
26-44 224 1.12 (0.11) 0.11 (0.07) -90 (-92.3; -87.1) <0.001 
45-64 109 0.80 (0.11) 0.13 (0.07) -83.8 (-87.3; -79.4) <0.001 
65-98 64 0.87 (0.16) 0.12 (0.10) -85.6 (-90; -79.4) <0.001 
Educational level  
    
Low 120 0.78 (0.11) 0.14 (0.08) -82.6 (-86.6; -77.5) <0.001 
               Intermediate 100 1.11 (0.18) 0.12 (0.12) -89.5 (-93.1; -84.1) <0.001 
High 177 1.07 (0.11) 0.11 (0.06) -89.7 (-91.9; -86.9) <0.001 
*: adjusted by sex, age and educational level. 
Pre: before Spanish smoke-free bans (2004-2005). 
Post: after Spanish smoke-free bans (2013-2014). 
P-value: Wilcoxon test for paired samples.  
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Before both legislations, salivary cotinine concentration was significantly higher among those 
declaring to be exposed to SHS at any setting (GM exposed=1.07 vs GM non-exposed=0.67) 
and at home (GM exposed=1.75 vs GM non-exposed=0.85) (data not shown). Although the 
higher prevalence of self-reported SHS exposure post-legislations was found in leisure time (50.8%), 
salivary cotinine concentration was significantly higher only among those declaring to be 
exposed to SHS at home (GM exposed=0.33 vs GM non-exposed=0.11) (Table 2). 
Table 2. Prevalence of self-declared exposure to SHS at all the analyzed settings, geometric mean (GM) and 
geometric standard deviation (GSD), of salivary cotinine concentration (ng/mL) according to self-declared exposure 
to SHS after the implementation of both Spanish smoking legislations (2013-14).  
 
 
na 
% 
POST 
Geom. Mean 
(POST) 
p-value 
SHS exposure (Any setting)   
  
Yes 225 56.7 0.13 (0.07) 0.080 
No 172 43.3 0.11 (0.7) 
 
SHS exposure (Home)   
  
Yes 38 9.5 0.33 (0.18) <0.001 
No 359 90.5 0.11 (0.05) 
 
SHS exposure (Work)   
  
Yes 67 29.4 0.12 (0.13) 0.876 
No 161 70.6 0.11 (0.08) 
 
SHS exposure (Public 
transport) 
  
  
Yes 15 4.7 0.09 (0.18) 0.542 
No 291 95.3 0.12 (0.06) 
 
SHS exposure (Leisure time)   
  
Yes 201 50.8 0.13 (0.07) 0.077 
No 194 49.2 0.11 (0.06) 
 
na: The sum does not up the total for some variables because of some missing values. 
Post: after Spanish smoke-free bans (2013-2014). 
P-value: Mann-Whitney test for independent samples (Mann Whitney) 
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4. DISCUSSION  
Our study shows an important reduction of salivary cotinine concentration (around 88%) 
among non-smokers after both Spanish smoking legislations independently of 
sociodemographic variables.  
In this line, a previous repeated cross-sectional study showed that GM of the salivary cotinine 
concentration, among all adult non-smokers in Barcelona (Spain), significantly decreased, from 
0.93 ng/mL before the legislations, to 0.12 ng/mL after the legislations 16. Moreover, the 
change percentage in cotinine concentration obtained in this same study, after adjusting for 
sex, age, and educational level, was 87.9% 16. Similarly, another Spanish study showed a 
significant decrease in median urinary cotinine concentrations between 2010 (0.8 ng/mL) and 
2011 (0.7 ng/mL) among passive smokers 22.  
Other Spanish studies showed significant decrease in the environmental nicotine in hospitals 
after both Spanish legislations 23 and in hospitality venues between 2010 and 2011 24. 
Moreover, another longitudinal study, showed a significant decrease in the prevalence of self-
declared SHS exposure at workplaces, during leisure time, at home, and public transport after 
the application of the two Spanish smoking legislations 25. Other studies, carried out in Spain 
using questionnaire, showed a decrease in self-declared SHS exposure in all the studied 
settings after the application of the smoking legislations 16,26,27. Similar results can be found in 
Ireland 28, Scotland 29, Italy 30, and USA 31. In Europe, a secondary analysis showed that the 
enforcement of smoke-free legislation is inversely associated with SHS exposure 32.  
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Although the higher prevalence of self-reported SHS exposure post-legislations was found in 
leisure time (50.8%), our results show higher cotinine concentrations among those declaring 
exposure to SHS at home. This could be because the exposure in leisure time, particularly in 
hospitality venues, are shifted to the entrances of venues 24 reducing the time and intensity of 
exposure. Moreover, in a regular day people usually spend more time at home than at leisure 
time, therefore, being exposed at home could be harder in terms of time and intensity. In this 
sense, an increase in the prevalence of smoke-free homes was observed after the 
implementation of the two Spanish smoke-free bans in Spain 27 and more than half (57.4%) of 
the population of Barcelona (Spain) had complete indoor smoke-free rules at home in 2013-
2014 33. Moreover, in 2011, 6.7% of non-smokers reported SHS exposure at home indoors, 
18.8% at home outdoors, 1.3% at work indoors, and 15.0% at work outdoors 34. Therefore, 
there is a need to implement some public health interventions to continue reducing SHS 
exposure at home. The interventions may focus in convincing or helping smokers to quit or in 
getting smokers moving their smoking away from their home, that is to say, trying to promote 
smoke-free homes and smoke-free multi-unit housing 35,36.  
The main limitation of our study is the potential participation bias due to the attrition of the 
cohort of participants. In this sense, there were statistically significant differences according to 
age, level of education, and smoking status between the follow-up sample and the participant 
lost in both stages of the follow-up 27. Follow-up participants overestimate the young people 
and smokers in comparison with lost participants, for this reason the reduction of SHS 
exposure could be higher among lost participants. On the other hand, our final sample 
overestimated the older people compared with the distribution of population in Barcelona. 
However, we weighted the sample to minimize these limitations and to generate estimations 
representative of the general population. Moreover, the baseline sample size was 
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representative of the city of Barcelona 18,19 and the longitudinal design of our work maximizes 
the internal validity of the study. Other potential limitations are those related to survey based 
studies, as the use of a questionnaire to collect self-reported information, and bias due to non-
response. However, we used salivary cotinine as a specific biomarker of SHS exposure, we use 
the same definition of smoking status in both studies, we remove individuals with a salivary 
cotinine concentration incompatible with non-smoking (>10 ng/ml) and we used a face-to-face 
questionnaire with trained interviewers potentially increasing the internal validity of our 
results.   
5. CONCLUSION 
In conclusion, this study shows a large reduction in the salivary cotinine concentration among 
adult non-smokers after both Spanish legislations independently of sociodemographic 
variables. However, our results show higher cotinine concentrations among those declaring 
exposure to SHS at home after both legislations, revealing the need to implement some public 
health interventions to continuing reducing SHS exposure in homes. 
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ABSTRACT
Objective To assess the impact of two Spanish
smoking legislations in the adoption of voluntary smoke-
free-homes rules in Spain.
Methods This is a longitudinal study, before and after
the implementation of two national smoking bans (in
2005 and 2010), in a representative sample (n=1245)
of non-institutionalised adults (≥16 years) from
Barcelona (Spain) surveyed in 2004–2005 and followed
up in 2013–2014. The ﬁnal sample analysed was 736
individuals (400 women and 336 men). We deﬁned
smoking rules in the houses as complete (when smoking
was not allowed in the household), partial (when
smoking was allowed in some places inside the house)
or absent (when smoking was allowed everywhere). We
calculated relative changes in the prevalence of smoking
rules in homes before and after 2 national smoking
legislations by means of prevalence ratios (PRs) and their
95% CIs.
Results The households with voluntary smoke-free
rules (complete or partial) relatively increased 31% after
Spanish smoking bans (from 55.6% to 72.6%,
p<0.001). The houses with complete rules relatively
increased 57% (from 23.9% to 37.6%, p<0.001)
whereas the houses with partial rules increased 11%
(from 31.7% to 35.0%, p=0.148). The increase of any
type of rules (complete and partial) was statistically
signiﬁcantly independent of sex (PR between 1.29 and
1.33), age (PR between 1.24 and 1.33), educational
level (PR between 1.19 and 1.47) and minimum age in
house (PR between 1.12 and 1.40). However, this
increase was statistically and signiﬁcantly higher only
among never smokers (PR=1.46) at baseline.
Conclusions The implementation of the smoke-free
regulations in public and work places in Spain was
associated with an increasing of voluntary adoption of
smoke-free rules in homes. According to our data, the
Spanish smoking bans did not shift the tobacco
consumption from public and work places to private
places (homes).
INTRODUCTION
According to the Tobacco Atlas, globally, about
40% of children and a third of non-smoking adults
were exposed to secondhand smoke (SHS) in
2004.1 Moreover, SHS exposure has been classiﬁed
as a type I carcinogen by the International Agency
for Research on Cancer,2 being responsible for
around 603, 000 deaths worldwide.3
This has led to several countries to implement
tobacco control legislations, particularly smoke-free
public and workplaces, as suggested by the WHO
Framework Convention on Tobacco Control
(WHO FCTC).4 In fact, their implementation has
already been associated with a reduction in the
exposure to SHS, the incidence of acute coronary
events, respiratory symptoms, improvements of
perinatal and child health, along with a moderate
decrease in tobacco smoking prevalence.5–7
Furthermore, SHS exposure during pregnancy has
harmful effects on placenta and fetal growth8 and
is associated with preterm labour,9 10 intrauterine
growth restriction and low birth weight.8
Nevertheless, private places (mainly cars and
homes), where children are more exposed,11 are
never or rarely included in tobacco control policies.
However, the household is usually the main source
of exposure to SHS in children.11 A study carried
out in 21 countries showed that almost 50% of
children had been exposed to SHS in the home
(daily, weekly or monthly) between 2009 and
2013.12 In addition, children are especially vulner-
able to SHS exposure due to them breathing more
rapidly, inhaling more pollutants per pound of
body weight than adults,13 with an increased risk
of sudden infant death syndrome, acute respiratory
infections, ear problems and mental disorders.14–16
In Spain, two smoke-free laws have been passed
after the approval of the FCTC. In 2005, a smoke-
free legislation (law 28/2005) came into effect. This
law was a great advancement for public health in
Spain. The ban was a compendium of public health
measures against smoking and included regulations
on publicity, sale, supply and consumption of
tobacco products.17 Smoking was banned in all
indoor workplaces, public places, public transport
facilities including enclosed stations, hospitals and
other healthcare facilities, schools and universities
as well as in retail stores and shopping centres.
However, hospitality venues were subject to only a
partial ban. In bars and restaurants of <100 m2,
the proprietor could choose between permitting or
prohibiting smoking. Bars and restaurants larger
than 100 m2 are deﬁned as smoke free, but the law
allows the proprietor to provide a physically sepa-
rated and independently ventilated smoking area
comprising <30% of the total ﬂoor area. For this
exception the Spanish smoking law was known as
the ‘Spanish model’.18 The scientiﬁc evaluation of
this law showed the need to promote a total ban19–21
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and motivate the modiﬁcation of the law in 2010 (law 42/2010)
that extended the smoke-free regulation to all hospitality
venues22 without exception and extended the ban to some out-
doors areas, including hospital premises, educational campuses
and playgrounds.
In Barcelona (Spain), in 2011–2012, 84% of smokers
reported smoking at home, and 35.9% of them smoked in
outdoor areas of the home.23 Moreover, a common belief
among smokers is that cigarette smoking in outdoor places does
not affect indoor places,23 whereas a previous study indicated
that SHS from outdoors settings drifts to adjacent indoors
spaces.24 However, currently, few studies have evaluated the
impact of Spanish smoke-free legislations in SHS exposure at
home25 26 and there is a lack of information in Spain, to the
best of our knowledge, on the impact of the smoke-free laws in
the adoption of smoke-free homes (SFHs). Therefore, the
objective of this study is to assess the impact of Spanish tobacco
control legislations in the voluntary adoption of SFHs rules in
Spain.
METHODS
This is a longitudinal study of a representative sample of the
adult (≥16 years) non-institutionalised population of Barcelona
(Spain; n=1,245, 694 women and 551 men) called ‘determi-
nants of cotinine phase 3’ project (dCOT3, website: http://
bioinfo.iconcologia.net/es/content/estudio-dcot3). The baseline
survey was conducted between 2004 and 2005, and it is
detailed elsewhere.27 28 We followed up adult participants who
responded to a face-to-face questionnaire in 2004–2005 and
agreed to take part in future studies. At the beginning of 2013,
we updated the vital status and contact information (addresses
and telephone numbers) of all participants teaming with Insured
Central Registry of Catalonia. We restricted the follow-up to the
participants who were alive in 2013 and still lived in the prov-
ince of Barcelona.
We traced 1010 participants out of the 1245 from the base-
line study (101 died, 49 migrated out of the province of
Barcelona, and 85 did not give consent to be followed or were
minors, <18 years, in 2004–2005 because their parents did not
provide consent to be recontacted). The percentage of follow-up
in this ﬁrst stage was 81.1%. The follow-up survey was con-
ducted between May 2013 and February 2014. In total, 72.9%
of the eligible sample agreed to participate and answered the
questionnaire (736 of 1010 traced, second stage of follow-up),
18.5% refused to participate, 7.2% moved elsewhere and 1.3%
died. The ﬁnal sample analysed was 736 individuals (400
women and 336 men). Finally, the percentage of participation
in both stages was 59.1% (736 of 1245). There were no statis-
tically signiﬁcant differences between the followed up sample
(n=736) and the participants lost in the second stage (n=274)
according to age, sex, level of education and smoking status.
However, there were statistically signiﬁcant differences accord-
ing to age, level of education and smoking status between the
follow-up sample (n=736) and the participants lost in both
stages of the follow-up (n=509; table 1). For this reason, the
ﬁnal sample was skewed as older in comparison with the popu-
lation of Barcelona. Therefore, we use inverse probability
weights to weigh our data according to age distribution of the
city of Barcelona to maintain the representativeness of the
sample.
Both questionnaires (before and after the two laws) included
the following question about the smoking rules at home:
‘Which of the following situations best describe the smoking
rules inside your house?’ with three possible answers: ‘Nobody
can smoke’, ‘You can only smoke in some places’ and ‘You can
smoke everywhere’. According to this question we deﬁned
smoking rules inside the household as complete (when smoking
was not allowed inside the house), partial (when smoking was
allowed in some places inside the house) or absent (when
smoking was allowed everywhere inside the house). Finally, we
dichotomised the variables as ‘Rules’ indicating whether there
were any kind of smoking rules (complete or partial) and ‘No
rules’ indicating there were no smoking rules in the house.
We calculated the prevalence and the prevalence ratio (PR)
with their 95% CIs of the voluntary adoption level of smoke-
free rules in homes before and after the implementation of the
two national tobacco control policies. We also used Generalized
Estimating Equation (GEE) models with individuals as random
effects and using Poisson family with log link, to calculate the
PR adjusted for sex, age and month when the survey was con-
ducted. Moreover, the results were stratiﬁed by sex, age, educa-
tional level (categorised as low: unschooled, elementary school
completed or uncompleted and special education; intermediate:
high school and training cycles and high: university education),
married, minimum age in house (categorised as <5, 5–14 and
≥15 years), smoking status (current, former and never smoker)
at baseline, intention to quit (indicating whether the person is
trying to quit smoking at that time or not) and the Fagerström
Test for Cigarette Dependence (FTCD) score. We also included
information about the places where smoking is allowed in
houses with partial SFH through the following open question:
‘in what places of your home can you smoke?’. The statistical
programs used were STATAV.14 and R V.3.0.2.
RESULTS
A 55.6% of households declared having some type of voluntary
SFH (complete or partial) at baseline in 2004–2005 (before the
Spanish smoking bans came into force). This percentage signiﬁ-
cantly rose to 72.6% after the implementation of the two
Spanish smoke-free bans (table 2). In particular, we observed a
statistically signiﬁcant relative increase of 57% in the prevalence
of complete SFH (from 23.9% to 37.6%, PR=1.57) while the
Table 1 Differences (prevalence for qualitative variables and
mean (SD) for quantitative variable) between follow-up sample and
lost in both stages of the follow-up
Lost (both stages)
n=509
Follow-up
n=736 p Value
Sex
Men 42.2% 45.7% 0.257*
Women 57.8% 54.3%
Age (years) mean (SD) 58 (39.00) 49 (26.25) <0.001†
Age
<45 35.2% 43.9% <0.001*
45–64 22.0% 37.5%
≥65 42.8% 18.65
Educational level
Primary 53.0% 38.9% <0.001*
Secondary 20.5% 24.2%
Superior 26.5% 36.9%
Smoking status (follow-up)
Smoker 24.1% 31.1% 0.009*
No smoker 75.9% 68.9%
*χ2 test.
†Mann-Whitney test.
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Table 2 Prevalence, prevalence ratio (PR), adjusted prevalence ratio (PRa) and their 95% CIs of the voluntary adoption of smoke-free homes (SFHs) rules (complete and partial) before (2004–2005)
and after (2013–2014) the implementation of both Spanish smoking bans
Any type of rules (complete and partial) Complete rules Partial rules
na Pre % Post % PR (95% CI) PRa (95% CI) Pre % Post % PR (95%CI) PRa (95%CI) Pre % Post % PR (95% CI) PRa (95% CI)
Overall 731 55.6 72.6 1.31 (1.22 to 1.40)*** 1.30 (1.20 to 1.41)*** 23.9 37.6 1.57 (1.36 to 1.83)*** 1.61 (1.35 to 1.93)*** 31.7 35.0 1.11 (0.96 to 1.27) 1.07 (0.91 to 1.26)
Sex
Men 336 51.8 68.8 1.33 (1.18 to 1.50)*** 1.31 (1.14 to 1.49)*** 21.5 35.7 1.66 (1.29 to 2.12)*** 1.64 (1.24 to 2.16)** 30.3 33.1 1.10 (0.88 to 1.36) 1.07 (0.84 to 1.37)
Women 395 58.8 75.9 1.29 (1.18 to 1.41)*** 1.28 (1.16 to 1.42)*** 25.9 39.3 1.51 (1.26 to 1.82)*** 1.60 (1.28 to 2.01)*** 32.9 36.6 1.11 (0.93 to 1.33) 1.04 (0.84 to 1.29)
Age
26–44 418 57.5 76.6 1.33 (1.21 to 1.47)*** 1.29 (1.15 to 1.43)*** 22.5 37.2 1.65 (1.32 to 2.07)*** 1.63 (1.24 to 2.14)*** 35.1 39.6 1.13 (0.94 to 1.36) 1.08 (0.88 to 1.33)
45–64 201 52.3 67.0 1.28 (1.14 to 1.44)*** 1.34 (1.17 to 1.53)*** 21.5 33.1 1.53 (1.19 to 1.98)** 1.73 (1.29 to 2.31)*** 30.7 33.9 1.10 (0.89 to 1.38) 1.08 (0.84 to 1.39)
65–98 112 54.3 67.6 1.24 (1.04 to 1.49)* 1.29 (1.05 to 1.59)* 33.5 47.6 1.42 (1.09 to 1.85)* 1.48 (1.09 to 2.00)* 20.8 20.0 0.96 (0.62 to 1.51) 0.96 (0.53 to 1.73)
Educational level
Low 239 56.4 68.5 1.21 (1.08 to 1.36)** 1.25 (1.10 to 1.43)** 25.1 35.5 1.41 (1.13 to 1.77)** 1.48 (1.10 to 1.99)** 31.2 33.0 1.05 (0.86 to 1.31) 1.07 (0.83 to 1.37)
Intermediate 206 56.9 67.9 1.19 (1.04 to 1.36)** 1.21 (1.05 to 1.40)** 23.2 35.6 1.55 (1.14 to 2.09)** 1.59 (1.13 to 2.25)** 33.8 32.1 0.95 (0.72 to 1.25) 0.96 (0.70 to 1.32)
High 286 53.9 79.6 1.47 (1.30 to 1.67)*** 1.41 (1.23 to 1.60)*** 23.4 40.7 1.74 (1.35 to 2.23)*** 1.76 (1.31 to 2.37)*** 30.5 38.9 1.27 (1.01 to 1.61)* 1.14 (0.87 to 1.50)
Married
Yes 491 58.2 71.8 1.23 (1.13 to 1.34)*** 1.26 (1.15 to 1.38)*** 24.2 37.7 1.55 (1.30 to 1.86)*** 1.61 (1.31 to 1.97)*** 33.9 34.1 1.00 (0.85 to 1.19) 1.01 (0.83 to 1.22)
No 240 52.5 73.8 1.40 (1.24 to 1.59)*** 1.34 (1.17 to 1.54)*** 23.5 37.5 1.60 (1.25 to 2.04)*** 1.61 (1.18 to 2.20)** 29 36.2 1.25 (0.99 to 1.58) 1.14 (0.87 to 1.50)
Minimum age in house
0–4 62 78.6 87.6 1.12 (0.98 to 1.27) 1.06 (0.95 to 1.18) 27.3 40.5 1.48 (0.95 to 2.30) NC 51.3 47.1 0.92 (1.67 to 1.27) NC
5–14 112 67.4 75.9 1.13 (0.95 to 1.34) 1.13 (0.94 to 1.35) 27.8 36.9 1.32 (0.89 to 1.98) NC 39.6 39.0 0.99 (0.71 to 1.36) 1.00 (0.72 to 1.40)
≥15 491 49.6 69.6 1.40 (1.27 to 1.54)*** 1.41 (1.26 to 1.57)*** 22.6 36.2 1.60 (1.33 to 1.93)*** 1.62 (1.27 to 2.05)*** 27 33.4 1.23 (1.02 to 1.49)* 1.23 (0.98 to 1.55)**
Smoking status (baseline)
Current 252 55.9 62.7 1.12 (0.98 to 1.28) 1.11 (0.95 to 1.30) 14 17.8 1.27 (0.83 to 1.93) 1.33 (0.78 to 2.28) 24.8 28.1 1.07 (0.89 to 1.30) 1.07 (0.86 to 1.33)
Former 188 56.8 75.6 1.33 (1.18 to 1.50)*** 1.27 (1.11 to 1.46)** 28.2 42.9 1.52 (1.18 to 1.96)** 1.36 (1.03 to 1.80)* 41.8 44.9 1.14 (0.86 to 1.50) 1.20 (0.88 to 1.63)
Never 291 54.5 79.4 1.46 (1.30 to 1.64)*** 1.45 (1.29 to 1.64)*** 29.7 51.4 1.73 (1.42 to 2.10)*** 1.95 (1.54 to 2.46)*** 28.6 32.6 1.13 (0.85 to 1.50) 0.94 (0.67 to 1.31)
Intention to quit
Yes 23 56.2 62.3 1.11 (0.67 to 1.82) 1.09 (0.46 to 2.59) 22.1 20.3 0.92 (0.25 to 3.35) NC 34 41.9 1.23 (0.54 to 2.80) NC
No 174 58.3 58.9 1.01 (0.88 to 1.16) 1.04 (0.89 to 1.21) 9.4 11.5 1.23 (0.70 to 2.15) NC 48.9 47.5 0.97 (0.81 to 1.16) 1.00 (0.80 to 1.26)
FTCD
≥4 121 65.7 65.1 0.99 (0.85 to 1.15) 1.00 (0.82 to 1.21) 16.1 13.8 0.85 (0.49 to 1.48) NC 49.6 51.3 1.03 (0.83 to 1.29) 1.04 (0.77 to 1.40)
5 23 51.8 43.3 0.84 (0.45 to 1.56) NC 0 11.7 – – 51.8 31.5 0.61 (0.32 to 1.15) NC
>5 27 38.5 54.2 1.41 (0.85 to 2.34) NC 0 9.3 – – 38.5 44.9 1.17 (0.72 to 1.89) NC
*p<0.05, **p<0.01, ***p<0.001.
na: the sum does not up the total for some variables because of some missing values.
PRa: prevalence ratio adjusted for sex, age and month when the survey was conducted.
Pre: before Spanish smoke-free bans (2004–2005).
Post: after Spanish smoke-free bans (2013–2014).
NC, non-converging GEE model with random effects.
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increase in the prevalence of houses with partial SFH was not
statistically signiﬁcant (from 31.7% to 35.0%, PR=1.11). We
also observed a statistically signiﬁcant decrease in the prevalence
of houses without smoking rules (from 44.4% to 27.4%,
PR=0.62). We obtained similar PR adjusting by sex, age, and
month when the survey was conducted (table 2).
The increase of any type of rules (complete and partial) was
statistically signiﬁcantly independent of sex (PR man=1.33 vs
PR women=1.29), age (PR 65–98 years=1.24 and PR in 26–
44 years 1.33), educational level (PR intermediate level=1.19
and PR high level=1.47) and minimum age in house (PR 0–4
years=1.12 and PR ≥15 years=1.40). However, the increase
was statistically and signiﬁcantly higher only among never
smokers (PR=1.46) at baseline (table 2). We obtained similar
PR after adjusting for sex, age and month where the survey was
conducted (table 2). The prevalence of any type of SFH rules
before and after the implementation of the two national smoke-
free legislations were the highest in house where minors lived
(<15 years); however, the increase was not statistically signiﬁ-
cant (table 2). Among smokers, the highest increase of SFH was
observed among those who had intention to quit and higher
FTCD (>5 points) although the increase was not statistically sig-
niﬁcant (table 2).
Regarding complete SFH, we observed a higher increase
among men than women (PR in men=1.66 vs PR in
women=1.51), young people26–44 (PR=1.65), with higher edu-
cation (PR=1.74), with a minor member at home (<15 years)
(PR=1.60) and never smokers at baseline (PR=1.73). A similar
pattern was observed in the PR of partial SFH (table 2).
We observed that, in houses with partial SFH rules, outside
areas of the houses (balconies, courtyard, terraces and gardens)
were the places where there was increase in smoking after the
Spanish smoking bans (from 32.6% to 70.0%; PR=2.15, 95%
CI 1.66 to 2.86) while inside it decreased, such as common
areas (from 9.9% to 2.3%, PR=0.23, 95% CI 0.05 to 0.49)
and the dining room (20.7% to 2.5%; PR=0.12, 95% CI 0.03
to 0.23). Similar results were observed in the PR of the places
where smoking is allowed in houses adjusting by sex, age and
the month where the survey was conducted.
DISCUSSION
Our results show that there is an increase in the prevalence of
SFH, particularly in the case of a complete SFH, after the
implementation of the two Spanish smoke-free bans in 2006
and 2011. This result is in agreement with previous ecological
studies conducted in Europe29 30 which found a positive correl-
ation between the level of implementation of the smoke-free
legislation and the prevalence of SFH rules adoption. At indi-
vidual level, data from Scotland,11 Ireland, France, Germany
and the Netherlands31 show a signiﬁcant increase in SFH preva-
lence after the implementation of tobacco control laws. Similar
results were found in the USA,32 Canada, the UK and
Australia.33 Conﬁrming the positive impact of smoke-free bans
in adopting SFH rules in a Southern Mediterranean population
with still a relatively high prevalence of smoking is of import-
ance to reassure the power of smoke-free bans for tobacco
control.
Our results show a greater impact of complete SFH than
partial SFH. In this line, the study conducted in ﬁve European
countries among adult smokers,31 showed a greater impact of
complete SFH while the PR of houses with partial rules
remained more stable. The Scottish study conducted among
children showed that children surveyed after the implementation
of the smoke-free legislation were 25% less likely to have partial
home rules than those surveyed before its introduction.11
Moreover, a US study found a dose–response relationship
between the implementation of tobacco control laws and the
voluntary adoption of SFH, being full coverage laws associated
with higher odds of adopting a complete SFH than partial
coverage laws.34
Furthermore, previous studies showed that the SFH rules are
more common in households inhabited with married people,31
non-smoking adults33 35–37 and with children.31 33 35–37 Some
studies also showed the SFH can result in a reduced exposure to
SHS in children37 38 and in a reduction in consumption over
time, and increased quitting among smokers helping them to
remain abstinent.39 We found a higher increase of SFH after the
implementation of Spanish smoking bans among men, young
people, persons with high educational level, singles and never
smokers. However, we found the lowest increase of SFH rules
in houses where a minor lives and an indirect relation between
the minimum age at home and the prevalence of SFH (data not
shown). This result could be due to a ‘ceiling effect’, since the
prevalence of SFH in these households was the highest before
the bans.
Our results also show an increased prevalence of allowing
smoking in most ventilated places or outside areas, in houses
with partial SFH after the implementation of the Spanish
smoke-free legislations. This could be due to an increasing risk
perception of SHS exposure in the population. However,
although this could lead to a decrease in the SHS exposure at
homes, it could also result in an increase in the SHS exposure
between neighbours. In a study carried out in 2010 in
Denmark, 22% of those living in multiunit dwellings reported
exposure to neighbour smoke and 58% of the exposed people
preferred to live in smoke-free buildings.40 In any case, cur-
rently smoke-free multiunit housing are still uncommon in
Europe although are gaining popularity in the USA where multi-
unit housing operators reported having complete or partial
smoke-free building policies for at least some of their
properties.41
The tobacco industry and the hospitality sector, during the
debate on implementation of smoke-free policies in different
countries, argued that the restriction of smoking in public places
will displace tobacco consumption to private venues, particularly
in homes.42 Hence, it was expected that the exposure to SHS
among children in households would have increased after the
implementation of the two national smoking bans. In this sense,
there are only two studies,14 43 to the best of our knowledge,
conducted in the USA and Hong Kong supporting that hypoth-
esis. Our results, and the results from other studies,11 29–34 coun-
teract the displacement hypothesis. Moreover, we observed a
higher increase in complete SFH and in the outdoor places as
the venues designed to smoking in partial SFH. In addition,
some other studies44 45 have shown a widespread support to
smoking restrictions in all public places in those countries where
tobacco control policies are more advanced. In particular, an
ecological study, found a positive strong correlation between the
level of smoke-free legislation across European countries and
the support to smoking bans in restaurants, bars, pubs and
clubs.44 Similar results were observed in the USA, where increas-
ing antismoking climate correlates with the decline in smoking
prevalence, the increase in antismoking policies and public
health awareness reports.45
Although the prevalence of SFH has increased, our data
showed that currently around 30% of households did not have
any voluntary smoke-free rules after the implementation of the
Spanish smoking legislation in 2010. Moreover, around half of
4 Lidón-Moyano C, et al. Tob Control 2016;0:1–6. doi:10.1136/tobaccocontrol-2016-053114
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the houses with SFH rules have a partial rule. In this sense, a
previous study46 using cotinine as a biomarker of SHS exposure
concluded that the home continues to be the main source of
SHS exposure for non-smokers who live in non-SFHs.
Therefore, there is a need to implement some public health
interventions to continuing reducing SHS exposure in homes.
The interventions may focus in convincing or helping smokers
to quit or in getting smokers moving their smoking away from
their home, that is to say, trying to promote SFHs and smoke-
free multiunit housing.47 48
The main limitation of our study is the potential of participa-
tion bias due to the attrition of the cohort of participants. In this
sense, there were statistically signiﬁcant differences according to
age, level of education and smoking status between the follow-up
sample and the participants lost in both stages of the follow-up.
Follow-up participants overestimated the young people and
smokers in comparison with lost participants (table 1), for this
reason the increase of SFH could be higher among lost partici-
pants. On the other hand, our ﬁnal sample overestimated the
older people compared with the distribution of population in
Barcelona. However, we weighted the sample to minimise these
limitations and to generate estimations representative of the
general population. Moreover, the baseline sample size was
representative of the city of Barcelona27 28 and the longitu-
dinal design of our work maximises the internal validity of the
study. Other potential limitations are those related to survey-
based studies, as the use of a questionnaire to collect self-
reported information, the potential for over-reporting of SFH
due to social desirability (unlikely, since it has received few or
null attention by the media) and bias due to non-response.
However, by using a face-to-face questionnaire with trained
interviewers we potentially increased the internal validity of
our results as compared with internet and self-administered
surveys in order to avoid misinterpretation of the questions.49
Finally, we have not gathered information about the prevalence
of SFH between both surveys to assess the impact of both
Spanish legislations (independently or combined)
In conclusion, the implementation of the two smoke-free leg-
islations in Spain is related to an increasing of voluntary adop-
tion of SFH rules, in particular with an increase in complete
SFH rules. According to our data, the Spanish smoke-free bans
did not shift the tobacco consumption from public and work
places to private places (homes). Unfortunately, one of three
households in Spain still do not have any type of smoke-free
rule. For this reason, in Spain, a public health priority should be
promoting the adoption of SFH rules.
What this paper adds
▸ The implementation of the smoke-free regulations in public
and workplaces in Spain (law 28/2005 and law 42/2010)
was associated with an increase in voluntary adoption of
smoke-free rules in homes, particularly complete smoke-free
homes.
▸ In houses with partial smoke-free rules, outside areas of the
houses (balconies, courtyard, terraces, and gardens) were
the places that showed increase in smoking after Spanish
smoking bans.
▸ According to our data, the Spanish smoke-free bans did not
shift the tobacco consumption from public and work places
to private places (homes).
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ABSTRACT
Objective: To describe the voluntary adoption of
smoke-free homes in Spain among general population
and to identify variables associated with its voluntary
adoption.
Methods: Cross-sectional study of a representative
sample (n=731) of the adult population (>26 years) of
Barcelona, Spain, in 2013–2014. We defined smoking
rules inside the households as complete indoor rules
(when smoking was not allowed inside the house), and
partial or absent indoor rules (when smoking was
allowed in some designated places inside the house or
when smoking was allowed everywhere) and described
them according to the perceived risk of the
secondhand smoke (SHS) exposure. We calculated the
prevalence and prevalence ratios (PR) according to
sociodemographic variables.
Results: 57.4% of households had complete indoor
smoke-free rules. The prevalence of households with
complete indoor rules was higher among women (PRa:
1.15; 95% CI 1.00 to 1.33), married (PRa: 1.18; 95%
CI 1.01 to 1.38), never-smokers (PRa: 2.68; 95% CI
2.06 to 3.50) and in households where a minor lived
(PRa: 1.40; 95% CI: 1.20–1.65). Believe that breathing
tobacco smoke from smokers is dangerous for non-
smokers (PRa: 1.77; 95% CI: 1.06–2.97) is associated
with the voluntary adoption of complete indoor smoke-
free home.
Conclusions: Risk perceptions of SHS exposure were
associated with the voluntary adoption of indoor
smoke-free homes.
INTRODUCTION
The health consequences of secondhand
smoke (SHS) exposure on non-smoker’s are
well known.1 Moreover, passive exposure
could be due to different settings such as
workplaces, public places (bars, restaurants,
etc), public transport or private places. For
this reason, since the introduction of the
WHO Framework Convention on Tobacco
Control (WHO FCTC), many countries have
implemented smoke-free policies in public
and workplaces to reduce the impact of SHS
exposure in non-smoker’s health; conse-
quently, there has been a reduction in SHS
exposure after their implementation in work-
places and public places.2 However, private
settings (mainly cars and homes) are never
or rarely included in tobacco control pol-
icies. Nevertheless, the household is usually
the main source of exposure to SHS in chil-
dren.3 4 In addition, children are especially
vulnerable to SHS exposure because they
breathe more rapidly and inhale more pollu-
tants per pound of body weight than adults.5
In addition, SHS exposure is a risk for infant
death syndrome, acute respiratory infections,
ear problems and mental disorders in
Strengths and limitations of this study
▪ There is scarce evidence about the relationship
between voluntary adoption of smoke-free
homes and the risk perception of secondhand
smoke exposure.
▪ One strength of our study is the use of a
face-to-face questionnaire with trained inter-
viewers, we potentially increase the internal val-
idity of our results when compared with internet
and self-administered surveys because avoid
misinterpretation of the questions.
▪ The main limitation of this study is the potential
bias of participation due to the attrition of the
cohort of participants. However, all analyses
used weighted data to generate representative
estimates of the city of Barcelona.
▪ The study was conducted only in the city of
Barcelona, and generalisation of the results to
the rest of Spain should be cautious.
▪ Another potential limitation is the cross-sectional
nature of the data, which allows one to establish
associations but not to infer causality.
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children.6 7 Accordingly, the harmful effects of passive
exposure in private venues have received scant attention
in public health policies, including the promotion of vol-
untary smoke-free homes.
In Europe, according to the Eurobarometer 332,8
61% of households had some kind of smoke-free home
rules in 2009. The highest prevalence of smoke-free
homes was observed in Finland (95%) and the lowest in
Macedonia (30%), whereas 44% of the Spanish house-
holds had smoke-free home rules. However, these results
are previous to the last smoke-free legislation in Spain
(Law 42/2010),9 that bans smoking in public places and
extends the ban to all hospitality venues without excep-
tion and to some outdoor public areas, including health-
care premises, children educational campuses and
playgrounds. This new regulation makes Spain one of
the countries with the most stringent national smoke-
free laws in Europe.
Currently, to the best of our knowledge, there are no
national descriptive studies about the adoption of
smoke-free homes in Spain after the Spanish tobacco
control legislations. Moreover, there is scarce evidence
about the relationship between voluntary adoption of
smoke-free homes and the risk perception of SHS expos-
ure. Therefore, the objective of this study is to describe
the voluntary adoption of smoke-free homes in Spain
and to identify variables associated with its voluntary
adoption, including risk perception towards SHS
exposure.
METHODS
We used the follow-up data of a cohort study from a rep-
resentative sample of the adult population (≥16 years)
of the city of Barcelona (Catalonia, Spain). The object-
ive of the cohort study was to assess the impact of the
Spanish smoking bans on tobacco consumption and
SHS exposure. The baseline study was carried out
during the years 2004–2005 through a representative
random sample of the adult (≥16 years old) non-
institutionalised population of Barcelona (Spain)10 11
(n=1245). We obtained the personal data and addresses
from the updated ofﬁcial Census, as provided by the
Institute of Statistics of Barcelona. We sent a personal
letter to introduce the study; afterwards trained inter-
viewers administered a face-to-face questionnaire (in
Spanish or Catalan) at the participant’s home to gather
information on sociodemographic data and active and
passive smoking. The follow-up took place in 2013–2014.
For this study, we exclusively used the follow-up data.
From the baseline sample, we excluded 235 participants;
150 after checking their data in the Insured Central
Registry of Catalonia (101 had died and 49 had migrated
out of the province of Barcelona) and another 85 did
not give consent to be followed up or were <18 years old
in 2004–2005, because they were not legally adults at
that time and we did not ask to their parents any
consent to be recontacted. Follow-up was conducted
between May 2013 and February 2014. In total, 72.9% of
the eligible sample agreed to participate and answered
the questionnaire, 18.5% (187) refused to participate,
7.2% (73) had moved elsewhere and 1.3%14 had died.
The ﬁnal sample included 736 individuals. There were
statistically signiﬁcant differences between the follow-up
sample and the participant lost in the follow-up accord-
ing to age, level of education and smoking status.
Followed-up participants overestimate the young people
and smokers in comparison with lost participants, for
this reason, the increase in smoke-free homes could be
higher among lost participants. On the other hand, the
ﬁnal sample overestimated the older people compared
with the distribution observed in the population of
Barcelona. Therefore, we used inverse probability
weights to balance our data according to age distribution
of the city of Barcelona to maintain its representative-
ness of the sample.
For this analysis, we have available data from 731 out
of the 736 individuals, due to missing data in the vari-
able of interest. The primary outcome was the voluntary
adoption of smoking rules at home, which was obtained
from the question: ‘Which of the following situations
best describe the smoking rules in your house?’ with
three possible answers: ‘Nobody can smoke’, ‘Smoking is
allowed in some places’ and ‘Smoking is allowed every-
where’. According to this question, we deﬁned smoking
rules inside the households as ‘complete indoor rule’
(when smoking was not allowed inside the house), and
‘partial or absent indoor rule’ (when smoking was
allowed in some designated areas inside the house or
when smoking was allowed everywhere).
We also obtained information about the risk percep-
tion of SHS exposure through the degree of agreement
with a set of statements: (1) SHS bothers you; (2)
breathing tobacco smoke from others is harmful; (3)
SHS is dangerous for adults; (4) SHS is dangerous for
children; and (5) tobacco smoke is dangerous for non-
smokers. The answers were collected in a ﬁve-point
Likert scale (‘Totally agree’, ‘Agree’, ‘Neither agree nor
disagree’, ‘Disagree’ and ‘Totally disagree’). Finally, we
dichotomised each statement as ‘Agree’, indicating the
participant answered either ‘Totally agree’ or ‘Agree’,
and ‘Disagree’ otherwise. We also included information
about nicotine dependence of smokers using the
Fagerström test for cigarette dependence (FTCD).12
We calculated the prevalence of smoke-free rules at
home, prevalence ratios (PR) and their 95% CIs, strati-
ﬁed by sociodemographic variables and selected
smoking characteristics. We also ﬁtted log-binomial
regression models to calculate the PR, adjusted for sex
and age (PRa). The statistical programs used were
R-3.0.2 and STATAV.14.
RESULTS
About 57.4% of participants lived in households with
complete indoor rules, while 42.6% lived in households
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Table 1 Level of voluntary adoption of smoke-free rules at home in Barcelona (Spain) in 2013–2014 according to sociodemographics and selected smoking
characteristics
Complete indoor ban Partial or absent indoor ban
n Per cent PR (95% CI) PRa (95% CI) Per cent PR (95% CI) PRa (95% CI)
Overall 731 57.4 – – 42.6 – –
Sociodemographic variables
Sex
Men 336 53.4 1 1 46.6 1 1
Women 395 60.8 1.14 (0.99 to 1.30) 1.15 (1.00 to 1.33)* 39.2 0.84 (0.70 to 1.01) 0.84 (0.71 to 1.01)
Age (years)
26–44 299 60.4 1.09 (0.93 to 1.28) 1.11 (0.95 to 1.30) 39.6 0.88 (0.71 to 1.10) 0.89 (0.71 to 1.11)
45–64 237 55.4 1.00 (0.86 to 1.17) 1.00 (0.86 to 1.17) 44.6 1.00 (0.82 to 1.20) 1.00 (0.83 to 1.21)
65–98 195 55.2 1 1 44.8 1 1
Educational level
Low 129 54.8 1 1 45.23 1 1
Intermediate 275 50.4 0.92 (0.76 to 1.11) 0.93 (0.76 to 1.13) 49.6 1.10 (0.82 to 1.36) 1.06 (0.83 to 1.35)
High 327 64.4 1.17 (0.99 to 1.39) 1.17 (0.97 to 1.40) 35.6 0.79 (0.62 to 1.00) 0.77 (0.58 to 1.03)
Employment
Yes 458 61.1 1.20 (1.04 to 1.37)* 1.15 (1.00 to 1.31) 38.9 0.80 (0.67 to 0.95)* 0.69 (0.54 to 0.87)***
No 273 51.1 1 1 48.9 1 1
Married
Yes 491 60.1 1.16 (1.00 to 1.35) 1.18 (1.01 to 1.38)* 39.9 0.83 (0.69 to 0.99)* 0.80 (0.67 to 0.97)*
No 240 51.8 1 1 48.2 1 1
Minor at home
Yes 193 72.0 1.41 (1.23 to 1.62)*** 1.40 (1.20 to 1.65)*** 28.0 0.57 (0.44 to 0.75)*** 0.56 (0.42 to 0.75)***
No 435 50.9 1 1 49.1 1 1
Smoking-related variables
Smoking status
Current 191 28.4 1 1 71.6 1 1
Former 250 62.7 2.21 (1.69 to 2.89)*** 2.36 (1.79 to 3.10)*** 37.3 0.52 (0.43 to 0.63)*** 0.39 (0.34 to 0.46)***
Never 290 72.0 2.53 (1.95 to 3.29)*** 2.68 (2.06 to 3.50)*** 28.0 0.39 (0.32 to 0.48)*** 0.31 (0.26 to 0.37)***
FTCD (among smokers)
≤4 89 29.7 1.60 (0.65 to 3.95) 1.69 (0.68 to 4.18) 70.3 0.70 (0.60 to 0.81)*** 0.78 (0.65 to 0.92)**
5 15 0.0 – – 100.0 – –
>5 34 18.6 1 1 81.4 1 1
Intention to quit (among smokers)
Yes 13 40.4 1.85 (0.85 to 3.99) 1.95 (0.89 to 4.28) 59.6 0.76 (0.47 to 1.23) 0.81 (0.50 to 1.31)
No 146 21.9 1 1 78.1 1 1
n not always sum up due to missing data.
*p<0.05, ** p<0.01, ***p<0.001.
PR, prevalence ratio; PRa, prevalence ratio adjusted for sex and age.
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with partial or absent indoor rules. Voluntary adoption
of complete indoor rules at home was statistically signiﬁ-
cantly more frequent among women (PRa: 1.15; 95% CI
1.00 to 1.33), married (PRa: 1.18; 95% CI 1.01 to 1.38),
never-smokers (PRa: 2.68; 95% CI 2.06 to 3.50) and in
households where a minor lived (PRa: 1.40; 95% CI 1.20
to 1.65) (table 1). Similarly, voluntary adoption of
partial or absent indoor rules was statistically signiﬁcantly
less frequent among working individuals (PRa: 0.69;
95% CI 0.54 to 0.87), married (PRa: 0.80; 95% CI 0.67
to 0.97), never-smokers (PRa: 0.31; 95% CI 0.26 to 0.37),
smokers with lower FTCD score (PRa: 0.78; 95% CI 0.65
to 0.92) and participants living with a minor (PRa: 0.56;
95% CI 0.42 to 0.75) (table 1).
Smokers were those with the lowest prevalence of
adoption of complete indoor smoke-free home rules.
Among them, those with a medium and high depend-
ence (FTCD), and those who did not attempt to stop
smoking (table 1).
Table 2 shows the association between voluntary adop-
tion of smoke-free homes rules and the risk perception
of SHS exposure. The prevalence of complete indoor
smoke-free home rules was higher among participants
who perceived SHS exposure as a risk for health.
Particularly, voluntary adoption of complete indoor
smoke-free rules at home was statistically signiﬁcantly
more frequent among those who agree with the state-
ment ‘breathing tobacco smoke from smokers is danger-
ous for non-smokers’ (PRa: 1.77; 95% CI 1.06 to 2.97)
(table 2). Moreover, voluntary adoption of partial or
absent indoor smoke-free rules at home was statistically
signiﬁcantly less frequent among those who agree with
the statements ‘SHS bothers you’ (PRa: 0.70; 95% CI
0.50 to 0.98), ‘breathing tobacco smoke from smokers is
harmful’ (PRa: 0.67; 95% CI 0.51 to 0.87), ‘SHS is dan-
gerous for adults’ (PRa: 0.72; 95% CI 0.54 to 0.96) and
‘SHS is dangerous for non-smokers’ (PRa: 0.63; 95% CI
0.49 to 0.81) (table 2).
DISCUSSION
More than half (57.4%) of the population of Barcelona
(Spain) had complete indoor smoke-free rules at home
in 2013–2014. This prevalence is higher than that
obtained in the Eurobarometer8 (44%), maybe because
the Eurobarometer considers as complete smoke-free
homes those households where smoking is not allowed,
without distinction between indoor and outdoor areas.
On the other hand, there are some studies showing that
this EU survey generates estimates that are in some cases
widely discrepant from more substantive national
sources and does not provide age or gender-speciﬁc
data by country.13 Similarly, our result is also higher
than what was observed in other countries like Scotland
(51.8%)3 and the USA, where this percentage was 53%
in states with lax tobacco control legislations and higher
in states with comprehensive policies.14 Moreover, as
observed in previous studies,15–19 the adoption of
smoke-free homes in our study was higher among never-
smokers and among those who lived with a minor. The
prevalence of adoption of smoke-free homes among
households with non-smokers was 23.5% in the UK,
39.2% in the USA, 39.1% in Canada and 44.3% in
Australia.15 The prevalence of adoption of smoke-free
home among households with infants and preprimary
children was 29% and 26% in the UK, 38.9% and 51.5%
in the USA, 41% and 48.8% in Canada and 60.3% and
52.7% in Australia, respectively.15 Our study showed that
28.4% of smokers had complete indoor smoke-free
home rules. In this line, the prevalence of complete
smoke-free home rules observed among smokers in
other European countries is 16% in Ireland, 25% in
France, 38% in Germany, 17% in the Netherlands and
25% in the UK;19 thus, there is room for improvement
in this regard.
During the debate about the implementation of
smoke-free policies in different countries, the tobacco
industry and the hospitality sector argued that the
restriction of smoking in public places would displace
tobacco consumption to private settings, particularly to
home. We have previously found a decrease in SHS
exposure at home in non-smoker adults after the
national comprehensive legislation.20 In this line, this
analysis show high prevalence of complete indoor
smoke-free rules (57.4%). This could be due to an
increasing perception of the harmful effects of SHS
exposure among the general population. In fact, we
observed the highest prevalence (72%) of complete
indoor smoke-free home rules in households with
minors.
Our data show that the voluntary adoption of com-
plete indoor smoke-free home rules is higher among
never-smokers and among people who lived with
minors. Never smokers present statistically signiﬁcant
higher risk perception of SHS exposure than smokers
and former smokers (data not shown). This could be
one reason why complete indoor smoke-free home rules
are higher among never smokers. However, we found
similar prevalence of SHS risk perception among people
who lived with and without minors (data not shown).
On the other hand, people who had some kind of risk
perception of SHS exposure showed higher adoption of
complete smoke-free homes rules. Similar results were
obtained in a study in Italy about the support for
tobacco regulation and consumption in private vehicles
in the presence of minors.21
Our results highlight the need to increase awareness
of the health risks of SHS in private settings, especially
among smokers. In this regard, the awareness campaigns
should inform about the health risks of SHS exposure,
especially in private settings. Besides, smoking preven-
tion among adolescents at schools should also consider
including the prevention of exposure to SHS.22
Furthermore, it should also be reported the health ben-
eﬁts of having a smoke-free home by health system and
social media.
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Table 2 Level of voluntary adoption of smoke-free rules at home in Barcelona (Spain) in 2013–2014, according to the perceived risk of the exposure to secondhand
smoke
Complete indoor ban Partial or absent indoor ban
n Per cent PR (95% CI) PRa (95% CI) Per cent PR (95% CI) PRa (95% CI)
SHS bothers you
Disagree 31 40.8 1 1 59.2 1 1
Agree 700 58.2 1.42 (0.88 to 2.30) 1.44 (0.89 to 2.33) 41.8 0.71 (0.50 to 0.99)* 0.70 (0.50 to 0.98)*
Breathing tobacco smoke from smokers is harmful
Disagree 36 37.7 1 1 62.3 1 1
Agree 690 58.7 1.56 (1.01 to 2.40)* 1.51 (0.97 to 2.34) 41.3 0.66 (0.50 to 0.87)** 0.67 (0.51 to 0.87)**
SHS is dangerous for adults
Disagree 35 40.7 1 1 59.3 1 1
Agree 692 58.4 1.43 (0.95 to 2.16) 1.38 (0.91 to 2.10) 41.6 0.70 (0.52 to 0.94)* 0.72 (0.54 to 0.96)*
SHS is dangerous for children
Disagree 25 52.0 1 1 48.0 1 1
Agree 705 57.8 1.11 (0.74 to 1.67) 1.09 (0.72 to 1.66) 42.2 0.88 (0.57 to 1.37) 0.89 (0.58 to 1.38)
Secondhand smoke is dangerous for non-smokers
Disagree 35 32.5 1 1 67.5 1 1
Agree 692 59.0 1.81 (1.09 to 3.02)* 1.77 (1.06 to 2.97)* 41.0 0.61 (0.47 to 0.79)*** 0.63 (0.49 to 0.81)***
n not always sum up due to missing data.
*p<0.05, **p<0.01, ***p<0.001.
PR, prevalence ratio; PRa, prevalence ratio adjusted for sex and age.
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The main limitation of this study is the potential of
participation bias due to the attrition of the cohort of
participants; our data are, particularly, older than the
population of the city of Barcelona. For this reason, all
analyses used weighted data to generate representative
estimates of the city of Barcelona. Moreover, the study
was conducted only in the city of Barcelona and general-
isation of the results to the rest of Spain should be cau-
tious. Another potential limitation is the cross-sectional
nature of the data, which allow to establish associations
but not to infer causality.
In conclusion, 6 out of 10 households in Barcelona
(Spain) have complete indoor smoke-free rules after
comprehensive tobacco control legislation in Spain. In
addition, we observed an association between complete
indoor smoke-free homes adoption and the perceived
risk of SHS exposure. Improving the proportion of
homes with smoke-free rules through different social
interventions should be considered in the strategy
towards the endgame.23 In addition, warning campaigns
about the harmful effects of SHS exposure at home,
especially in the presence of children, should be pro-
moted in Spain.
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ABSTRACT
Objective To analyse the correlation between the
implementation of tobacco control policies and tobacco
consumption, particularly rolling tobacco, electronic
cigarettes (e-cigarettes) users and the intent to quit
smoking in 27 countries of the European Union.
Design Ecological study with the country as the unit of
analysis.
Data sources We used the data from tobacco control
activities, measured by the Tobacco Control Scale (TCS),
in 27 European countries, in 2010, and the prevalence
of tobacco consumption data from the Eurobarometer of
2012.
Analysis Spearman correlation coefﬁcients (rsp) and
their 95% CIs.
Results There was a negative correlation between TCS
and prevalence of smoking (rsp=−0.41; 95% CI −0.67
to −0.07). We also found a negative correlation
(rsp=−0.31) between TCS and the prevalence of ever
e-cigarette users, but it was not statistically signiﬁcant.
Among former cigarette smokers, there was a positive
and statistically signiﬁcant correlation between TCS and
the consumption of hand-rolled tobacco (rsp=0.46; 95%
CI 0.06 to 0.70). We observed a similar correlation
between TCS and other tobacco products (cigars and
pipe) among former cigarette smokers. There was a
signiﬁcant positive correlation between TCS and intent to
quit smoking in the past 12 months (rsp=0.66; 95% CI
0.36 to 0.87).
Conclusions The level of smoke-free legislation among
European countries is correlated with a decrease in the
prevalence of smoking of conventional cigarettes and an
increase in the intent to quit smoking within the past
12 months. However, the consumption of other tobacco
products, particularly hand-rolled tobacco, is positively
correlated with TCS among former cigarette smokers.
Therefore, tobacco control policies should also consider
other tobacco products, such as rolling tobacco, cigars
and pipes.
INTRODUCTION
Tobacco is the single greatest cause of preventable
death in the world.1 Several countries have imple-
mented smoke-free legislation focused on the
reduction of secondhand smoke exposure (SHS).
However, the adoption of tobacco control policies
focuses (eg, the increase of price) mainly on manu-
factured cigarettes and often neglects other tobacco
products, such as hand-rolled tobacco.2 In fact, the
consumption of hand-rolled tobacco has increased
in the past few years3–5 and hand-rolled cigarettes
were smoked by one in three European smokers in
2011.6 Moreover, the use of electronic cigarettes
(e-cigarettes) has rapidly increased worldwide.7
A previous study conducted in Europe8 showed a
negative relationship between tobacco control pol-
icies and the smoking of conventional cigarettes as
well as exposure to SHS in workplaces. Moreover,
the tobacco control policies in Europe were not
correlated with an increase of tobacco consumption
in private venues9 and were correlated with a rise
in the prevalence of smoke-free homes.10 However,
there is a lack of evidence, to the best of our
knowledge, about the impact of tobacco control
bans on the consumption of other tobacco
products, such as rolling tobacco and the use of
e-cigarettes. The objective of this study is to analyse
the correlation between the implementation of
tobacco control policies and tobacco consumption,
particularly rolling tobacco, e-cigarettes users and
the intent to quit smoking in 27 countries of the
European Union (EU).
METHODS
This is an ecological study with each country as the
unit of analysis. We used data from tobacco control
activities, measured by the Tobacco Control Scale
(TCS)11 proposed by Joossens and Raw,12 in 27
European countries, in 2010, and the data of
the prevalence of tobacco consumption from the
Eurobarometer of 2012.13 The Special
Eurobarometer 38513 is a cross-sectional study
(n=26 751) conducted between February and
March of 2012 among the adult population
(>15 years old).
We obtained the following variables through dif-
ferent questions from the Eurobarometer:
Information regarding cigarette consumption
obtained through the speciﬁc question: ‘Regarding
smoking cigarettes, cigars or a pipe, which of the
following applies to you?’. In which the possible
answers were: ‘You currently smoke’; ‘You used to
smoke but you have stopped’ and ‘You have never
smoked’, and were measured by way of the preva-
lence of smoking. We deﬁned current smokers as
people who answered ‘You currently smoke’.
Additionally, we obtained information on other
tobacco product consumption (boxed cigarettes,
hand-rolled cigarettes, cigars and pipe) through the
question: ‘How often do/did you use the following
tobacco products?’. The answers to this question
were grouped as regular users (daily, weekly or
monthly) and non-regular users, and differentiating
between smokers and former cigarette smokers.
Lidón-Moyano C, et al. Tob Control 2016;0:1–4. doi:10.1136/tobaccocontrol-2015-052482 1
Research paper
 TC Online First, published on February 17, 2016 as 10.1136/tobaccocontrol-2015-052482
Copyright Article author (or their employer) 2016. Produced by BMJ Publishing Group Ltd under licence. 
group.bmj.com on February 17, 2016 - Published by http://tobaccocontrol.bmj.com/Downloaded from 
Eurobarometer also provided information on other ways of
smoking through the question: ‘Have you ever tried any of the
following products? Water pipe, oral tobacco, chewing or nasal
tobacco, e-cigarettes, and smokeless cigarettes’, and the answers
to this question were grouped as either ‘Yes’ or ‘No’. This ques-
tion was given to the whole population (smokers, former
smokers and non-smokers).
Previous intent to quit smoking was measured by way of the
prevalence of the answer ‘Yes, in the past 12 months’ from the
question: ‘Have you ever tried to quit smoking?’.
Self-reported exposure to SHS at work among non-smokers
was obtained asking the question: ‘How often are you exposed
to tobacco smoke indoors at your workplace?’, where the
answers were grouped as either exposed or non-exposed.
We used the TCS from 2010 to measure the level of the six
most cost-effective tobacco control policies in European coun-
tries in 2010.12
We analysed the correlation between TCS score (and their six
policies) and the different rates of prevalence (eg, cigarette con-
sumption, use of other tobacco products, previous intent to
quit, etc) by calculating Spearman correlation coefﬁcients (rsp)
and their 95% conﬁdence intervals (CIs).
RESULTS
There was an inverse and statistically signiﬁcant correlation
between TCS and prevalence of smoking of conventional cigar-
ettes (table 1). The correlation between TCS and intent to quit
smoking within the past 12 months was positive and statistically
signiﬁcant (rsp=0.66; 95% CI 0.36 to 0.87). The correlation
between TCS and SHS exposure at work was negative (rsp=
−0.59; 95% CI −0.81 to −0.22).
Among current smokers, there were positive correlations,
only statistically signiﬁcant in the case of pipe smoking (rsp-
=0.49; 95% CI 0.13 to 0.73), between TCS and consumption
of other tobacco products. Among former cigarette smokers,
there were positive and statistically signiﬁcant correlations
between TCS and other tobacco products with the exception of
boxed cigarettes (table 1).
We found statistically signiﬁcant negative correlation between
TCS and the prevalence of having ever tried a water pipe (rsp=
−0.39; 95% CI −0.62 to −0.06). The correlation of TCS with
the prevalence of ever e-cigarette use was not statistically signiﬁ-
cant (rsp=−0.31; 95% CI −0.61 to 0.03).
DISCUSSION
Our results, at the ecological level, show that there is an inverse
correlation between the levels of tobacco control policies imple-
mented across European countries and the consumption of con-
ventional cigarettes and exposure to SHS at work. These results
are in agreement with previous ecological,8 9 multilevel10 and
individual studies.14 However, there is positive correlation
between the different levels of tobacco control policies imple-
mented among countries and the consumption of other tobacco
products among former cigarette smokers, particularly
hand-rolled tobacco. This correlation should be interpreted with
caution because the question of the Eurobarometer does not
permit the restriction of this analysis to former cigarette
smokers who had quit smoking cigarette after the implementa-
tion of tobacco control policies. Therefore, the prevalence of
other tobacco products, including hand-rolled tobacco, among
former cigarette smokers cannot be guaranteed to be a conse-
quence of the six tobacco control policies measured in the TCS.
However, previous studies showed an increase of daily
consumption, per capita, of hand-rolled tobacco and market
share of rolling tobacco in the past decade.3 15
Thereby, our results could be backing the hypothesis of a
switch of smokers to cheaper tobacco products, such as hand
rolled cigarettes, because the tobacco control policies, particu-
larly increasing of prices, are focused on conventional cigarettes.
Previous studies showed that daily per capita consumption of
hand-rolled cigarettes increased on average by 14.1% per year
from 1991 to 2012 in Spain, while the consumption of manu-
factured cigarettes decreased by 3% on average.3 A similar
pattern has been found in other countries such as Canada, the
USA, the UK, Australia4 and New Zealand.5 These changes in
the consumption of tobacco could also be due to the belief that
this tobacco product is healthier than conventional manufac-
tured cigarettes.16
Furthermore, price increase is consistently reported as one
of the most effective means of reducing tobacco consump-
tion;17 nevertheless, the real prices of the cheapest cigarettes
have remained largely unchanged since 2006, and the gap
between the cheapest and the most expensive cigarettes has
been widened.18 In fact, hand-rolled cigarettes were taxed at
half the level of manufactured cigarettes in 2014.18 Bearing
this in mind, there is a need to equalise the prices of all
tobacco products by applying the same taxing level as,
indeed, is recommended by the article 6 of the Framework
Convention on Tobacco Control.19
Regarding the consumption of e-cigarettes, the public
awareness has grown substantially in recent years.20 However,
we observed unexpected negative correlation between TCS
and the prevalence of having ever tried e-cigarettes, although
it was not statistically signiﬁcant. This result could be due to
the fact that the countries with larger TCS are more active in
tobacco control and therefore may have prevented the wide-
spread use of the e-cigarettes by, for instance, better consumer
information.
We found a positive correlation between TCS and the previ-
ous intent to quit smoking (in the past 12 months). This correl-
ation could underestimate the real correlation between TCS and
intention to quit because the question of Eurobarometer mea-
sured only the previous intention to quit and not the current
intention. However, the mean score for Europe in the policies
of the treatment to help quit smoking was very low (5.11 up to
10) in comparison with other policies. This could mean that,
although the smokers may have the intention to quit, they may
not receive the help needed to succeed.
The main limitation of this study derives from its ecological
design, which yields to the fact that no information about the
intensity of association at individual level can be inferred.
Moreover, there are some studies showing that the main EU
survey generates estimates that are in some cases widely discrep-
ant from more substantive national sources and does not
provide age or gender-speciﬁc data by country.21 In addition,
the 2-year gap between the measure of TCS and the
Eurobarometer survey does not allow detecting the effect of
measures adopted between 2010 and 2012. Nevertheless, the
design of the Eurobarometer was the same for all countries,
increasing comparability across countries at an ecological level,
and the sample size was satisfactorily large and representative by
country, and the interviews were face-to-face. In addition, indi-
vidual studies backing our results exist.22 23
In conclusion, our results suggest the need to revise the
current legislation, particularly increasing the prices, in order
to consider all tobacco products and not only conventional
cigarettes.
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Table 1 Spearman correlation coefficients (rsp) between TCS (and the six policies of TCS) and prevalence of smoking, prevalence of consumption of other tobacco products (among smokers and
former cigarette smokers), prevalence of the intent to quit smoking in the past 12 months and prevalence of self-reported to SHS exposure at work
TCS Price Public place bans Public information campaigns Advertising bans Health warnings Treatment
Current cigarette consumption
Smoking cigarettes −0.41 (−0.67 to −0.07)* −0.09 (−0.44 to 0.28) −0.35 (−0.63 to 0.07) −0.36 (−0.63 to −0.03) −0.17 (−0.56 to 0.23) 0.03 (−0.3 to 0.36) −0.47 (−0.75 to −0.08)*
Other tobacco products (smokers)
Boxed cigarettes −0.30 (−0.64 to 0.11) −0.19 (−0.55 to 0.25) −0.26 (−0.60 to 0.14) −0.54 (−0.76 to −0.22)* 0.04 (−0.31 to 0.38) −0.12 (−0.52 to 0.34) −0.33 (−0.64 to 0.08)
Hand-rolled cigarettes 0.27 (−0.11 to 0.60) 0.14 (−0.26 to 0.51) 0.32 (−0.06 to 0.62) 0.46 (0.12 to 0.72)* −0.09 (−0.44 to 0.31) 0.15 (−0.35 to 0.54) 0.07 (−0.37 to 0.47)
Cigars 0.28 (−0.10 to 0.62) −0.09 (−0.49 to 0.32) 0.41 (0.06 to 0.72)* 0.39 (0.06 to 0.65)* 0.16 (−0.22 to 0.52) 0.06 (−0.36 to 0.46) 0.15 (−0.24 to 0.53)
Pipe 0.49 (0.13 to 0.73)* 0.12 (−0.25 to 0.44) 0.52 (0.10 to 0.81)* 0.41 (0.05 to 0.68) 0.15 (−0.31 to 0.61) −0.01 (−0.01 to 0.30) 0.31 (−0.10 to 0.62)
Other tobacco products (former cigarette smokers)
Boxed cigarettes −0.04 (−0.41 to 0.37) 0.10 (−0.30 to 0.45) −0.12 (−0.51 to 0.29) −0.07 (−0.44 to 0.30) 0.08 (−0.36 to 0.45) −0.04 (−0.04 to 0.37) −0.22 (−0.63 to 0.17)
Hand-rolled cigarettes 0.46 (0.06 to 0.70)* 0.14 (−0.28 to 0.53) 0.51 (0.11 to 0.77)* 0.65 (0.40 to 0.78)** 0.21 (−0.18 to 0.60) 0.19 (−0.33 to 0.59) 0.35 (−0.08 to 0.69)
Cigars 0.41 (0.08 to 0.66)* 0.0007 (−0.41 to 0.39) 0.41 (0.05 to 0.68)* 0.70 (0.47 to 0.81)** 0.25 (−0.12 to 0.56) 0.19 (−0.27 to 0.57) 0.34 (−0.08 to 0.68)
Pipe 0.41 (0.03 to 0.66)* −0.01 (−0.37 to 0.35) 0.44 (0.01 to 0.70)* 0.64 (0.34 to 0.81)** 0.25 (−0.19 to 0.61) 0.09 (−0.32 to 0.46) 0.29 (−0.11 to 0.63)
Other ways of smoking (all populations: smokers, former cigarette smokers and non-smokers)
Water pipe −0.39 (−0.62 to −0.06)* −0.42 (−0.71 to −0.02)* −0.23 (−0.61 to 0.20) −0.1 (−0.46 to 0.25) −0.03 (−0.44 to 0.36) −0.18 (−0.54 to 0.26) −0.16 (−0.54 to 0.25)
Oral tobacco −0.01 (−0.47 to 0.40) −0.19 (−0.54 to 0.25) 0.06 (−0.37 to 0.47) 0.13 (−0.29 to 0.48) 0.03 (−0.45 to 0.52) −0.01 (−0.32 to 0.32) 0.13 (−0.24 to 0.51)
E-cigarettes −0.31 (−0.61 to 0.03) −0.07 (−0.44 to 0.30) −0.4 (−0.70 to −0.04)* −0.14 (−0.54 to 0.29) −0.04 (−0.44 to 0.35) 0.04 (−0.38 to 0.41) −0.05 (−0.47 to 0.41)
Smokeless cigarettes 0.12 (−0.31 to 0.52) −0.27 (−0.64 to 0.13) 0.23 (−0.16 to 0.59) 0.13 (−0.28 to 0.50) 0.3 (−0.13 to 0.66) 0.02 (−0.35 to 0.40) 0.23 (−0.22 to 0.60)
Intent to quit smoking
Past 12 months 0.66 (0.36 to 0.87)** 0.39 (−0.01 to 0.70)* 0.52 (0.14 to 0.92)* 0.59 (0.30 to 0.78)* 0.40 (−0.04 to 0.73)* 0.48 (0.17 to 0.72)* 0.45 (0.08 to 0.74)*
Exposure to SHS at work
−0.59 (−0.81 to −0.22)* −0.19 (−0.59 to 0.23) −0.67 (−0.85 to 0.35)** −0.64 (−0.84 to −0.35)* −0.42 (−0.72 to −0.007)* −0.15 (−0.54 to 0.30) −0.37 (−0.70 to 0.03)
TCS, Tobacco Control Scale (maximum 100 points) quantifies the full implementation of tobacco control policies at country level and collects information about of the six most cost-effective tobacco control policies. Price: price increases through higher
taxes on tobacco products (maximum 30 points); Public place bans: bans/restrictions on smoking in public and work places (maximum 22 points); Public information campaign spending: better consumer information including public information
campaigns, media coverage and publicising of research findings (maximum 15 points); Advertising bans: comprehensive bans on the advertising and promotion of all tobacco products, logos and brand names (maximum 13 points); Health warnings: large
direct health warning labels on cigarette boxes and other products (maximum 10 points); Treatment: treatment to help dependent smokers to quit, including increased access to medications (maximum 10 points).
*p<0.05; **p<0.001.
SHS, secondhand smoke exposure.
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What this paper adds
▸ There is positive correlation between the different levels of
tobacco control policies implemented among European
countries and the consumption of other tobacco products
among former cigarette smokers, particularly hand-rolled
tobacco.
▸ There is an indirect, but not statistically signiﬁcant,
correlation between the prevalence of ever e-cigarette use
and the levels of tobacco control policies implemented in
Europe.
▸ The level of smoke-free legislation among European
countries is correlated with a decrease in the prevalence of
smoking of conventional cigarettes and an increase in the
previous intent to quit smoking (in the past months).
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ABSTRACT 
 
Objective: To describe the acceptability of the recently implemented tobacco products 
regulations and to explore their relation with tobacco control legislation levels in Europe. 
Design: We used data on tobacco control activities in 27 European countries in 2007, 2010 and 
2013 measured by the Tobacco Control Scale (TCS) and data regarding attitudes about tobacco 
control regulations from the Special Eurobarometer of 2009, 2012 and 2014 (n= 80,831). 
Analysis: We calculated the prevalence ratio (and 95% confidence intervals (CI)) of favorable 
attitudes towards tobacco products restrictions in 2009 vs. in 2014, and the effect of previous 
TCS on the attitudes towards tobacco products regulations, adjusted for sex, age and age at 
finishing education (PRa). Moreover, we analyzed the correlation between previous TCS and 
the prevalence of support for tobacco products regulations by calculating Spearman 
correlation coefficients (rsp) and the 95% CI.  
Results: Great support for the studied tobacco products regulations, which modestly increased 
over time, was observed. The highest support was seen for health warnings (80.8% in 2012) 
while the lowest was found in increasing taxes (58.6% in 2012). Moreover, a positive relation 
was generally observed between TCS and support for the studied tobacco products regulations 
at both ecological and individual level.  
Conclusions: In conclusion, our results show great support for the studied tobacco products 
regulations which were positively related with European tobacco control levels of 
implementation at both ecological and individual level. 
Keywords: Tobacco Control, Tobacco Control Scale, Tobacco Control Legislations, Attitudes 
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INTRODUCTION 
In 2009, the European Commission (EC) made the decision to revise the outdated 2001 
Tobacco Products Directive (TPC), which regulates the manufacture, sale and presentation of 
controlled tobacco products, in light of new market and scientific developments and at the 
recommendations of the World Health Organization Framework Convention on Tobacco 
Control (WHO FTCT) for countries to implement and manage tobacco control interventions (1). 
The update of the Tobacco Products Directive (2,3), passed in 2014 and implemented in 2016, 
was a significant success in European tobacco control and aimed to strengthen tobacco control 
policies across all European Members while still allowing the European tobacco control leaders 
to regulate even further. This update includes, among others, the following regulations: 
Increasing the size of graphic health warnings; banning images of tobacco products targeted at 
consumers; banning characterizing flavors of tobacco products; regulation of electronic 
cigarettes; banning promotional and misleading descriptions on tobacco products packaging; 
and introducing EU-wide tracking and tracing to combat illicit trade. 
However, a key element in the implementation of any tobacco control policy is the public’s 
support, as levels of acceptability may critically influence their effectiveness. In this regard, a 
recent review (4) found that smoking restrictions acceptability increased with time and was 
associated with the stage of implementation, becoming generally more acceptable once they 
had been introduced. In addition, the same review (4) showed that support was generally 
higher for interventions perceived as less intrusive and for measures aimed at commercial 
business rather than individuals. Acceptability also varies with the respondent’s characteristics; 
those engaging in the targeted behavior being less supportive of interventions and women and 
older individuals more likely to endorse more restrictive measures (4).  
To our knowledge, there is a lack of updated information at the European level on the 
attitudes towards the latest tobacco products regulations. Therefore, the objective of this 
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study is to describe the acceptability of the recently implemented tobacco products 
regulations and to explore their relation with tobacco control legislation levels in Europe.  
 METHODS 
This is a repeated cross-sectional study. We used data on tobacco control activities in 27 
European countries in 2007 (5), 2010 (6) and 2013 (7) measured by the Tobacco Control Scale 
(TCS) and the data regarding attitudes about tobacco control regulations from the Special 
Eurobarometer of 2009 (8), 2012 (9) and 2014 (10). The TCS is a tool proposed by Joossens and 
Raw (11) to quantify and assess the strength of tobacco control policies implemented in 
European countries. The Special Eurobarometer is a cross-sectional study conducted in 27 
Member States of the European Union by TNS Opinion & Social. The fieldwork of each 
Eurobarometer was performed in October 2009, between February and March of 2012, and 
between November and December of 2014, respectively. The final sample was 80,831 (sample 
of Eurobarometer of 2009: 27,288; sample of Eurobarometer of 2012: 26,751; and sample of 
Eurobarometer of 2014: 26,792) adults (older than 15 years old). The interviews were 
conducted face-to-face at the participants’ homes in their native languages. 
Variables 
The following variables were obtained through different questions from the Eurobarometer: 
Attitudes towards tobacco products regulations: Would you be in favour of or opposed to any 
of the following measures? Banning advertising of tobacco products in points of sale/shops; 
keeping tobacco products out of sight in shops/points of sale; banning the sale of tobacco 
products via the Internet; banning the sale of tobacco products through vending machines; 
putting picture health warnings on all packages of tobacco products; banning flavors that make 
tobacco products more attractive; banning colors, logos and promotional elements from 
packets of tobacco products; increasing taxes on tobacco products; introducing an extra fee on 
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manufacturers of tobacco products to cover the health costs of tobacco use; banning the use 
of electronic cigarettes in environments where smoking is prohibited; and improving the 
traceability of tobacco products in order to reduce their illicit trade even if this makes them a 
few cents more expensive. Through this question, the prevalence of people in favour of each 
regulation was obtained.  
Tobacco control policies: we used the TCS of 2007, 2010 and 2013 to measure and quantify the 
level of implementation of tobacco control activities of European countries. The TCS is a score 
(maximum 100 points) developed by a group of experts from the Association of European 
Cancer Leagues (ECL) and the European Network for Smoking Prevention (ENSP). This scale 
quantifies the full implementation of tobacco control policies at the country level and collects 
information about the six most cost-effective tobacco control policies: price increases through 
higher taxes on cigarettes and other tobacco products (maximum 30 points); bans or 
restrictions on smoking in public and work places (maximum 22 points); better consumer 
information  (maximum 15 points);  comprehensive bans on the advertising and promotion of 
all tobacco products, logos and brand names (maximum 13 points); large, direct health 
warning labels on cigarette boxes and other tobacco products (maximum 10 points); treatment 
to help dependent smokers stop, including increased access to medications (maximum 10 
points). 
Statistical analysis 
We calculated the prevalence of favorable attitudes towards tobacco products regulations in 
2009, 2012 and 2014. We used Generalized Lineal Mixed Models (GLMM) with country as a 
random effect and using Poisson family with log link, to calculate the prevalence ratio (and 
95% confidence intervals (CI)) of favorable attitudes towards tobacco products restrictions in 
2009 vs. 2014, and the effect of previous TCS on attitudes towards tobacco products 
regulations, adjusted for sex, age and age at finishing education (PRa). Moreover, we analyzed 
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the correlation between previous TCS and the prevalence of different attitudes towards 
tobacco products regulations by calculating Spearman correlation coefficients (rsp) and the 
95% confidence intervals (CI) at the ecological level. All the analyses used weighted data to 
obtain more representative results for each country. The statistical programs used were R-
3.0.2 and STATA v.14. 
RESULTS 
Great support was obtained for the studied tobacco products regulations, this support being 
stronger among non-smokers or former smokers than smokers (Table 1). The highest support 
overall was observed for adding picture health warnings on all packages of tobacco products 
(80.8% in 2012) while the lowest was observed for increasing taxes on tobacco products 
(60.7% in 2014). Similarly, regarding smokers, the highest support was also observed for health 
warnings on tobacco products (65.2% in 2012) while the lowest was observed for increasing 
taxes on tobacco products (20.6% in 2014). Moreover, a modest increase in support of tobacco 
products regulations was observed for all studied regulations with the exception of increasing 
taxes on tobacco products, which showed a statistically significant decrease among non-
smokers (PRa: 0.96; 95%CI: 0.93, 1.00), former smokers (PRa: 0.91; 95%CI: 0.86, 0.97) and 
smokers (PRa: 0.85; 95%CI: 0.73, 0.99) (Table 1).  
In addition, at the ecological level a positive relation was generally observed between TCS and 
support for the studied tobacco products regulations; being statistically significant in the case 
of keeping tobacco products out of sight in shops/points of sale (rsp: 0.22; 95%CI: 0.00, 0.43); 
banning colors, logos and promotional elements from packets of tobacco products (rsp: 0.25; 
95%CI: 0.01, 0.46); and increasing taxes on tobacco products (rsp: 0.29; 95%CI: 0.10, 0.48) 
(Table 2). Similar results were obtained when studying the tobacco control policies included in 
the TCS individually. However, the bans or restrictions on smoking in public and work places 
seemed to be the most related with increasing support for the studied tobacco products 
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regulations, showing the strongest correlations (statistically significant in 6 out of the 11 
studied tobacco products regulations) (Table 2).  
At the individual level, similar results were obtained through adjusted prevalence ratios of 
increasing TCS 10 units in 10 units as the direction of the association was generally the same as 
at the ecological level (Table 3).  
DISCUSSION 
Our results show great support for the studied tobacco products regulations which modestly 
increased over time. The highest support, both overall and among smokers, was observed for 
adding picture health warnings on all packages of tobacco products while the lowest was 
observed for increasing taxes on tobacco products. Moreover, a positive relation was generally 
observed between TCS and support for the studied tobacco products regulations at both the 
ecological and individual levels.  
Similar results were found in a recent systematic review (4) which shows that smoking 
restrictions acceptability increased with time. Moreover, a previous ecological study (12) 
included in the systematic review found that EU countries with higher overall TCS scores had 
greater public support for smoke-free legislations. Similar results were found in a cross-
sectional study (13) carried out in UK, US, Canada and Australia which showed the greatest 
support in countries with the strongest regulations. These results may suggest that increasing 
tobacco control legislations is positively related to the social denormalisation of tobacco. In 
addition, the cross-sectional study (13) analyzed 12 questions relating to aspects of tobacco 
industry and tobacco product regulations in 2008, showing highest overall support for 
preventing industry promotion of their products (67-86% across countries) and lowest for plain 
packaging (24-37%). However, the systematic review (4)  showed that support was generally 
higher for interventions perceived as less intrusive. For instance, warning labels and 
educational campaigns were consistently more likely to be supported than policies introducing 
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disincentives designed to influence behavior such as tax based incentives to discourage 
smoking (4).   
Regarding the price increase on cigarettes and other tobacco products, similar results were 
found in a recent cross-sectional study (14) in Norway which also shows that more intrusive 
interventions, such as limitations on sale and increased taxes, received lower support. 
However, price increase has been proven to be the most effective and cost-effective 
intervention in reducing smoking consumption (15) and therefore strategies 
to increase support for tax measures should be considered. 
On the other hand, the high support of health warnings observed in our study, even among 
smokers, suggests plain packaging may be successfully implemented in Europe. Plain packaging 
involves the removal of all branding and advertising from packs, such that packs are relatively 
indistinguishable from one another, other than the brand name in mandated text, size and 
style (16). Moreover, available evidence suggests that plain packaging may reduce smoking 
prevalence (17). In 2012, Australia implemented laws requiring plain (standardized) packaging 
of tobacco products. Scientific evaluation shows support for plain packaging increased 
significantly among Australian smokers after implementation of the law (being 28.2% after the 
implementation and 49% before) (18). Moreover, support for plain packaging is associated 
with higher levels of quitting activity while opposition mainly comes from those who smoke 
heavily and those who underestimate the risk of future smoking related harms (18). In 
addition, a recent systematic review shows plain packaging is associated with a reduction in 
package attractiveness and smoking appeal, and that it will make the legally required health 
warnings to be more salient (19). Since then, France, Ireland and UK have passed laws to 
implement plain packaging and several other countries have initiated legislative processes with 
the same goal (16). Furthermore, evidence to support the implementation of plain packaging 
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was obtained in Australia, New Zealand, Canada, UK, Norway, Belgium, France, Italy, Brazil and 
India (20).  
The main limitations of this study are those related to survey based studies, as the use of a 
questionnaire to collect self-reported information, the potential for over-reporting of support 
for studied tobacco products regulations due to social pressures and bias due to non-response. 
Moreover, there are some studies that show that the main EU survey generates estimates that 
are in some cases widely discrepant from more substantive national sources and does not 
provide age or gender-specific data by country (21). Nevertheless, the design of the 
Eurobarometer was the same for all countries and years increasing comparability across 
countries at the ecological level, the sample size was satisfactorily large and representative by 
country in each year and the interviews were face-to-face. In addition, the time intervals 
between the TCS measurements and the carrying out of the Eurobarometer allow us to see the 
effect that the application of the tobacco policies had in the different countries and years. In 
addition, the main strength of our study is the use of Generalized Lineal Mixed Models 
(GLMM) with country as a random effect to analyze individual level effect. Moreover, we used 
Poisson family in the GLMM as they provide more robust results and we obtained prevalence 
ratio despite obtaining high prevalences to avoid possible overestimation of the studied effect.  
In conclusion, our results show great support for the studied tobacco products regulations 
which were positively related with European tobacco control levels of implementation at both 
the ecological and individual levels. The high support observed for health warnings encourages 
plain packaging implementation in Europe. Moreover, the lowest support was observed in 
increasing taxes on tobacco products showing the need to implement strategies 
to increase support for such measures.  
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What this paper add 
- Our results show great support for the recently implemented Tobacco Products 
Directive regulations which modestly increased over time.  
- The highest support, both overall and among smokers, was observed for adding 
picture health warnings on all packages of tobacco products (80.8% in 2012) while the 
lowest was observed for increasing taxes on tobacco products (58.6% in 2012).  
- Moreover, a positive relation was generally observed between TCS and support for the 
studied tobacco products regulations at both the ecological and individual levels.  
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Table 1. Prevalence, and the adjusted prevalence ratio (PRa) in 2009 vs. in 2014 when possible (in 2009 vs. in 2012 otherwise) with their 95% confidence 
intervals, of favorable attitudes towards tobacco products regulations. 
 
 
n
a
: Available information of each question. 
PRa: Adjusted by sex, age and age of finishing education.  
* p-value <0.05, ** p-value<0.01, *** p-value<0.001 
P-value: Obtained through adjusted Generalized Linear Multilevel Model effect coefficient. 
NC: Non-convergent Generalized Linear Multilevel Model. 
Tobacco products regulations: banning advertising of tobacco products in points of sales/ shops (advertising); keeping tobacco products out of sight in shop/ points of sale (keep out of sight); 
banning the sales of tobacco products via the Internet (sales via Internet); banning the sales of tobacco products through vending machines (sales via vending machine); putting picture health 
warnings on all packages of tobacco products (put health warnings); banning flavors that make tobacco products more attractive (flavors); banning colors, logos and promotional elements 
from packets of tobacco products (promotional elements); increasing taxes on tobacco products (increase taxes); introducing an extra fee on manufacturers of tobacco products to cover the 
health costs of tobacco use (extra manufactures fee); banning the use of electronic cigarettes in environments where smoking is prohibited (use of e-cigarettes); and improving the traceability 
of tobacco products in order to reduce their illicit trade even if this makes them a few cents more expensive (reduce illicit trade). 
 
 
 
Overall (n=80,831) Non Smokers (n=41,715) Former Smokers (n=16,357) Smokers (n=22,582) 
 
n
a
 2009 2012 2014 PRa 2009 2012 2014 PRa 2009 2012 2014 PRa 2009 2012 2014 PRa 
Advertising 53,912 71.9 71.6 75.3 1.04 (1.00, 1.08)* 80.1 79.9 83.2 1.04 (1.00, 1.07)* 73.8 73.7 76.9 1.04 (1.00, 1.08) 56.9 54.6 56.9 1.00 (0.93, 1.08) 
Keep out of sight 48,279 63.1 64.9 68.5 1.08 (1.03, 1.13)** 74.2 74.7 78.2 1.05 (1.02, 1.09)** 63.9 66.6 69.9 1.09 (1.04, 1.15)** 44.6 46.2 46.9 1.07 (0.98, 1.17) 
Sales via Internet 50,333 69.6 70.4 72.9 1.04 (1.01, 1.08)* 77.6 78.0 80.4 1.04 (1.01, 1.07)* 70.3 71.4 74.3 1.06 (1.02, 1.10)** 55.3 55.5 55.6 1.01 (0.94, 1.09) 
Sales via vending machines 29,354 60.3 60.5 - 1.00 (0.97, 1.04) 72.4 71.3 - 0.99 (0.95, 1.02) 62.2 62.5 - 1.01 (0.97, 1.05) 39.1 39.1 - 1.02 (0.94, 1.11) 
Put health warnings 40,735 79.7 80.8 - 1.02 (0.99, 1.04) 87.8 88.6 - 1.01 (0.99, 1.03) 79.3 82.5 - 1.04 (1.00, 1.07)* 66.4 65.2 - 0.99 (0.95, 1.04) 
Flavors  49,757 68.8 69.6 70.6 1.02 (0.98, 1.06) 78.8 79.7 80.3 NC 70.6 71 72.9 1.03 (0.98, 1.09) 51.3 50.5 48.2 NC 
Promotional elements 45,340 62.8 64.3 65.5 1.03 (0.99, 1.08) 74.1 75.3 76.1 1.03 (0.99, 1.07) 64.5 65.5 66.5 1.03 (0.98, 1.08) 43.1 43.6 42.4 NC 
Increase taxes 45,409 62.1 58.6 60.7 0.96 (0.92, 1.00) 81.7 78.7 78.9 0.96 (0.93, 1.00)* 71.6 66.5 65.6 0.91 (0.86, 0.97)** 24.7 18.7 20.6 0.85 (0.73, 0.99)* 
Extra manufactures fee 37,894 73.0 80.2 - 1.10 (1.07, 1.12)*** 86.1 89.0 - 1.03 (1.02, 1.05)*** 78.8 82.8 - 1.05 (1.02, 1.08)*** 47.6 62.5 - 1.32 (1.22, 1.43)*** 
Use of e-cigarettes 16,891 - - 71.6 - - - 80.8 - - - 72.7 - - - 51.4 - 
Reduce illicit trade 18,913 - - 79.7 - - - 88.0 - - - 83.3 - - - 59.4 - 
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Table 2. Spearman correlation, with 95% confidence intervals, between previous TCS (and the six most cost-effective tobacco control policies) and favorable 
attitudes towards tobacco products regulations. 
 
 
TCS Price Public  Bans Campaigns Advertising Health warnings Treatment 
Advertising 0.18 (-0.07, 0.39) 0.22 (0.00, 0.42)* 0.25 (0.02, 0.45)* 0.02 (-0.30, 0.31) 0.20 (-0.03, 0.40) 0.01 (-0.21, 0.23) 0.10 (-0.10, 0.30) 
Keep out of sight 0.22 (0.00, 0.43)* 0.11 (-0.14, 0.34) 0.37 (0.16, 0.55)*** 0.21 (-0.09, 0.50) 0.16 (-0.08, 0.38) -0.04 (-0.25, 0.18) 0.12 (-0.09, 0.34) 
Sales via Internet 0.18 (-0.04, 0.39) 0.19 (-0.02, 0.38) 0.28 (0.06, 0.47)* 0.03 (-0.26, 0.33) 0.15 (-0.09, 0.38) 0.00 (-0.22, 0.22) 0.06 (-0.15, 0.27) 
Sales via vending machines 0.25 (-0.02, 0.48) 0.25 (-0.02, 0.47) 0.18 (-0.08, 0.44) 0.08 (-0.27, 0.44) 0.23 (-0.04, 0.47) 0.07 (-0.22, 0.32) 0.21 (-0.08, 0.42) 
Put health warnings 0.16 (-0.12, 0.44) 0.24 (-0.03, 0.48) 0.21 (-0.10, 0.45) 0.09 (-0.26, 0.40) 0.09 (-0.19, 0.36) 0.05 (-0.24, 0.33) -0.15 (-0.43, 0.12) 
Flavors  0.22 (0.00, 0.42) 0.30 (0.08, 0.50)** 0.30 (0.07, 0.51)** 0.13 (-0.18, 0.42) 0.04 (-0.18, 0.25) 0.02 (-0.19, 0.25) 0.04 (-0.18, 0.25) 
Promotional elements 0.25 (0.01, 0.46)* 0.30 (0.08, 0.48)** 0.34 (0.11, 0.55)** 0.21 (-0.11, 0.48) 0.12 (-0.12, 0.33) 0.05 (-0.18, 0.27) 0.04 (-0.19, 0.27) 
Increase taxes 0.29 (0.10, 0.48)** 0.15 (-0.05, 0.34) 0.16 (-0.10, 0.39) 0.12 (-0.17, 0.40) 0.39 (0.19, 0.56)*** 0.17 (-0.05, 0.38) 0.24 (0.03, 0.44)* 
Extra manufactures fee -0.01 (-0.26, 0.28) 0.06 (-0.23, 0.31) 0.26 (-0.02, 0.48) 0.14 (-0.23, 0.51) -0.16 (-0.40, 0.09) -0.56 (-0.73, -0.36)*** 0.09 (-0.19, 0.36) 
Use of e-cigarettes -0.01 (-0.38, 0.33) -0.14 (-0.48, 0.22) 0.22 (-0.16, 0.56) 0.21 (-0.55, 0.86) 0.19 (-0.25, 0.57) -0.02 (-0.37, 0.33) 0.05 (-0.36, 0.42) 
Reduce illicit trade 0.34 (-0.09, 0.69) 0.36 (-0.04, 0.67) 0.44 (0.06, 0.72)* 0.37 (-0.38, 0.93) 0.36 (-0.08, 0.68) 0.27 (-0.10, 0.62) 0.24 (-0.19, 0.61) 
 
* p-value <0.05, ** p-value<0.01, *** p-value<0.001 
Tobacco products regulations: banning advertising of tobacco products in points of sales/ shops (advertising); keeping tobacco products out of sight in shop/ points of sale (keep out of sight); 
banning the sales of tobacco products via the Internet (sales via Internet); banning the sales of tobacco products through vending machines (sales via vending machine); putting picture health 
warnings on all packages of tobacco products (put health warnings); banning flavors that make tobacco products more attractive (flavors); banning colors, logos and promotional elements 
from packets of tobacco products (promotional elements); increasing taxes on tobacco products (increase taxes); introducing an extra fee on manufacturers of tobacco products to cover the 
health costs of tobacco use (extra manufactures fee); banning the use of electronic cigarettes in environments where smoking is prohibited (use of e-cigarettes); and improving the traceability 
of tobacco products in order to reduce their illicit trade even if this makes them a few cents more expensive (reduce illicit trade). 
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Table 3. Adjusted Prevalence Ratios of increasing TCS 10 units in 10 units, with their 95% confidence intervals, of favorable attitudes towards tobacco 
products regulations.  
 
 
* p-value <0.05, ** p-value<0.01, *** p-value<0.001 
 P-value: Obtained through adjusted (by sex, age and age of finishing education and smoking status) Generalized Linear Mixed Model effect coefficient. 
Tobacco products regulations: banning advertising of tobacco products in points of sales/ shops (advertising); keeping tobacco products out of sight in shop/ points of sale (keep out of sight); 
banning the sales of tobacco products via the Internet (sales via Internet); banning the sales of tobacco products through vending machines (sales via vending machine); putting picture health 
warnings on all packages of tobacco products (put health warnings); banning flavors that make tobacco products more attractive (flavors); banning colors, logos and promotional elements 
from packets of tobacco products (promotional elements); increasing taxes on tobacco products (increase taxes); introducing an extra fee on manufacturers of tobacco products to cover the 
health costs of tobacco use (extra manufactures fee); banning the use of electronic cigarettes in environments where smoking is prohibited (use of e-cigarettes); and improving the traceability 
of tobacco products in order to reduce their illicit trade even if this makes them a few cents more expensive (reduce illicit trade). 
 
 
 
 
TCS (30-40) TCS (40-50) TCS (50-60) TCS (60-70) TCS (70-80) TCS (90-100) 
Advertising 1 1.03 (0.99, 1.08) 1.01 (0.94, 1.10) 1.02 (0.94, 1.10) 1.11 (1.07, 1.14)*** 1.07 (1.03, 1.11)** 
Keep out of sight 1 1.07 (1.04, 1.11)*** 0.99 (0.96, 1.03) 0.96 (0.91, 1.01) 0.96 (0.92, 1.00) 0.87 (0.84, 0.90)*** 
Sales via Internet 1 1.04 (1.00, 1.08)* 1.05 (0.99, 1.10) 1.00 (0.92, 1.10) 1.09 (1.04, 1.14)*** 1.14 (1.10, 1.19)*** 
Sales via vending machines 1 1.17 (1.12, 1.22)*** 1.10 (1.06, 1.14)*** 1.06 (1.03, 1.10)** 0.99 (0.95, 1.03) 0.92 (0.89, 0.95)*** 
Put health warnings 1 1.06 (1.02, 1.11)** 1.13 (1.06, 1.21)*** 1.18 (1.10, 1.26)*** 1.20 (1.14, 1.27)*** 1.22 (1.14, 1.30)*** 
Flavors  1 1.08 (1.03, 1.13)** 1.08 (1.04, 1.12)*** 1.06 (0.99, 1.13) 1.15 (1.12, 1.18)*** 1.14 (1.10, 1.17)*** 
Promotional elements 1 1.09 (1.04, 1.14)*** 1.10 (1.04, 1.16)*** 1.00 (0.95, 1.07) 1.15 (1.07, 1.23)*** 1.17 (1.12, 1.22)*** 
Increase taxes 1 1.00 (0.81, 1.24) 0.97 (0.74, 1.26) 0.93 (0.68, 1.27) 0.95 (0.77, 1.18) 0.94 (0.76, 1.16) 
Extra manufactures fee 1 0.96 (0.91, 1.01) 0.97 (0.91, 1.05) 1.00 (0.92, 1.08) 1.01 (0.93, 1.10) 0.96 (0.97, 1.07) 
Use of e-cigarettes 1 1.05 (0.94, 1.17) 1.09 (0.97, 1.22) 1.11 (1.02, 1.22)* 0.95 (0.87, 1.05) - 
Reduce illicit trade 1 0.99 (0.95, 1.02) 1.01 (0.95, 1.07) 1.04 (0.96, 1.14) 1.08 (0.97, 1.19) 1.08 (0.96, 1.22) 
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According to the results obtained in the scientific articles that compose this doctoral thesis, the 
implementation of the stepwise smoke-free legislations in Spain is related to a reduction in 
smoking prevalence and SHS exposure. The following is a joint discussion of the seven articles 
of the thesis.   
 
 
6.1 Impact of Spanish smoking bans on tobacco 
consumption 
 
The results obtained in the first article of this doctoral thesis (77) show a reduction in smoking 
prevalence after both Spanish legislations, along with an increase in the consumption of other 
tobacco products, particularly RYO cigarettes, among young population. Moreover, the second 
article of this doctoral thesis (78) shows an increase in salivary cotinine concentration (around 
29%) among continuing smokers, and a switch from conventional to RYO cigarettes or to dual 
use in 21.3% of them, after both Spanish smoking legislations. In this line, the sixth article of 
this doctoral thesis (79) shows an inverse correlation between the levels of tobacco control 
policies implemented across European countries and the consumption of conventional 
cigarettes in addition to a positive correlation between the different levels of tobacco control 
policies implemented among countries and the consumption of other tobacco products among 
former smokers, particularly RYO cigarettes.  
 
The results obtained on smoking consumption trends are consistent with a recent report (43) 
that assess the impact of both Spanish smoking legislations which shows a decline of 
prevalence before the Spanish smoke-free legislations, that became a little more pronounced 
after their implementation among women but not among men (43). However, a recent 
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systematic review showed the effect of smoke-free legislations on the smoking prevalence is 
not consistent in all the included studies, as some studies showed reduction in the smoking 
prevalence while other did not find changes in the smoking prevalence or in its tendency 
following a smoke-free legislation (80). In regard to the increase of RYO cigarettes, the 
economic crisis that took place in Spain in 2008 could have affected the shift on tobacco 
products as has been also reported (43,81).  
 
In addition, smoking prevalence observed in the follow-up survey of the first article of this 
doctoral thesis (77) was higher than that observed in other studies (23.6% (2) and 20.7% (82)), 
with information gathered at national level in 2011-2012. This could be because our study was 
carried out in the city of Barcelona while the other study includes information about all the 
regions in Spain, and historically it has been reported slight differences in smoking prevalence 
among regions in Spain (83). Another possible explanation is that young and smoker 
participants in our sample could have been overestimated because of the loss of older and no-
smoker participants. 
 
Nevertheless, the impact of the two National smoke-free legislations is similar to the one 
found in previous studies conducted in Spain (84,85) and with previous ecological (86,87), 
multilevel (88) and individual studies(89) in Europe. In fact a systematic review (90) has 
concluded that the implementation of smoke-free policies and restrictions in public spaces, 
workplaces or residences lead to a decrease in smoking prevalence and cigarette consumption. 
However, the observed increase in the prevalence of RYO cigarettes and other tobacco 
products provide more support to the hypothesis of a change on the smoking pattern in 
consuming cheaper tobacco products, especially among young people. These results agree 
with some previous studies in Spain (45,82,85) and can be due to tobacco control policies, 
particularly increasing of prices, which are mainly focused on conventional cigarettes leading 
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to real prices of the cheapest cigarettes have remained largely unchanged and the gap 
between the cheapest and the most expensive cigarettes has widened (45). Furthermore, 
according to our results (78), the highest value of salivary cotinine after Spanish smoking bans, 
according to kind of tobacco smoked, was observed in smokers who switch from conventional 
to RYO cigarettes or to dual use, this fact may counteract the popular belief that RYO 
cigarettes are less harmful than conventional cigarettes. This aspect could be involved in the 
observed increase in salivary cotinine after the implementation of Spanish smoking bans, being 
the highest increase observed in those smokers who switch from conventional to RYO 
cigarette (70.0%) according to our results. 
 
Regarding the consumption of other products such as e-cigarettes, another article annexed in 
this doctoral thesis (91) shows a negative correlation between TCS and the prevalence of 
having ever tried e-cigarettes. This result could be due to the fact that the countries with larger 
TCS are more active in tobacco control and therefore they may have prevented the 
widespread of the e-cigarettes by better consumer information for instance. In addition, the 
use of e-cigarettes in Spain is scarce (10.3% ever users), and predominates among young 
people and tobacco smokers although one out of four current e-cigarette users have never 
smoked (91). Therefore, e-cigarette could be a gateway to the consumption of other tobacco 
products and dual consumption.  
 
 
6.2 Impact of Spanish smoking bans in quitting 
smoking and dependence 
 
According to the results obtained in this doctoral thesis (78) a significant decrease in the 
proportion of individuals classified as medium FTCD was found. Nonetheless, there was not 
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any significant change in the number of cigarettes smoked daily. In addition, a positive 
correlation between TCS and the previous intent to quit smoking (in the last 12 months) has 
been found in this doctoral thesis (79).  
 
According to the hardening hypothesis, when smoking prevalence decreases, the smokers who 
quit are those less dependent, and the remaining smokers are those with hard smoking 
dependence (92). In this regard, our results (78) do not show any significant change in the 
FTCD score after the application of the Spanish smoking legislations, counteracting the 
hardening hypothesis. Alike results can be found in Italy (93) and Norway (94). Moreover, an 
18 countries European study suggests that as the lower country-specific smoking prevalence, 
the lower the dependence (95), giving more evidence to reject the hardening hypothesis. 
However, none of these studies use salivary cotinine to assess nicotine dependence. In this 
sense, we didn’t found differences at baseline neither in the salivary cotinine concentration 
nor in the FTCD among smokers who quit smoking and continue smoking (78). Moreover, no 
significant increase was found in the FTCD score nor in the number of cigarettes smoked daily 
among smokers who continue smoking, which are other conventional measures used as a 
proxy to cigarette dependence. Nonetheless, although there is a positive relation between the 
FTCD score, tobacco consumption and salivary cotinine (96,97) other factors might also have 
an effect on cotinine concentration.  
 
We also found a positive correlation between TCS and the intent to quit smoking in the last 12 
months (79). This seems to be in agreement with previous studies that showed that the 
intention to quit smoking increased by 9% after recently implemented tobacco control 
measures in 2006 in Greece (98). However, according to the TCS obtained in 2013 (76), the 
Spanish score in the policies to the treatment to help to quit smoking was low (6 up to 10) in 
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comparison with other policies. This could mean that smokers may not receive the help 
needed to succeed when trying to stop smoking.  
 
 
6.3 Impact of Spanish smoking bans in 
secondhand smoke exposure 
 
The results of this thesis also show an important reduction in SHS exposure in all settings 
(workplace, leisure time, home, and public transport) after the implementation of the two 
Spanish smoke-free bans in Spain (77). Similar results were obtained in the third article of this 
doctoral thesis (99), in which SHS exposure was assessed by salivary cotinine concentrations 
and information on self-reported exposure. Moreover, according to the fourth article of this 
doctoral thesis (100) there is an increase in the prevalence of SFH, particularly in the case of a 
complete SFH, after the implementation of the two Spanish smoke-free bans. Specifically, the 
results of the fifth article of this doctoral thesis (101) show that more than half (57.4%) of the 
population of Barcelona (Spain) had complete indoor smoke-free rules at home in 2013-2014. 
In addition, further results of this thesis show an inverse correlation between the levels of 
tobacco control policies implemented across European countries and work SHS exposure at 
ecological level (79).  
 
The results obtained in this doctoral thesis are consistent with other studies carried out in 
Spain, which show a decrease in SHS exposure in all the studied settings after the application 
of the smoking legislations either using cotinine concentrations (102,103) or questionnaire 
information (84,102). Similarly, a previous systematic review (90) reported reductions in SHS 
exposure with smoke-free policies, in both adults and children, and across various settings 
including workplaces, public spaces and hospitality establishments. In Europe, a secondary 
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analysis showed that the enforcement of smoke-free legislation is inversely associated with 
SHS exposure (104).  
 
On the other hand, our results show that the highest prevalence of self-reported exposure to 
SHS, before and after the implementation of the two Spanish smoke-free bans, as well as the 
lower reduction, was obtained in the leisure time and in work (77). In this regard, other 
Spanish studies showed significant decrease in the environmental nicotine in hospitals after 
both Spanish legislations (105) and in hospitality venues between 2010 and 2011 (106). 
Regarding work setting, according to our results, most of the exposed ones declared spending 
most of the time outdoors and not having specific areas for smokers after the implementation 
of the two Spanish smoke-free bans (77). These results are consistent with another Spanish 
study, which showed that more than one-third of the population were passively exposed at 
work and at leisure time two years after the Spanish smoking legislations (102). In this regard, 
previous studies have shown that both consumption and self-reported SHS exposure were very 
low in indoor settings regulated by the Spanish legislation, therefore, the exposure of non-
smokers to SHS mostly occurs in outdoor areas where smoking is allowed (107).  
 
In addition, according to the results obtained in this doctoral thesis (99), although the higher 
prevalence of self-reported SHS exposure post-legislations was found in leisure time, higher 
cotinine concentrations among those declaring exposure to SHS were found at home. This 
could be because in a regular day people usually spend more time at home than at leisure 
time, therefore, being exposed at home could be harder in terms of time and intensity. 
However, our results also show that the adoption of SFH was higher among never-smokers and 
among those who lived with a minor (101). On the other hand, we found an increased 
prevalence of allowing smoking in most ventilated places, or outside areas, in houses with 
partial SFH after the implementation of the Spanish smoke-free legislations (100). This could 
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be due to an increasing risk perception of SHS exposure in the population. In fact, according to 
our results, people who had some kind of risk perception of SHS exposure showed higher 
adoption of complete SFH rules highlighting the need to increase awareness of the health risks 
of SHS in private settings, especially among smokers (101).  
 
During the debate about the implementation of smoke-free policies in different countries, the 
tobacco industry and the hospitality sector argued that the restriction of smoking in public 
places would displace tobacco consumption to private settings, particularly to home. Our 
results, and the results from other studies (61,108-112), counteract the displacement 
hypothesis. Nevertheless, the results obtained in two articles of this doctoral thesis (100,101) 
show that around half of the houses with SFH rules have a partial rule.  
 
 
6.4 Attitudes toward policies of the tobacco 
products directive in Europe 
 
Finally, in the last article of this doctoral thesis (113) was assessed the support of the tobacco 
products directive in Europe. The results of this article (113) show great support in Europe for 
the studied tobacco products regulations which modestly increased over time. The highest 
support, both overall and among smokers, was observed for adding picture health warnings on 
all packages of tobacco products while the lowest was observed for increasing taxes on 
tobacco products. Moreover, a positive relation was generally observed between TCS and 
support for the studied tobacco products regulations at both the ecological and individual 
levels.  
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Similar results were found in a recent systematic review (114) which shows that smoking 
restrictions acceptability increased with time. Moreover, a previous ecological study (86) 
included in the systematic review found that EU countries with higher overall TCS scores had 
greater public support for smoke-free legislations. Similar results were found in a cross-
sectional study (115) carried out in UK, US, Canada and Australia which showed the greatest 
support in countries with the strongest regulations. These results may suggest that increasing 
tobacco control legislations is positively related to the social denormalisation of tobacco. In 
addition, a cross-sectional study (115) analyzed 12 questions relating to aspects of tobacco 
industry and tobacco product regulations in 2008, showing highest overall support for 
preventing industry promotion of their products (67-86% across countries) and lowest for plain 
packaging (24-37%). However, the systematic review (114)  showed that support was generally 
higher for interventions perceived as less intrusive. For instance, warning labels and 
educational campaigns were consistently more likely to be supported than policies introducing 
disincentives designed to influence behavior such as tax based incentives to discourage 
smoking (114).   
 
Regarding the price increase on cigarettes and other tobacco products, similar results were 
found in a recent cross-sectional study (116) in Norway which also shows that more intrusive 
interventions, such as limitations on sale and increased taxes, received lower support. 
However, price increase has been proven to be the most effective and cost-effective 
intervention in reducing smoking consumption (31) and therefore strategies 
to increase support for tax measures should be considered. 
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The main limitation of our studies is the potential participation bias due to the attrition of the 
cohort of participants in four of the seven articles of this thesis (77,78,99,100). In this sense, 
there were statistically significant differences according to age, level of education, and 
smoking status between the follow-up sample and the participant lost in both stages of the 
follow-up. Followed-up participants overestimate young people and smokers in comparison 
with lost participants, for this reason the reduction of conventional tobacco consumption and 
SHS, and the increase of hand-rolled consumption and smoke-free homes could be higher 
among lost participants while the increase in salivary cotinine could be smaller among lost 
participants. On the other hand, our final sample overestimated the older people compared 
with the distribution of population in Barcelona. However, we weighted the sample to 
minimize these limitations and to generate estimations representative of the general 
population. Moreover, the baseline sample size was representative of the city of Barcelona 
(68,69) and the longitudinal design used in almost all the studies maximizes the internal 
validity of the study. In the case of the cross-sectional study carried out in this doctoral thesis 
(101), another potential limitation is that the nature of the data allows to establish 
associations but not to infer causality. In addition, the studies were conducted only in the city 
of Barcelona and generalization of the results to the rest of Spain should be cautious.  
 
Other potential limitations are those related to survey based studies, as the use of a 
questionnaire to collect self-reported information, and bias due to non-response. However, we 
used salivary cotinine as a specific biomarker in two articles of the thesis (78,99) and we also 
used the same definition of smoking status in both studies, checking self-reported smoking 
status with a salivary cotinine concentration incompatible with non-smoking (>10 ng/ml) and 
we used a face-to-face questionnaire with trained interviewers potentially increasing the 
internal validity of our results as compared with internet and self-administered surveys 
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because avoid misinterpretation of the questions. In addition, in the second (78) and third (99) 
articles of this doctoral thesis, salivary cotinine was used as a specific biomarker of nicotine 
dependence and using the same definition of smoking status in both studies potentially 
increasing internal validity.  
 
Regarding the ecological studies (79,113), their main limitation derives from its ecological 
design that yields to the fact that no information about the intensity of association at 
individual level can be inferred. Moreover, there are some studies that show that the main EU 
survey generates estimates that are in some cases widely discrepant from more substantive 
national sources and does not provide age or gender-specific data by country (117). In 
addition, in the sixth article of this doctoral thesis (79), the two years gap of time between the 
measure of TCS and the Eurobarometer survey doesn’t allow detecting the effect of measures 
adopted between 2010 and 2012. Regarding the seventh article of this doctoral thesis, there 
exists potential over-reporting of support for the studied tobacco products regulations due to 
social pressures and bias due to non-response. In addition, regarding the last article of this 
doctoral thesis (113), the time intervals between the TCS measurements and the carrying out 
of the Eurobarometer allow us to see the effect that the application of the tobacco policies 
had in the different countries and years. In addition, the main strength of this last article of the 
doctoral thesis (113) is the use of Generalized Lineal Mixed Models (GLMM) with country as a 
random effect to analyze individual level effect, Poisson family in the GLMM was also used as 
they provide more robust results and it allows us to obtain prevalence ratio despite obtaining 
high prevalence and to avoid possible overestimation of the studied effect. Moreover, the 
design of the Eurobarometer was the same for all countries increasing comparability across 
countries at an ecological level, the sample size was satisfactorily large and representative by 
country and the interviews were face-to-face. 
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 The implementation of the two smoke-free legislations in Spain is related to a reduction in 
smoking prevalence and SHS exposure (either using salivary cotinine concentrations or 
information on self-reported exposure). However, the consumption of other tobacco 
products, particularly RYO cigarettes, has increased specially among young population. 
 
 A significant increase was found in the salivary cotinine concentration among adult 
continuing smokers after both Spanish legislations. Moreover, we observed a shift to other 
tobacco products, particularly RYO cigarettes.  
 
 After the implementation of the two Spanish smoke-free bans, the main settings of SHS 
exposure was leisure time and in work, where most of the exposed ones declared 
expending most of the time outdoor and not having specific areas for smokers. However, 
cotinine concentrations in non-smokers were significantly higher only among those 
declaring exposure to SHS at home after both legislations.  
 
 The implementation of the two smoke-free legislations in Spain is related to an increasing 
of voluntary adoption of SFH rules, in particular with an increase in complete SFH rules. In 
addition, we observed an association between complete indoor SFH adoption and the 
perceived risk of SHS exposure. 
 
 Great support for the studied tobacco products regulations was found which were 
positively related with European tobacco control levels of implementation at both the 
ecological and individual levels.  
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 Future tobacco control legislations should consider applying the same taxing level to all 
tobacco products, particularly RYO. Moreover, it should be considered to increase the 
resources to implement further treatments to help smoker to quit, in order to continuing 
reducing smoking prevalence. 
 
 Given the switch of smokers to other tobacco products, the FTCD score should be 
redefined to measure nicotine dependence not only in conventional cigarette. 
 
 Further research is needed to analyze possible factors related to cotinine concentration as 
well as ensure cotinine concentration properly measures nicotine dependence.  
 
 
 There is a need to implement some public health interventions to continuing reducing SHS 
exposure. These interventions may include introducing some outdoor of public and 
workplaces, promoting the adoption of SFH rules and increase warning campaigns about 
the harmful effects of SHS exposure at home, especially in the presence of children. 
 
 The high support observed for health warnings encourages plain packaging 
implementation in Europe. Moreover, the lowest support observed in increasing taxes on 
tobacco products shows the need to implement strategies to increase support for such 
measures.  
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Abstract 
A growing body of literature conclude that smoke-free bans are associated with a decrease in 
morbidity and/or mortality of smoking related diseases, although, the path is far more 
complicated. One common approach to represent key causal relations is Directed Acyclic 
Graphs (DAGs). To our knowledge, there is a lack of articles focused in a methodological 
approach to analyze the association between the smoke-free bans and its health effects in the 
population. In this article we propose a tool for the tobacco researchers and epidemiologists in 
order to analyze the health impact in any possible disease scenario of the smoke-free 
legislations, by considering all the possible pathways, intermediate variables and confounders. 
We conclude that key variables influencing on the described association are intention to quit, 
smoking prevalence and its tendency, secondhand smoke exposure, nicotine dependence 
(FTCD) and the sociodemographic characteristics.  
 
Keywords: Directed Acyclic Graphs, smoke-free legislations 
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1. INTRODUCTION 
The design of statistical analysis in epidemiological studies usually includes three different set 
of variables: the exposure, the outcome and the confounders. The exposure and the outcome 
are easily specified by the study objective. On the contrary, the selection of possible 
confounders is quite more difficult and if it is not done properly it can introduce bias to the 
results found. Consequently, when selecting confounders, it is highly recommended to 
understand how the variables are related between them, with the exposure and with the 
outcome. One common approach to represent key causal relations is Directed Acyclic Graphs 
(DAGs). They are a simple way to encode our subject-matter knowledge, and our assumptions, 
about the qualitative causal structure of a problem (1).  
Summarizing, DAGs are particularly useful for presenting graphically assumed relationships 
between variables, visualizing and understanding confounding (common causes) and 
mediation (total, direct and indirect effects), identifying the minimal set of adjustments for 
reducing bias (bias due to unmeasured confounding, over adjustment, selection, and 
measurement error) (1–6).  
1.1. Burden of disease attributable to tobacco  
Accordingly to data from the Institute for Health Metrics from 2015, 11.5% of the total deaths 
and 6% of the disability-adjusted life-years (DALYs) were attributable to the tobacco, being the 
second risk factor of death worldwide. From the 11.5% of total deaths explained just for 
tobacco smoking the major causes of death are cardiovascular diseases, neoplasms, chronic 
respiratory diseases, lower respiratory diseases, other common infectious diseases, 
tuberculosis, diabetes and other endocrine diseases. In the same line, 1.6% of total deaths 
were attributable to tobacco secondhand smoke (SHS) exposure and 1.2% of total DALYs were 
attributable to SHS worldwide (7). From the 1.6% of total deaths explained just for SHS the 
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major causes of death were cardiovascular diseases, neoplasms, chronic respiratory diseases 
and lower respiratory diseases. 
The association between tobacco smoking and cancer has been widely described. The 
International Agency for Research on Cancer (IARC) classified tobacco and SHS exposure as 
carcinogenic to humans (group 1) (8,9). Cancers that are considered by IARC to be causally 
related to tobacco are lung, oral cavity, nasal cavity and paranasal sinuses, nasopharynx, 
oropharynx, hypopharynx, larynx, esophagus (adenocarcinoma and squamous cell carcinoma), 
upper aero digestive tract combined, stomach, pancreas, liver, kidney (body and pelvis), 
ureter, urinary bladder, cervix and myeloid leukemia (9). Moreover, a recent meta-analysis 
shows that smoking is also associated with head, neck, higher colorectal gastric and breast 
cancer (10). Based on the existing evidence, SHS causes cancer of the lung. Moreover, there is 
a positive association between exposure to SHS and larynx and pharynx cancers (8).  
Therefore, as it has been described tobacco smoking as well as SHS exposure is associated with 
many diseases. This associations share common risk factors (i.e. low quality diet or sedentary 
behavior), and are influenced or have similar patterns when stratified by sociodemographic 
characteristics (i.e. social class or sex). In consequence, when tobacco is the main variable in a 
study, the possible interrelationships and effects of other variables with the health effects 
should be taken into account.  
1.2. Tobacco control legislations 
During the last decade, several countries (11) have implemented tobacco control bans as 
suggested by the World Health Organization Framework Convention on Tobacco Control (WHO 
FCTC) (12) which aims to protect present and future generations from the devastating health, 
social, environmental and economic consequences of tobacco consumption and exposure to 
SHS. This international treaty was adopted by WHO member countries in 2003 and entered 
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into force in 2005, after it had been ratified, accepted, or approved by 40 States; in 2015 the 
WHO FTCD already covered about 90% of the world’s population (11).  
Moreover, World Bank fact sheet, Tobacco control at a glance (13), described in 2003 six cost 
effective tobacco control interventions: higher taxes on cigarettes and other tobacco products; 
bans/restrictions on smoking in public and workplaces (schools, health facilities, public 
transport, restaurants, cinemas, etc.); comprehensive bans on advertising and promotion of all 
tobacco products, logos and brand names; better consumer information (counter-advertising, 
media coverage, research findings, etc.); large, direct warning labels on cigarette boxes and 
other tobacco products; help for smokers who wish to quit, including increased access to 
nicotine replacement and other cessation therapies. Price increase is the most effective and 
cost-effective intervention in reducing smoking consumption, however, the best results are 
achieved when a comprehensive set of measures are implemented (13).  
1.3. Health impact of the smoke free legislation 
Since the implementation of tobacco control bans, it has been widely assessed the extent to 
which these bans or legislations, particularly restrictions of smoking in public and workplaces 
(smoke-free bans), reduce exposure to SHS, reduce tobacco consumption or lower smoking 
prevalence and affect the health. In this regard, several systematic reviews of international 
institutions (14–16) have summarized the available evidence.  
According to the 2009 IARC review (16), exposure to SHS harms to health include lung cancer 
and cardiovascular disease in adults, respiratory disease in adults and children, and sudden 
infant death syndrome. SHS exposure has both acute and chronic health effects and 
consequently, both immediate and longer-term benefits to public health can be anticipated 
from implementing smoke-free policies. Such policies usually obtain majority support for 
smoke-free public and workplaces. Public support among both smokers and nonsmokers for 
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smoke-free policies increases following implementation of legislation. When smoke-free 
policies are implemented as described in the WHO FCTC guidelines, compliance is moderate to 
high. Moreover, implementation of smoke-free policies leads to a substantial decline in 
exposure to SHS, reduces social inequalities in SHS exposure at work, appears to cause a 
decline in heart disease morbidity (the published data on this are consistent, but longer-term 
follow-up is required), and decreases respiratory symptoms in workers. Lung cancer incidence 
in nonsmokers can be expected to decline 10-20 years after smoke-free legislation is put into 
action. Smoke-free workplaces reduce cigarette consumption among continuing smokers and 
lead to increased successful cessation among smokers. Smoke-free policies appear to reduce 
tobacco use among youth. In addition, there is a greater decline in smoking when smoke-free 
policies are part of a comprehensive tobacco control program.  
Other of these reviews (14), carried out in 2010, included 50 studies from 13 countries. 31 
reported exposure to SHS, 19 of them measured by the use of biomarkers. All studies clearly 
showed reduced reported SHS exposure. There was consistent evidence that smoking bans 
reduced exposure to SHS in workplaces, restaurants, pubs and in public places. There was a 
greater reduction in exposure to SHS in hospitality workers compared to the general 
population. Concerning SHS at home, there was no change in the prevalence or duration of 
reported exposure to SHS as smoke free bans effect, although some studies reported positive 
findings. In addition, more recent studies does show a significant decrease in self-declared 
exposure to SHS at home, work, public transport and leisure time (17) and an increase in 
smoke-free homes, after the implementation of national smoke-free bans (18).  
Twenty-three studies reported measures of active smoking, often as a co-variable rather than 
an endpoint in itself and with diverse measurements, making it difficult to compare the 
findings. The effect of smoking bans on smoking prevalence was inconclusive, with smoking 
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prevalence declining slightly in most of the population based studies. There was inconsistent 
evidence of a reduction in cigarette consumption, but in studies where declines in prevalence 
were recorded, consumption levels also fell. Furthermore, other systematic review conducted 
in 2012 which included 88 studies, found high or moderately strong evidence that tobacco 
control policies can reduce smoking prevalence in the general population (19). This review also 
shows evidence about the effect of tobacco control policies in increasing the smoking 
cessation and reducing smoking initiation.  
In the review conducted by Callinan et al. in 2010 (14), twenty-five studies reported health 
indicators as an outcome. Self-reported respiratory and sensory symptoms were measured in 
12 studies, with lung function measured in five of them. There was consistent evidence of a 
reduction in hospital admissions for cardiac events as well as an improvement in some other 
health indicators after the ban.  
The review updated and conducted by Frazer et al. (15), carried out in 2016, included 77 
studies from 21 countries. 15 analyzed smoking prevalence, with more consistent evidence of 
the impact of smoking bans on reducing smoking prevalence rates and tobacco consumption. 
In addition, other studies not included in these review also show a significant reduction in 
smoking prevalence after the implementation of national smoke-free bans (17). Moreover, 4 
studies provided evidence of reduced SHS following the introduction of smoking bans, 
consistent with evidence from the previous version of the review (14).  
Seventy-two studies reported health outcomes, including cardiovascular, respiratory and 
perinatal outcomes (15). There is consistent evidence of a positive impact of national smoking 
bans on improving cardiovascular health outcomes based on 44 studies. From those, 43 
evaluated incidence of acute myocardial infarction (AMI) and acute coronary syndrome (ACS), 
33 of which detected significant associations between introduction of bans and reductions in 
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events. 6 studies evaluated stroke incidence and 5 detected significant associations between 
smoke free bans and reduction in events (15). 21 studies were included for analyzing the 
association with respiratory outcomes, but there were conflicting results and therefore the 
evidence is classified as very low. Nevertheless, 6 of 11 studies reported significant reductions 
in COPD (Chronic Obstructive Pulmonary Disease) admissions, and 7 of 12 reported significant 
reductions in asthma admissions (15). Perinatal outcomes provide evidence of reduced 
maternal smoking and acknowledged impact on fetal health (15). But the effects on perinatal 
health were less consistent due to unclear study designs and possibility of biased and 
confounded associations (15). Another meta-analysis published found that smoke-free 
legislation was associated with reductions in preterm birth and hospital attendances for 
asthma but no significant effect was found on low birthweight (20). Therefore, it is suggested 
that smoke free bans are associated with perinatal health even with the limitations of the 
literature published. Eleven studies reported national mortality rate for smoking-related 
diseases (15), from those, 8 detected significant associations between introduction of bans and 
reduced smoking-related mortality. 
 1.4. Justification and objectives 
Most of the studies conclude that smoke-free bans are associated with a decrease in morbidity 
and/or mortality of smoking related diseases, although, the path is far more complicated. 
Moreover, to our knowledge, there is no previous literature published that focused on 
assessing the impact of the smoke-free legislation in health-related outcomes. Therefore, the 
aim of this article is to describe a methodological approach based on DAGs in order to analyze 
the association between the smoke-free bans and its health effects in the population. 
2. Suggested DAG to assess the impact of smoking legislation on health of population 
Based on the published literature, as previously described above (in the section 1.4.), smoke-
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free bans are associated with a decrease in smoking prevalence and SHS exposure which in 
consequence have effects in children and adult health and therefore in the increase in the life 
expectancy. According to that, we have proposed the DAG showed in the figure 1 to assess the 
total effect of the smoke-free legislation in the adult and/or child health.  
Moreover, each country has passed a different level or type of legislation (more or less 
restrictive and comprehensive), has started applying them at different time and ways, and has 
different pressure of the stakeholders (i.e. lobbies, tobacco companies, and attitudes toward 
smoking). Also, each country has a political and economic model that influence on the socio-
demographic characteristics of the population (inequities). Furthermore, it is important to take 
into account that smoke-free bans are associated with an increase on quit smoking of the 
general population and thus with a decrease on smoking prevalence and, what is more, by 
reducing smoking prevalence also the exposure to SHS is reduced (14–16). However, changes 
on smoking prevalence over time can also be due to secular trends as expected according to 
the four-stage descriptive model of the tobacco epidemic (21).  
In addition, the hardening hypothesis suggests that tobacco control activities have mostly 
influenced the less dependent smokers and, thus, remaining smokers are those who are less 
likely to quit smoking (22). In this regard, a study based on 18 European countries suggests 
that the lower the dependence is, the lower the country-specific smoking prevalence, 
counteracting the hardening hypothesis (23). In any case, tobacco dependence may influence 
smoking cessation and, thus, in the smoking prevalence. For this reason, the Fagerström Test 
for Cigarette Dependence (FTCD) score (24) is widely used to gather information about 
tobacco dependence.  
Furthermore, tobacco use and tobacco-related deaths are much higher in certain social 
groups. Inequities in smoking have been observed based on educational level, sex, 
occupational level, ethnicity, housing tenure and other measures of health (25). Moreover, the 
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impact of the smoke-free legislations has been shown to be different depending on sex (15), 
socioeconomic status (26) and age (15). More specifically, socioeconomic gradients indicated 
that men in lower socioeconomic groups took more benefit from the effect of smoke-free 
legislation (15). A longitudinal study based on the immediate mortality effects on the national 
Irish smoking ban found a reduction in the inequalities in smoking-related mortality (26). 
However, it is important to take into account that the impact on health inequalities is 
uncertain as few studies have assessed post-ban effects by sociodemographic characteristics 
(26). Therefore, it is important to take into account the effect of sociodemographic 
characteristics in the smoking prevalence and SHS, as their attributable effect in health (i.e. life 
expectancy).  
Finally, exposure (legislation) and outcomes (children and adults’ health) variables are 
associated with some ancestors variables that depend on the specific scenario that researchers 
are interested in analyze. Considering all this evidence from literature previously discussed in 
this section, a graphical representation of all the possible mechanisms and pathways affecting 
the association between smoke-free legislations and their health impact can be observed in 
figure 1.  
The hypothesis would be that there is a causal relationship between smoking legislations and 
children and/or adults’ health. The exposure (legislation) and the outcomes (children health 
and adults’ health) are represented in bold font. A back door path closed can be found in the 
colliders (secondhand smoke and smoking prevalence), therefore, there is no need to 
conditioning on these variables. On the other hand, there is a confounding pathway between 
adults/children health and socio-demographic variables or country nodes. We could adjust for 
any of the two nodes, in the case of the figure 1, we are conditioning on the node socio-
demographic variables (squared).  
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Figure 1. Directed Acyclic Graph (DAG) of the total effect of the smoke-free legislation on the incidence of children 
and adults health. 
 
2.1. Scenario 1: Example of a DAG for the hypothesis that smoking legislation is causally 
related to acute myocardial infarction.  
Assuming there is one study that wants to test the hypothesis that the implementation of 
smoke-free legislations has produced a decrease on the incidence of acute myocardial 
infarction cases. For that purpose, the information related to the predictors of the smoke-free 
ban (exposure) and the acute myocardial infarction (outcome) have been gathered; as other 
related variables in the causal pathway. As it is well known, the main factors, excluding active 
and passive exposure to tobacco, causing acute myocardial infarction are alcohol consumption, 
unhealthy diet, sedentary behavior and Body Mass Index (BMI), as well as socio-economic 
characteristics (i.e. age, social class). Supposing the study is carried out with a sample from a 
specific country, the node legislation would have a direct arrow to the node socio-economic 
status (Figure 2).  
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As there is a confounding path (unblocked back door path) between the outcome (acute 
myocardial infarction), the socioeconomic status and the exposure (legislation), it is necessary 
to condition on socio-economic status (block the back door path).       
 
Figure 2. Directed Acyclic Graph (DAG) for total effect of the smoke-free legislation in the acute myocardial 
infarction incidence.  
 
2.2. Scenario 2: DAG to assess the impact of smoking legislations in low birth weight.   
Assuming there is one study that wants to test the hypothesis of the effect of the 
implementation of smoke-free legislation on the reduction of low birth weight incidence cases 
in European countries. Again we assume information related to the predictors of the smoke-
free ban (exposure) and low birth weight (outcome) have been gathered, as well as 
information of other related variables in the causal pathway. The main predictors of low birth 
weight, excluding active and passive exposure to tobacco, described are the maternal life-style 
characteristics, such as diet, use of alcohol, physical activity, BMI, previous pregnancies (i.e. 
parity) and parental socio-economic characteristics (i.e. maternal age, educational or social 
level). Supposing the study is carried out with a sample from the 28 countries of the European 
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Union and the information related to socio-economic characteristics is not available (Figure 3). 
Therefore, the 2 possible confounding paths; (i) the outcome (low birth weight), the parental 
socioeconomic status and the exposure (legislation), and (ii) the outcome (low birth weight), 
the country and the exposure (legislation), would be reduced to the one which includes 
country. So, it is necessary to condition on country to block the back door path.  
Figure 3.  Directed Acyclic Graph (DAG) for total effect of the smoke-free legislation in the low birth weight 
incidence.   
 
3. Discussion   
To our knowledge, this is the first article focused in a methodological approach to analyze the 
association between the smoke-free bans and its health effects in the population. In this article 
we propose a tool for the tobacco researchers and epidemiologist in order to analyze the 
health impact in any possible disease scenario of the smoke-free legislations, by considering all 
the possible pathways, intermediate variables and confounders.  
Almost any of the studies published used DAGs as part of their methodology. In the previous 
14 
 
commented review (15) the evidence found in some cases was very low due to the study 
design was unclear and to the possibility of confounding associations. Therefore, a major 
priority from public health is to improve the methodological quality of the research in order to 
obtain more consistent evidence to work with the stakeholders and finish with the tobacco 
epidemic. In this regard, there is just one study, that we know, that used a DAG to describe the 
recognized pathways contributing to the link between tobacco control policies and a specific 
health outcome based on the literature. However, the aim of the study was not to introduce a 
tool to the tobacco researchers but to investigate the tobacco control policies effect on key 
perinatal outcomes known to be associated with maternal smoking and/or SHS exposure (27). 
Consequently, the DAG that is shown in their study can just be applied for the objective of 
their study and could not be used in studies focused in other diseases.  
Howbeit, it is important to keep in mind that there are other possible strategies for 
confounder identification. The main confounding evaluation strategies are three (28): (i) The 
stepwise procedure, the implicit assumption underlying this approach is that, although not all 
variables selected will be confounders, all important confounders will be selected. (ii) The 
change in effect estimates (by 5% or 10%), compares adjusted and unadjusted effect 
estimates, the implicit assumption is that any variable substantially associated with an 
estimate change is worth adjusting for. (iii) The standard confounder selection, consist on 
whether some necessary criteria for confounding are met. Generally, it is stated that a 
confounder is a variable associated with exposure in the population, associated with the 
outcome conditional on the exposure, and not in the causal pathway between the exposure 
and the outcome. The third approach does not rule out bias or unnecessary adjustment. All the 
three strategies may lead to bias from the omission of important confounders or inappropriate 
adjustment for non-confounders.  
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The presence of common causes, and therefore of confounding, can be represented by DAGs. 
Those also have some limitations per se. First of all we cannot quantify the magnitude of the 
effect, nor show the direction of the effect and of the interaction (synergism or antagonism). 
But DAGs can give us accurate information about the possible confounding variables we should 
take into account for our models (1). Therefore, the best approach we propose would be to 
combine the DAGs with the common confounding evaluation strategies.  
The model we propose (figure 1) reaches all the possible factors that could be involved in the 
impact of the smoke-free bans and the health related outcomes by several pathways. 
However, there is an emerging concept in tobacco exposure, third-hand smoke (THS) made of 
residual tobacco smoke gases and particles that settle on surfaces and dust (29). It would have 
been interesting to introduce this novel concept in the DAG proposed, but the literature 
regarding this topic is scarce making it difficult to understand the possible relations. This 
reflects the need to shed more light about the THS and its health effects helping to modify or 
to create new tobacco legislations. In our opinion, introducing the variable THS in the DAG 
would not modify any of the existing arrows, instead it would open a new pathway being an 
intermediate factor between the SHS and smoking prevalence and the children and adult 
health. Moreover, it would be affected by sociodemographic variables.  
In conclusion, studies that assess the effect of the smoke-free legislation on health outcomes 
may not forget to include key variables that could influence on their association. Those would 
be intention to quit, smoking prevalence and its tendency, secondhand smoke exposure, 
nicotine dependence (FTCD) and the sociodemographic characteristics. For this reason, DAGs 
and the model proposed to assess the impact of smoking legislation in the health of the 
population could be useful for the future research.  
 
16 
 
Competing Interests 
The authors declare that they have no conflicts of interest.   
Funding 
This study did not receive any type of funding.  
Author Contributions  
NMS and CLM drafted the manuscript (both contributed equally to this article). All authors 
contributed substantially to the interpretation of the data and to revising the manuscript. All 
authors approved its final version. 
  
17 
 
References 
1.  Hernán MA, Robins JM. Causal Inference [Internet]. 2016. Available from: 
https://www.hsph.harvard.edu/miguel-hernan/causal-inference-book/ 
2.  Greenland S, Pearl J, Robins JM. Causal Diagrams for Epidemiologic Research. 
Epidemiology. 1999;10:37–48.  
3.  Greenland S, Brumback B. An overview of relations among causal modelling methods. 
Int J Epidemiol. 2002;31:1030–7.  
4.  Parascandola M, Weed DL. Causation in epidemiology. 2001;905–12.  
5.  Robins JM. Data , Design , and Background Knowledge in Etiologic Inference. 
Epidemiology. 2001;11:313–20.  
6.  Hernan MA, Hernández-Díaz S, Robins JM. A Structural Approach to Selection Bias. 
Epidemiology. 2004;15(5):615–25.  
7.  Forouzanfar MH, Afshin A, Alexander LT, Anderson HR, Bhutta ZA, Biryukov S, et al. 
Global, regional, and national comparative risk assessment of 79 behavioural, 
environmental and occupational, and metabolic risks or clusters of risks, 1990???2015: 
a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 
2016;388(10053):1659–724.  
8.  IARC Working group. Second-hand tobacco smoke. Vol. 100 E, IARC Monographs on the 
Evaluation of Carcinogenic Risks to Humans. 2012.  
9.  IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Personal 
habits and indoor combustions. Volume 100 E. A review of human carcinogens. Vol. 
100, IARC monographs on the evaluation of carcinogenic risks to humans / World 
18 
 
Health Organization, International Agency for Research on Cancer. 2012.  
10.  Ordóñez-Mena JM, Schöttker B, Mons U, Jenab M, Freisling H, Bueno-de-Mesquita B, et 
al. Quantification of the smoking-associated cancer risk with rate advancement periods: 
meta-analysis of individual participant data from cohorts of the CHANCES consortium. 
BMC Med [Internet]. 2016;14(1):62. Available from: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4820956&tool=pmcentrez
&rendertype=abstract 
11.  Eriksen M, Mackay J, Schulger N, Islami Gomeshtapeh F, Drope J. The Tobacco Atlas. 
American Cancer Society. 2015.  
12.  WHO. The WHO Framework Convention on Tobacco Control: An Overview [Internet]. 
2015. Available from: 
http://www.who.int/tobacco/mpower/publications/en_tfi_mpower_brochure_r.pdf 
13.  World Bank Data. Tobacco control. 2003.  
14.  Callinan JE, Clarke A, Doherty K, Kelleher C. Legislative smoking bans for reducing 
secondhand smoke exposure, smoking prevalence and tobacco consumption. Cochrane 
Database Syst Rev. 2010;(4):CD005992.  
15.  Frazer K, Callinan JE, McHugh J, van Baarsel S, Clarke A, Doherty K, et al. Legislative 
smoking bans for reducing harms from secondhand smoke exposure , smoking 
prevalence and tobacco consumption ( Review ) SUMMARY OF FINDINGS FOR THE 
MAIN COMPARISON. Cochrane Database Syst Rev. 2016;2(CD005992).  
16.  International Agency for Research on Cancer. Evaluating the effectiveness of smoke-
free policies. [Internet]. Vol. 13. 2009. 374 p. Available from: 
19 
 
http://w2.iarc.fr/en/publications/pdfs-online/prev/handbook13/handbook13.pdf 
17.  Lidón-Moyano C, Fu M, Ballbè M, Martín-Sánchez JC, Matilla N, Martínez C, et al. 
Impact of the Spanish smoking laws on tobacco consumption and secondhand smoke 
exposure: a population longitudinal study. Revis.  
18.  Lidón-Moyano C, Martínez-Sánchez JM, Fu M, Ballbè M, Martín-Sánchez JC, Martínez C, 
et al. Impact of the Spanish smoking legislations in the adoption of smoke-free rules at 
home: a longitudinal study in Barcelona (Spain). Tob Control. 2016;0:1–6.  
19.  Wilson LM, Avila Tang E, Chander G, Hutton HE, Odelola OA, Elf JL, et al. Impact of 
tobacco control interventions on smoking initiation, cessation, and prevalence: A 
systematic review. J Environ Public Health. 2012;2012.  
20.  Been J V., Nurmatov UB, Cox B, Nawrot TS, Van Schayck CP, Sheikh A. Effect of smoke-
free legislation on perinatal and child health: A systematic review and meta-analysis. 
Lancet [Internet]. 2014;383(9928):1549–60. Available from: 
http://dx.doi.org/10.1016/S0140-6736(14)60082-9 
21.  Lopez AD, Collishaw NE, Piha T. A descriptive model of the cigarette epidemic in 
developed countries. Tobacco. 1994;3:242–7.  
22.  Hughes JR. The hardening hypothesis: Is the ability to quit decreasing due to increasing 
nicotine dependence? A review and commentary. Drug Alcohol Depend [Internet]. 
2011;117(2–3):111–7. Available from: 
http://dx.doi.org/10.1016/j.drugalcdep.2011.02.009 
23.  Fernández E, Lugo A, Clancy L, Matsuo K, La Vecchia C, Gallus S. Smoking dependence in 
18 European countries: Hard to maintain the hardening hypothesis. Prev Med (Baltim) 
20 
 
[Internet]. 2015;81:314–9. Available from: 
http://dx.doi.org/10.1016/j.ypmed.2015.09.023 
24.  K. F. Determinants of tobacco use and renaming the FTND to the Fagerstrom Test for 
Cigarette Dependence. Nicotine Tob Res. 2012;14:75–8.  
25.  World Health Organization (WHO). Tobacco and Inequities. 2014.  
26.  Stallings-Smith S, Goodman P, Kabir Z, Clancy L, Zeka A. Socioeconomic differentials in 
the immediate mortality effects of the national irish smoking ban. PLoS One. 2014;9(6).  
27.  Peelen MJ, Sheikh A, Kok M, Hajenius P, Zimmermann LJ, Kramer BW, et al. Tobacco 
control policies and perinatal health: a national quasi-experimental study. Sci Rep 
[Internet]. 2016;6(October 2015):23907-. Available from: 
http://dx.doi.org/10.1038/srep23907 
28.  Hernán MA, Hernández-díaz S, Werler MM, Mitcheil AA. Causal Knowledge as a 
Prerequisite for Confounding Evaluation: An Application to Birth Defects Epidemiology. 
Am J Epidemiol. 2002;155(2):176–84.  
29.  Acuff L, Fristoe K, Hamblen J, Smith M, Chen J. Third-Hand Smoke: Old Smoke, New 
Concerns. J Community Health. 2016;41(3):680–7.  
 
ANNEXES 
195 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
II. Prevalence and use profile of electronic 
cigarette in Spain (2014) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ANNEXES 
196 
 
 
  
OP
C
J
a
b
c
d
e
i
H
R
A
O
P
C
C
P
K
E
T
P
0
nGac Sanit. 2016;30(6):432–437
riginal
revalencia  y  perﬁl  de  uso  del  cigarrillo  electrónico  en  Espan˜a  (2014)
ristina  Lidón-Moyanoa, Jose  M.  Martínez-Sáncheza,b,c,∗,  Marcela  Fub,c,d, Montse  Ballbèb,c,e,
uan  Carlos  Martín-Sáncheza y  Esteve  Fernándezb,c,d
Unidad de Bioestadística, Departamento de Ciencias Básicas, Universitat Internacional de Catalunya, Sant Cugat del Vallès (Barcelona), Espan˜a
Unidad de Control de Tabaco, Programa de Control y Prevención del Cáncer, Instituto Catalán de Oncología (ICO), L’Hospitalet de Llobregat (Barcelona), Espan˜a
Grupo de Control y Prevención del Cáncer, Instituto de Investigación Biomédica de Bellvitge (IDIBELL), L’Hospitalet de Llobregat (Barcelona), Espan˜a
Departamento de Ciencias Clínicas, Universitat de Barcelona, Barcelona, Espan˜a
Unidad de Adicciones, Departamento de Psiquiatría, Instituto de Neurociencias, Hospital Clínic de Barcelona, Barcelona, Espan˜a
nformación  del  artículo
istoria del artículo:
ecibido el 29 de enero de 2016
ceptado el 22 de marzo de 2016
n-line el 16 de mayo de 2016
alabras clave:
igarrillo electrónico
onsumo de tabaco
revalencia
r  e  s  u  m  e  n
Objetivo:  Describir  la  prevalencia  y  el perﬁl  de  uso  de  los  cigarrillos  electrónicos  en  la población  adulta
espan˜ola  y  evaluar  el potencial  uso  dual  de  estos  dispositivos  con  el tabaco  combustible  o convencional,
en  Espan˜a,  en  2014.
Métodos: Estudio  transversal  en una  muestra  representativa  de  la  población  adulta  (16-75 an˜os  de  edad)
espan˜ola  (n  = 1016).  Se realizó  una  encuesta  telefónica  asistida  por ordenador  en el  an˜o 2014.  Se calcu-
laron  prevalencias  y  sus  intervalos  de  conﬁanza  del  95%  (IC95%)  para  el  uso  del cigarrillo  electrónico
estratiﬁcado  por  sexo,  edad,  consumo  de  tabaco  y clase  social.  Se  ponderó  la  muestra  y se  ajustó  un
modelo  de regresión  logística  para  calcular  las  odds ratios  (OR) crudas  y ajustadas  por sexo,  edad  y  clase
social.
Resultados:  El  10,3%  (IC95%:  8,6-12,4)  de  la población  adulta  espan˜ola  declaró  haber  usado  en alguna
ocasión  el  cigarrillo  electrónico  (2%  usuarios/as  actuales,  3,2%  usuarios/as  en  el  pasado  y  5,1% usuarios/as
experimentadores/as).  Entre  los/las  usuarios/as  actuales  de  cigarrillos  electrónicos,  el 57,2%  fumaba  tam-
bién tabaco  combustible  o  convencional,  el 28%  nunca  había  fumado  y  el  14,8%  eran  ex  fumadores/as.  La
prevalencia  de  uso  del cigarrillo  electrónico  fue mayor  entre  la población  joven  (OR  ajustada  = 23,8;  IC95%:
2,5-227,7)  y entre  las  personas  fumadoras  de  tabaco  combustible  (OR  ajustada  = 10,1;  IC95:  5,8-17,5).
Conclusiones:  El  uso  de  cigarrillos  electrónicos  en  Espan˜a  es  poco  frecuente  y predomina  en  las  personas
jóvenes  y las fumadoras  de  tabaco.  Sin  embargo,  uno/a  de  cada  cuatro  usuarios/as  actuales  del  cigarrillo
electrónico  nunca  habían  fumado.  Por ello,  debería  reforzarse  la  regulación  de  estos  dispositivos  para
evitar una  posible  puerta  de  entrada  al  uso  de  productos  con  nicotina.
© 2016  SESPAS.  Publicado  por  Elsevier  Espan˜a,  S.L.U.  Este es un  artı´culo  Open  Access  bajo  la  licencia
CC BY-NC-ND  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Prevalence  and  user  proﬁle  of  electronic  cigarettes  in  Spain  (2014)
eywords:
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Objective:  To  describe  the  prevalence  and  user  proﬁle  of  electronic  cigarettes  among  Spanish  adults  and
evaluate  the  potential  dual  use of  these  devices  with  combustible  or conventional  tobacco  in  2014  in
Spain.
Methods:  Cross-sectional  study  of  a representative  sample  of  the  Spanish  adult  (16-75  years  old)  popula-
tion  (n  = 1,016).  A  computer-assisted  telephone  survey  was conducted  in  2014.  The  prevalence  and  95%
conﬁdence  intervals  (95%  CI)  for the use  of  electronic  cigarettes  stratiﬁed  by gender,  age, tobacco  con-
sumption  and  social  status were  calculated.  The  sample  was  weighted  and  a logistic  regression  model
adjusted  to  obtain  the  crude  odds  ratios  (OR)  adjusted  by gender,  age  and social  status.
Results:  10.3%  (95%  CI: 8.6-12.4)  of the  Spanish  adult  population  stated  being  ever users  of  electronic
cigarettes (2%  current  users,  3.2%  past  users  and 5.1%  experimental  users).  Among  current  electronic
cigarette  users,  57.2%  also smoked  combustible  or conventional  tobacco,  28%  had  never smoked  and  14.8%
were  former  smokers.  The  prevalence  of  electronic  cigarette  use  was  higher  in  the  younger  population
(adjusted  OR  =  23.8;  95%  CI: 2.5-227.7)  and  smokers  of  combustible  tobacco  (adjusted  OR  =  10.1;  95%  CI:
5.8-17.5).
Conclusions:  The  use of  electronic  cigarettes  in Spain  is  scarce  and  is  most  prevalent  among  young  people
and  tobacco  smokers.  Neverthe
Hence,  the regulation  of  thes
products  among  never  smoker
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ntroducción
Los primeros cigarrillos electrónicos aparecieron en 2007 y sólo
odían adquirirse por Internet. Desde entonces, y especialmente
n los últimos an˜os, ha aumentado su interés y popularidad. Sin
mbargo, al igual que ha sucedido en otros países, en las ciudades
span˜olas las tiendas especializadas donde pueden adquirirse los
igarrillos electrónicos y todo tipo de productos relacionados con
stos dispositivos empezaron a contarse por decenas a partir de
013, cuando se registró un máximo de 3500 tiendas1. Según la
sociación Nacional del Cigarrillo Electrónico (ANCE)2, la factura-
ión de estos dispositivos aumentó un 12% de 2014 a 2015, aunque
ctualmente estas tiendas se han reducido signiﬁcativamente en
span˜a1.
Los posibles riesgos y beneﬁcios del cigarrillo electrónico a
edio y largo plazo todavía son desconocidos, lo que ha gene-
ado un intenso debate en las revistas cientíﬁcas y en los medios
e comunicación. Algunos/as investigadores/as3 y ciudadanos/as,
n particular los/las usuarios/as de los cigarrillos electrónicos y
mpresarios/as con intereses económicos en ellos, deﬁenden estos
ispositivos como una herramienta útil para dejar de fumar o redu-
ir el consumo de tabaco, como estrategia de reducción del dan˜o
ara las personas fumadoras. Un reciente metaanálisis4 basado en
3 estudios (dos ensayos aleatorizados controlados y 11 estudios
e cohortes controlados) ha mostrado que los cigarrillos electró-
icos podrían ayudar a prevenir la recaída entre las personas ex
umadoras o promover el abandono del tabaco entre los/las fuma-
ores/as actuales, aunque no ha logrado demostrar que ayuden a
ejar de fumar a largo plazo en comparación con el placebo. Sin
mbargo, un estudio longitudinal posterior5 mostró que el aban-
ono depende del tipo de cigarrillos electrónicos utilizados y de
u frecuencia de uso. Por otro lado, investigadores/as6 y activistas
el control del tabaquismo sen˜alan al cigarrillo electrónico como
na amenaza a las legislaciones sobre espacios públicos y centros
e trabajo libres de humo, además de favorecer nuevos dependien-
es de la nicotina (y potenciales personas fumadoras de tabaco),
n especial entre la población más  jóven7–9, fomentando su uso
ual con otros productos de tabaco, tal como demuestran algunos
studios10–12.
En Espan˜a, casi la totalidad de la población sabe qué son los
igarrillos electrónicos11,13,14, pero sólo se dispone de información
obre su uso en la ciudad de Barcelona13. Por ello, el objetivo de este
rabajo de ámbito nacional es describir la prevalencia y el patrón de
so de los cigarrillos electrónicos en la población adulta espan˜ola,
 evaluar el potencial uso dual de estos dispositivos con el tabaco
ombustible o convencional.
étodos
Los datos utilizados proceden de la encuesta Ómnibus del
nstituto DYM15. Se trata de un estudio transversal en una mues-
ra representativa de la población adulta espan˜ola (n = 1016) de
ntre 16 y 75 an˜os de edad, residentes en municipios de más
e 500 habitantes, en la Península y las Islas Baleares. El taman˜o
uestral se calculó con la fórmula del muestreo aleatorio simple
N = ([Z·p·(1-p)]/e)2) para una prevalencia (p) estimada del 50%
prevalencia que maximiza el taman˜o muestral), un nivel de con-
anza del 95% ( = 0,05; Z = 1,96) y una precisión o error del 3,15%
e = 0,0315). Cabe destacar que al utilizar en el cálculo del taman˜o
uestral una prevalencia esperada que maximiza el taman˜o mues-
ral y superior a la prevalencia de uso del cigarrillo electrónico,
ntre el 5% y el 10%11,16,17, aumenta la validez externa del estudio.
l taman˜o necesario para estudiar el uso del cigarrillo electró-
ico en la población espan˜ola utilizando una prevalencia esperada
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865 individuos. La encuesta se llevó a cabo en octubre y noviembre
de 2014 mediante entrevista telefónica asistida por ordenador. La
selección de los hogares a entrevistar se realizó a partir de directo-
rios telefónicos de municipios seleccionados aleatoriamente. Para
la selección del individuo a entrevistar se utilizaron cuotas de
edad, sexo y actividad laboral, por lo que la muestra ﬁnal se pon-
deró mediante pesos de disen˜o basados en la distribución de los
datos obtenidos del Instituto Nacional de Estadística para obtener
una mayor representatividad de Espan˜a. La ponderación se rea-
lizó según sexo, edad, zona de residencia (Este, Levante, Sur, etc.),
taman˜o del municipio de residencia y ocupación.
Variables
Para estimar la prevalencia de usuarios/as de cigarrillo elec-
trónico se usó la pregunta «¿Ha utilizado el cigarrillo electrónico
alguna vez?», con las posibles respuestas «Sí, actualmente», «Sí, pero
en el pasado», «Sólo lo he probado» y «Nunca lo he probado». A par-
tir de esta pregunta se deﬁnieron los/las usuarios/as que alguna
vez habían probado los cigarrillos electrónicos como las personas
que respondieron «Sí, actualmente», «Sí, pero en el pasado»,  «Sólo
lo he probado» (o «experimentadores»). Aunque en la actualidad
no existe una pregunta validada para medir el uso del cigarrillo
electrónico, en nuestro estudio hemos utilizado la misma  pregunta
utilizada ampliamente en estudios previos11,17–20 para aumentar
la validez interna de nuestro trabajo y la comparabilidad con otros.
También se preguntó por el consumo de tabaco y se clasiﬁcó a
los participantes en personas fumadoras (diarias y ocasionales), ex
fumadoras y nunca fumadoras.
Se recogió información sobre la edad (categorizada en los gru-
pos de 16-45 an˜os, 46-65 an˜os y 66-75 an˜os), el sexo de la persona
entrevistada y su clase social (categorizada en alta, media y baja,
basándose en el nivel educativo de la persona entrevistada y la
ocupación de la persona sustentadora de la familia).
Se calcularon las prevalencias y su intervalo de conﬁanza del
95% (IC95%) del uso del cigarrillo electrónico estratiﬁcado por sexo,
edad, consumo de tabaco y clase social. Se utilizaron las pruebas de
2 de Pearson y de 2 de tendencia para valorar la asociación entre
el uso del cigarrillo electrónico y diversas variables sociodemográﬁ-
cas. Se ajustó un modelo de regresión logística para calcular las odds
ratios (OR) crudas y ajustadas por sexo, edad y clase social, junto
con sus IC95%. Los análisis de los datos se realizaron con el software
estadístico SPSS versión 21. Además, todos los análisis estadísticos
incorporaron las ponderaciones derivadas del disen˜o muestral.
Resultados
El 24,4% (IC95%: 21,9-27,1) de las personas encuestadas aﬁrmó
ser fumador/a de tabaco, el 27,7% (IC95%: 25,0-30,5) ex fumador/a
y el 47,9% (IC95% = 44,9-51,0) nunca fumador/a. Los hombres decla-
raron fumar más  que las mujeres (27,8% frente a 21%, p = 0,012), y
se observó una tendencia decreciente y signiﬁcativa del consumo
de tabaco con la edad (p de 2 de tendencia <0,001).
El 10,3% (IC 95%: 8,6-12,4) de la población adulta espan˜ola
declaró haber usado en alguna ocasión el cigarrillo electró-
nico (tabla 1). La prevalencia de uso del cigarrillo electrónico
en alguna ocasión fue mayor, y estadísticamente signiﬁcativa,
entre la población joven (OR ajustada = 23,8; IC95%: 2,5-227,7)
y entre las personas fumadoras de tabaco combustible (OR
ajustada = 10,1; IC95%: 5,8-17,5). No se observaron diferencias esta-
dísticamente signiﬁcativas en el uso del cigarrillo electrónico según
el sexo ni la clase social (tabla 1). Los resultados obtenidos entre las
OR crudas y las OR ajustadas fueron similares.
En la tabla 2 se muestra la prevalencia de uso actual, pasado y
de experimentación del cigarrillo electrónico según las variables
434 C. Lidón-Moyano et al. / Gac Sanit. 2016;30(6):432–437
Tabla 1
Prevalencia (%) del uso de cigarrillo electrónico, odds ratio cruda (OR) y ajustada (ORa), y sus intervalos de conﬁanza del 95% (IC95%), según sexo, edad, clase social y consumo
de  tabaco. Espan˜a, 2014
n % (IC95%) p OR (IC95%) ORaa (IC95%)
Uso del cigarrillo electrónico 1016 10,3 (8,6-12,4) - - -
Sexo
Mujer  509 8,8 (6,7-11,6) 0,117b 1 1
Hombre  507 11,8 (9,3-15,0) 1,4 (0,9-2,1) 1,3 (0,9-2,0)
Edad  (an˜os)
16-45 560 14,8 (12,1-18,0) <0,001b 24,7 (2,6-235,5) 23,8 (2,5-227,7)
46-65 344 6,1 (4,0-9,1) <0,001c 9,5 (1,0-93,2) 9,2 (0,9-90,8)
66-75  112 0,9 (0,2-5,0) 1 1
Clase  social
Alta 56 14,3 (7,4-25,7) 0,282b 1 1
Media  679 10,9 (8,8-13,5) 0,113c 1,8 (0,8-4,0) 1,2 (0,5-2,7)
Baja  281 8,3 (5,5-12,0) 1,8 (0,8-4,3) 1,3 (0,5-3,1)
Consumo de tabaco
Nunca fumador/a 487 3,9 (2,5-6,0) <0,001b 1 1
Ex  fumador/a 281 5,0 (3,0-8,2) 1,3 (0,7-2,7) 1,6 (0,8-3,2)
Fumador/a 248 29,0 (23,7-35,0) 10,2 (6,0-15,5) 10,1 (5,8-17,5)
IC95%: intervalo de conﬁanza del 95%; OR: odds ratio; ORa: OR ajustada.
a Ajustada por sexo, edad y clase social.
b 2 de Pearson.
c 2 de tendencia.
Tabla 2
Prevalencia (%) de uso actual, pasado y de experimentación del cigarrillo electrónico según sexo, edad, clase social y consumo de tabaco. Espan˜a, 2014
n Uso actual
% (IC95%)
p Uso pasado
% (IC95%)
p Experimentación
% (IC95%)
p
Uso del cigarrillo electrónico 1016 2,0 (1,3-3,0) - 3,2 (2,3-4,5) - 5,1 (3,9-6,6) -
Sexo
Mujer 509 1,2 (0,5-2,5) 0,046a 3,1 (1,9-5,0) 0,846a 4,5 (3,0-6,7) 0,559a
Hombre 507 3,0 (1,8-4,8) 3,3 (2,1-5,3) 5,5 (3,8-7,9)
Edad  (an˜os)
16-45 560 3,0 (1,9-4,8) 0,042a 4,1 (2,7-6,1) 0,158a 7,7 (5,7-10,2) <0,001a
46-65 344 1,2 (0,4-2,9) 0,013b 2,6 (1,4-4,9) 0,055b 2,3 (1,2-4,5) <0,001b
66-75 112 0,0 (0-3,3) 0,9 (0,2-4,9) 0,0 (0,0-3,3)
Clase social
Alta 56 0,0 (0,0-6,4) 0,026a 5,4 (1,8-14,6) 0,613a 8,9 (3,9-19,3) 0,754a
Media 679 2,8 (1,8-4,3) 0,147b 3,1 (2,0-4,7) 0,486b 5,0 (3,6-6,9) 0,734b
Baja 281 0,4 (0,1-2,0) 2,9 (1,4-5,5) 5,0 (3,0-8,2)
Consumo de tabaco
Nunca fumador/a 487 1,2 (0,6-2,7) 0,002a 0,0 (0,0-0,8) <0,001a 2,7 (1,6-4,5) <0,001a
Ex fumador/a 281 1,1 (0,4-3,1) 0,003b 0,7 (0,2-2,6) <0,001b 3,2 (1,7-6,0) <0,001b
Fumador/a 248 4,8 (2,8-8,3) 12,5 (8,9-17,2) 11,7 (8,3-16,3)
IC95%: intervalo de conﬁanza del 95%.
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ociodemográﬁcas. El 2% (IC95%: 1,3-3,0) de la muestra declaró ser
suario/a actual del cigarrillo electrónico, el 3,2% (IC95%: 2,3-4,5)
suarios/as en el pasado y el 5,1% (IC95%: 3,9-6,6) experimentado-
es/as. En cuanto al uso actual del cigarrillo electrónico, se observó
n mayor uso en los hombres (3% frente a 1,2% en las mujeres,
 = 0,046), así como una tendencia decreciente y signiﬁcativa de su
so con la edad (p de 2 de tendencia = 0,013) y con el consumo
e tabaco (nunca fumador/a: 1,2%; ex fumador/a: 1,1%; fumador/a:
,8%). Respecto al uso pasado, únicamente se observan diferencias
igniﬁcativas en función del consumo de tabaco (nunca fumador/a:
%; ex fumador/a: 0,7%; fumador/a: 12,5%). Por último, en lo refe-
ente a la experimentación, se observa una tendencia decreciente
 signiﬁcativa del uso del cigarrillo electrónico con la edad (p de
2 de tendencia <0,001) y el consumo de tabaco (nunca fumador/a:
,7%; ex fumador/a: 3,2%; fumador/a: 11,7%).
En la ﬁgura 1 se muestra la distribución porcentual del consumo
e tabaco entre las personas usuarias del cigarrillo electrónico. El
7,5% de las personas que declararon haber usado en alguna ocasión
Nun ca fu mado r/a Ex fumador/ a Fumador/a
Figura 1. Distribución porcentual del consumo de tabaco entre las personas usua-
rias  (actuales, pasadas y experimentadoras) de cigarrillos electrónicos. Espan˜a, 2014.
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l cigarrillo electrónico eran fumadoras de tabaco combustible, el
8,1% nunca fumadoras y el 14,4% ex fumadoras en el momento del
studio. Entre quienes usaban actualmente el cigarrillo electrónico,
l 57,2% fumaban tabaco (usuarios/as «duales»), el 14,8% eran ex
umadores/as y el 28% declararon no haber fumado nunca. Además,
odas las personas usuarias actuales de cigarrillo electrónico que
eclararon ser «nunca fumadoras» pertenecían al grupo de menor
dad (16-45 an˜os). Finalmente, de las personas que solo lo habían
robado, el 54,7% eran fumadoras, el 19,7% ex fumadoras y el 25,6%
unca fumadoras (ﬁg. 1).
iscusión
Este estudio muestra que el 10,3% de las personas espan˜olas
dultas han probado en alguna ocasión el cigarrillo electrónico. Este
orcentaje es mayor que el observado en la ciudad de Barcelona
6,5%) en 2013-201411, lo cual puede deberse a que en el estudio
e Barcelona estaba sobrerrepresentada la población adulta. Por
tro lado, una reciente revisión sistemática de 21 artículos16 mostró
na variabilidad en la prevalencia del uso del cigarrillo electrónico
ependiendo del grupo de edad estudiado. Por otro lado, este estu-
io muestra una mayor prevalencia de uso entre la población más
oven y entre las personas fumadoras. En Europa17 en general, y en
arcelona en particular11, también se ha observado un mayor uso
el cigarrillo electrónico entre la población joven. En este sentido,
a revisión antes mencionada16 mostró que solamente el consumo
e tabaco fue la variable que siempre se correlacionó con el uso de
os cigarrillos electrónicos.
En Europa, el 20,3% de las personas fumadoras, el 4,7% de las ex
umadoras y el 1,2% de las nunca fumadoras reportaron en 2012
aber usado alguna vez el cigarrillo electrónico17. En Barcelona
e observaron prevalencias similares en 2013-2014 (21,1% de las
ersonas fumadoras, 4,1% de las ex fumadoras y 0,3% de las nunca
umadoras)11. Sin embargo, los resultados del presente estudio de
mbito nacional muestran una mayor prevalencia en comparación
on dichos estudios, en especial entre las personas fumadoras y
unca fumadoras. Esta diferencia podría deberse a una mejor repre-
entatividad de la presente muestra (sin sobrestimar la población
ás  adulta), como comentábamos antes, o a que fue justamente en
014 cuando se extendió más  la experimentación y el uso de los
igarrillos electrónicos entre la población más  joven, antes de su
eclive (como muestra el cierre de tiendas especializadas en estos
ispositivos)1.
Un aspecto importante, relativo a los cigarrillos electrónicos, es
u uso en población nunca fumadora, en particular entre la gente
ás  joven, lo que fomenta una nueva puerta de entrada a la depen-
encia de la nicotina, así como un uso dual con otros productos de
abaco (hipótesis del gateway de los cigarrillos electrónicos)10. En
uestro estudio observamos que la prevalencia de personas nunca
umadoras era mayor entre los/las usuarios/as actuales (28%) de
igarrillo electrónico y entre los/las experimentadores/as (25,6%)
n comparación con los/las que lo utilizaron en el pasado (ﬁg. 1), y
demás estas personas nunca fumadoras pertenecían al grupo de
enor edad (18-45 an˜os). Tales cifras apoyan la hipótesis de que los
igarrillos electrónicos pueden representar una puerta de entrada a
a adicción a la nicotina, y por lo tanto también muy probablemente
 ser fumadores/as de tabaco combustible. Sin embargo, debemos
omar estos resultados con precaución porque no se dispone de
nformación a partir de la encuesta sobre el uso de los cigarrillos
lectrónicos con o sin nicotina. Aun así, debería aumentar la regu-
ación de estos dispositivos (publicidad, uso en espacios públicos acceso a menores), como recomienda la Organización Mundial
e Salud21, con el ﬁn de prevenir que los cigarrillos electrónicos
ean una nueva puerta de entrada a la adicción a la nicotina, espe-
ialmente entre los jóvenes nunca fumadores. Además, un estudioit. 2016;30(6):432–437 435
previo13 realizado en Barcelona mostró que los canales de comuni-
cación clásicos (prensa, radio y televisión) eran el medio a través del
cual más  individuos (57,8%) conocieron los cigarrillos electrónicos.
Nuestros resultados también muestran una baja prevalencia en
el uso actual y pasado del cigarrillo electrónico entre ex fuma-
dores/as, con un alto porcentaje de uso dual (57,2%) de estos
dispositivos junto con tabaco convencional. Aunque estudios pre-
vios han mostrado que la principal motivación para empezar a usar
el cigarrillo electrónico es dejar de fumar18,22, el alto porcentaje de
personas usuarias duales con el tabaco combustible observado en
nuestro trabajo pone realmente en duda la utilidad de los cigarrillos
electrónicos para ese ﬁn. Al tratarse de un estudio transversal, sin
embargo, no podemos evaluar la verdadera utilidad de los cigarri-
llos electrónicos para dejar de fumar o reducir el consumo de
tabaco.
Por otro lado, nuestros resultados concuerdan con otros estu-
dios, tanto transversales12,17,23 como longitudinales11,19,24,25, que
han observado también una alta prevalencia de uso dual con
otros productos del tabaco. Además, un estudio previo mostró
que alrededor del 40% de las personas que han probado alguna
vez el cigarrillo electrónico no estaban satisfechas con su uso11.
Por otro lado, existe la popular creencia de que los cigarri-
llos electrónicos son menos perjudiciales para la salud que los
convencionales13,23,26. Además, el 29,9% de la población general
opina que estos dispositivos son útiles para dejar de fumar y el
50,6% opina que son útiles para reducir el consumo de cigarrillos
convencionales27. En este sentido, uno de los principales mensajes
utilizados para captar clientes es la utilidad de estos dispositivos
para dejar de fumar o su menor nocividad en comparación con los
cigarrillos convencionales28. La tercera oleada del Barómetro Sani-
tario del Centro de Investigaciones Sociológicas de 2014 mostró
que el 48,6% de las personas que tienen conocimiento del cigarri-
llo electrónico consideran que puede suponer un riesgo para la
salud14. No obstante, se requiere más  investigación para demos-
trar la verdadera utilidad de estos dispositivos para dejar de fumar
o reducir el consumo de tabaco. Además, sería conveniente mejo-
rar las campan˜as de información a los/las consumidores/as sobre
este producto y regular su publicidad basándose en la evidencia
cientíﬁca.
Las principales limitaciones de este estudio son las derivadas
de la utilización de encuestas29. En concreto, al tratarse de un
cuestionario mediante entrevista telefónica asistida por ordena-
dor, existe una potencial amenaza a la validez interna derivada de
un sesgo de información. Sin embargo, estimamos que este posible
sesgo es mínimo debido a que el uso de los cigarrillos electrónicos
no está socialmente estigmatizado. Además, podría haber un sesgo
de información al utilizar como población a muestrear las perso-
nas incluidas en los listines telefónicos, que no incluyen teléfonos
móviles, siendo estos el único tipo de teléfono que la población
más joven suele utilizar. Cabe mencionar que en la actualidad no
existe una pregunta estándar para medir el uso del cigarrillo elec-
trónico, lo que diﬁculta la comparación entre diferentes estudios30.
De todos modos, la pregunta que se utilizó en este trabajo es la
misma que se ha empleado en muchos otros anteriormente11,17–20,
y esto facilita la comparación de los resultados obtenidos en dife-
rentes estudios. Aunque no se incluyó información de Canarias, una
fortaleza de nuestro estudio es que la muestra fue representativa de
la población adulta espan˜ola. Además, todos los análisis utilizaron
datos ponderados para garantizar estimaciones representativas de
la población espan˜ola, aumentando así la validez externa del estu-
dio. Sin embargo, el reducido taman˜o de la muestra ﬁnal impide
cualquier análisis por regiones.
En conclusión, el uso de cigarrillos electrónicos en Espan˜a es más
frecuente en las personas más  jóvenes y en las personas fumadoras
de tabaco. Además, nuestros datos muestran que uno/a de cada
cuatro usuarios/as actuales del cigarrillo electrónico eran nunca
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umadores/as. Por ello, debería reforzarse la regulación de estos
ispositivos, en particular su acceso para los menores, con el ﬁn de
vitar que sean una posible puerta de entrada en las personas que
unca han fumado productos con nicotina.
ditora responsable del artículo
Ma Felicitas Domínguez Berjón.
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xplicado.
¿Qué se sabe sobre el tema?
Estudios anteriores muestran un rápido aumento del uso
del cigarrillo electrónico entre los jóvenes, además de un alto
porcentaje de uso dual del cigarrillo electrónico con otros
productos de tabaco, particularmente con el cigarrillo conven-
cional. No obstante, en Espan˜a, solo se dispone de información
sobre el uso del cigarrillo electrónico en la ciudad de Barcelona.
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Este trabajo de ámbito nacional describe la prevalencia y
el patrón de uso de los cigarrillos electrónicos en la población
adulta espan˜ola y evalúa el potencial uso dual de estos dis-
positivos con el tabaco combustible o convencional. Nuestros
resultados muestran que el uso de cigarrillos electrónicos en
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Cover letter to the editor of Addictive Behaviours 
 
 
Barcelona, January 24rd, 2017. 
 
 
 
Prof. Peter M. Miller 
Editor 
Addictive Behaviours  
 
Dear Prof. Miller, 
Please find enclosed our manuscript “Impact of the Spanish smoking laws on tobacco 
consumption and second-hand smoke exposure: a population longitudinal study” for your 
consideration in Addictive Behaviours as a Full Length Article. 
 
Currently, few studies have evaluated the impact of smoking legislation using a general 
population cohort. Our study assess the impact of both Spanish smoke-free legislations 
(partial and comprehensive) in active and passive smoking in a cohort of adult general 
population of the city of Barcelona. We found a reduction in smoking prevalence and SHS 
exposure. However, the use of other tobacco products, particularly hand-rolled tobacco, 
has increased among young population. In addition, the main setting of SHS is in the leisure 
time and in work, where most of the exposed ones declared expending most of the time 
outdoor and not having specific areas for smokers after the implementation of the two 
Spanish smoke-free bans. Therefore, future tobacco control legislations should consider 
applying the same taxing level to all tobacco products in order to equalize their prices as 
well as including some outdoor restrictions to ensure higher protection against SHS. 
All the authors carefully read the manuscript and fully approve of it. In their name I also 
declare that the manuscript is original and it is not submitted anywhere other than your 
journal. The authors declare there are no conflicts of interest.  
We would of course be ready to provide further information about our data and methods 
you desire. Correspondence about the manuscript should be addressed to me as indicated 
in the first page of the manuscript. 
Thank you very much for your kind attention. 
Yours sincerely, 
 
Jose M Martínez-Sánchez, PhD, MPH, BSc 
E-mail: jmmartinez@uic.es   
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Editor's response and comments from the Addictive Behaviours reviewers 
 
 
-----Mensaje original----- 
De: eesserver@eesmail.elsevier.com [mailto:eesserver@eesmail.elsevier.com] 
Enviado el: viernes, 26 de mayo de 2017 16:13 
Para: jmmartinez@uic.es 
Asunto: Your Submission 
 
Ms. Ref. No.:  ADDICTBEH-D-17-00099 
Title: Impact of the Spanish smoking laws on tobacco consumption and secondhand smoke 
exposure: a population longitudinal study Addictive Behaviors 
 
Dear Dr. Jose M Martínez-Sánchez, 
 
Your manuscript has been reviewed for Addictive Behaviors and our editorial decision is to ask you 
to revise and resubmit your paper. Attached are the comments of our referees. Please modify your 
manuscript according to their recommendations and provide responses to their questions. I look 
forward to reading your revised manuscript. 
 
To submit a revision, please go to https://ees.elsevier.com/addictbeh/ and login as an Author. 
 
Your username is: jmmartinez@uic.es 
 
If you need to retrieve password details, please go to: 
http://ees.elsevier.com/addictbeh/default.asp 
 
NOTE: Upon submitting your revised manuscript, please upload the source files for your article. For 
additional details regarding acceptable file formats, please refer to the Guide for Authors 
at: http://www.elsevier.com/journals/addictive-behaviors 
/0306-4603/guide-for-authors 
 
When submitting your revised paper, we ask that you include the following items: 
 
Manuscript and Figure Source Files (mandatory) 
 
We cannot accommodate PDF manuscript files for production purposes. We also ask that when 
submitting your revision you follow the journal formatting guidelines.  Figures and tables may be 
embedded within the source file for the submission as long as they are of sufficient resolution for 
Production. For any figure that cannot be embedded within the source file (such as *.PSD Photoshop 
files), the original figure needs to be uploaded separately.Refer to the Guide for Authors for additional 
information. 
http://www.elsevier.com/journals/addictive-behaviors 
/0306-4603/guide-for-authors 
 
Highlights (mandatory) 
 
Highlights consist of a short collection of bullet points that convey the core findings of the article and 
should be submitted in a separate file in the online submission system. Please use 'Highlights' in the 
file name and include 3 to 5 bullet points (maximum 85 characters, including spaces, per bullet 
point). See the following website for more information http://www.elsevier.com/highlights 
 
Graphical Abstract (optional) 
 
Graphical Abstracts should summarize the contents of the article in a concise, pictorial form designed 
to capture the attention of a wide readership online. Refer to the following website for more 
information: http://www.elsevier.com/graphicalabstracts 
 
 
On your Main Menu page is a folder entitled "Submissions Needing Revision". You will find your 
submission record there. 
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Please note that this journal offers a new, free service called AudioSlides: brief, webcast-style 
presentations that are shown next to published articles on ScienceDirect (see 
also http://www.elsevier.com/audioslides). If your paper is accepted for publication, you will 
automatically receive an invitation to create an AudioSlides presentation. 
 
Addictive Behaviors features the Interactive Plot Viewer, 
see: http://www.elsevier.com/interactiveplots. Interactive Plots provide easy access to the data 
behind plots. To include one with your article, please prepare a .csv file with your plot data and test it 
online at http://authortools.elsevier.com/interactiveplots/verification before submission as 
supplementary material. 
 
Sincerely, 
 
Theodore V. Cooper, Ph.D. 
Associate Editor 
 
Reviewers' comments: 
 
 
Reviewer #1: Summary: This study examined the impact of two smoking laws passed in Spain in 
2005 and 2010, respectively. The first law banned smoking in public and in businesses and, following 
up from issues with the first law, the second law banned smoking on hospital grounds, educational 
campuses, playgrounds, and other outdoor areas. The authors used data collected in 2004-2005, 
before the first law was passed, on smoking status/frequency, nicotine dependence, and exposure to 
secondhand smoke. They followed the same sample in 2013-2014, retaining about half of the original 
participants, and administered the same questionnaires to assess change from the first time point. 
The results showed that after the smoking legislation was passed overall smoking rates and 
exposure to secondhand smoke decreased. However, consumption of other tobacco products (e.g., 
hand rolled cigarettes, e-cigarettes, etc.) notably increased, particularly amongst young people. The 
authors suggest that the increased consumption of other tobacco products may be because they are 
cheaper than cigarettes, which are taxed at a higher rate. They conclude that a tax increase on other 
tobacco products may be effective to further decrease rates of tobacco consumption. 
 
 
Overall Impressions: This was a well-executed, interesting study that is within the scope of Addictive 
Behaviors. Examining health policy is incredibly important and this study is a solid contribution to the 
literature. The methodology is sound and the authors were mindful of confounds and threats to 
internal validity. The structure is logical, easy to follow, and each idea connects to the other. Their 
conclusions are supported by the data and they discuss limitations to the study. Their 
recommendation to raise taxes on other tobacco products and increase restrictions on outdoor 
smoking is grounded in the results and a logical next step for policy. 
 
 
Comments: 
 
 
1.The paper could benefit from some editorial work to assess correct grammar, punctuation, verb 
tense, and overall flow. Each section has a number of instances in which sentences could be 
rephrased to enhance clarity and flow. 
 
 
2.What are the psychometrics of the FTCD? A sentence or two here reviewing previous validation 
studies should suffice. 
 
 
3.The authors should further comment on other potential threats to internal validity (this can be in the 
paper if warranted or in a response to the reviewers) to demonstrate they considered them. For 
example, are there other confounding variables or history/maturation issues in the sample which 
could account for the results? Have there been any anti-smoking public health campaigns in Spain 
during the time of the study? Have there been documented changes in the attitudes/perceptions of 
smoking which could partially explain the decrease in smoking? Generally, what else in addition to 
the legislation might explain the results? 
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4.The authors should briefly mention in the limitations that causality cannot be established as is 
generally the case with policy research. 
 
 
Reviewer #2: This is a population-based longitudinal study.  It examines the impacts of Spanish 
smoking legislations on active and passive smoking. The effective indicators includes smoking 
prevalence ratio, daily smokers' tobacco consumption and nicotine dependence, and non-smokers' 
secondhand smoke exposure. Although many studies have assessed the effects of smoking control 
policies, this study still provides some new insights about this issue. In addition, the authors clearly 
state the research problems and purposes, and the design is suitable for answering the posed 
question. Overall, its quality is good except the analyses of smoking status. Some points in this 
manuscript need to be clarified and added. The deficiencies in various sections of this manuscript 
and specific comments and suggestions are listed as follows. 
 
1. "Abstract" 
As stated in the "Background" part of the Abstract, this study includes the impacts of smoking 
legislations on the active and passive smoking. However, the "Methods" part of the Abstract only 
focuses on the active smoking but not the passive smoking. How the data of passive smoking 
measured and analyzed needs to be addressed. In addition, it would be better to indicate the impacts 
of smoking legislations on the active and passive smoking separately in the "Results" part of the 
Abstract. 
 
2. "INTRODUCTION" Section 
Page 3, Line 14 
 The word "Consequently" as the  first word of one paragraph is a little bit odd. It is better to be 
deleted. 
 
3. "METHODS" Section 
Page 5, Line 9 
Page 4 Line 13 to Page 5 Line 10 have described the two-waves participants clearly; therefore,  Fig. 
1 isn't needed.  To make it more concise, the words " (Fig. 1)" on Page 5 Line 9 and the 
corresponding Figure 1 on Pages 20-21 both could be deleted. 
 
Page 5, Lines 10-18 
To be a representative sample, the  participants were randomly selected by age, sex, and district of 
the adult population of Barcelona (Spain) according to  Reference 20. However, the authors 
compared differences in age, sex, level of education and smoking status between  the follow-up and 
the lost participants in both surveys on Page 5 Lines 10-18, but not district. To represent the follow-
up group with the population of Barcelona, age, sex, and district all three criteria for sample selection 
need to be examined and addressed here. 
 
Page 6, Lines 1-22 
There is one problem regarding "Smoking status" variable. As stated on Page 6 Lines 1-9, the 
participants were divided into three groups including smokers, former smokers, and never smokers. 
There was no daily smokers. But the "Number of cigarettes smoked per day" and "FTCD score" 
variables were only related to daily smokers. Since daily smokers are different from smokers, it is 
needed to define and mention who are daily smokers. Are those who smoke everyday (at least one 
cigarette per day) classified as daily smokers? If "yes", please indicate it in the text. Similarly, why 
and how the participants are regrouped into smokers and non-smokers for the following analysis 
needs to be mentioned. In addition, is the "Type of tobacco product used" variable only related to 
daily smokers? All of these questions need to be clarified and addressed more detail. 
 
Page 6, Lines 20-22 
The last sentence of this paragraph  ("The answers to this question were dichotomized as 
'cigarettes', 'hand-rolled tobacco' and 'other products'.")  is confusing. Especially, the  word 
"dichotomized" is a little bit odd. It needs to be clarified and edited. 
 
Page 7, Lines 1-25 
Are the "Exposure to SHS in different settings (home, work, public transport, and leisure time) " items 
related to former smokers and/or never smokers? It needs to be clarified and addressed here. 
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4. "RESULTS " Section 
Page 9, Lines 1-6 
In this study, smoking status is first mentioned and a very basic variable. Moreover, the other 
variables (prevalence, prevalence ratio, number of cigarettes smoked per day, nicotine 
dependence,  types of tobacco product used, exposure to SHS) are accompanied  with smoking 
status. Therefore, smoking status of the participants at the baseline and follow-up and its change are 
all important results, though smoking prevalence ratio are the main impact of smoking bans in this 
study. In addition, the last sentence of this paragraph ("20.2% (95% CI: 17.4-23.4) are smokers and 
65.9%  (95% CI: 62.3-69.3) are non-smokers at baseline and at follow-up (data not shown).") is 
problematical. It is recommended to show the data and address the results in detail in the first part of 
the "RESULTS " section. 
 
Pages 9, 10 & 11 
The titles and styles of Tables 1, 2, and 3 need to be shorten and simplified. In addition, the footnote 
of Tables 1 needs to add the number of daily smokers. In Table 2, it is suggested to add a column for 
the number of overall, sex (men & women), Age (26-44, 45-64, & >=65 ) and education level (Low, 
Intermediate, and High). 
 
 
Page 11, Lines 5-8 
The results regarding SHS at indoors, outdoors and specific areas in work setting ("In addition, after 
the implementation of the two Spanish smoke-free bans, 80.1% ... declared not having specific areas 
for smokers (data not shown).") are redundant because they aren't variables of this study and 
mentioned in the "METHODS" Section. Therefore, Page 11 Line 5-8 could be left out. If the authors 
would like to keep these results, justification for  these variables need to be added in the 
"METHODS" Section. Moreover, both the baseline and the follow up data need to be considered 
because there might be some difference. 
 
5. "DISCUSSION " Section 
The authors have discussed most important findings of this study in some detail.  However, it will be 
better if the authors could address more about smoking status (rate) and its change of the population 
in Spanish after the two smoking regulations as suggested in the "RESULTS " Section. For example, 
authors could compare the smoking rate of the population in Barcelona at baseline with previous 
studies to enhance the validity of the findings. Moreover, the prevalence rate of smoking among the 
participants in the baseline and follow-up was 34.5% and  26.1% , respectively (shown in Table 1), 
which are both higher than a previous study of Spanish population (23.6%, Reference 3). Therefore, 
the related findings are worth discussing and adding. 
 
Page 14 Line 17- Page 15 Line 2 
The discussion of the smoking ban regarding indoor and outdoor of workplaces ("Regarding work 
setting, most of the exposed ones declared spending most of the time outdoors... outdoor of public 
and workplaces to ensure higher protection against SHS.") should be cautious since it isn't a 
mentioned variable of this study (see also comments for Page 11, Lines 5-8). 
 
 
For further assistance, please visit our customer support site 
at http://help.elsevier.com/app/answers/list/p/7923. Here you can search for solutions on a range of 
topics, find answers to frequently asked questions and learn more about EES via interactive tutorials. 
You will also find our 24/7 support contact details should you need any further assistance from one of 
our customer support representatives. 
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Response to the Addictive Behaviours reviewer’s comments 
 
 
ADDICTBEH-D-17-00099  
 
Impact of the Spanish smoking laws on tobacco consumption 
and secondhand smoke exposure: a longitudinal population 
study 
 
Response to the Reviewers’ comments 
 
 
We thank the editor and the reviewers for the useful comments.  
 
We enclose a point-by-point response and we have highlighted the changes in the text of the 
manuscript. 
 
 
 
 
Reviewer #1:  
 
Summary: This study examined the impact of two smoking laws passed in Spain in 2005 and 
2010, respectively. The first law banned smoking in public and in businesses and, following 
up from issues with the first law, the second law banned smoking on hospital grounds, 
educational campuses, playgrounds, and other outdoor areas. The authors used data 
collected in 2004-2005, before the first law was passed, on smoking status/frequency, 
nicotine dependence, and exposure to secondhand smoke. They followed the same sample 
in 2013-2014, retaining about half of the original participants, and administered the same 
questionnaires to assess change from the first time point. The results showed that after 
the smoking legislation was passed overall smoking rates and exposure to secondhand 
smoke decreased.  
 
However, consumption of other tobacco products (e.g., hand rolled cigarettes, e-cigarettes, 
etc.) notably increased, particularly amongst young people. The authors suggest that the 
increased consumption of other tobacco products may be because they are cheaper than 
cigarettes, which are taxed at a higher rate. They conclude that a tax increase on 
other tobacco products may be effective to further decrease rates of tobacco consumption.  
 
Overall Impressions: This was a well-executed, interesting study that is within the scope of 
Addictive Behaviors. Examining health policy is incredibly important and this study is a solid 
contribution to the literature. The methodology is sound and the authors were mindful of 
confounds and threats to internal validity. The structure is logical, easy to follow, and each 
idea connects to the other. Their conclusions are supported by the data and they discuss 
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limitations to the study. Their recommendation to raise taxes on other tobacco products and 
increase restrictions on outdoor smoking is grounded in the results and a logical next step 
for policy.  
 
Thank you very much for the kind comments to our work.  
 
 
Comments: 
 
 
1. The paper could benefit from some editorial work to assess correct grammar, punctuation, 
verb tense, and overall flow. Each section has a number of instances in which sentences 
could be rephrased to enhance clarity and flow.  
 
As suggested, we have revised carefully the last version of the manuscript and we have 
corrected the grammar mistakes.  
 
2. What are the psychometrics of the FTCD? A sentence or two here reviewing previous 
validation studies should suffice. 
 
Thank you for the useful comment. As suggested, we have included two sentences about the 
validation and psychometrics of the FTCD in the Methods section as follows: 
“Fagerström Test for Cigarette Dependence (FTCD) is a standard instrument for 
assessing the intensity of physical addiction to nicotine, it includes 6 
items/questions and the score ranges from 0 to 10. The six items are: time to 
first cigarette (0 – 3 points), difficulty to refrain (0 – 1 points), hardest cigarette 
to give up (0 – 1 points), cigarettes smoked per day (0 – 3 points), smoking 
more in the morning than during the rest of the day (0 – 1 points), and 
smoking when ill (0 – 1 points). The FTCD was developed to decide whether or 
not nicotine replacement therapy is needed to treat withdrawal syndrome. A 
previous study has demonstrated the reliability of the test (0.66) (23). In our 
study, these questions were only addressed to daily smokers as recommended 
by guidelines (24).”  
 
______________________ 
New reference added in the manuscript:  
(23) Becona E, Vazquez FL. The Fagerstrom Test for Nicotine Dependence in a Spanish sample. 
Psychol Rep 1998;83(3 Pt 2):1455-1458. 
(24) 2008 PHS Guideline Update Panel, Liaisons, and Staff. Treating tobacco use and 
dependence: 2008 update U.S. Public Health Service Clinical Practice Guideline executive 
summary. Respir Care 2008;53(9):1217-1222. 
 
 
3. The authors should further comment on other potential threats to internal validity (this 
can be in the paper if warranted or in a response to the reviewers) to demonstrate they 
considered them. For example, are there other confounding variables or history/maturation 
issues in the sample which could account for the results? Have there been any anti-
smoking public health campaigns in Spain during the time of the study? Have there been 
documented changes in the attitudes/perceptions of smoking which could partially explain 
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the decrease in smoking? Generally, what else in addition to the legislation might explain the 
results? 
As suggested, we have included more details about other factors potentially influencing the 
results in the Discussion section as follows: 
“Our results on smoking consumption trends are consistent with a recent 
evidence booklet published which shows a decline of prevalence before the 
Spanish smoke-free laws, that became more striking after their 
implementation mainly among women but not among men (13). In regards to 
the increase of hand-rolled cigarettes the economic crisis that took place in 
Spain in 2008 could have affected the shift on tobacco products as also 
reported (13,25).” 
In addition, we have updated information about the monograph regarding Spanish 
smoking legislations including the last monography recently published. 
______________________ 
New reference added in the manuscript:  
(13) Grupo de Trabajo sobre Tabaquismo de la Sociedad Española de Epidemiología. 
Evaluación de las políticas de control del tabaquismo en España (Leyes 28/2005 y 42/2010). 
Revisión de la evidencia. 2017; http://www.seepidemiologia.es/documents/dummy/V9.0%20-
%20Libro%20Tabaquismo%202017%20-%20Abierto%20Final.pdf (accessed 14 Juny 2017). 
(25) Sureda X, Fu M, Martinez-Sanchez JM, Martinez C, Ballbe M, Perez-Ortuno R, et al. 
Manufactured and roll-your-own cigarettes: A changing pattern of smoking in Barcelona, 
Spain. Environ Res 2017;155:167-174. 
4. The authors should briefly mention in the limitations that causality cannot be established 
as is generally the case with policy research.  
 
We completely agree with the reviewer’s comment. As the reviewer suggests, we have 
mentioned in the limitations that causality cannot be established from our study as follows: 
“In addition, regardless its longitudinal nature, the study does not allow to 
establish strong causal inferences regarding the effectiveness of the smoke 
free legislation.” 
 
 
 
 Reviewer #2:  
 
This is a population based longitudinal study.  
It examines the impacts of Spanish smoking legislations on active and passive smoking. The e
ffective indicators include smoking prevalence ratio, daily 
smokers' tobacco consumption and nicotine dependence, and non-
smokers' secondhand smoke exposure. Although many studies have assessed the effects 
of smoking control policies, this study still provides some new insights about this issue. In 
addition, the authors clearly state the research problems and purposes, and the design is 
suitable for answering the posed question. Overall, its quality is good except the analyses 
of smoking status. Some points in this manuscript need to be clarified and added. The 
deficiencies in various sections of thi manuscript and specific comments and suggestions are 
listed as follows. 
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Thank you very much for the kind comment to our work.  
  
"Abstract" 
 
1. As stated in the "Background" part of the Abstract, this study includes the impacts 
of smoking legislations on the active and passive smoking. However, the "Methods" part of 
the Abstract only focuses on the active smoking but not the passive smoking. How the data 
of passive smoking measured and analyzed needs to be addressed. In addition, it would be 
better to indicate the impacts of smoking legislations on the active and passive smoking 
separately in the "Results" part of the Abstract.  
 
As the reviewer suggests, we have included more information about how data of passive 
smoking was measured and analyzed in the Methods Section of the abstract as follows:  
 
“Methods This is a longitudinal study before and after the implementation of 
two national smoking bans in Spain in a representative sample (n=1,245) of 
adults (≥16 years old) from Barcelona (Spain) surveyed in 2004-2005 and 
followed-up in 2013-2014. The final sample analyzed was 736 individuals. Both 
questionnaires (before and after the two laws) included the same variables 
about active and passive smoking. We calculated the prevalence and the 
prevalence ratio (PR, with their 95% confidence intervals, 95% CI) of smoking 
cigarettes and hand-rolled tobacco and also the prevalence of exposure to 
secondhand smoke (SHS) at home, work, public transport, leisure time and at 
any setting after vs. before Spanish legislations.” 
 
We have also indicated, as suggested, the impacts of smoking legislations on the active and 
passive smoking separately in the Results Section of the abstract as follows: 
 
“Results After the implementation of the two Spanish smoke-free bans, a 
significant decrease was observed in the smoking prevalence (from 34.5% to 
26.1%, PR=0.76, p<0.001), in the average cigarettes per day (median from 15.2 
to 10.0, p<0.001), in the percentage of conventional tobacco consumption 
(from 92.6% to 74.4%, PR=0.80, p<0.001). Furthermore, a significant increase 
in the use of hand-rolled tobacco (from 6.1% to 30.9%, PR=5.07, p<0.001) and 
other tobacco products (from 17.1% to 32.8%, PR=1.92, p<0.001) was 
observed. In addition, a significantly decrease in the self-reported SHS 
exposure was observed in all the assessed settings (home, work, transport, and 
leisure time).” 
 
 
"INTRODUCTION"  
 
2. Page 3, Line 14. The word "Consequently" as the first word of one paragraph is a little bit 
odd. It is better to be deleted.  
 
We have removed the word “Consequently” as suggested. 
 
 
"METHODS" 
 
3. Page 5, Line 9, Page 4 Line 13 to Page 5 Line 10 have described the two-wave participants 
clearly; therefore, Fig. 1 isn't needed.  To make it more concise, the words "(Fig. 1)" on Page 
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5 Line 9 and the corresponding Figure 1 on Pages 20-21 both could be deleted.   
 
We have removed the Figure 1 as suggested. 
 
4. Page 5, Lines 10-18. To be a representative sample, the participants were randomly 
selected by age, sex, and district of the adult population of Barcelona (Spain) according to 
Reference 20. However, the authors compared differences in age, sex, level of education 
and smoking status between the follow-up and the lost participants in both surveys on Page 
5 Lines 10-18, but not district. To represent the follow-up group with the population of 
Barcelona, age, sex, and district all three criteria for sample selection need to be examined 
and addressed here.  
 
Thank you for the comment. We have added the information regarding district differences 
between followed-up and lost participants as follows: 
 
“There were no statistically significant differences between the participants 
followed-up (n=736) and those lost in the second stage (n=274) according to 
age, sex, level of education, district and smoking status. However, there were 
statistically significant differences according to age, level of education and 
smoking status between the follow-up sample (n=736) and the participants 
lost in both stages of the follow-up (n=509) (data not shown).” 
 
5. Page 6, Lines 1-22. There is one problem regarding "Smoking status" variable. As stated on 
Page 6 Lines 1-9, the participants were divided into three groups including smokers, former 
smokers, and never smokers. There were no daily smokers. But the "Number of cigarettes 
smoked per day" and "FTCD score" variables were only related to daily smokers. Since daily 
smokers are different from smokers, it is needed to define and mention who are daily 
smokers. Are those who smoke everyday (at least one cigarette per day) classified as daily 
smokers? If "yes", please indicate it in the text. Similarly, why and how the participants are 
regrouped into smokers and non-smokers for the following analysis needs to be mentioned. 
In addition, is the "Type of tobacco product used" variable only related to daily smokers? All 
of these questions need to be clarified and addressed more detail. 
 
Thank you for the useful comment. As suggested we have clarified the definition of daily 
smokers and non-smokers as follows: 
 
“Smoking status, was obtained from the question: “Which of the following 
statements better describes your smoking status?” with the possible answers: 
“Nowadays I smoke everyday (at least one cigarette per day)”, these are 
current daily smokers; “Nowadays I smoke occasionally (less than one cigarette 
per day)”, these are current occasionally smokers; “I don’t smoke now, but I 
smoked before every day”, these are former daily smokers; “I don’t smoke 
now, but I smoked before occasionally”, these are former occasionally 
smokers; and “I have never smoked”, these are never smokers. We also 
aggregate these categories when appropriate as “smokers” (current daily and 
occasionally smokers) and “non-smokers” (former daily and occasionally 
smokers plus never-smokers).” 
 
Moreover, we have made clear in the text that the analysis regarding type of tobacco 
product used was carried out for daily and occasional smokers as follows: 
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“Type of tobacco product used, obtained through the question: “What type of 
tobacco product do you usually smoke?” with the possible answers: 
“cigarettes”, “hand-rolled tobacco”, “cigars”, “little cigars”, “pipes”, “hookah” 
and “e-cigarettes”. The answers to this question were aggregated as 
‘cigarettes’, ‘hand-rolled tobacco’ and ‘other products’ including cigars and 
little cigars. This question was gathered from daily and occasional smokers.” 
 
6. Page 6, Lines 20-22. The last sentence of this paragraph ("The answers to this question 
were dichotomized as 'cigarettes', 'hand-rolled tobacco' and 'other products'.") is confusing. 
Especially, the word "dichotomized" is a little bit odd. It needs to be clarified and edited. 
 
Thank you for the comment, as suggested, we have clarified and edited this sentence (see 
comment 5, reviewer #2). 
 
7. Page 7, Lines 1-25. Are the "Exposure to SHS in different settings (home, work, public 
transport, and leisure time)" items related to former smokers and/or never smokers? It 
needs to be clarified and addressed here.  
 
The information about SHS exposure in different settings is provided for former and never 
smokers. As suggested, we have clarified that in the “methods” section.  
 
 
"RESULTS"  
 
8. Page 9, Lines 1-6. In this study, smoking status is first mentioned and a very basic variable. 
Moreover, the other variables (prevalence, prevalence ratio, number of cigarettes smoked 
per day, nicotine dependence, types of tobacco product used, and exposure to SHS) are 
accompanied with smoking status. Therefore, smoking status of the participants at the 
baseline and follow-up and its change are all important results, though smoking prevalence 
ratio are the main impact of smoking bans in this study. In addition, the last sentence of this 
paragraph ("20.2% (95% CI: 17.4-23.4) are smokers and 65.9% (95% CI: 62.3-69.3) are non-
smokers at baseline and at follow-up (data not shown).") is problematical. It is 
recommended to show the data and address the results in detail in the first part of the 
"RESULTS" section. 
 
As suggested, we have included more information about smoking status changes in the first 
part of the “results” section as follows:  
  
“Overall, it was observed a significant decrease in smoker’s prevalence from 
34.5% to 26.1% (PR=0.76, p-value=0.006) along with a significant increase in 
former smoker’s prevalence from 25.6% to 34.1% (PR=1.33, p-value=0.004) 
(figure 1).  
 
Moreover, 20.2% (95% CI: 17.4-23.4) are smokers and 65.9% (95% CI: 62.3-
69.3) are non-smokers (never and former smokers) at baseline and at follow-
up. 22.6% (95% IC: 19.7-25.8) were persistent smokers (at baseline and follow-
up), 10.9% (95% CI: 8.7-13.4) of smokers in the baseline quit smoking at the 
follow-up and 3.0% (95% CI: 1.9-4.6) of non-smokers in the baseline initiated 
or relapsed tobacco use at the follow-up (0.3% were never smokers at baseline 
and 2.7% were former smokers).” 
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In addition, we have added a new figure showing the prevalence and prevalence ratio (PR) of 
smoking status before and after the implementation of both Spanish smoke-free bans, Figure 
1, which can be found at the end of this document. 
 
9. Pages 9, 10 & 11. The titles and styles of Tables 1, 2, and 3 need to be shorten and 
simplified. In addition, the footnote of Tables 1 needs to add the number of daily smokers. In 
Table 2, it is suggested to add a column for the number of overall, sex (men & women), Age 
(26-44, 45-64, & >=65) and education level (Low, Intermediate, and High).  
 
As suggested we have shortened the title of Table 1, 2 and 3; we have added a footnote in 
Table 1 to add the number of daily smokers; and we have added a column for the number of 
overall, sex, age and educational level in Table 2.   
 
 
10. Page 11, Lines 5-8. The results regarding SHS at indoors, outdoors and specific areas in 
work setting ("In addition, after the implementation of the two Spanish smoke-free bans, 
80.1% ... declared not having specific areas for smokers (data not shown).") are redundant 
because they aren't variables of this study and mentioned in the "METHODS" Section. 
Therefore, Page 11 Line 5-8 could be left out. If the authors would like to keep these results, 
justification for these variables needs to be added in the "METHODS" Section. Moreover, 
both the baseline and the follow up data need to be considered because there might be 
some difference. 
 
As suggested we have removed this sentence in the “results” section.  
 
 
"DISCUSSION"  
 
11. The authors have discussed most important findings of this study in some 
detail.  However, it will be better if the authors could address more about smoking status 
(rate) and its change of the population in Spanish after the two smoking regulations as 
suggested in the "RESULTS" Section. For example, authors could compare the smoking rate 
of the population in Barcelona at baseline with previous studies to enhance the validity of 
the findings. Moreover, the prevalence rate of smoking among the participants in the 
baseline and follow-up was 34.5% and 26.1%, respectively (shown in Table 1), which are 
both higher than a previous study of Spanish population (23.6%, Reference 3). Therefore, the 
related findings are worth discussing and adding.  
  
Thank you for the useful comment. As suggested we have added the following information to 
the “discussion” section: 
 
“In addition, smoking  prevalence observed in our follow-up survey was higher 
than that observed in another studies (23.6% (3) and 20.7% (26)), with 
information gathered at national level in 2011-2012. This could be because our 
study was carried out in the city of Barcelona while the other study includes 
information about all the regions in Spain, and historically it has been reported 
slight differences in smoking prevalence among regions in Spain (27). Another 
possible explanation is that young and smoker participants in our sample could 
have been overestimated because of the loss of older and no-smoker 
participants. 
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______________________ 
New reference added in the manuscript:  
(27) Observatorio Español de las drogas y las toxicomanías. Informe 2015. Alcohol, tabaco y 
drogas ilegales en España. 2015; 
http://www.pnsd.msssi.gob.es/profesionales/sistemasInformacion/informesEstadisticas/pdf/I
NFORME_2015.pdf (accessed 24 Juny 2017). 
 
12. Page 14 Line 17- Page 15 Line 2. The discussion of the smoking ban regarding indoor and 
outdoor of workplaces ("Regarding work setting, most of the exposed ones declared 
spending most of the time outdoors... outdoor of public and workplaces to ensure higher 
protection against SHS.") should be cautious since it isn't a mentioned variable of 
this study (see also comments for Page 11, Lines 5-8). 
 
Thank you for the comment. As suggested, we have removed the sentence regarding our 
results not shown (see comment 10, reviewer #2) in the “discussion” section.  
 
 
 
 
Figure 1. Prevalence and prevalence ratio (PR) of smoking status before and after the 
implementation of both Spanish smoke-free bans. 
 
 
 
 
 
 
 
 
 
 
**p-value<0.01 
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Letter of acceptance of Addictive Behaviours journal  
 
 
-----Original message----- 
De: eesserver@eesmail.elsevier.com [mailto:eesserver@eesmail.elsevier.com] 
Enviado el: martes, 27 de junio de 2017 22:39 
Para: jmmartinez@uic.es 
Asunto: Your Submission 
 
Ms. Ref. No.:  ADDICTBEH-D-17-00099R1 
Title: Impact of the Spanish smoking laws on tobacco consumption and secondhand smoke 
exposure: a longitudinal population study Addictive Behaviors 
 
Dear Dr. Jose M Martínez-Sánchez, 
 
We are pleased to inform you that your manuscript has been accepted for publication in Addictive 
Behaviors. Congratulations. We look forward to seeing your article in print. 
 
I am pleased to inform you about AudioSlides, a new complimentary service available to all authors 
publishing in <Journal>. AudioSlides are 5-minute, online presentations that are shown next to the 
article on ScienceDirect. This format gives you the opportunity to promote your work and summarize 
your research in your own words, helping readers to better understand what your paper is about and 
determine its relevancy. Here's an 
example: http://www.sciencedirect.com/science/article/pii/S1550728912000664. 
 
To create AudioSlides presentations, Elsevier has developed an easy-to-use website where you can 
upload slides and add voice-over audio recordings using only a web browser and a computer with a 
microphone. After acceptance of your paper, you will receive an invitation from Elsevier to create an 
AudioSlides presentation. You will find more information about this service 
on http://www.elsevier.com/audioslides. 
I hope that you share my enthusiasm for this new feature, and hope you will accept the invitation to 
create an AudioSlides presentation when your paper which will be sent to you shortly. 
 
Your accepted manuscript will now be transferred to our production department and work will begin 
on creation of the proof. If we need any additional information to create the proof, we will let you 
know. If not, you will be contacted again in the next few days with a request to approve the proof and 
to complete a number of online forms that are required for publication. 
 
When your paper is published on ScienceDirect, you want to make sure it gets the attention it 
deserves. To help you get your message across, Elsevier has developed a new, free service called 
AudioSlides: brief, webcast-style presentations that are shown (publicly available) next to your 
published article. This format gives you the opportunity to explain your research in your own words 
and attract interest. You will receive an invitation email to create an AudioSlides presentation shortly. 
For more information and examples, please visit http://www.elsevier.com/audioslides 
 
Sincerely, 
 
Theodore V. Cooper, Ph.D. 
 
Comments from the Editors and Reviewers: 
 
Thank you for attending meaningfully to referee suggestions. Congratulations! 
 
For further assistance, please visit our customer support site 
at http://help.elsevier.com/app/answers/list/p/7923. Here you can search for solutions on a range of 
topics, find answers to frequently asked questions and learn more about EES via interactive tutorials. 
You will also find our 24/7 support contact details should you need any further assistance from one of 
our customer support representatives. 
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Cover letter to the editor of Tobacco Control 
 
 
Barcelona, April 11th, 2016. 
 
 
 
 
 
Prof. Ruth Malone 
Editor 
Tobacco Control 
 
Dear Prof. Malone, 
Please find enclosed our manuscript “Impact of the Spanish smoking legislations in the 
adoption of smoke-free rules at home: a longitudinal study” for your consideration in 
Tobacco Control as a Research Paper. 
Currently, few studies have evaluated the impact of both Spanish smoke-free legislations 
(partial and comprehensive) in secondhand smoke exposure at home; however, there is a 
lack of information in Spain on the impact of the smoke-free laws in the adoption of smoke-
free homes. We assess the impact of Spanish smoking bans in the adoption of voluntary 
smoke-free homes rules in Spain. Our results show that the implementation of the smoke-
free regulations in public and workplaces in Spain was associated with an increasing of 
voluntary adoption of smoke-free rules in homes, particularly complete smoke-free home. 
Moreover, the Spanish smoking bans did not shift the tobacco consumption from public 
and workplaces to private places (homes). 
All the authors carefully read the manuscript and fully approve of it. In their name I also 
declare that the manuscript is original and it is not submitted anywhere other than your 
journal. The authors declare there are no conflicts of interest.  
We would of course be ready to provide further information about our data and methods 
you desire. Correspondence about the manuscript should be addressed to me as indicated 
in the first page of the manuscript. 
Thank you very much for your kind attention. 
Yours sincerely, 
 
Jose M Martínez-Sánchez, PhD, MPH, BSc 
E-mail: jmmartinez@iconcologia.net  
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Editor's response and comments from the Tobacco Control reviewers 
 
 
-----Mensaje original----- 
De: onbehalfof+tobaccocontrol+bmj.com@manuscriptcentral.com [mailto:onbehalfof+tobaccocontrol
+bmj.com@manuscriptcentral.com] 
Enviado el: lunes, 18 de julio de 2016 16:28 
Para: jmmartinez@iconcologia.net 
CC: clidon@uic.es; jmmartinez@iconcologia.net; mfu@iconcologia.net; mballbe@iconcologia.net; jc
martin@uic.es; cmartinez@iconcologia.net; esteve.salto@gencat.cat; efernandez@iconcologia.net 
Asunto: Tobacco Control - Decision on Manuscript ID tobaccocontrol-2016-053114 
 
18-Jul-2016 
 
Dear  Dr. Martínez-Sánchez: 
 
Manuscript ID tobaccocontrol-2016-053114 entitled "Impact of the Spanish smoking legislations in 
the adoption of smoke-free rules at home: a longitudinal study Word Count: 2622" which you 
submitted to Tobacco Control, has been reviewed.  Following review, the editors have decided that 
the paper requires revision. We will be happy to reconsider it after revision, providing you have 
responded to the comments of the referee(s) (see below). 
 
Please note, by offering to reconsider a revised paper, we are making no commitment to publish a 
revised version. 
 
Important: Please CUT AND PASTE THE REVIEW COMMENTS BELOW INTO A SEPARATE 
DOCUMENT. With spaces between each comment and your response, provide a specific reply to 
each reviewer comment, making it clear whether or not you have incorporated the changes as 
suggested and indicating where the relevant changes are now found in the text. If you elect not to 
follow reviewers' suggestions or respond to particular criticisms, please provide a response in each 
case so that the editors might consider your reasoning. 
 
Tobacco Control is published six times per year, and because of the inherent delay in publication 
with this schedule, we are concerned to avoid overly lengthy periods between notifying authors that a 
paper needs revision and receipt of the revised version. 
 
If you DO intend to resubmit a revised version, please inform us of the likely submission date. 
 
If we do not hear from you within 4 weeks, we will assume that you do not intend to resubmit and will 
withdraw your paper. If you need to request an extension of this deadline, please contact us as soon 
as possible. 
 
To revise your manuscript, log into https://mc.manuscriptcentral.com/tobaccocontrol and enter your 
Author Center, where you will find your manuscript title listed under "Manuscripts with 
Decisions."  Under "Actions," click on "Create a Revision."  Your manuscript number has been 
appended to denote a revision. 
 
Please check that all author names are correctly entered as this will be the name displayed in any 
PubMed search. 
 
You may also click the below link to start the revision process (or continue the process if you have 
already started your revision) for your manuscript. If you use the below link you will not be required to 
login to ScholarOne Manuscripts. 
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https://mc.manuscriptcentral.com/tobaccocontrol?URL_MASKJbbbd00ad61419d9edc77231c8965ba 
 
 
You will be unable to make your revisions on the originally submitted version of the 
manuscript.  Instead, revise your manuscript using a word processing program and save it on your 
computer.  Please also highlight the changes to your manuscript within the document by using the 
track changes mode in MS Word or by using bold or colored text. 
 
Once the revised manuscript is prepared, you can upload it and submit it through your Author Center. 
 
When submitting your revised manuscript, you will be able to respond to the comments made by the 
reviewer(s) in the space provided.  You can use this space to document any changes you make to 
the original manuscript.  In order to expedite the processing of the revised manuscript, please be as 
specific as possible in your response to the reviewer(s). 
 
You will receive a proof if your article is accepted, but you will be unable to make substantial changes 
to your manuscript, please take this opportunity to check the revised submission carefully. 
 
IMPORTANT:  Your original files are available to you when you upload your revised 
manuscript.  Please delete any redundant files before completing the submission. 
 
Because we are trying to facilitate timely publication of manuscripts submitted to Tobacco Control, 
your revised manuscript should be submitted before 16-Sep-2016. Your option to submit a revision 
expires on that date. If it is not possible for you to submit your revision by this date, we may have to 
consider your paper as a new submission. 
 
We also ask that in addition to the revised paper you provide a point by point response to the 
reviewer comments, and upload a marked copy of your paper highlighting the changes you have 
made - preferably 'tracked changes' if using Microsoft word. Please upload this as a supplemental file 
and label it 'Marked Copy' (your paper will not be able to be processed without this). 
 
All material submitted is assumed to be submitted exclusively to the journal unless the contrary is 
stated. Submissions may be returned to the author for amendment if presented in the incorrect 
format. 
 
Please note that only the article text (from first word of main text to the last word in reference list) will 
be used to typeset your article. 
 
All other data (known as the metadata), such as article title, author names and addresses, abstract, 
funding (etc) statements will be taken from the fields you have filled in at submission, so you must 
ensure that these are up to date and accurate. 
 
I hope you will find the comments useful. 
 
Respectfully, 
 
Andrew Hyland, 
Senior Editor, Tobacco Control 
tobaccocontrol@bmj.com 
 
FORMATTING AMENDMENTS 
Required amendments will be listed here (if any); please include these changes in your revised 
version: 
1. Please remove all figures from the body of the manuscript and reupload your figure files 
separately. 
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Please note that we do not accept figures in Word document, PDF or PowerPoint format. 
 
All figures and images should be supplied as high quality image files, we recommend TIFF format. 
Please ensure images are a minimum of 300dpi (resolution). 
 
Please include figure legends at the end of the main manuscript text only and label the figure files 
appropriately to correspond. 
 
 
Reviewer(s)' Comments to Author: 
 
Reviewer: 1 
 
Comments to the Author 
This is an important paper reviewing the impact of the Spanish smoke-free law on smoking in homes. 
It is significant due to the historical problems encountered in Spain with the tobacco industry and 
passing smoke-free laws, including the ‘Spanish Model’ that existed for a period of time. 
 
In some places some editing is needed for grammar. 
 
Abstract 
 
I would make it clear in title that the study is city of Barcelona and not a national study (Spain) 
Results  - why higher among males? 
I would either use the word comprehensive or complete smoke-free ban throughout, it is confusing to 
go back and forth. 
 
Introduction 
 
Other references to smoke-free could be added, e.g., Cochrane review on smoke-free laws Add in 
further details on study about children exposed to SHS, I think this is the % exposed a least weekly 
but have not re-checked reference? 
Some further details about the Spanish model would be helpful, was it small or large venues that 
could allow smoking, it does not specify in intro. I think small.. 
 
 
Methods 
 
Page 6, line 54, did 101 out of the original 1245 really die? 8.1% of sample? Or am I reading this 
wrong? What was the average age of the sample at baseline and follow-up? A table of sample 
characteristics would be helpful, even though it is stated there were no major differences between 
baseline and follow-up, what was the actual composition of the sample? 
If the sample is representative of 16+ then why at page 7, line 2, do you say that those less than 18 
were not followed? 
Page 7, lines 5-10. Is it the case that the participants for follow-up were first traced, and then re-
contact was attempted to survey? Seems to have been two stages to re-contact where participants 
were lost? 
Please include detail on how smoking in specific areas was measured (e.g., terrace, dining room). 
There are details on this in the results, but not sure how this was measured or analysed because 
there are no details in the methods, and nothing in introduction about research questions related to 
smoking in these spaces. 
 There were differences in terrace smoking/outdoors - any possibility this was due to differences in 
time of survey (seasonal) - any adjustment for this? Should clearly outline times/months when 
respondents were surveyed. Generally in surveys assessing outdoor smoking, some adjustment for 
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season is needed. 
Why was this examined using McNemar and stratified models? Would it not have made more sense 
to use a multivariable model with GEE? 
 
Results 
Line 31, Page 9, these results on smoking in specific areas need to be explained in intro and 
methods - no details for measures or why these additional analyses were conducted? Difficult to 
interpret. 
 
Discussion 
 
The results for households with minors may have been different if the ages of the minors were 
known, previous research has found younger children seem to have more impact on SFH. 
Page 11, line 44, provide references to TI activity around smoke-free in Spain. 
Again, line 3, page 12, references to bans in outdoor places is confusing due to lack of explanation of 
these analyses in intro and methods. 
Why would face-to-face increase internal validity? 
 
Figures and Tables 
 
Figure needs axis titles. Slightly confusing are years survey years or ban years? 
Table 1 needs to indicate years that PRs show difference between. The table should standalone 
without having to read a lot of additional text. I see that this is in the bottom notes but would be better 
in title. I would also shorten the title, no need to have all the details starting at ..according to. 
Table 1 difficult to read, goes over two pages without repeating headings, PRs go over two lines. 
Please format correctly to make it easier to read. 
Table 1. Although with 95% CIs it is possible to see where changes are significant, it would be better 
to add p-values, or indicate somehow where effects are significant to guide reader, again the table is 
just hard to read due to poor formatting. 
 
Reviewer: 2 
 
Comments to the Author 
An interesting paper that focusses directly on the effects of a smoking ban(s) on smokers’ behaviour 
rather than on clinical outcomes so a welcome addition to the body of evidence on smoking 
cessation.  It appears to have been conducted well but I have some suggestions for  improvement. 
 
Introduction 
There are a few grammatical errors in here and the entire manuscript would benefit from a thorough 
proof read. I’m not going to list them all but one example is in lines 39-41 “….they breathe….” would 
read better if those words were substituted with “them breathing”. 
 
Key references are missing here as well. There are no references to the well documented effect of 
smoking bans on asthma admissions nor on the impact on birth outcomes such as low birthweight, 
growth restriction, preterm birth etc. These are important omissions and should be included. 
 
 
Methods 
Need some more detail here on how the weights were calculated and applied. i.e were the weights 
probability weights, analytical weights, importance weights ..or ….? 
 
I don’t think log-binomial regression is the best method to use here as these models can have 
difficulty converging, and you state this later on in the manuscript. In addition confidence intervals are 
too narrow. It would better if you used a Poisson family with log link but make sure you use ROBUST 
standard errors. I suspect you will have more success with the models that fail to converge. I don’t 
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understand why McNemars test was used to get the P value. I know you have within subject 
correlation but surely there are other methods that will allow you to run a regression model and 
produce an appropriate P value? 
 
You have used random effects but don’t state why….I’m assuming it’s because you have repeated 
measures, in which case why did you choose random effects over a GEE model? The GEE would 
allow you to incorporate/model the correlation within individuals more directly and would give you a 
valid P value. Overall, I am not convinced by what you have written that your approach is the best 
approach to use. If you insist on using your approach you will need to explain in more detail what you 
did and why and justify (to the editors) why it would be better than the more common GEE. At the 
moment I am not convinced but that could be because there is a lack of detail. 
 
Results 
Line 51: should be “males” and line 52 should be “females” 
 
I strongly believe that if models failed to converge then they should *NOT* be reported as both the 
point estimate and the standard errors could be out by a magnitude. It would be misleading in my 
opinion to report them. However, if you modify your analysis, at the very least using a Poisson family 
and log link,  I suspect that this problem will disappear. 
 
Why did you choose the age cut-offs that you present?  Younger children/infants tend to spend more 
time at home so it would be interesting to know if the presence of young children has had a marked 
increase in SFH. I’d suggest 0-4 years 5-15 and 15+. I think these are more meaningful cut-offs. If 
you did consider these cut-offs then you need to say why they were not used. 
 
Tables are a bit messy and busy. Is there any way you could present them graphically such as a 
forest plot? “coeffplot” command in R would do this for you. I think you could be a bit more creative 
here. 
 
I’d lose figure 1 as it doesn’t really add anything and would be incorporated into a forest plot anyway. 
The %columns are not at all useful. 
 
 
I felt the discussion was a bit too long and it could be edited down 
 
 
Reviewer: 3 
 
Comments to the Author 
Methods: 
1. What was the response rate for the baseline survey? Is there any indication that initial response to 
the baseline survey differed according to smoke-free home rules?  It appears that the original intent 
of the survey was not designed to look at chances in smoking rules between these two time points, 
but in changes in salivary cotinine exposures instead.  Perhaps this should be mentioned in the 
methods section? 
2. At baseline, individual ≥16 years of age were included as “adults”, yet in the follow-up survey, 
n  were excluded (or deemed ineligible) because they were <18 years old in 2004-2005.  What was 
the reasoning behind these differences in eligibility criteria? 
3. In the results (page 9, 3rd paragraph), the authors mention areas outside of the house and 
changes to smoking rules in these areas, particularly as they relate to homes with partial smoke-free 
home rules.  However, there is no mention of these questions in the methods section. Can you 
please describe how these results were obtained? 
4. Given that this is longitudinal data, I wonder why the prevalence ratio is used instead of the risk 
ratio?  The risk ratio will give an indication of how more/less likely a group (with an exposure) is to 
acquire the outcome over the follow-up period relative to another, unexposed group as opposed to 
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strictly changes over time 5. The prevalence ratio was only adjusted for age and sex.  However, 
these results are stratified by several covariates.  Did the authors think about conducting modeling 
(i.e. GEE or otherwise) to look at multivariable-adjusted analyses, perhaps stratified only by smoking 
status at baseline?  I think it would be interesting to note whether there are different covariates that 
would impact smoke-free home rules between current smokers and non-smokers before and after 
the implementation of the smoke-free air legislation. 
Results: 
6. Page 8, last paragraph through Page 9, line 29: The authors mention that increases in smoke-free 
home rules were higher among men (vs. women), young people (presumably vs. older individuals), 
those with higher education, etc. However, the confidence intervals overlap – for example by sex: 
Men: PR=33, 95% CI: 1.18-1.50 vs. Women: PR=29, 95% CI: 1.18-1.41 (Table 1, any rules by 
sex).  Statistical testing was conducted according to the McNemar’s test in figure 1 to look at 
changes over time (please add this in a footnote), but there is no indication in Table 1 what 
differences are statistically significant (i.e. men vs. woman, age groups, etc.).  I think the results 
would be strengthened if there was some comparison completed between these characteristics as 
opposed to only conducting the multiple stratified analyses. Or, please re-phrase the results so as 
not to imply that these comparisons are being made. 
8. In the footnote of table 1: there is a statement “Non-converging log-binomial regression model with 
random effects”.  What is the implication of this non-convergence?  The authors make no note in the 
limitations or elsewhere what may have been the cause of this non-convergence. Moreover, what are 
the random effect(s) that were used? 
9. Figure 1: It would be nice if the actual percentages were presented in this figure too (above each 
bar). As mentioned in #6, there should be a footnote with this figure describing the PR calculation, 
the McNemar’s test, etc. 
Discussion: 
10. There were 2 distinct smoke-free laws implemented – the first in 2006 (right after this baseline 
assessment) and the next 5 years later in 2011.  The authors are not treating these two laws as 
separate events, given that there was only one follow-up study (2013-2014).  Therefore, it is unclear 
whether the increases in smoke-free home rules observed in this study occurred following the first 
law (2006) or whether the more comprehensive smoke-free air law with few exceptions was 
associated with the increases (or some combination of both).  However, the authors make no 
mention of this in the discussion or in the limitations.  It does not appear that this study was initially 
conceived to assess these changes due to the smoke-free air legislation, given the focus on cotinine 
collection, which may be why there was not follow-up after each smoke-free air law was passed. 
11. The authors state that their results counteract the displacement hypothesis, but this isn’t 
necessarily true, given that there were increases in allowing smoking in outdoor areas of the home 
(balconies, courtyards, gardens, etc.). So, even though there were decreases in smoking inside the 
home, there was an increase in smoking behaviors in private outdoor spaces. 
12. Throughout the paper, there are some grammatical and linguistic errors. For example: in the 
results: “increasing vs. increase” and “...outside areas of the houses were the places that more 
increased in allowing smoking...”  I’d recommend having a translator look at a final version of this 
paper prior to any publication. 
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Response to the Tobacco Control reviewer’s comments 
 
 
 
tobaccocontrol-2016-053114  
Impact of the Spanish smoking legislations in the adoption of 
smoke-free rules at home: a longitudinal study 
Response to the Reviewers’ comments 
 
 
We thank the editor and the reviewers for the useful comments.  
 
We enclose a point-by-point response and we have highlighted the changes in the text of the 
manuscript. 
 
 
 
FORMATTING AMENDMENTS 
 
1. Please remove all figures from the body of the manuscript and reupload your figure files 
separately. 
 
Please note that we do not accept figures in Word document, PDF or PowerPoint format. 
 
All figures and images should be supplied as high quality image files, we recommend TIFF 
format. Please ensure images are a minimum of 300dpi (resolution). 
 
Please include figure legends at the end of the main manuscript text only and label the figure 
files appropriately to correspond. 
 
Current version of the manuscript has not any figure because we have removed the figure as 
one of the reviewers suggested. 
 
 
Reviewer: 1 
 
This is an important paper reviewing the impact of the Spanish smoke-free law on smoking in 
homes. It is significant due to the historical problems encountered in Spain with the tobacco 
industry and passing smoke-free laws, including the ‘Spanish Model’ that existed for a period 
of time. 
 
Thank you very much for the kind comment to our work.  
 
1) In some places some editing is needed for grammar.  
 
As suggested, we have revised carefully the last version of the manuscript and we have 
corrected the grammar mistake.  
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Abstract 
 
2) I would make it clear in title that the study is city of Barcelona and not a national 
study (Spain).  
 
As the reviewer suggested, we have modified the title to clarify that the study was carry out in 
the city of Barcelona (Spain) as follows: 
 
“Impact of the Spanish smoking legislations in the adoption of smoke-free rules at 
home: a longitudinal study in Barcelona (Spain)” 
 
 
Results   
 
3) why higher among males? 
 
In the abstract, we have only reported the higher increase according to the sociodemographic 
variables. The increase of SFH after the implementation of Spanish smoking legislations were 
33% among men and 29% among women, both statistically significant.  The higher increase 
among men could be due the low prevalence in the baseline (51.8% among men and 58.8% 
among women).  
 
We have re-written the Results section of the abstract to clarify it as follows: 
 
“The increase of any type of rules (complete and partial) was statistically 
significantly independently of sex (PR between 1.29 and 1.33), age (PR between 
1.24 and 1.33), educational level (PR between 1.19 and 1.47), and minimum age in 
house (PR between 1.11 and 1.40). However, this increase was statistically and 
significantly higher only among never smokers (PR=1.46) at baseline.”    
 
4) I would either use the word comprehensive or complete smoke-free ban throughout, 
it is confusing to go back and forth. 
 
Thank you very much for the comment. We have used the word complete smoke-free ban 
throughout abstract and manuscript.  
 
 
Introduction 
 
5) Other references to smoke-free could be added, e.g., Cochrane review on smoke-
free laws Add in further details on study about children exposed to SHS, I think this is 
the % exposed a least weekly but have not re-checked reference? 
 
Thank you for the comment. As suggested, we have referenced the Cochrane review in the 
Introduction section.  
“In fact, their implementation has already been associated with a reduction in the 
exposure to SHS, the incidence of acute coronary events, respiratory symptoms, 
improvements of perinatal and child health, along with a moderate decrease in 
tobacco smoking prevalence (5-7)” 
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In addition, we have provided more details on the studies about SHS exposure among children 
as follows: 
“A study carried out in 21 countries showed that almost 50% of children had been 
exposed to SHS in the home (daily, weekly or monthly) between 2009 and 
2013(12).” 
 
Moreover, as reviewer #2 suggested (please see comment number 2), we have added more 
information about the effect of smoking bans in low birth weight and preterm birth as follows: 
 
“In fact, their implementation has already been associated with a reduction in the 
exposure to SHS, the incidence of acute coronary events, respiratory symptoms, 
improvements of perinatal and child health, along with a moderate decrease in 
tobacco smoking prevalence (5-7)(118,119)(118,119). Furthermore, SHS exposure 
during pregnancy has harmful effects on placenta and fetal growth (8) and is 
associated with preterm labor (9,10), intrauterine growth restriction, and low 
birth weight (8).” 
 
 
______________________ 
New reference added in the manuscript:  
7) Frazer K, Callinan JE, McHugh J, et al. Legislative smoking bans for reducing harms from 
secondhand smoke exposure, smoking prevalence and tobacco consumption. Cochrane 
Database Syst Rev 2016;2:CD005992. 
 
8) Mackay DF, Nelson SM, Haw SJ, et al. Impact of Scotland's smoke-free legislation on 
pregnancy complications: retrospective cohort study. PLoS Med 2012;9:e1001175. 
9) Fantuzzi G, Aggazzotti G, Righi E, et al. Preterm delivery and exposure to active and passive 
smoking during pregnancy: a case-control study from Italy. Paediatr Perinat Epidemiol 
2007;21:194-200. 
10) Nabet C, Ancel PY, Burguet A, et al. Smoking during pregnancy and preterm birth according 
to obstetric history: French national perinatal surveys. Paediatr Perinat Epidemiol 2005;19:88-
96. 
 
 
6) Some further details about the Spanish model would be helpful, was it small or large 
venues that could allow smoking, it does not specify in intro. I think small. 
 
We agree with the reviewer to provide more details about the partial ban that came into effect 
on January 1st of 2006. Following this recommendation, we have added the following 
information in the Introduction section:  
 
“In Spain, two smoke-free laws have been passed after the approval of the FCTC. 
In 2005, it came into effect a smoke-free legislation (Law 28/2005). This law was a 
great advance for public health in Spain. The ban was a compendium of public 
health measures against smoking and included regulations on publicity, sale, 
supply, and consumption of tobacco products (17). Smoking was banned in all 
indoor workplaces, public places, public transport facilities including enclosed 
stations, hospitals and other health care facilities, schools and universities as well 
as in retail stores and shopping centres. However, hospitality venues were subject 
to only a partial ban. In bars and restaurants of less than 100 m2, the proprietor 
could choose between permitting or prohibiting smoking. Bars and restaurants 
larger than 100 m2 are defined as smoke-free, but the law allows the proprietor 
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to provide a physically separated and independently ventilated smoking area 
comprising less than 30% of the total floor area. For this exception the Spanish 
smoking law was known as the “Spanish model” (18).” (…) 
 
______________________ 
New reference added in the manuscript:  
17) Ministerio de Sanidad y Consumo. Ley 28/2005, de 2006 de diciembre, de medidas 
sanitarias frente al tabaquismo y reguladora de la venta, el suministro, el consumo y la 
publicidad de los productos del tabaco. Madrid: Ministerio de Sanidad y Consumo; 2005. 
  
 
Methods 
 
7) Page 6, line 54, did 101 out of the original 1245 really die? 8.1% of sample? Or am I 
reading this wrong? What was the average age of the sample at baseline and follow-
up? A table of sample characteristics would be helpful, even though it is stated there 
were no major differences between baseline and follow-up, what was the actual 
composition of the sample? 
 
As the reviewer points, 8.1% of the participants in 2004-2005 died because the baseline 
sample overestimates the old population (Fu et al. 2009; Martínez-Sánchez et al. 2009). For 
this reason, we have weighted the final sample.  
 
Moreover, we have added information about both stages of the follow-up according to 
recommendation of the reviewer #1 (see comment number 9). We agree with the reviewer 
about the importance to report the differences between lost and follow-up. We have not 
observed statistically significant differences according to sex, age, and educational level 
between follow-up (n=736) and lost (n=274) in the second stage of the follow-up. However, we 
have observed statistically significant differences according to age, educational level, and 
smoking status between follow-up (n=736) and lost (n=509) in both stages. As the reviewer 
suggested, we have included a table with the differences between follow-up and lost in both 
stages.  Moreover, we have added more information about the lost in the Methods section: 
 
“There were no statistically significant differences between the followed-up 
sample (n=736) and the participants lost in the second stage (n=274) according to 
age, sex, level of education and smoking status. However, there were statistically 
significant differences according to age, level of education and smoking status 
between the follow-up sample (n=736) and the participant lost in both stages of 
the follow-up (n=509) (table 1). For this reason, the final sample was skewed as 
older in comparison with the population of Barcelona.” 
 
______________________ 
Bibliography: 
Fu M, et al. 2009. Salivary cotinine concentrations in daily smokers in Barcelona, Spain: a cross-
sectional study. BMC Public Health;9:320. 
 
Martínez-Sánchez et al. 2009. Assessment of exposure to secondhand smoke by questionnaire 
and salivary cotinine in the general population of Barcelona, Spain (2004-2005). Prev 
Med;48:218-23. 
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8) If the sample is representative of 16+ then why at page 7, line 2, do you say that 
those less than 18 were not followed? 
 
We could not follow those under 18 because they were not legally adults and we did not ask 
about the possibility to be re-contacted in the future. Moreover, the consent form signed by 
their parents was only for the study in 2004-05, we did not required by minors (less than 18 
years old) to participate in a future study. We have clarified this as follows: 
 
“We traced 1010 participants out of the 1245 from the baseline study (101 died, 
49 migrated out of the province of Barcelona, and 85 did not give consent to be 
followed or were  minors ,<18 years old, in 2004-2005 because their parents did 
not provide consent inform to be re-contacted).” 
 
9) Page 7, lines 5-10. Is it the case that the participants for follow-up were first traced, 
and then re-contact was attempted to survey? Seems to have been two stages to re-
contact where participants were lost? 
 
As the reviewer correctly interpreted we first traced the participants for follow-up, at this 
point we lost some participants due to death and migration out of the province of Barcelona 
after linkage in the Insured Central Registry of Catalonia, or because they did not give consent 
to be followed-up or because they were under 18 in 2004-2005. In this stage the follow-up was 
81.1% (1010 out 1245). Afterwards, we re-contacted them to be surveyed, 72.9% (736 out 
1010) of the eligible sample agreed to participate and answered the questionnaire (second 
stage). According to the two stages the percentage of participation was 59.1% (736 out 1245). 
We have clarified this aspect in the manuscript as follows: 
 
“The percentage of follow-up in this first stage was 81.1%. The follow-up survey 
was conducted between May 2013 and February 2014. In total, 72.9% of the 
eligible sample agreed to participate and answered the questionnaire (736 out 
1010 traced, second stage of follow-up), 18.5% refused to participate, 7.2% 
moved elsewhere and 1.3% died. The final sample analyzed was 736 individuals 
(400 women and 336 men). Finally, the percentage of participation in both stages 
was 51.9% (736 out 1245). There were no statistically significant differences 
between the followed-up sample (n=736) and the participants lost in the second 
stage (n=274) according to age, sex, level of education and smoking status. 
However, there were statistically significant differences according to age, level of 
education and smoking status between the follow-up sample (n=736) and the 
participant lost in both stages of the follow-up (n=509) (table 1). For this reason, 
the final sample was skewed as older in comparison with the population of 
Barcelona.” 
 
10) Please include detail on how smoking in specific areas was measured (e.g., terrace, 
dining room). There are details on this in the results, but not sure how this was 
measured or analysed because there are no details in the methods, and nothing in 
introduction about research questions related to smoking in these spaces. 
 
As the reviewer suggested, we have added information in the Methods section about how we 
obtained information about smoking in specific areas through the questionnaire: 
 
“We also included information about the places where smoking is allowed in 
houses with partial SFH through the following open question: “In what places of 
your home can you smoke?” 
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Besides, we have added some information about outdoor smoking in the Introduction section 
as the reviewer #1 suggested in their comment number 13: 
 
“In Barcelona (Spain), in 2011-2012, 84% of smokers reported smoking at home, 
and 35.9% of them smoked in outdoor areas of the home (23). Moreover, a 
common belief among smokers is that cigarette smoking in outdoor places does 
not affect indoor places (23), whereas a previous study indicated that SHS from 
outdoors settings drifts to adjacent indoors spaces (24).” 
 
______________________ 
New reference:  
23) Sureda X, Fernandez E, Martinez-Sanchez JM, et al. Secondhand smoke in outdoor settings: 
smokers' consumption, non-smokers' perceptions, and attitudes towards smoke-free 
legislation in Spain. BMJ Open 2015;5:e007554-2014-007554. 
 
24) Sureda X, Martinez-Sanchez JM, Lopez MJ, et al. Secondhand smoke levels in public 
building main entrances: outdoor and indoor PM2.5 assessment. Tob Control 2012;21:543-
548. 
11) There were differences in terrace smoking/outdoors - any possibility this was due to 
differences in time of survey (seasonal) - any adjustment for this? Should clearly 
outline times/months when respondents were surveyed. Generally, in surveys 
assessing outdoor smoking, some adjustment for season is needed. 
 
Thank you for the interesting comment. As the reviewer suggested, we have adjusted the 
prevalence ratio of the places where smoking is allowed in houses with partial SFH for sex, age 
and the month where the survey was conducted, as the best proxy for seasonal adjustment.  
 
We add the following sentence to the Methods section: 
 
“We also used GEE models with individuals as random effects and using Poisson 
family with log link, to calculate the prevalence ratio adjusted for sex, age and 
month when the survey was conducted (PRa).” 
 
 
And in the Result section: 
 
“Similar results were also observed in the prevalence ratio of the places where 
smoking is allowed in houses adjusting for sex, age and the month when the 
survey was conducted.” 
 
12) Why was this examined using McNemar and stratified models? Would it not have 
made more sense to use a multivariable model with GEE? 
 
We conducted McNemar test in bivariate analysis due to the paired nature of the data (the 
same subjects observed in two different moments, this is, non-independent samples). We 
agree with the reviewer that the McNemar and bivariate analyses of stratified models could be 
redundant. However, we thought that provide both analyses could be useful for the potential 
reader. As the reviewer suggested, we have deleted McNemar test. However, if the editor 
considers appropriate to include the p-values of McNemar to provide more information for the 
potential readers we will be ready to include it again. 
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On the other hand, as the reviewer suggested, we have re-calculated all analyses using GEE 
models with Poisson family as also recommended the reviewer #2 (please see comment 
number 4 of reviewer #2) and taking into account the survey weights. 
 
 
Results 
 
13) Line 31, Page 9, these results on smoking in specific areas need to be explained in 
intro and methods - no details for measures or why these additional analyses were 
conducted? Difficult to interpret. 
 
As the reviewer suggested, we have added information in the Introduction and in the Methods 
section about outdoor smoking (please see comment number 10 of reviewer #1). 
 
 
Discussion 
 
14) The results for households with minors may have been different if the ages of the 
minors were known, previous research has found younger children seem to have 
more impact on SFH. 
 
Thank you for the comment. In this sense, and as the reviewer # 2 suggests (please see 
comment number 8), we have changed the cut-off of the minimum age at home to <5 years, 5-
14 and ≥15 in order to know if the presence of young children has had a marked increase in 
SFH. 
 
Moreover, we have introduced the minimum age at home as a numerical variable and added 
some information in the Discussion section according to the obtained results: 
 
“However, we found the lowest increase of SFH rules in houses where a minor live 
and an indirect relation between the minimum age at home and the prevalence of 
SFH (data not shown)”. 
 
15) Page 11, line 44, provide references to TI activity around smoke-free in Spain. 
 
As reviewer suggested, we have added some references about tobacco industry around 
smoke-free in Spain in the Discussion section: 
 
“Tobacco industry and the hospitality sector, during the debate of implementation 
of smoke-free policies in different countries, argued that the restriction of 
smoking in public places will displace tobacco consumption to private venues, 
particularly in home (42).” 
 
______________________ 
New references:  
(42) Muggli ME, Lockhart NJ, Ebbert JO, et al. Legislating tolerance: Spain's national public 
smoking law. Tob Control 2010;19:24-30. 
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16) Again, line 3, page 12, references to bans in outdoor places is confusing due to lack 
of explanation of these analyses in intro and methods. 
 
As the reviewer suggested, we have added information in the Introduction and in the Methods 
section about smoking outdoors (please see comment number 10 of reviewer #1). 
 
17) Why would face-to-face increase internal validity? 
 
Face-to-face questionnaire, with trained interviewers, reduce the misinterpretation of the 
questions of the survey in comparison with internet and self-administered surveys. We have 
added the following sentence in the Discussion section to explain it:  
 
“However, by using a face-to-face questionnaire with trained interviewers we 
potentially increase the internal validity of our results as compared with internet 
and self-administered surveys because avoid misinterpretation of the questions 
(49).” 
 
______________________ 
New reference:  
(49) World Health Organization. Health interview surveys: Towards international 
harmonization of methods and instruments, 1996. 
http://www.euro.who.int/__data/assets/pdf_file/0017/111149/E72841.pdf (accessed 1 
August 2016). 
 
Figures and Tables 
 
18) Figure needs axis titles. Slightly confusing are years survey years or ban years? 
 
Thank you for the comment. However, as the reviewer # 2 suggested (please see comment 10 
of reviewer #2), we have removed this figure.  
 
19) Table 1 needs to indicate years that PRs show difference between. The table should 
standalone without having to read a lot of additional text. I see that this is in the 
bottom notes but would be better in title. I would also shorten the title, no need to 
have all the details starting at according to. 
 
Thank you very much for the comment, as the reviewer suggested, we have modified the title 
of the Table 1 (now Table 2) as follows: 
 
“Table 2: Prevalence, prevalence ratio (PR), adjusted prevalence ratio (PRa) and 
their 95% confidence interval (95%CIs) of the voluntary adoption of smoke-free 
homes (SFH) rules (complete and partial) before (2004-2005) and after (2013-
2014) the implementation of both Spanish smoking bans.” 
 
20) Table 1 difficult to read, goes over two pages without repeating headings, PRs go 
over two lines. Please format correctly to make it easier to read. 
 
As the reviewer suggests, we have formatted correctly the table to make it easier to read.  
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21) Table 1. Although with 95% CIs it is possible to see where changes are significant, it 
would be better to add p-values, or indicate somehow where effects are significant 
to guide reader, again the table is just hard to read due to poor formatting.  
 
We agree with the reviewer that 95%CIs is enough to know if the differences are significant. 
However, as the reviewer suggested, we have indicated in the Table 1 (now Table 2) when 
effects are significant, to guide the reader, including the following symbols: * p-value <0.05, ** 
p-value<0.01, *** p-value<0.001. If the editor finds it necessary, we can as well add the p-
values.  
 
 
Reviewer: 2 
 
Comments to the Author 
 
An interesting paper that focusses directly on the effects of a smoking ban(s) on smokers’ 
behaviour rather than on clinical outcomes so a welcome addition to the body of evidence 
on smoking cessation.  It appears to have been conducted well but I have some suggestions 
for improvement. 
 
Thank you very much for the kind comment to our work.  
 
 
Introduction 
 
1) There are a few grammatical errors in here and the entire manuscript would benefit 
from a thorough proof read. I’m not going to list them all but one example is in lines 
39-41 “…. they breathe….” would read better if those words were substituted with 
“them breathing”.   
 
We have corrected the mistake and we have revised carefully the last version of the 
manuscript and we have corrected the grammar mistake, as reviewer suggested.  
 
 
2) Key references are missing here as well. There are no references to the well 
documented effect of smoking bans on asthma admissions nor on the impact on 
birth outcomes such as low birthweight, growth restriction, preterm birth etc. These 
are important omissions and should be included. 
 
Thank you for the comment. As suggested by the reviewer # 1 (see comment 5 of reviewer #1), 
we have referenced the Cochrane review in the Introduction section. Moreover, we have 
added more information about the effect of smoking bans in low birth weight between others: 
 
“In fact, their implementation has already been associated with a reduction in the 
exposure to SHS, the incidence of acute coronary events, respiratory symptoms, 
improvements of perinatal and child health, along with a moderate decrease in 
tobacco smoking prevalence (5-7). Furthermore, SHS exposure during pregnancy 
has harmful effects on placenta and fetal growth (8) and is associate with preterm 
labor (9,10), intrauterine growth restriction, and low birth weight (8).” 
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_______________________ 
New reference:  
8) Mackay DF, Nelson SM, Haw SJ, et al. Impact of Scotland's smoke-free legislation on 
pregnancy complications: retrospective cohort study. PLoS Med 2012;9:e1001175. 
9) Fantuzzi G, Aggazzotti G, Righi E, et al. Preterm delivery and exposure to active and passive 
smoking during pregnancy: a case-control study from Italy. Paediatr Perinat Epidemiol 
2007;21:194-200. 
10) Nabet C, Ancel PY, Burguet A, et al. Smoking during pregnancy and preterm birth according 
to obstetric history: French national perinatal surveys. Paediatr Perinat Epidemiol 2005;19:88-
96. 
 
Methods 
 
3) Need some more detail here on how the weights were calculated and applied. i.e 
were the weights probability weights, analytical weights, importance weights or ….? 
 
The weights are proportional to the inverse of the probability of being included in the sample, 
ie a d_i weight for individual i can be interpreted broadly, as the i individual represents d_i 
individuals in the population of the sample. Such weights are known as inverse probability 
weights. As the reviewer suggested, we have added this information to make this clear:  
 
“Therefore we use inverse probability weights to weight our data according to age 
distribution of the city of Barcelona to maintain its representativeness of the 
sample.” 
 
4) I don’t think log-binomial regression is the best method to use here as these models 
can have difficulty converging, and you state this later on in the manuscript. In 
addition confidence intervals are too narrow. It would better if you used a Poisson 
family with log link but make sure you use ROBUST standard errors. I suspect you 
will have more success with the models that fail to converge. I don’t understand why 
McNemars test was used to get the P value. I know you have within subject 
correlation but surely there are other methods that will allow you to run a regression 
model and produce an appropriate P value? 
 
We agree with the reviewer comment. For this reason, we have re-analysed our data, as the 
reviewer suggests, and we have performed GEE models, using Poisson family with log link 
taking into account weights instead of log-binomial regression. Furthermore, as the reviewer 
mentioned, we improve the convergence problem by using a Poisson regression although 
some model continues without convergence. Therefore, we have made the following change 
in the Methods section: 
 
“We also used GEE models with individuals as random effects and using Poisson 
family with log link, to calculate the prevalence ratio adjusted for sex, age and 
month when the survey was conducted (PRa).” 
 
Moreover, as the reviewer suggested, we have deleted the McNemar p-value. In this sense, we 
have highlighted the interval confidences which were statistically significant (please see 
comment number 21 of the reviewer#1). 
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5) You have used random effects but don’t state why. I’m assuming it’s because you 
have repeated measures, in which case why did you choose random effects over a 
GEE model? The GEE would allow you to incorporate/model the correlation within 
individuals more directly and would give you a valid P value. Overall, I am not 
convinced by what you have written that your approach is the best approach to use. 
If you insist on using your approach you will need to explain in more detail what you 
did and why and justify (to the editors) why it would be better than the more 
common GEE. At the moment I am not convinced but that could be because there is 
a lack of detail. 
 
As the reviewer mentioned, we have used random effects due to using repeated measures 
(same individuals observed in different moments in the longitudinal study). In addition, as the 
reviewer suggests, we have performed GEE models, using Poisson family with log link taking 
into account weights (see comment 4 of reviewer #2).  
 
 
Results 
 
6) Line 51: should be “males” and line 52 should be “females” 
 
We have re-calculated all PR using a GEE model, as the reviewers suggested. For this reason, 
we have changed in the text all values of PR and corrected this mistake.  
 
 
7) I strongly believe that if models failed to converge then they should *NOT* be 
reported as both the point estimate and the standard errors could be out by a 
magnitude. It would be misleading in my opinion to report them. However, if you 
modify your analysis, at the very least using a Poisson family and log link, I suspect 
that this problem will disappear. 
 
As the reviewer suggested, we have used GEE models, using Poisson family with log link taking 
into account weights (see comment 4 of reviewer #2). By doing this we have improved the 
convergence problem in the models as the reviewer mentioned. 
 
8) Why did you choose the age cut-offs that you present?  Younger children/infants 
tend to spend more time at home so it would be interesting to know if the presence 
of young children has had a marked increase in SFH. I’d suggest 0-4 years 5-15 and 
15+. I think these are more meaningful cut-offs. If you did consider these cut-offs 
then you need to say why they were not used.  
 
As the reviewer suggested, we have changed the cut-off of the minimum age at home by <5 
years, 5-14 and ≥15.  
 
9) Tables are a bit messy and busy. Is there any way you could present them graphically 
such as a forest plot? “coeffplot” command in R would do this for you. I think you 
could be a bit more creative here. 
 
We have used the coeffplot command as suggested. The figures are in the end of this 
response. However, we decided to keep the table in the manuscript because it provides more 
information about our study for the potential readers. However, if the editor finds it better to 
provide the new figures created in the main text, we are available to provide it and include the 
current Table 2 as complementary files. 
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10) I’d lose figure 1 as it doesn’t really add anything and would be incorporated into a 
forest plot anyway. The %columns are not at all useful. 
 
Thank you for the comment. As the reviewer suggests we have removed this figure. However, 
if the editor finds it is better to provide this figure, we are available to provide it again. 
 
11) I felt the discussion was a bit too long and it could be edited down.  
 
As the reviewer suggested, we have shortened the Discussion section deleting the following 
paragraph: 
 
“In Spain, other study has shown a decrease in SHS exposure in non-smokers 
adults after the legislations, with exposure assessment by questionnaire and 
biomarkers (cotinine) (25). Specifically, the prevalence ratio of SHS exposure 
showed a significant decrease in the SHS in home after the legislation (PR = 0.78, 
95%CI: 0.65, 0.94) (25).”   
 
If the editor finds it better to provide this paragraph in the main text, we are available to 
provide it again. 
 
Reviewer: 3 
 
Methods 
 
1) What was the response rate for the baseline survey? Is there any indication that 
initial response to the baseline survey differed according to smoke-free home rules?  
It appears that the original intent of the survey was not designed to look at chances 
in smoking rules between these two time points, but in changes in salivary cotinine 
exposures instead.  Perhaps this should be mentioned in the methods section?  
 
Thank you very much for the interesting comment. As previous reviewer mentioned (please 
see reviewer’s #1 comment 9), we have included information of lost and follow-up sample in 
the Method section as follows: 
 
“The percentage of follow-up in this first stage was 81.1%. The follow-up survey 
was conducted between May 2013 and February 2014. In total, 72.9% of the 
eligible sample agreed to participate and answered the questionnaire (736 out of 
1010 traced, second stage of follow-up), 18.5% refused to participate, 7.2% 
moved elsewhere and 1.3% died. The final sample analyzed was 736 individuals 
(400 women and 336 men). Finally, the percentage of participation in both stages 
was 51.9% (736 out 1245). There were no statistically significant differences 
between the followed-up sample (n=736) and the participants lost in the second 
stage (n=274) according to age, sex, level of education and smoking status. 
However, there were statistically significant differences according to age, level of 
education and smoking status between the follow-up sample (n=736) and the 
participant lost in both stages of the follow-up (n=509) (table 1). For this reason, 
the final sample was skewed as older in comparison with the population of 
Barcelona.” 
 
Moreover, we have compared the salivary cotinine concentration in baseline between lost and 
follow-up. Although there were statistically significant differences according to smoking status 
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there was a not statistically significant difference according to salivary cotinine concentration. 
We have decided not provide information about salivary cotinine concentration in the table 
with lost and follow-up participants because we have not information about this biomarker in 
the follow-up and also for not confound the reader. However, if the editor finds this 
information necessary, we may add it into table 1.   
 
We have also included in the Discussion section the limitation of the differences observed 
between lost and follow-up as follows: 
 
 “In this sense, there were statistically significant differences according to age, 
level of education, and smoking status between the follow-up sample and the 
participant lost in both stages of the follow-up. Follow-up participants 
overestimate the young people and smokers in comparison with lost participant 
(table 1), for this reason the increase of SFH could be higher among lost 
participant. On the other hand, our final sample overestimated the older people 
compared with the distribution of population in Barcelona.” 
 
2)  At baseline, individual ≥16 years of age were included as “adults”, yet in the follow-
up survey,  were excluded (or deemed ineligible) because they were <18 years old in 
2004-2005.  What was the reasoning behind these differences in eligibility criteria? 
 
Please see response to comment number 8 of the reviewer #1.  
 
3)  In the results (page 9, 3rd paragraph), the authors mention areas outside of the 
house and changes to smoking rules in these areas, particularly as they relate to 
homes with partial smoke-free home rules.  However, there is no mention of these 
questions in the methods section. Can you please describe how these results were 
obtained?  
 
As the reviewer suggested, we have added information in the Methods section about outdoor 
smoking (please see comment number 10 of reviewer #1). 
 
4) Given that this is longitudinal data, I wonder why the prevalence ratio is used 
instead of the risk ratio?  The risk ratio will give an indication of how more/less likely 
a group (with an exposure) is to acquire the outcome over the follow-up period 
relative to another, unexposed group as opposed to strictly changes over time.  
 
The objective of our study was to assess the impact of Spanish smoking bans in the prevalence 
of adoption of SFH, for this reason, we think more appropriate to measure the changes in the 
prevalence with prevalence ratio. Other interesting study could be to analyse the correlates 
and “risk” to adoption of SFH. In this case, we think more appropriate to use risk ratio. Due to 
the objective of our study we have decided to keep prevalence ratio. Moreover, we have 
conducted a GEE analyses as the three reviewers as suggested. However, if the editor 
considers more appropriate to perform a risk ratio we are available to conduct this analyses.  
 
 
5) The prevalence ratio was only adjusted for age and sex.  However, these results are 
stratified by several covariates.  Did the authors think about conducting modeling 
(i.e. GEE or otherwise) to look at multivariable-adjusted analyses, perhaps stratified 
only by smoking status at baseline?  I think it would be interesting to note whether 
there are different covariates that would impact smoke-free home rules between 
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current smokers and non-smokers before and after the implementation of the 
smoke-free air legislation.  
 
Please see response to comment number 4 of the reviewer #2.  
 
 
Results: 
6)  Page 8, last paragraph through Page 9, line 29: The authors mention that increases 
in smoke-free home rules were higher among men (vs. women), young people 
(presumably vs. older individuals), those with higher education, etc. However, the 
confidence intervals overlap – for example by sex: Men: PR=33, 95% CI: 1.18-1.50 vs. 
Women: PR=29, 95% CI: 1.18-1.41 (Table 1, any rules by sex).  Statistical testing was 
conducted according to the McNemar’s test in figure 1 to look at changes over time 
(please add this in a footnote), but there is no indication in Table 1 what differences 
are statistically significant (i.e. men vs. woman, age groups, etc.).  I think the results 
would be strengthened if there was some comparison completed between these 
characteristics as opposed to only conducting the multiple stratified analyses. Or, 
please re-phrase the results so as not to imply that these comparisons are being 
made.  
 
Thank you for the comment. We have only highlighted the higher increase in the prevalence 
ratios not compare the prevalence ratio according to the sociodemographic variables. We have 
re-written the results section to clarify this as follows: 
 
“The increase of any type of rules (complete and partial) was statistically 
significantly independently of sex (PR man = 1.33 vs. PR women =1.29), age (PR 
65-98 years = 1.24 and PR in 26-44 years 1.33), educational level (PR intermediate 
level = 1.19 and PR high level = 1.47), and minimum age in house (PR 0-4 years = 
1.11 and PR ≥15 years = 1.40). However, the increase was statistically and 
significantly higher only among never smokers (PR=1.46) at baseline.” 
 
Moreover, as the reviewer suggested, we have indicated in the Table 1 when effects are 
significant, to guide the reader, including the following symbols: * p-value <0.05, ** p-
value<0.01, *** p-value<0.001. If the editor finds it necessary, we can as well add the p-values. 
We have also added a footnote indicating statistical test used in the tables.  
 
7)  In the footnote of table 1: there is a statement “Non-converging log-binomial 
regression model with random effects”.  What is the implication of this non-
convergence?  The authors make no note in the limitations or elsewhere what may 
have been the cause of this non-convergence. Moreover, what are the random 
effect(s) that were used?  
 
Thank you for the comment. As the three reviewers suggested, we have performed GEE 
models, using Poisson family with log link taking into account weights instead of log-binomial 
regression obtaining convergent models in all the cases. Moreover, we have used random 
effects to take into account repeated individual. To clarify this, we have added the following 
sentence to the Method section: 
 
“We also used GEE models with individuals as random effects and using Poisson 
family with log link, to calculate the prevalence ratio adjusted by sex, age and 
month when the survey was conducted (PRa).” 
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We have also clarified it in the footnote of the table. 
 
8)  Figure 1: It would be nice if the actual percentages were presented in this figure too 
(above each bar). As mentioned in #6, there should be a footnote with this figure 
describing the PR calculation, the McNemar’s test, etc.  
 
We have removed this figure as suggested the reviewer #2 (please see comment number 10 of 
reviewer #2). 
 
 
Discussion 
 
9)  There were 2 distinct smoke-free laws implemented – the first in 2006 (right after 
this baseline assessment) and the next 5 years later in 2011. The authors are not 
treating these two laws as separate events, given that there was only one follow-up 
study (2013-2014).  Therefore, it is unclear whether the increases in smoke-free 
home rules observed in this study occurred following the first law (2006) or whether 
the more comprehensive smoke-free air law with few exceptions was associated 
with the increases (or some combination of both).  However, the authors make no 
mention of this in the discussion or in the limitations.  It does not appear that this 
study was initially conceived to assess these changes due to the smoke-free air 
legislation, given the focus on cotinine collection, which may be why there was not 
follow-up after each smoke-free air law was passed.  
 
Thank you very much for the interesting comment. We agree with the reviewer, it is unclear 
whether the increases in smoke-free home rules observed in this study occurred following the 
first law (2006) or whether the more comprehensive smoke-free air law with few exceptions 
was associated with the increases (or some combination of both). Therefore we included the 
following limitation in the Discussion section: 
 
 “Finally, we have not gathered information about the prevalence of SFH between 
both surveys to assess the impact of both Spanish legislations (independently or 
combined).”      
 
10)  The authors state that their results counteract the displacement hypothesis, but this 
isn’t necessarily true, given that there were increases in allowing smoking in outdoor 
areas of the home (balconies, courtyards, gardens, etc.). So, even though there were 
decreases in smoking inside the home, there was an increase in smoking behaviors in 
private outdoor spaces.   
 
Thank you very much for the comment. In our opinion, the decrease in smoking inside the 
home together with the increase in smoking behaviour in private outdoor spaces counteract 
the displacement hypothesis in the sense that, according to our results, we would expect a 
decrease in second-hand smoke exposure inside the house.  
 
11)  Throughout the paper, there are some grammatical and linguistic errors. For 
example: in the results: “increasing vs. increase” and “...outside areas of the houses 
were the places that more increased in allowing smoking...”  I’d recommend having a 
translator look at a final version of this paper prior to any publication. 
 
We have corrected the mistakes and we have revised carefully the last version of the 
manuscript and we have corrected all mistakes detected, as reviewer suggested.  
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NEW FIGURES CREATED 
Figure 1: Any type (complete and partial) of SFH rules (prevalence ratio) 
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Figure 2: Complete SFH rules (prevalence ratio) 
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Figure 3: Partial of SFH rules (prevalence ratio) 
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Letter of acceptance of Tobacco Control journal  
 
 
-----Mensaje original----- 
De: onbehalfof+tobaccocontrol+bmj.com@manuscriptcentral.com [mailto:onbehalfof+tobaccocontrol
+bmj.com@manuscriptcentral.com] 
Enviado el: miércoles, 24 de agosto de 2016 18:16 
Para: jmmartinez@iconcologia.net 
CC: clidon@uic.es; jmmartinez@iconcologia.net; mfu@iconcologia.net; mballbe@iconcologia.net; jc
martin@uic.es; cmartinez@iconcologia.net; esteve.salto@gencat.cat; efernandez@iconcologia.net 
Asunto: Tobacco Control - Decision on Manuscript ID tobaccocontrol-2016-053114.R1 
 
24-Aug-2016 
 
Dear Dr. Jose Martínez-Sánchez, 
 
Manuscript ID tobaccocontrol-2016-053114.R1 - Impact of the Spanish smoking legislations in the 
adoption of smoke-free rules at home: a longitudinal study in Barcelona (Spain) 
 
 
We are pleased to accept your article for publication in Tobacco Control. 
 
Your paper will shortly be sent for editing and typesetting and you will receive a proof to check in 
about 10-15 working days. Please check your junk mail if you have not received your proof within this 
time, in case the automatic email goes there. 
 
Video abstract 
In order to help explain the importance of their work to a wider audience, authors of original research 
articles are encouraged to submit a video abstract to be published as part of their paper. Some 
instructions on how to prepare and submit a video are available on the journal's instructions for 
authors at http://tc.bmj.com/site/about/guidelines.xhtml. The video can be submitted at any time 
between now and the time that you return the proof corrections for your article (usually around 2 
weeks from the point of acceptance). If you have any queries about video abstracts, please contact 
the Editorial Office. 
 
Open Access 
If you wish to have your article published under our Open Access option, please ensure you pay the 
fee of £1950 (plus applicable VAT) within 48 hours, so that we can process your article. If you have 
selected our Open Access option, please be aware that your article will be published behind access 
controls if payment is not verified within 40 days from acceptance. If payment is received after 
publication, access controls will be removed once this has been verified. You can choose to pay by 
card or invoice, using our secure 3rd party online system. For more details on our Open Access 
option please visit http://journals.bmj.com/site/authors/openaccess.xhtml. 
 
BMJ has partnered with the Copyright Clearance Center to offer a payment method via their 
RightsLink system. If payment is due, you will receive a separate email from Copyright Clearance 
Centre with instructions on how to pay. 
 
Please note, a number of institutions have taken out Open Access Memberships with BMJ, which 
either cover the full cost of open access publishing for authors at participating institutions, or allow 
authors to receive a discount on the Open Access fee. Please visit our open access page 
at http://journals.bmj.com/site/authors/openaccess.xhtml to see a full list of participating institutions, 
find out if you are eligible, and see how to obtain your discount code. 
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When will we publish your article? 
Most articles are published Online First in their final form (copyedited and typeset) about 3 weeks 
after acceptance. Online First publication establishes primacy for the work; the article is deposited 
with indexing databases (e.g., PubMed) and is fully citable. For further details please 
visit http://journals.bmj.com/site/authors/editorial-policies.xhtml#onlinefirst. Publication in a 
subsequent print version of the journal is determined by the Editor in Chief. 
 
Post publication 
You will be sent a link to your article by email when it is published online and you will be able to track 
its usage. All articles have individual usage statistics that are updated monthly; these can be 
accessed from the “Article Usage Statistics” link in the “Services” section to the right of the article 
online. 
 
We encourage you to sign up for content alerts so you don’t miss anything published in  Tobacco 
Control – it only takes a few seconds and we only need your email 
address: http://tobaccocontrol.bmj.com/cgi/alerts/etoc. You can unsubscribe at any time. 
 
If you have any questions, please contact me, quoting the manuscript ID. 
 
 
Yours sincerely, 
 
Andrew Hyland, 
Senior Editor 
Tobacco Control 
 
http://tobaccocontrol.bmj.com/ 
Twitter: @TC_BMJ 
Blog: http://blogs.bmj.com/tc/ 
 
 
Reviewer(s)' Comments to Author: 
 
 
We are constantly trying to find ways of improving our peer review system and continually monitor 
processes and methods by including article submissions and reviewers’ reports in our research. If 
you do not wish your paper or review entered into a our peer review research programme, please let 
us know by emailing The BMJ's editorial office papersadmin@bmj.com as soon as possible. 
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V. Correspondence of the thesis article: 
Secondhand smoke risk perception and 
smoke-free rules in homes: a cross-sectional 
study in Barcelona (Spain) 
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Cover letter to the editor of BMJ Open  
 
 
Barcelona, September 8th, 2016. 
 
 
 
 
 
Dr. Trish Groves 
Editor in Chief 
British Medical Journal Open  
 
 
Dear Dr. Groves, 
Please find enclosed our manuscript “Secondhand smoke risk perception and smoke-free 
rules in homes: room for improvement” for your consideration in the British Medical 
Journal Open. 
 
We observed that there are an association between the smoke-free homes adoption and 
the perceived risk of secondhand smoke exposure. Our data highlight the need to increase 
awareness of the health risks of tobacco passive exposure in private settings, especially 
among smokers. In this sense, warning campaigns about the harmful effects of secondhand 
smoke exposure at homes, especially in the presence of minors, should be promoted in 
Spain. Furthermore, it should also be reported by the media the health benefits of having a 
smoke-free home. 
All the authors carefully read the manuscript and fully approve of it. In their name I also 
declare that the manuscript is original and it is not submitted anywhere other than your 
journal. The authors declare there are no conflicts of interest.  
We would of course be ready to provide further information about our data and methods 
you desire. Correspondence about the manuscript should be addressed to me as indicated 
in the first page of the manuscript. 
Thank you very much for your kind attention. 
Yours sincerely, 
 
Jose M Martínez-Sánchez, PhD, MPH, BSc 
E-mail: jmmartinez@uic.es  
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Editor's response and comments from the BMJ Open reviewers 
 
 
 
-----Mensaje original----- 
De: onbehalfof+info.bmjopen+bmj.com@manuscriptcentral.com [mailto:onbehalfof+info.bmjopen+bm
j.com@manuscriptcentral.com] 
Enviado el: martes, 11 de octubre de 2016 14:36 
Para: jmmartinez@uic.es 
CC: clidon@uic.es; jmmartinez@uic.es; mfu@iconcologia.net; mballbe@iconcologia.net; jcmartin@u
ic.es; cmartinez@iconcologia.net; efernandez@iconcologia.net 
Asunto: BMJ Open - Decision on Manuscript ID bmjopen-2016-014207 
 
11-Oct-2016 
 
Dear Dr. Martínez-Sánchez, 
 
Manuscript ID bmjopen-2016-014207 entitled "Secondhand smoke risk perception and smoke-free 
rules in homes: 
room for improvement" which you submitted to BMJ Open, has been reviewed. The comments of the 
reviewers are included at the bottom of this letter. 
 
The reviewers have recommended revisions to your manuscript. Therefore, I invite you to respond to 
the reviewers' comments and revise your manuscript. Please remember that the reviewers' 
comments and the previous drafts of your manuscript will be published as supplementary information 
alongside the final version. 
 
In addition to the above, please address the editorial requests towards the end of this letter. 
 
To revise your manuscript, log into https://mc.manuscriptcentral.com/bmjopen and enter your Author 
Center, where you will find your manuscript title listed under "Manuscripts with Decisions."  Under 
"Actions," click on "Create a Revision."  Your manuscript number has been appended to denote a 
revision. 
 
You may also click the below link to start the revision process (or continue the process if you have 
already started your revision) for your manuscript. If you use the below link you will not be required to 
login to ScholarOne Manuscripts. 
 
https://mc.manuscriptcentral.com/bmjopen?URL_MASK=63f9e5de76f9460caf8a2ed7e23ef0c8 
 
 
You will be unable to make your revisions on the originally submitted version of the 
manuscript.  Instead, revise your manuscript using a word processing program and save it on your 
computer.  Please also highlight the changes to your manuscript within the document by using the 
track changes mode in MS Word or by using bold or colored text.Once the revised manuscript is 
prepared, you can upload it and submit it through your Author Center. 
 
When submitting your revised manuscript, you will be able to respond to the comments made by the 
reviewer(s) in the space provided.  You can use this space to document any changes you make to 
the original manuscript.  In order to expedite the processing of the revised manuscript, please be as 
specific as possible in your response to the reviewer(s). 
 
You will receive a proof if your article is accepted, but you will be unable to make substantial changes 
to your manuscript, please take this opportunity to check the revised submission carefully. 
 
IMPORTANT:  Your original files are available to you when you upload your revised 
manuscript.  Please delete any redundant files before completing the submission. 
 
Because we are trying to facilitate timely publication of manuscripts submitted to BMJ Open, your 
revised manuscript should be submitted within 28 days. If it is not possible for you to submit your 
revision by this date, we may have to consider your paper as a new submission. 
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Once again, thank you for submitting your manuscript to BMJ Open and I look forward to receiving 
your revision. 
 
Sincerely, 
 
Dr Edward Sucksmith 
BMJ Open Managing Editor 
esucksmith@bmj.com 
 
 
Editorial Requests: 
 
- Please revise your title so that it includes your study design and setting. This is the preferred format 
for the journal. Please also remove "room for improvement" - we ask authors to refrain from using 
declarative titles (i.e those that state the study's main finding(s)). 
 
- Please re-write the 'Strengths and Limitations' section on page 3. Currently only the final bullet point 
is a strength or limitation of the study. 
 
- The manuscript contains some typographical/ grammatical errors. Please thoroughly copy-edit the 
paper. 
 
- Please include an ethics statement in the methods section of the manuscript. 
 
 
Reviewers' Comments to Author: 
 
Reviewer: 1 
Reviewer Name: Giuseppe Gorini 
Institution and Country: ISPO, Florence, Italy Competing Interests: None to declare 
 
Most studies on household SHS exposure considered indoor household ban, for instance, studies on 
effects of SHS exposure on children. If smokers go outdoor SHS levels are very low. 
Thus, in my opinion, it's important that there is an indoor ban, not an outdoor household ban. If 
smokers are allowed to smoke in terraces, patios and gardens, it's good. Instead, if smokers are 
allowed to smoke in one or more rooms, it's not good. So, I suggest to divide "partial ban" into two 
groups: " partial ban (only indoor is not allowed to smoke; about 70% of the 35% respondents in this 
group)" and "partial ban (it's allowed to smoke indoor in some areas; about 30% of the 35% 
respondents in partial ban group). 
Then I will put together your categories "complete ban" plus  the category " partial ban (only indoor is 
not allowed to smoke)", creating a new category "complete indoor ban". Moreover, I will put together 
"absent smoking rules" plus "partial ban (it's allowed to smoke indoor in some areas), creating a new 
category "partial or absent indoor ban" . Then, you have to run again the statistical analyses using 
these two new categories  "complete indoor ban" and "partial or absent indoor ban" 
 
 
Reviewer: 2 
Reviewer Name: S Phani Veeranki 
Institution and Country: Preventive Medicine and Community Health, University of Texas Medical 
Branch, Galveston, TX USA Competing Interests: None declared 
 
In this study, the authors conducted a follow up of a previous cohort to investigate the prevalence of 
voluntary adoption of smoke free laws and identify factors associated with it. In addition, they also 
assessed the relationship between SHS risk perception and smoke-free rules in homes. This study 
has significant impact in the tobacco literature due to its investigation on voluntary smoke free laws. I 
commend the authors for their effort, however I have several reservations as highlighted below. 
 
The introduction does not present the background rationale of importance of the study question. Why 
voluntary smoke-free laws are important? What are health effects associated with SHS exposure 
inside home to children and young adolescents? Why voluntary and not mandatory? What are the 
other venues for SHS exposure? 
 
Data on US is out of context. I suggest the authors present a rationale in relation to venues of shs 
exposure and availability of smoking laws to cover these venues. 
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What is the rationale in conducting a follow up survey 3 years post implementation of comprehensive 
smoke free law? 
 
Provide more details on the survey- administration, questionnaire, how sample was accessed, type 
of sampling procedure etc. 
 
Did the original baseline survey include “<18 years”? Provide sufficient details about the original 
survey. 
 
Approximately 28% of survey participants were either loss to follow up or died or refused to 
participate. How did you address this in the statistical models? How were these different from those 
who participated in the survey? Inclusion/exclusion of these participants will influence the estimates. 
 
There are several other confounding variables that influence either voluntary adoption of smoke free 
laws or SHS risk perception other than age, sex and smoking status. For ex: occupation, 
employment, knowledge, access to tobacco products, tobacco industry advertising and promotions 
etc. 
 
Please describe how weights were determined and incorporated. 
 
It seems the authors purposefully presented results from unadjusted estimates, which is incorrect. 
You are supposed to present adjusted estimates.  Please revise the results section. Also there is no 
information on variables at baseline and follow up survey. 
 
The adjusted estimates in table 2 revealed no association between SHS risk perception and smoke-
free laws. What might be the reason? 
 
 
Reviewer: 3 
Reviewer Name: Emilia Zainal Abidin 
Institution and Country: Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Malaysia 
Competing Interests: None declared. 
 
Paper is well-written. The following are a few suggestions regarding the need for modifications of 
some parts of the text to further increase the readability of this paper. 
 
Abstract 
1. line 23, secondhand instead of second; methods, first line consider revising sentence 2. 
"perceptions", suggestion: Briefly state the significant variables of risk perceptions; breathing tobacco 
smoke from smokers is harmful (PR: 1.50; 95% CI: 1.07-2.11), second-hand tobacco smoke is 
dangerous for adults (PR: 1.44; 95% CI: 1.04 - 2.00) and non-smokers (PR: 1.65; 95% CI: 1.12 -
2.44) were associated with the voluntary adoption of smoke-free home. 
3. line 45-48, rephrase to make sentence clearer 4. Line 32-35, did  the Euro-barometer consider 
smoking in outdoor areas at home as complete ban? 
 
Strength & limitation 
1. Suggest to revise the points regarding strength of the study, 
 
Introduction 
1. Acronym not defined; SHS and Line 7, since the introduction of... 
2. Line 37. Reference for law missing 
3. Line 48, consider revising 
4. Justification for paper not included 
 
Methods 
Page 5 
1. Line 12, 2014, instead of 1014. Add a brief sentence explaining the method of baseline data 
collection. 
2. Line 26, add frequency in parentheses to explain percentages 3. Line 32, The final number of 
subject included in this study is 736 or 731? statement contradict with  next paragraph. 
Page 5 
4. Line 6, 8, 11; request to standardise SHS term used 5. Reference for FCTD is missing 6. Please 
state language used and ethical approval statement 
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Results 
1. In households with partial rules, outdoor areas as balconies, patios, terraces and gardens, were 
the most commonly designated places for smoking (70.0%). ---- is there a reason why outdoor 
smoking (balconies, patios, terraces and gardens) not considered as complete ban? Or does this 
follow the Euro-barometer? 
2. This is an important point, suggest that author include data. ---> Besides, enclosed areas of the 
home were the least designated for smoking (data not shown). 
3. For table 1 and 2, suggest to add * to indicate p<0.05, or bold, or whatever is easier 
 
Discussions 
1. Line 31, please state the percentages of adoption of smoke-free home adoption among never 
smokers and among those who lived with minor in these previous studies. 
2. line 34, it is suggested to discuss why the adoption of smoke-free home was higher among never 
smoker and among those who lived with minors. Additional statistical analysis could be  performed to 
confirm if there are significant differences of any kind of risk perceptions towards SHS exposure 
across smoking status and the presence of minors at home. 
3. Line 29, 33 page 12 tobacco passive exposure, consider revising 4. Are there any link between the 
findings and the effectiveness of the last smoke-free legislation in Spain (Law 42/2010)? Please 
identify and add relevant information if any and references to further strengthen the discussions. 
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Response to the BMJ Open reviewer’s comments 
 
 
bmjopen-2016-014207 
Secondhand smoke risk perception and smoke-free rules 
in homes: room for improvement 
 
 
We thank the editor and the reviewers for their useful comments.  
 
We enclose a point-by-point response and we have highlighted the changes in the text of the 
manuscript. 
 
 
Editorial Requests:  
 
- Please revise your title so that it includes your study design and setting. This is the preferred 
format for the journal. Please also remove "room for improvement" - we ask authors to 
refrain from using declarative titles (i.e those that state the study's main finding(s)). 
As the editor suggests, we have changed the title as follows: 
“Secondhand smoke risk perception and smoke-free rules in homes: a cross-
sectional study in Barcelona (Spain)” 
 
- Please re-write the 'Strengths and Limitations' section on page 3. Currently only the final 
bullet point is a strength or limitation of the study. 
We have re-written the ‘Strengths and Limitations’ section as follows: 
“• The main limitation of this study is the potential bias of participation due to the 
attrition of the cohort of participants. However, all analyses used weighted data to 
generate representative estimates of the city of Barcelona. 
• The study was conducted only in the city of Barcelona and generalization of the 
results to the rest of Spain should be cautious.  
• Another potential limitation is the cross-sectional nature of the data, which allow to 
establish associations but not to infer causality.” 
 
- The manuscript contains some typographical/ grammatical errors. Please thoroughly copy-
edit the paper. 
We have carefully revised the manuscript and edited the typographical and grammatical 
errors.  
- Please include an ethics statement in the methods section of the manuscript. 
This statement has been added in the page number 6 (last paragraph).  
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Reviewer: 1 
Reviewer Name: Giuseppe Gorini 
Institution and Country: ISPO, Florence, Italy 
Competing Interests: None to declare 
 
1. Most studies on household SHS exposure considered indoor household ban, for instance, 
studies on effects of SHS exposure on children. If smokers go outdoor SHS levels are very low. 
Thus, in my opinion, it's important that there is an indoor ban, not an outdoor household 
ban. If smokers are allowed to smoke in terraces, patios and gardens, it's good. Instead, if 
smokers are allowed to smoke in one or more rooms, it's not good. So, I suggest to divide 
"partial ban" into two groups:  "partial ban (only indoor is not allowed to smoke; about 70% 
of the 35% respondents in this group)" and "partial ban (it's allowed to smoke indoor in 
some areas; about 30% of the 35% respondents in partial ban group). 
Then I will put together your categories "complete ban" plus the category" partial ban (only 
indoor is not allowed to smoke)", creating a new category "complete indoor ban". Moreover, 
I will put together "absent smoking rules" plus "partial ban (it's allowed to smoke indoor in 
some areas), creating a new category "partial or absent indoor ban". Then, you have to run 
again the statistical analyses using these two new categories "complete indoor ban" and 
"partial or absent indoor ban". 
We thank the reviewer for the interesting comment. According to his suggestion, we have re-
calculated all analyses using the proposed categorization about smoke-free rules at home 
(“complete indoor rules” and “partial or absent indoor rules”). The prevalence of the new 
categories are 57.4% for complete indoor rules and 42.6% for partial or absent indoor rules. 
We explain the new re-codification in the Methods section, have modified the tables, and have 
re-written the Results section accordingly. 
Moreover, due to the new categorization, the log-binomial regression model adjusted for sex, 
age, and smoking status do not converge. For this reason, we have decided to remove the 
smoking status from the adjustment; thus, the models were adjusted for sex and age. We have 
clarified this in the methods section as follows: 
“We also fitted a log-binomial regression models to calculate the prevalence 
ratios, adjusted for sex and age (PRa).” 
 
 
 
Reviewer: 2 
Reviewer Name: S Phani Veeranki 
Institution and Country: Preventive Medicine and Community Health, 
University of Texas Medical Branch, Galveston, TX USA 
Competing Interests: None declared 
 
In this study, the authors conducted a follow up of a previous cohort to investigate the 
prevalence of voluntary adoption of smoke free laws and identify factors associated with it. 
In addition, they also assessed the relationship between SHS risk perception and smoke-free 
rules in homes. This study has significant impact in the tobacco literature due to its 
investigation on voluntary smoke free laws. I commend the authors for their effort, however 
I have several reservations as highlighted below. 
Thank you very much for the kind comment to our work.  
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1. The introduction does not present the background rationale of importance of the study 
question. Why voluntary smoke-free laws are important? What are health effects associated 
with SHS exposure inside home to children and young adolescents? Why voluntary and not 
mandatory? What are the other venues for SHS exposure? 
We thank the reviewer for these insights. Following the reviewer’s queries, we provide 
additional information in the Introduction section: 
“The health consequences of second-hand smoke (SHS) exposure on non-
smoker’s are well-known(1). Moreover, passive exposure could be due to 
different settings such as workplaces, public places (bars, restaurants, etc.), public 
transport, or private places. For this reason, since the introduction of the World 
Health Organization Framework Convention on Tobacco Control (WHO FCTC), 
many countries have implemented smoke-free policies in public and workplaces 
to reduce the impact of SHS exposure in non-smoker’s health; consequently there 
has been a reduction in SHS exposure after their implementation in workplaces 
and public places(2). However, private settings (mainly cars and homes) are never 
or rarely included in tobacco control policies. Nevertheless, the household is 
usually the main source of exposure to SHS in children(3,4). In addition, children 
are especially vulnerable to SHS exposure because they breathe more rapidly and 
inhale more pollutants per pound of body weight adults(5). In addition, SHS 
exposure is a risk for infant death syndrome, acute respiratory infections, ear 
problems, and mental disorders in children(6,7).”  
 
And, 
 
“Currently, to our knowledge, there are no national descriptive studies about the 
adoption of smoke-free homes in Spain after the Spanish tobacco control 
legislations. Moreover, there is scarce evidence about the relationship between 
voluntary adoption of smoke-free homes and the risk perception of SHS exposure. 
Therefore, the objective of this study is to describe the voluntary adoption of 
smoke-free homes in Spain and to identify variables associated to its voluntary 
adoption, including risk perception towards SHS exposure.” 
______________________ 
New references:  
(1) U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES. The Health Consequences of Smoking—50 
Years of Progress. A Report of the Surgeon General. 2014. Available at: 
http://www.surgeongeneral.gov/library/reports/50-years-of-progress/full-report.pdf 
(5) Canadian Institute of Child Health.  Environmental hazards: Protecting children. 1997. 
http://www.cich.ca/PDFFiles/EnvFactSheetsENG.pdf (accessed 20 October 2016). 
(6) Padrón A, Galán I, Garcia-Esquinas E, et al. Exposure to secondhand smoke in the home and mental 
health in children: a population-based study. Tob Control 2015 25:307-12. 
(7) Hahn EJ. Smokefree legislation: a review of health and economic outcomes research. Am J Prev Med 
2010;39:S66-76. 
 
 
2. Data on US is out of context. I suggest the authors present a rationale in relation to venues 
of shs exposure and availability of smoking laws to cover these venues. 
We have removed the information about smoke-free homes in US. Moreover, as the reviewer 
suggested, we have added the following paragraph in the Introduction section: 
“The health consequences of second-hand smoke (SHS) exposure on non-
smoker’s are well-known(1). Moreover, passive exposure could be due to 
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different settings such as workplaces, public places (bars, restaurants, etc.), public 
transport, or private places. For this reason, since the introduction of the World 
Health Organization Framework Convention on Tobacco Control (WHO FCTC), 
many countries have implemented smoke-free policies in public and workplaces 
to reduce the impact of SHS exposure in non-smoker’s health; consequently there 
has been a reduction in SHS exposure after their implementation in workplaces 
and public places(2).” 
 
 
3. What is the rationale in conducting a follow up survey 3 years post implementation of 
comprehensive smoke free law? 
This work is part of a longitudinal study, aims to assess the impact of the Spanish smoking 
bans. The follow-up was conducted 3 years after the implementation of the current 
comprehensive smoke-free legislation. This work has used exclusively the follow-up data. We 
have clarified this issue in the Methods section (please see comments from 4 to 6 of reviewer 
#2). If the editor considers appropriate to provide detailed information of the study, we will be 
ready to include it.  
  
 
4. Provide more details on the survey- administration, questionnaire, how sample was 
accessed, type of sampling procedure etc. 
As the reviewer suggests, we have added more details on the baseline survey in the Methods 
section: 
  “We used the follow-up data of a cohort study from a representative sample of 
the adult population (≥16 years) of the city of Barcelona (Catalonia, Spain). The 
objective of the cohort study was to assess the impact of the Spanish smoking 
bans on tobacco consumption and SHS exposure. The baseline study was carried 
out during the years 2004-2005 through a representative random sample of the 
adult (≥ 16 years old) non-institutionalized population of Barcelona (Spain) 
(10,11)(n = 1,245). We obtained the personal data and addresses from the 
updated official Census, as provided by the Institute of Statistics of Barcelona. We 
sent a personal letter to introduce the study; afterwards trained interviewers 
administered a face-to-face questionnaire (in Spanish or Catalan) at the 
participant’s home to gather information on socio-demographic data and active 
and passive smoking. The follow-up took place in 2013-2014.  
For this study, we exclusively used the follow-up data.” 
 
 
5. Did the original baseline survey include “<18 years”? Provide sufficient details about the 
original survey. 
The baseline study in 2004-2005 was carried out through a representative sample of the adult 
(≥ 16 years old) non-institutionalized population of Barcelona. However, we could not follow 
those under 18 years old, because they were not legally adults at that time and we did not ask 
them any consent to be re-contacted in the future. Moreover, the consent form signed by 
their parents was only for the study in 2004-05. As the reviewer suggested, we provide more 
details about the original survey as follows: 
 
“From the baseline sample, we excluded 235 subjects; 150 after checking their 
data in the Insured Central Registry of Catalonia (101 had died and 49 had 
migrated out of the province of Barcelona) and another 85 did not give consent to 
be followed up or were <18 years old in 2004-2005, because they were not legally 
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adults at that time and we did not ask to their parents any consent to be re-
contacted.” 
 
In addition, as also recommended by the reviewer #2 (please see comment 4), we have 
added more details on the baseline survey and the cohort study in the Methods section.  
 
 
6. Approximately 28% of survey participants were either loss to follow up or died or refused 
to participate. How did you address this in the statistical models? How were these different 
from those who participated in the survey? Inclusion/exclusion of these participants will 
influence the estimates. 
We thank the reviewer for the useful comment. As the reviewer points, approximately 28% of 
the survey participants were lost in the follow-up. Moreover, the final sample was skewed as 
slightly older in comparison with the general population of Barcelona. For this reason, we have 
weighted the final sample by age to assure the representativeness of the sample. We now 
explain this and the weight method in the Methods section.   
 
We agree with the reviewer about the importance of reporting the differences between the 
lost (n=509) and followed up participants (n=736). We have observed statistically significant 
differences according to age, educational level, and smoking status. We have added more 
information about the lost individuals in the Methods section as follows: 
 
 “There were statistically significant differences between the follow-up sample 
and the participant lost in the follow-up according to age, level of education, and 
smoking status. Followed-up participants overestimate the young people and 
smokers in comparison with lost participants, for this reason, the increase of 
smoke-free homes could be higher among lost participants. On the other hand, 
the final sample overestimated the older people compared with the distribution 
observed in the population of Barcelona. Therefore we used inverse probability 
weights to balance our data according to age distribution of the city of Barcelona 
to maintain its representativeness of the sample.” 
 
7. There are several other confounding variables that influence either voluntary adoption of 
smoke free laws or SHS risk perception other than age, sex and smoking status. For ex: 
occupation, employment, knowledge, access to tobacco products, tobacco industry 
advertising and promotions etc. 
We fully agree with the reviewer’s comment. Unfortunately, the survey did not include such 
detailed information, because its objective was not focused only on smoke-free rules in private 
settings. Nevertheless, the survey gathered information about employment and access to 
tobacco products. We analyzed the smoke rules at home according to these variables and we 
have only found statistically significant differences according to the employment of the 
participants. For this reason, we have decided to include only the information of the latter 
variable to make the analysis simpler to the reader.  If the editor considers better to include 
also the information about the access to tobacco products, we are ready to provide it.  
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8. Please describe how weights were determined and incorporated. 
The weights are proportional to the inverse of the probability of being included in the sample, 
i.e., a d_i weight for individual i can be interpreted broadly, as the i individual represents d_i 
individuals in the sample population. Such weights are known as inverse probability weights. 
As the reviewer suggests, we have added this information to make this clear:  
 
“Therefore we used inverse probability weights to balance our data according to 
age distribution of the city of Barcelona to maintain its representativeness of the 
sample.” 
 
 
9. It seems the authors purposefully presented results from unadjusted estimates, 
which is incorrect. You are supposed to present adjusted estimates.  Please revise the 
results section. Also there is no information on variables at baseline and follow up 
survey. 
As the reviewer suggests, we have presented the results for adjusted estimates.  
We had not provided information of the baseline survey because we have focused only in the 
follow-up data (cross-sectional study). In order to clarify the data we used, we have added 
more information about the variables at baseline and at follow-up (please, see comment from 
4 to 6 of the reviewer #2). 
10. The adjusted estimates in table 2 revealed no association between SHS risk perception 
and smoke-free laws. What might be the reason?  
We thank the reviewer for the observation. The reason of that lack of association was the 
inclusion of the variable ‘smoking status’ in the adjustment. Following the reviewer #1’s 
recommendation, we have recoded the variable ‘smoke-free homes’. Moreover, the 
regression model did not converge due to the smoking status variable. For this reason, we re-
run the models according to the new categories proposed by the reviewer 1 for the ‘smoke-
free homes’ variable and we have decided to remove the ‘smoking status’ variable of the 
adjustment, based on these results. Currently, in the new version of the analysis, the statistical 
significance of these variables is the same in the adjusted and unadjusted models.   
 
 
Reviewer: 3 
Reviewer Name: Emilia Zainal Abidin 
Institution and Country: Faculty of Medicine and Health Sciences, 
Universiti Putra Malaysia, Malaysia 
Competing Interests: None declared. 
 
Paper is well-written. The following are a few suggestions regarding the need for 
modifications of some parts of the text to further increase the readability of this paper. 
 
Thank you very much for the kind comment to our work.  
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Abstract 
1. line 23, secondhand instead of second; methods, first line consider revising sentence 
We have corrected the word in line 23 and changed the first line of the Methods section in the 
abstract as follows: 
“Cross-sectional study of a representative sample (n=731) of the adult population 
(>26 years) of Barcelona, Spain, in 2013-14.” 
 
 
2. "perceptions", suggestion: Briefly state the significant variables of risk perceptions; 
breathing tobacco smoke from smokers is harmful (PR: 1.50; 95% CI: 1.07-2.11), second-hand 
tobacco smoke is dangerous for adults (PR: 1.44; 95% CI: 1.04 - 2.00) and non-smokers (PR: 
1.65; 95% CI: 1.12 -2.44) were associated with the voluntary adoption of smoke-free home. 
As the reviewer suggests, we have stated the significant variables of risk perceptions as 
follows: 
 
“Believe that breathing tobacco smoke from smokers is dangerous for non-
smokers (PRa: 1.77; 95% CI: 1.06-2.97) is associated with the voluntary adoption 
of complete indoor smoke-free home.” 
 
 
3. line 45-48, rephrase to make sentence clearer 
We have rephrased the conclusions statement in the Abstract section as follows: 
“Risk perceptions of secondhand smoke exposure were associated with the 
voluntary adoption of indoor smoke-free homes.” 
 
 
4. Line 32-35, did the Euro-barometer consider smoking in outdoor areas at home as 
complete ban? 
The Eurobarometer uses the same question to our study regarding smoke-free homes. The 
question used in the Eurobarometer is “Which of the following situations best describe the 
smoking rules in your house?” with three possible answers: ‘Nobody can smoke’, ‘Smoking is 
allowed in some places’ and ‘Smoking is allowed everywhere’. However, the report of the 
Eurobarometer analyzes this question without differencing indoor and outdoor smoking.  We 
have clarified this in the Discussion section as follows: 
“This prevalence is higher than that obtained in the Eurobarometer(8) (44%), 
maybe because the Eurobarometer considers as complete smoke-free homes 
those households where smoking is not allowed, without distinction between 
indoor and outdoor areas.” 
 
 
Strength & limitation 
5. Suggest to revise the points regarding strength of the study. 
We have re-written the ‘Strengths and Limitations’ section (please, see the editorial requests).  
 
 
Introduction 
6. Acronym not defined; SHS and Line 7, since the introduction of... 
We have defined all acronyms.  
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7. Line 37. Reference for law missing 
As the reviewer suggests, we have added the reference for the law 
 
 
8. Line 48, consider revising 
We have modified this line, following the recommendation by the reviewer #2 (see comment 2 
of the reviewer #2). 
 
 
9. Justification for paper not included 
 
We have added the following justification before the objective of the study: 
 
“Currently, to our knowledge, there are no national descriptive studies about the 
adoption of smoke-free homes in Spain after the Spanish tobacco control 
legislations. Moreover, there is scarce evidence about the relationship between 
voluntary adoption of smoke-free homes and the risk perception of SHS exposure. 
Therefore, the objective of this study is to describe the voluntary adoption of 
smoke-free homes in Spain and to identify variables associated to its voluntary 
adoption, including risk perception towards SHS exposure.” 
 
 
Methods 
10. Page 5, Line 12, 2014, instead of 1014. Add a brief sentence explaining the method of 
baseline data collection. 
We edited the typographical error. Moreover, we have added more details on the baseline 
survey in the Methods section (see comment 4 of the reviewer #2). 
 
 
11. Line 26, add frequency in parentheses to explain percentages 
Done.  
 
 
12. Line 32, The final number of subject included in this study is 736 or 731? statement 
contradict with  next paragraph. 
In this study we have available data from 731 individuals due to missing data in the variable of 
interest. We have clarified this in the Methods section as follows: 
 
“For this analysis, we have available data from 731 out of the 736 individuals, due 
to missing data in the variable of interest.” 
 
 
13. Page 6, Line 6, 8, 11; request to standardise SHS term used 
 
As the reviewer suggests, we have standardized the SHS term across the manuscript. 
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14. Reference for FCTD is missing 
As the reviewer suggests, we have added the following reference for FCTD. 
______________________ 
New references:  
 
(12) Fagerström K. Determinants of tobacco use and renaming the FTND to the Fagerstrom Test for 
Cigarette Dependence. Nicotine Tob Res. 2012;14:75-8. 
 
 
15. Please state language used and ethical approval statement 
We have included an ethics statement in the Methods section (see editorial requests).  
Moreover, we have indicated the language of the survey (Spanish and Catalan) and the 
statistical software used.  
 
 
Results 
16. In households with partial rules, outdoor areas as balconies, patios, terraces and 
gardens, were the most commonly designated places for smoking (70.0%). ---- is there a 
reason why outdoor smoking (balconies, patios, terraces and gardens) not considered as 
complete ban? Or does this follow the Euro-barometer? 
We thank the reviewer for the interesting comment. We have re-calculated all analyses using 
the new categories “complete indoor rules” and “partial or absent indoor rules”, following the 
reviewer 1 suggestion (see comment 1 of the reviewer #1). Thus, we have finally considered 
smoking in outdoor areas of the households as complete rules. 
 
 
17. This is an important point, suggest that author include data. ---> Besides, enclosed areas 
of the home were the least designated for smoking (data not shown). 
We thank the reviewer for the comment. According to the reviewer #1, we have decided to re-
calculate all analyses using the new categories “complete indoor rules” and “partial or absent 
indoor rules” (see comment 1 of the reviewer #1). Therefore, we have removed the 
information regarding to partial smoke-free home rules across the manuscript.  
 
 
18. For table 1 and 2, suggest to add * to indicate p<0.05, or bold, or whatever is easier. 
As the reviewer suggests, we have indicated when prevalence ratio are significant, to guide the 
reader, including the following symbols: * p-value <0.05, ** p-value<0.01, *** p-value<0.001. 
If the editor considers it appropriate, we can also provide the p-values.  
 
Discussions 
19. Line 31, please state the percentages of adoption of smoke-free home adoption among 
never smokers and among those who lived with minor in these previous studies. 
We thank the reviewer for the comment. We agree with the importance to report more 
information about previous studies. However, the five articles cited reference eight countries, 
and three cities. In our opinion, it would be a lot of information to state. Moreover, not all of 
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the articles provide this information. Therefore, we have decided to include grouped 
information about Europe (UK), United States, Canada and Australia: 
“Moreover, as observed in previous studies(15-19), the adoption of smoke-free 
homes in our study was higher among never-smokers and among those who 
lived with a minor. The prevalence of adoption of smoke-free homes among 
households with non-smokers was 23.5% in UK, 39.2% in USA, 39.1% in Canada, 
and 44.3% in Australia(15). The prevalence of adoption of smoke-free home 
among households with infants and pre-primary children was 29 % and 26% in 
UK, 38.9% and 51.5% in USA, 41% and 48.8% in Canada, and 60.3% and 52.7% in 
Australia, respectively(15).” 
 
However, if the editor considers appropriate to include information of more countries and 
cities, we are able to provide it.  
 
 
20. line 34, it is suggested to discuss why the adoption of smoke-free home was higher 
among never smoker and among those who lived with minors. Additional statistical analysis 
could be performed to confirm if there are significant differences of any kind of risk 
perceptions towards SHS exposure across smoking status and the presence of minors at 
home. 
We thank the interesting comment. As the reviewer suggests, we have performed additional 
statistical analysis to confirm if non-smokers and participants who lived with minors have 
higher percentage of perception of risk. According to the new analyses, the perception of risk 
of the five questions was always higher among non-smokers and those who lived with a minor. 
For this reason, there are higher adoption of smoke-free homes among never smokers and 
among those who lived with minors. We have included the following text in the Discussion 
section: 
“Our data show that the voluntary adoption of complete indoor smoke-free home 
rules is higher among never-smokers and among people who lived with minors. 
Never smokers present statistically significant higher risk perception of SHS 
exposure than smokers and former smokers (data not shown). This could be one 
reason why complete indoor smoke-free home rules are higher among never 
smokers. However, we found similar prevalence of SHS risk perception among 
people who lived with and without minors (data not shown). On the other hand, 
people who had some kind of risk perception of SHS exposure showed higher 
adoption of complete smoke-free homes rules. Similar results were obtained in a 
study in Italy about the support for tobacco regulation and consumption in private 
vehicles in the presence of minors(21).” 
 
21. Line 29, 33 page 12 tobacco passive exposure, consider revising 
As the reviewer suggests, we have changed this sentence as follows: 
“These results highlight the need to increase awareness of the health risks of SHS 
in private settings, especially among smokers.” 
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22. Are there any link between the findings and the effectiveness of the last smoke-free 
legislation in Spain (Law 42/2010)? Please identify and add relevant information if any and 
references to further strengthen the discussions. 
Even though the data analyzed were gathered after the last national smoking ban, it is not 
possible to determine any link between our findings and the effectiveness of the legislation, 
due to the cross-sectional nature of the study. The objective of this study is to update the 
descriptive information on the voluntary adoption of smoke-free homes in Spain according to 
sociodemographic variables and to the perception of risk of SHS exposure. 
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Letter of acceptance of BMJ Open journal  
 
 
-----Mensaje original----- 
De: onbehalfof+info.bmjopen+bmj.com@manuscriptcentral.com [mailto:onbehalfof+info.bmjopen+bm
j.com@manuscriptcentral.com] 
Enviado el: viernes, 02 de diciembre de 2016 12:09 
Para: jmmartinez@uic.es 
CC: clidon@uic.es; jmmartinez@uic.es; mfu@iconcologia.net; mballbe@iconcologia.net; jcmartin@u
ic.es; cmartinez@iconcologia.net; efernandez@iconcologia.net 
Asunto: BMJ Open - Decision on Manuscript ID bmjopen-2016-014207.R1 
 
02-Dec-2016 
 
Dear Dr. Martínez-Sánchez: 
 
It is a pleasure to inform you that your manuscript "Secondhand smoke risk perception and smoke-
free rules in homes: A cross-sectional study in Barcelona (Spain)" has been accepted for publication 
in BMJ Open. 
 
**Please see the editorial comments towards the end of this letter.** 
 
To enable all research published in BMJ Open to be fully open access, an article-processing charge 
is levied. This charge supports the peer review process, production costs (typesetting, copy editing, 
etc.), and the costs of maintaining the content online and marketing it to readers. 
 
Therefore, your payment of £1350 (excluding VAT) for manuscript bmjopen-2016-014207.R1 is now 
due. 
 
A separate e-mail will follow shortly with a link to payment options (please check your spam if this 
has not arrived). 
 
You can choose to pay by card or invoice, using our secure 3rd party online system.. 
 
BMJ has partnered with the Copyright Clearance Center to offer a payment method via their 
RightsLink system. If payment is due, you will receive a separate email from Copyright Clearance 
Centre with instructions on how to pay. Your article will not be processed further until payment is 
completed. 
 
If you have reviewed for the journal within the 12 months prior to submitting this paper, please 
contact the editorial office (info.bmjopen@bmj.com) about your discount. Information regarding 
waivers and discounts is included in our instructions for authors; however, we anticipate that most 
authors will have the resources to pay. 
 
Please note, a number of institutions have taken out Open Access Memberships with BMJ, which 
either covers the cost of open access publishing for authors at participating institutes, or allows 
authors to receive a discount on the article-processing charge. Please visit our open access page to 
see a full list of participating institutions, find out if you are eligible and how to obtain your discount 
code - http://journals.bmj.com/site/authors/openaccess.xhtml#open-access-institutional-
memberships. 
 
All accepted papers are reviewed for their media potential by our PR office within two weeks of 
acceptance. If your paper is selected for press release by the journal, we will let you know within this 
timeframe. 
 
Once your article is published online you will be able to keep track of usage. Each article published in 
BMJ Open has individual usage statistics which are updated daily and can be accessed from the 
Article Usage Statistics link in the Services section of the right hand column on each page of the 
article. In this column you can also sign up to be alerted about any e-letter responses to your article. 
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Thank you for your contribution, and we hope that you will continue to submit to the journal in future. 
 
Sincerely, 
 
Dr Edward Sucksmith 
BMJ Open Managing Editor 
esucksmith@bmj.com 
 
 
**Editorial Comments: 
 
When you receive the author proofs, please revise the second bullet point of the strengths and 
limitations section (page 3) to: "In this study we used a face-to-face questionnaire with trained 
interviewers that potentially increased the internal validity of our results as compared with internet 
and self-administered surveys." 
 
Please also remember to carefully check the rest of the manuscript for typographical/ grammatical 
errors. 
 
 
Reviewer Comments to Authors: 
 
Reviewer: 2 
Reviewer Name: S Phani Veeranki 
Institution and Country: Preventive Medicine and Community Health, University of Texas Medical 
Branch, USA Competing Interests: None declared 
 
I believe the authors have adequately addressed the queries. I have no further comments. I look 
forward to reading the paper in print. 
 
Reviewer: 3 
Reviewer Name: Emilia Zainal Abidin 
Institution and Country: Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Malaysia 
Competing Interests: None declared 
 
---------------------- 
We are constantly trying to find ways of improving our peer review system and continually monitor 
processes and methods by including article submissions and reviewers’ reports in our research. If 
you do not wish your paper or review entered into a our peer review research programme, please let 
us know by emailing The BMJ's editorial office papersadmin@bmj.com as soon as possible. 
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VI. Correspondence of the thesis article: 
Correlation between tobacco control 
policies, consumption of rolled tobacco and 
e-cigarettes, and intention to quit 
conventional tobacco, in Europe 
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Cover letter to the editor of Tobacco Control 
 
 
 
Barcelona, May 25th, 2015. 
 
 
 
Prof. Ruth Malone 
Editor 
Tobacco Control 
 
Dear Prof. Malone, 
Please find enclosed our manuscript “Correlation between tobacco control policies and 
consumption of rolling tobacco, electronic cigarette users, and intent to quit conventional 
tobacco in Europe” for your consideration in Tobacco Control as a Research Paper. 
The level of smoke-free legislation among European countries is correlated with a decrease 
of prevalence of smoking of conventional cigarettes and an increase of intent to quit 
smoking. However, our study show there is positive correlation between the different levels 
of tobacco control policies implemented among European countries and the consumption 
of other tobacco products among former smokers of conventional cigarettes, particularly 
hand-rolled tobacco. Moreover, there is an indirect, but not statistically significant, 
correlation between the prevalence the prevalence of ever e-cigarette users and the levels 
of tobacco control policies implemented in Europe.  
All the authors carefully read the manuscript and fully approve of it. In their name I also 
declare that the manuscript is original and it is not submitted anywhere other than your 
journal. The authors declare there are no conflicts of interest.  
We would of course be ready to provide further information about our data and methods 
you desire. Correspondence about the manuscript should be addressed to me as indicated 
in the first page of the manuscript. 
Thank you very much for your kind attention. 
Yours sincerely, 
 
Jose M Martínez-Sánchez, PhD, MPH, BSc 
E-mail: jmmartinez@iconcologia.net  
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Editor's response and comments from the Tobacco Control reviewers 
 
-----Mensaje original----- 
De: onbehalfof+tobaccocontrol+bmj.com@manuscriptcentral.com [mailto:onbehalfof+tobaccocontrol
+bmj.com@manuscriptcentral.com] En nombre de tobaccocontrol@bmj.com 
Enviado el: miércoles, 05 de agosto de 2015 9:21 
Para: jmmartinez@iconcologia.net 
CC: clidon@uic.es; jcmartin@uic.es; patrickuic@uic.es; jan.graffelman@upc.edu; jmmartinez@iconc
ologia.net 
Asunto: Tobacco Control - Decision on Manuscript ID tobaccocontrol-2015-052482 
 
05-Aug-2015 
 
Dear Dr. Martínez-Sánchez: 
 
Thank you for submitting your manuscript ID tobaccocontrol-2015-052482 entitled "Correlation 
between tobacco control policies and consumption of rolling tobacco, electronic cigarette users, and 
intent to quit conventional tobacco in Europe". Please accept my apologies for the delay in 
responding to this submission. It has taken longer than we would have liked to receive reviews on 
this, but I'm pleased to let you know we have now done so and are able to make a decision on this. 
 
The editorial team would like to invite you to revise and resubmit this manuscript as a brief report 
(http://tobaccocontrol.bmj.com/site/about/guidelines.xhtml#brief) of not more than 1,500 words with a 
single table. 
 
In making these revisions, we feel it would be helpful to reference the previously published analysis 
(Martínez-Sánchez  et al (2010) Smoking behaviour, involuntary smoking, attitudes towards smoke-
free legislations, and tobacco control activities in the European Union. PLoS One doi: 
10.1371/journal.pone.0013881) and to clarify how the objectives of this study differ from those of the 
previous analysis. 
 
We will be happy to reconsider this manuscript after revision, providing you have responded to the 
comment above and those of the referees (see below). 
 
Please note, by offering to reconsider a revised paper, we are making no commitment to publish a 
revised version. 
 
Important: Please CUT AND PASTE THE REVIEW COMMENTS BELOW INTO A SEPARATE 
DOCUMENT. With spaces between each comment and your response, provide a specific reply to 
each reviewer comment, making it clear whether or not you have incorporated the changes as 
suggested and indicating where the relevant changes are now found in the text. If you elect not to 
follow reviewers' suggestions or respond to particular criticisms, please provide a response in each 
case so that the editors might consider your reasoning. 
 
Tobacco Control is published six times per year, and because of the inherent delay in publication 
with this schedule, we are concerned to avoid overly lengthy periods between notifying authors that a 
paper needs revision and receipt of the revised version. 
 
If you DO intend to resubmit a revised version, please inform us of the likely submission date. 
 
If we do not hear from you within 4 weeks, we will assume that you do not intend to resubmit and will 
withdraw your paper. If you need to request an extension of this deadline, please contact us as soon 
as possible. 
 
To revise your manuscript, log into https://mc.manuscriptcentral.com/tobaccocontrol and enter your 
Author Center, where you will find your manuscript title listed under "Manuscripts with 
Decisions."  Under "Actions," click on "Create a Revision."  Your manuscript number has been 
appended to denote a revision. 
 
Please check that all author names are correctly entered as this will be the name displayed in any 
PubMed search. 
 
You may also click the below link to start the revision process (or continue the process if you have 
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already started your revision) for your manuscript. If you use the below link you will not be required to 
login to ScholarOne Manuscripts. 
 
https://mc.manuscriptcentral.com/tobaccocontrol?URL_MASK=f44d1af2242f4271ac07129daa39208f 
 
 
You will be unable to make your revisions on the originally submitted version of the 
manuscript.  Instead, revise your manuscript using a word processing program and save it on your 
computer.  Please also highlight the changes to your manuscript within the document by using the 
track changes mode in MS Word or by using bold or colored text. 
 
Once the revised manuscript is prepared, you can upload it and submit it through your Author Center. 
 
When submitting your revised manuscript, you will be able to respond to the comments made by the 
reviewer(s) in the space provided.  You can use this space to document any changes you make to 
the original manuscript.  In order to expedite the processing of the revised manuscript, please be as 
specific as possible in your response to the reviewer(s). 
 
You will receive a proof if your article is accepted, but you will be unable to make substantial changes 
to your manuscript, please take this opportunity to check the revised submission carefully. 
 
IMPORTANT:  Your original files are available to you when you upload your revised 
manuscript.  Please delete any redundant files before completing the submission. 
 
Because we are trying to facilitate timely publication of manuscripts submitted to Tobacco Control, 
your revised manuscript should be submitted before 04-Oct-2015. Your option to submit a revision 
expires on that date. If it is not possible for you to submit your revision by this date, we may have to 
consider your paper as a new submission. 
 
We also ask that in addition to the revised paper you provide a point by point response to the 
reviewer comments, and upload a marked copy of your paper highlighting the changes you have 
made - preferably 'tracked changes' if using Microsoft word. Please upload this as a supplemental file 
and label it 'Marked Copy' (your paper will not be able to be processed without this). 
 
All material submitted is assumed to be submitted exclusively to the journal unless the contrary is 
stated. Submissions may be returned to the author for amendment if presented in the incorrect 
format. 
 
Please note that only the article text (from first word of main text to the last word in reference list) will 
be used to typeset your article. 
 
All other data (known as the metadata), such as article title, author names and addresses, abstract, 
funding (etc) statements will be taken from the fields you have filled in at submission, so you must 
ensure that these are up to date and accurate. 
 
I hope you will find the comments useful. 
 
Respectfully, 
 
Dr Sarah Hill PhD MBChB 
Senior Lecturer, Global Public Health Unit Social Policy, School of Social & Political Science 
University of Edinburgh 15a George Square Edinburgh UK EH8 9LD Telephone +44 (0)131 650 
3884 s.e.hill@ed.ac.uk, Tobacco Control tobaccocontrol@bmj.com 
 
 
Reviewer(s)' Comments to Author: 
 
Reviewer: 1 
 
Comments to the Author 
The present manuscript shows the results of an ecological study aimed at analyzing the correlation 
between the implementation of tobacco control policies (measured through the Tobacco Control 
Scale) and smoking habits, including consumption of cigarettes and other tobacco products, intention 
to quit smoking and exposure to second-hand smoke, in 27 EU countries. Authors should consider 
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the following points: 
 
1)      Authors identify current smokers with intention to quit smoking through the question: “Have you 
ever tried to quit smoking?”. However, this question identifies previous quit attempts and not intention 
to quit. Thus, authors should use the appropriate question to give the prevalence of current smokers 
with intention to quit (if available in the Eurobarometer survey). Otherwise, authors should change 
the interpretation of results and conclusions to correctly interpret the correlation between TCS and 
quit attempts. 
 
2)      The description of other variables derived from the Eurobarometer survey is not clear (Methods 
section).For example: 
a.      the first question investigates cigarette consumption: “regarding smoking cigarettes, cigars or 
pipe, which of the following applies to you?”. Which were the possible answers to this question? Was 
this a single or a multiple choice answer? Cigarette users were defined as ever or current smokers? 
b.      Regarding the second question, in the methods section authors report that the use of other 
tobacco products was “differentiated between smokers and non-smokers”, while in table 1 users of 
other tobacco products appeared to be categorized in smokers and former smokers. Which was the 
correct categorization? 
c.      Was the use of water pipe, snus and e-cigarettes investigated only among cigarette smoking or 
also in never smokers? 
These points must be clarified and fixed in order to allow the reader to understand which measures 
were correlated with the TCS. 
 
3)      Besides analyzing the correlation between the use of different tobacco products (and other 
smoking-related variables) and overall TCS, authors also consider correlations with the 6 specific 
components of the TCS. However, these findings are not reported in tables or in the results sections. 
Since the manuscript includes only one table, I suggest author to add a table providing the 
correlations with each single component of the TCS, describing corresponding main results. This 
would put in evidence which are the strategies highly correlated with the various tobacco variables, 
and would also allow authors to show whether the price-component is more or less related to the use 
of cheaper tobacco products. 
 
4)      Authors analyze the correlation between TCS and the use of other tobacco products also 
among former smokers. However, among former smokers, a huge proportion of individuals likely 
quitted smoking several years before the implementation of specific control tobacco policies. 
Therefore, the fact that they smoked hand-rolled cigarettes or cigars or pipe may have been a choice 
rather than a consequence of, for example, the increase in conventional cigarettes price. Since it is 
not possible to restrict this analysis to former smokers who quitted smoking after the implementation 
of a tobacco control measure, I strongly suggest author to delete all the analyses on former smokers 
from the present paper. 
 
5)      In the Discussion section, authors state that “the two years gap of time between the measure of 
TCS and the Eurobarometer survey allows seeing the effect of the application of the tobacco policies 
in different countries”. I suggest to delete this from the strengths of the study. Otherwise authors 
should add to the limitations of their study that their choice did not allow them to detect the effect of 
measures adopted over the last two years (between 2010 and 2012). 
 
6)      Authors should cite in the Introduction or in the Discussion section two similar papers on this 
issue (Ferketich et al., 2014 Tob Control, PMID: 25335901; Martinez-Sanchez et al., 2010 PLoS 
One, PMID: 21079729). 
 
7)      The English language in the manuscript needs to be revised. A native English speaker with 
editorial experience should read the manuscript and make appropriate changes. 
 
8)      In table 1 the heading of the second column is wrong: please, substitute TCS with rsp. 
 
Reviewer: 2 
 
Comments to the Author 
This is a well written manuscript of intermediate interest/priority. 
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Response to the Tobacco Control reviewer’s comments 
 
 
Tobaccocontrol-2012-050877 
Do smoke-free policies in work and public places 
increase smoking in private venues? 
 
 
Response to the Reviewers’ comments 
 
 
We thank the editor and the reviewers’ comments for the useful comments.  
 
Reviewer #1 
 
This is an important topic and the regional size of the study (Europe) is great. However, I 
believe the conclusion of the paper is not reflective of what the study measured. As I read the 
paper, the variable used was strength of tobacco control (tobacco control score) and not 
passage of smoking bans. In addition, the data on smoking behavior is taken at one time so 
it is impossible to know if changes in work and public place bans lead to increases in private 
venues.  
 
We agree with the reviewer that TCS covers more than smoking bans –it is a scale including 
several components of tobacco control. We had already explained this in the “Tobacco control 
policies” section of the Methods. Moreover, the TCS also includes the level of implementation 
of smoke-free bans at work and public places (score between 0 and 22). Then, we focused 
mainly in this policy because this is the most relevant one to answer the debate raised about 
whether banning smoking in public places can move tobacco consumption to private settings. 
 
According to this comment we have included the following sentence in the results of the 
abstract: 
 
“A similar lack of association was observed between the TCS score of 
specific bans at work and in public places and smoking rules inside 
houses and cars.” 
 
The objective of our study was not to measure changes in smoking behavior. We aimed to 
evaluate the correlation between the level of tobacco control (as measured by the TCS) and 
prevalence of smoking behavior in private venues after the policies were implemented. We 
also tried to measure any possible correlation between level of smoke-free bans and tobacco 
consumption in private settings. Consequently, the ecological design of our study allowed us to 
analyze this correlation.  
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Instead, the study showed that in those countries with strong tobacco control, non-smoking 
behaviors extended to private locations. Problem is that in countries with weaker overall 
tobacco control - did these same benefits not transfer or perhaps was there increasing 
private exposure in those countries. You still a valuable brief but the overall claim of what 
the data shows could be sharpened.  
 
Our results showed there is no correlation between TCS, smoke-free bans, and smoking in 
private venues. If the restriction of smoking in public places would displace tobacco 
consumption to private venues, as the tobacco industry and the hospitality sector argued, this 
correlation would have been positive. Moreover, our data also showed a positive correlation, 
although statistically non significant, between TCS and the prevalence of smoke-free houses.  
 
We have included the following sentence in the discussion to clarify our results: 
 
“If the hypothesis argued by the tobacco industry and hospitality sector 
were true this relationship would have been positive.” 
 
 
Reviewer #2 
 
1. Page 2 line 48. Conclusion of abstract. 'and thus is not increasing the prevalence of second-
hand smoke exposure...' The data do not tell us anything about the intensity of exposure - it 
is entirely possible that in those houses and cars where people continue to smoke that they 
are now smoking more (due to their inability to smoke in public spaces). So while the 
prevalence is not increasing, those smokers who continue could, possibly be smoking more. 
 
We agree with the reviewer’s comment. We deleted this sentence in the conclusion of the 
abstract.  
 
2. Page 3 Line 32. it would be useful to mention the Akhtar study in the introduction. This 
study showed no evidence of displacement of smoking activity to homes after the 
introduction of smoke-free legislation in Scotland in 2006. 
 
We included in the Introduction a sentence on the Akhtar and other studies, providing the 
relevant reference: 
 
“To our knowledge, only one study,9 conducted in US, supports this 
hypothesis, whilst other studies show no displacement of smoking 
prevalence to home after the implementation of smoking ban. 2;10;11” 
 
3. Page 3 line 39. Again in the study objective I would recommend making it clear that it is to 
look at smoking prevalence in private venues. 
 
We have changed the sentence according to the suggestion of the reviewer.  
 
4. Page 4. Line 41 and 53. 'Tobacco consumption'. The data do not provide information aout 
consumption (i.e. there is no consideration of volume or frequency of smoking) and so I 
would recommend calling these two variables 'Tobacco use inside the house/car'. 
 
Done. 
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5. Page 5. Line 29. Typo '...indicating full implementation...' 
 
Done. 
 
6. Results. I think it would be useful to give a table with data including the TCS scores and 
public ban scores for each country. 
 
We agree with the reviewer on the utility of such a table. However, we do not have the 
possibility to include it; given the rules of the journal for brief reports (only one table is 
allowed). This information, moreover, is available in the TCS report (references 12 and 13, 
which can be accessed on the internet). 
 
7. Page 6. Line 53. The first sentence of the discussion again makes the mistake of saying 
that there is no relationship between smoke-free laws and exposure to SHS in private venues. 
What it should say is prevalence - we have no data on intensity of exposure among those 
who continue to be exposed. 
 
We changed it. 
 
8. Page 7/8. the discussion acknowledges the weakness of an ecological study. It may be 
useful here to explicitly acknowledge that at an individual level those who continue to be 
exposed may be exposed more often. 
 
We agree with the reviewer’s comment and we have included this limitation in the discussion 
section as follows: 
 
“We have no information about the intensity of SHS exposure19 at the 
individual level in the house where smoking continues to be allowed.” 
 
 
9. Page 8. Line 13. Wrong use of the word 'exposure' again: suggest correct with 'the 
prevalence of exposure' 
 
Done. 
 
10. The authors may wish to consider that this evidence may suggest that TC policies have 
little effect on private space prevalence of exposure and so have little effect on the de-
normalisation of smoking. Some consideration of why Finland has 95% smoke-free homes 
(and yet only a 58 point TCS score) may be useful. 
 
 
We agree with the reviewer’s comment. It is true that there is a sort of paradox with the 
Finnish data: high prevalence of smoke-free homes (and cars) whilst a “relatively” low TCS 
score (Finland ranks sixth among the 27 EU states). Perhaps there are other non-controlled 
factors, in addition to our primary focus – the TCS. Actually, Finland stands in the 4th stage 
(final stage) of the Lopez’s tobacco epidemic model, and has a relatively low smoking 
prevalence (and the country). This is also related to the prevalence of smoke-free homes. 
As suggested by the reviewer we have included a comment on this point: 
“Another potential limitation derives of the lack of information about 
the stage of the tobacco epidemic among different countries21. 
Countries at late stages have low prevalence of smokers and hence the 
likelihood of smoke-free homes is higher, even in the absence of strong 
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tobacco control policies. Data from Finland and Sweden illustrate this 
possible paradox.”  
 
Reviewer: 3 
 
• In terms of background information, it would be very useful to document any changes in 
country-level policies between 2007 and 2009 (your data collection points). 
 
We compared the TCS of 2007 and 2010 to document potential changes in the policy on 
smoking restriction in our period of data-collection. We did not find substantial changes 
(average of +2 points in the score) during this period. As suggested by the reviewer, we 
included a sentence in the discussion section to address this topic:  
 
“Moreover, the score of the policy on smoking bans in public and work 
places of the TCS in the period of our study, between 2007 and 2010, did 
not show appreciable changes: the score increased in 14 countries, did 
not change in 9 countries, and decreased in 5 countries. 22” 
 
• I would suggest that public place bans do not just protect non-smokers from SHS but also 
smokers. 
 
We agree with the reviewer’s comment as explained in the second sentence in the first 
paragraph of the introduction section. Moreover, we specified the protection of SHS among 
smokers as follows:  
 
“The implementation of comprehensive smoke-free policies decreases 
SHS exposure and associated health hazards for non-smokers and 
smokers as well” 
   
 
• You mention “exposure” in both your introduction and discussion section and suggest that 
your findings can inform us about exposure to SHS, however I do not believe that you can, at 
the end of the day, the questions from the Eurobarometer survey do not address exposure to 
SHS but just places where smoking is permitted. I might smoke only in the living room but if 
that is where everyone is sitting then they will be exposured more to SHS than me smoking 
only in the kitchen and bedroom that are not used as much.  Thus you cannot claim in any 
way that you are contributing to understand the influence of policy on SHS exposure.  You 
can only see if there is or isn’t an association between tobacco control policy and extent to 
which smoking is restricted in shared private places such as homes and cars.  This is less of 
interest to researchers in the field. 
 
We agree with the reviewer’s comment, as also pointed out by reviewer #2 (see comment #3). 
We have changed “exposure to SHS” by “prevalence of smoking” in the whole manuscript. 
Moreover, as the example cited by the reviewer illustrates, we have no information about the 
intensity of exposure from the Eurobarometer (see also comment #8, reviewer #2).  
 
 
• It makes less sense to me to look at the overall tobacco control score, you don’t make a 
clear case in your introduction, why you would expect total amount of tobacco control to 
influence where smoking is permitted.  I think that these two variables are so distal and it 
would be unlikely to find any effect even if a case was made. 
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All the initiatives for tobacco control, particularly smoke-free bans, have generated intense 
debate in the media among different actors according with their own interests (i.e.: the 
tobacco industry and hospitality representatives argued that this policy can move tobacco 
consumption from public to private places). Countries with high level of tobacco control have 
banned tobacco advertising and launched more frequently media campaigns (TV, radio, 
newspapers, etc.) about the adverse effects of exposure to SHS on non-smokers health. This 
information could partially explain the increased support to smoke-free bans and 
denormalisation of smoking (Fong et al. Tob Control 2006; Fichtenberg  et al. BMJ. 2002; 
Martinez-Sanchez et al. PLoS ONE. 2010; Willemsen et al. BMC Public Health. 2012). The 
increased support to smoking bans and the denormalisation of tobacco consumption could 
influence in the voluntary extension of smoke-free regulation to private venues. 
 
We have included the following sentence in the introduction section: 
 
“Moreover, the increase of the overall tobacco control measures may improve 
the support to smoking bans in public venues and to the denormalisation of 
tobacco consumption
4;5;7;8
 ; this could help the adoption of  voluntary smoke-
free homes and cars.” 
 
 
• Finally in terms of the prior results mentioned in your discussion, I would not say that your 
results are consistent as you didn’t find any effects and furthermore the studies discussed 
focus on more specific relationships and thus it is hard to compare your research with the 
prior research that you discuss. 
 
According to the reviewer comment, we have modified the sentence:  
 
“The results from this ecological analysis are in the line with those of 
other studies carried out with data at the individual level before and 
after national smoke-free bans at workplaces and in public places.” 
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Letter of acceptance of Tobacco Control journal  
 
 
 
-----Mensaje original----- 
De: onbehalfof+tobaccocontrol+bmj.com@manuscriptcentral.com [mailto:onbehalfof+tobaccocontrol
+bmj.com@manuscriptcentral.com] En nombre de tobaccocontrol@bmj.com 
Enviado el: miércoles, 06 de enero de 2016 9:32 
Para: jmmartinez@iconcologia.net 
CC: clidon@uic.es; jcmartin@uic.es; patrickuic@uic.es; jan.graffelman@upc.edu; jmmartinez@iconc
ologia.net 
Asunto: Tobacco Control - Decision on Manuscript ID tobaccocontrol-2015-052482.R1 
 
06-Jan-2016 
 
Dear Dr. Martínez-Sánchez: 
 
Manuscript ID tobaccocontrol-2015-052482.R1 entitled "Correlation between tobacco control policies 
and consumption of rolling tobacco, electronic cigarette users, and intent to quit conventional tobacco 
in Europe" which you submitted to Tobacco Control, has been reviewed. 
 
After considering your manuscript, we would be pleased to accept it for publication, providing you 
attend to the following minor changes: 
 
1. The title of the paper is slightly confusing (and doesn’t clearly map onto the study aim). Suggest 
revising this to: ‘Correlation between tobacco control policies, consumption of non-conventional 
tobacco and nicotine products, and intention to quit conventional tobacco in Europe’ OR ‘Correlation 
between tobacco control policies, consumption of rolled tobacco and e-cigarettes, and intention to 
quit conventional tobacco in Europe’ 
2. The abstract and text refer to use of non-conventional tobacco products among ‘former smokers’ – 
but these aren’t former smokers if they are still using smoked tobacco. Suggest replacing ‘former 
smokers’ with 'former cigarette smokers’ in all relevant places. 
3. The inclusion of the word ‘previous’ in your stated objective is somewhat confusing (presumably 
you were aiming to examine the correlation of TCS with actual intention to quit, though of course 
you’re limited to the specific measure included in the Eurobarometer survey – ie intention to quit in 
the last 12 months). I suggest you remove the word ‘previous’ from this sentence. 
 
 
To revise your manuscript, log into https://mc.manuscriptcentral.com/tobaccocontrol and enter your 
Author Center, where you will find your manuscript title listed under "Manuscripts with 
Decisions."  Under "Actions," click on "Create a Revision."  Your manuscript number has been 
appended to denote a revision. 
 
You may also click the below link to start the revision process (or continue the process if you have 
already started your revision) for your manuscript. If you use the below link you will not be required to 
login to ScholarOne Manuscripts. 
 
https://mc.manuscriptcentral.com/tobaccocontrol?URL_MASK=69dd8d4c755b41d5ad077aa250ef3c
a4 
 
 
You will be unable to make your revisions on the originally submitted version of the 
manuscript.  Instead, revise your manuscript using a word processing program and save it on your 
computer.  Please also highlight the changes to your manuscript within the document by using the 
track changes mode in MS Word or by using bold or colored text. 
 
Once the revised manuscript is prepared, you can upload it and submit it through your Author Center. 
 
When submitting your revised manuscript, you will be able to respond to the comments made by the 
reviewer(s) in the space provided.  You can use this space to document any changes you make to 
the original manuscript.  In order to expedite the processing of the revised manuscript, please be as 
specific as possible in your response to the reviewer(s). 
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IMPORTANT:  Your original files are available to you when you upload your revised 
manuscript.  Please delete any redundant files before completing the submission. 
 
Because we are trying to facilitate timely publication of manuscripts submitted to Tobacco Control, 
your revised manuscript should be submitted by 05-Feb-2016.  If it is not possible for you to submit 
your revision by this date, we may have to consider your paper as a new submission. 
 
We also ask that in addition to the revised paper you provide a point by point response to the 
reviewer comments, and upload a marked copy of your paper highlighting the changes you have 
made - preferably 'tracked changes' if using Microsoft word. Please upload this as a supplemental file 
and label it 'Marked Copy' (your paper will not be able to be processed without this). 
 
All material submitted is assumed to be submitted exclusively to the journal unless the contrary is 
stated. Submissions may be returned to the author for amendment if presented in the incorrect 
format. 
 
Please note that only the article text (from first word of main text to the last word in reference list) will 
be used to typeset your article. 
 
All other data (known as the metadata), such as article title, author names and addresses, abstract, 
funding (etc) statements will be taken from the fields you have filled in at submission, so you must 
ensure that these are up to date and accurate. 
 
I hope you will find the comments useful. 
 
Respectfully, 
 
 
Dr Sarah Hill PhD MBChB 
Senior Lecturer, Global Public Health Unit Social Policy, School of Social & Political Science 
University of Edinburgh 15a George Square Edinburgh UK EH8 9LD Telephone +44 (0)131 650 
3884 s.e.hill@ed.ac.uk, Tobacco Control tobaccocontrol@bmj.com 
